CN1989244A - Inhibitors of tgf-r signaling for treatment of cns disorders - Google Patents

Inhibitors of tgf-r signaling for treatment of cns disorders Download PDF

Info

Publication number
CN1989244A
CN1989244A CNA2005800098901A CN200580009890A CN1989244A CN 1989244 A CN1989244 A CN 1989244A CN A2005800098901 A CNA2005800098901 A CN A2005800098901A CN 200580009890 A CN200580009890 A CN 200580009890A CN 1989244 A CN1989244 A CN 1989244A
Authority
CN
China
Prior art keywords
seq
tgf
disease
oligonucleotide
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2005800098901A
Other languages
Chinese (zh)
Other versions
CN1989244B (en
Inventor
巫利希·柏格丹
路德威·艾格纳
法兰克·彼得·华什斯
贝亚特·温纳
尤尔根·温克勒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lu Dewei
You Li
Original Assignee
REGENION GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by REGENION GmbH filed Critical REGENION GmbH
Publication of CN1989244A publication Critical patent/CN1989244A/en
Application granted granted Critical
Publication of CN1989244B publication Critical patent/CN1989244B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/11Antisense

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Physical Education & Sports Medicine (AREA)

Abstract

The present invention relates to the use of oligonucleotides for the preparation of a pharmaceutical composition for the prevention or treatment of a disease, wherein neurogenesis and/or neuroregeneration has a beneficial effect, in particular a disease like Morbus Alzheimer, Morbus Parkinson, Lewy Body Dementia,-Amyotrophic Lateral Sclerosis, Spinocerebellar Atrophies, Creutzfeldt Jakob Disease, Frontemporal Dementia, Morbus Pick, AIDS Dementia Complex, Vascular Dementia, Progressive Supranuclear Palsy, Corticobasal Degeneration, Multisystem-Atrophy, Hallervorden Spatz Disease, Huntington's disease, Stroke, Traumatic Brain and spinal cord Injury, Retinitis Pigmentosa, Macular Degeneration, Glaucoma, Cochlea Degeneration, Depression, Schizophrenia, Multiple Sclerosis, and developmental neurodegeneration.

Description

The TGF-R signal that is used for the treatment of the CNS illness transmits inhibitor
Technical field
The present invention relates to oligonucleotide and be used to prepare that prevention or treatment are wherein neural takes place and/or neurotization has the purposes of medical composition of the disease of beneficial effect, described disease is neurodegenerative disease especially, as Alzheimer's disease (Alzheimer ' s disease), Parkinson's disease (Parkinson ' sdisease) (comprise multiple system atrophy (Multisystem Atrophy)), ophthalmic nerve nuclear paralysis disease on the carrying out property, cortex basal nuclei degeneration disease, dementia with Lewy body disease, amyotrophic lateral sclerosis (Amyotrophic Lateral Sclerosis) and other motor neuron diseases, Huntington's disease (Huntington ' s disease), spinocerebellum atrophy (SpinocerebellarAtrophy, SCA), storehouse Jia Shi disease (Creutzfeldt Jakob disease, CJD) and other serious prion diseases, Frontemporal Dementia (Frontemporal Dementia) (comprising Pick's disease), aids dementia complex, HallervordenSpatz Disease (Haliervorden Spatz disease), Huntington's disease, cerebrovascular disease (as vascular dementia), apoplexy, traumatic cerebral and Spinal injury, retinitis pigmentosa, macular degeneration, glaucoma, dysthymia disorders and schizophrenia and expansionary illness (for example Down's syndrome (Down ' s syndrome)).
Background technology
Many serious nerve degeneration illnesss have the serious social economic influence to modern society, for example as following each sick illness: Alzheimer's disease, follow dull-witted expansionary illness (for example Down's syndrome), Parkinson's disease, dementia with Lewy body disease, Frontemporal Dementia, Pick's disease, amyotrophic lateral sclerosis, the spinocerebellum atrophy, storehouse Jia Shi disease, aids dementia complex, vascular dementia, ophthalmic nerve nuclear paralysis disease on the carrying out property, cortex basal nuclei degeneration disease, multiple system atrophy, Huntington's disease, apoplexy, traumatic brain injury, retinitis pigmentosa, macular degeneration, glaucoma, dysthymia disorders, schizophrenia and multiple sclerosis.Common pathology physiology cause is found in heredity, give birth to the back or acquired defective in, it causes the gathering of cell debris to form or accumulation usually, finally causes carrying out sexual disorder, and causes neuronal cell at last or spongiocyte is dead and structure is disintegrated.Staticly around microgliacyte and the blood vessel hugely have a liking for cell, attempt scavenger cell and fragment of tissue through attracting and activation.This may take place in extremely short time span, as in the Jia Shi disease of storehouse, perhaps goes through and takes place decades, as in Parkinson's disease or multiple sclerosis.Activated microgliacyte/huge is had a liking for cell colony and discharge a large amount of inflammatory cytokines in extracellular matrix, thereby it is drained in Venule or the CSF space.Unfortunately, the nerve that can have advantageous effect (and no matter which kind of its individual specificity's pathophysiological mechanism is) to the clinical onset course of disease of above-mentioned disease takes place and neurotization is subjected to unknown so far machine-processed the inhibition.Therefore, the technical problem that the present invention is basic be to provide by disturb neural take place and the inhibition of neurotization to be suitable for treating or the prevent nerve degeneration illness or to be the means of the symptom relevant at least with described illness.
Summary of the invention
The embodiment that the solution of described technical problem characterizes by providing in claims is achieved.Known TGF-'beta ' family albumen, be that TGF-β 1, TGF-β 2 and TGF-β 3 and specific cell surface receptor TGF RI thereof, TGF RII, TGF RIII play a role at some critical aspects of embryo, and mainly be that development at mesenchymal cell/neural top layer (neuroektodermal) organ plays a role.This makes embryonic stem cell be divided into the neurone precursor cell, and has neuroprotective for injured mature neuron.Further known its differentiation has keying action to hemopoietic stem cell, thereby control propagation and differentiation.At the experimental session that the present invention carried out, find TGF-R, be that TGF R1 and TGF RII relate to the key factor in suppressing neural generation and neurotization, and therefore can disturb this bioactive compound of TGF R or TGF RII to can be used for treatment/prevention nerve degeneration illness and/or neural inflammatory conditions.
The experimental result that the present invention carried out is summarized as follows:
1., identify the physiological regulating control circulation that causes effective CNS regeneration level by precursor cell/stem cell although individual component is known (TGF-β, TGF-RII, celiolymph compartment, vitreum, endolymph fluid, neurone precursor cell etc.).This circulation is to cause the reason of closing neurotization in most of CNS pathology, and wherein the crucial target molecule TGF-RII of round-robin expresses in ventricle wall.
2. regulation and control that interesting is not are to take place via blood, lymph or extracellular matrix, but via taking place with neuronal cell and precursor cell thereof or the direct fluid in contact compartment of stem cell (celiolymph etc.).
3. find that neurone/oligodendroglia (oligodendroglial) or starlike regenerated physiology suppress circulation for repairing the dreamboat of the strategy that damages in the CNS, it can significantly be used for the nearly all destructive pathology of neural system.According to previous knowledge about TGF-β; more would rather attempt increasing but not reduction (referring to 5) TGF-β function, so that increase its known neuroprotective or immunosuppressive activity in CNS: our supposition is here transmitted by the TGF-RII signal of blocking ventricle wall and is reduced its inhibit feature for stem cell regenerating.
4. although infer for a long time that inflammatory process plays an important role in nerve degeneration, and a large amount of relatively clinical preceding and clinical datas shows supports described idea, but disclose major cycle now, it makes all separately metacyclic combinations harmoniously of regulation and control, for example cytokine (IL-1, IL-6, IL-12) and other.
5. in addition, should notice that Nature has preferentially proposed the preferential CNS of immunity in neuroprotective and the neurotization.Showed that so far immunity is preferential and not enough in neurotization through the CNS of highly protection (attacking and Neuron Apoptosis to avoid immunity through special protection); this is definite because this is preferential and because same molecular TGF-β; wherein because the TGF-beta system, so this immunity CNS preferential and through highly protecting is an integral part.As if the evolution notion help adhering to acute neuroprotective and the most of sophisticated functions thereof of high complexity CNS; In this article, as if individual neurotization is lower than the importance of individual neuroprotective for evolving.
The regulation and control circulation
The neural generation of the physiology of brain allows by precursor cell continuous repair out of the ordinary/replacement fault or aging neurone, oligodendroglia or stellate cell.The neurotization that is used for the brain reparation is to regulate and control through celiolymph by TGF-β-TGF-R (especially TGF RII also is TGF RI) system; Main cooperation is to produce TGF-β and via extracellular space it is secreted microgliacyte to CSF (and in vitreum, endolymph) compartment and neurone precursor cell/stem cell/huge and have a liking for cell line cell, and it is by receiving this signal at the TGF-RII or the TGF-RI of great expression on its surface tissue or ependyma lining form with same receptor via CSF (and in vitreum, endolymph).In most of CNS pathology, the neural generation through badly damaged or break down.Regulate neurogenetic regulation and control, normally have a liking for cell and suppress by activate microgliacyte/huge in CNS, it betides in the pathological situation of any specified disease.Have a liking for the regeneration that cell suppresses nerve degeneration, acute and chronic inflammatory, anoxic, atherosclerosis or aging brain soft tissue by this approach institute activatory microgliacyte/huge, described approach is CSF to ventricle district/other neural generating area down.Not only neurone differentiation is affected, and oligodendroglia and stellate cell system also are affected.To disturb this circulation to advocate to be treatment to improve all molecules of neurone/oligodendroglia/stellate cell regenerated.It also is considerable adopting the method for described round-robin diagnosis, prophylactic treatment (prophylaxis), prevention (prevention) or forecast CNS pathology, and it is used for the effect that monitor treatment is intervened convincingly.
In above-mentioned illness, the protein aggregation body in artery sclerosis or acute wound/anoxic dependency necrocytosis, cell debris, inflammation, Inflammatory response attract microgliacyte and the potential blood vessel static huge cell of having a liking on every side.This can be acute, subacute or chronic process.In reactivation process, activated microgliacyte colony (comprise from vessel wall or other sources huge and have a liking for cell) is released into a large amount of inflammatory cytokines in the extracellular matrix, drains into it in Venule or directly drains in the CSF space.These cytokines will arrive the CSF compartment, and can use in all positions immediately, and these positions are TGF-β by CSF around these cytokines to a certain extent.Verified (Monje, M.L, people such as H.Toda, (2003). " Inflammatory blockade restores adulthippocampal neurogenesis. " Science 302 (5651): 1760-1765) neural inflammation suppresses neural generation, and carry out the inflammatory blocking-up with common non-steroidal anti-inflammatory drug thing INDOMETHACIN (indomethacin) and after the inflammation of endotaxin induction, recover neural the generation, and after the skull irradiation, increase neural the generation.
Yet prior art does not disclose the TGF-β as neural generation of downward modulation and the neural main adjusting control agent of repairing under injured back or the pathological conditions.On the contrary, prior art thinks that TGF-β avoids necrocytosis as neuroprotective prevention of injuries or injured neurons, and attempts raising the TGF-β in the CNS disease.
People such as Zhang (Zhang, J.M., people (1997) such as R.Hoffmann. " Mitogenic andantiproliferative signals for neural crest cells and the neurogenicaction of TGF-betal. " Dev.Dyn.208 (3): 375-386.) proof TGF-β influences developmental quail neural crest cell.Here TGF-β suppresses multipotency neural crest cell (and/or its direct derivative) and loyal melanocytic propagation, thereby causes reducing of group's size.In addition and opposite with the present invention, the neural generation significantly increases under the TGF-β existing.In the positive group of the neuroblast of handling through TGF-β, the number in the group of each suprarenin cell and secreted neural unit presoma increases.
TGF-β has vital role in cell growth and differentiation, allelotaxis, matrix formation, wound repair and immunologic function.Although TGF-β is effective growth-inhibiting substance of many cell types, it stimulates the propagation of fibroblast and sclerocyte.It also is the effective stimulus agent of being produced by the extracellular matrix that fibroblast and sclerocyte carry out, and suppresses substrate degradation, and raises the matrix phase mutual effect of acceptor.Pointed out that TGF-β 1 is the crucial origin cause of formation factor in the pathogeny of hepatic fibrosis, and be a kind of crucial conditioning agent of Ciclosporin A (cyclosporine A) at least the useful and deleterious effect of immunity system and kidney.In addition, showed that various chronic progressive external fibrosis kidney illnesss are relevant with the stimulation of TGF-beta system in human and the experimental model.
TGF-β 1 reduces G1 and G2 cyclin-dependent kinase and cyclin aspect kinase activity and protein content.TGF-β 1 also in the human marrow leukemia cell a plurality of Serines and threonine residues place be suppressed to the product phosphorylation of retinocytoma suppressor gene pRb.Underphosphorylated pRb is relevant with transcription factor E2F-4 in the G1 phase, and through the pRb of phosphorylation mainly in conjunction with E2F-1 and E2F-3.Because TGF-β 1 raises p130 (pRb family member)/E2F-4 complex body and forms, and downward modulation p107 (pRb family member)/E2F-4 complex body forms, wherein the E2F-4 level is kept constant, so these results' announcements are worked as cell and are left the cell cycle, and when being attracted by the effect of TGF-β 1, E2F-4 changes pRb and p130 into from p107." cdk inhibitor " p27 is the positive and the negative conditioning agent of the cell cycle control that mediated of TGF-β 1.Be the selected inhibitor of normal original hemopoietic stem cell although reported TGF-β 1, TGF-β all suppresses bone marrow leukemia cells original and differentiation more and is.What mainly pay close attention to is neuroprotective activity, its effect and effect in the regulation and control immune response thereof in neurodevelopment (neurodevelopmental) of TGF-β 1.Showed that in many researchs TGF-β 1 has neuroprotective in vitro and in vivo.Agonist research has proved the infarct size after TGF-β 1 reduces neuronal cell death and deutocerebrum obstruction of artery (MCAO); and on the contrary; the neuronal cell death of increase and the infarct size behind the MCAO have been showed in antagonist research, and this discloses TGF-β 1 and have neuroprotective in cerebral ischemia.Recently further indicated the neuroprotective effect of TGF-β 1 in cerebral ischemia about the research of TGF-β 1 overexpression that in vivo adenovirus mediated in the mouse, the reduction of exporting as neuronal cell death, infarct size and neuroscience proves.In addition, many in vitro researchs have proved that TGF-β 1 is from the neuroprotective ability in the multiple species neurone of (comprising rat, mouse, chicken and the mankind).Especially interesting is to show that 1 pair of various dead inductor/injury of TGF-β has protectiveness, comprises Hypoxia, glutaminate exitotoxicity, amyloid beta, oxidative damage and human immunity disappearance virus.The neuroprotective effect of TGF-β 1 is kept the mitochondrial membrane electromotive force, is stablized Ca with it 2+Running balance, increase inhibitor of apoptosis protein Bcl-2 express, suppress Casprotease-3 and activate relevant with the ability of inducing Profibrinolysin activator inhibitor-1 with Bcl-xl.The verified original neural stem cell of research in the embryonic stem cell is to be transmitted the component of the nervous system standard of institute's negative regulation by TGF-β dependency signal.The neural generation of endogenous expression positive regulation grownup that has shown another TGF family member TGF-α.TGF-α breeds fully by the progenitor cell that is present in subependymal layer and the neurone presoma that migrates to olfactory bulb produce fully essential.In TGF-α knock-out mice, the propagation of these progenitor cells also reduces along with the age, and this may be because the prolongation of cell cycle.Endogenous TGF-α old and feeble or lack do not influence in the presence of Urogastron in vitro the number of isolating neural stem cell.
TGF-β is used for immunoregulatory purposes and seriously is subjected to its toxic inhibition in the mankind, comprise overstimulation, Toxicity of Kidney and other deleterious effects that matrix produces.TGF-β has carcinogenic potential, and has been involved in glomerule ephrosis, lung fibrosis, scleroderma and the chronic transplant versus-host disease.In addition, although TGF-β is the very effective immunosuppressant cell factor, some evidences show that the chronic stimulation (in disease-related or the transgenic animal model) that TGF-β expresses can cause or strengthen the autoimmunity inflammation unreasonably.
Exist ever-increasing evidence proof in the pathologic, physiologic of various CNS pathology, to play a crucial role as the strong inflammatory properties of the TGF-β of the reverse conditioning agent of t cell immune response.Therefore, think that this cytokine is the potential target that injured dependency peptide and treatment are intervened.Neural inflammation is relevant with many sacred diseases with mesoglia pathology.Here the most classical obviously is the nerve immunity disease, for example multiple sclerosis.But it also comprises cognitive illnesses, wherein notable feature is the loss of memory, for example Alzheimer's disease, dementia with Lewy body disease, aids dementia complex, vascular dementia, perhaps loss of memory significance is less, for example ophthalmic nerve nuclear paralysis disease, cortex basal nuclei degeneration disease and storehouse Jia Shi disease on Pick's disease, the carrying out property.In addition, after the acute injury of for example apoplexy, traumatic brain and Spinal injury, activate the inflammatory program.In the different animals model of storehouse Jia Shi disease, reported the rise (Baker of microglial activation and TGF-β 1, C.A., people (1999) such as Z.Y.Lu. " Microglialactivation varies in different models of Creutzfeldt-Jakob disease. " J Virol 73 (6): 5089-5097).
In hundreds of different nerve degeneration illnesss, only pay close attention to a few, comprise Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis.It should be noted that identical nerve degeneration process can influence the different zones of brain, make that to see institute on symptom position very different to disease.The nerve degeneration illness of central nervous system (CNS) can be divided into pallium disease (Alzheimer's disease), basal ganglia disease (Parkinson's disease), brain stem and little disease of brain or diseases of spinal cord (amyotrophic lateral sclerosis).
The example of nerve degeneration and nerve degeneration illness is: Alzheimer's disease, Parkinson's disease, storehouse Jia Shi disease (CJD), the neomorph of storehouse Jia Shi disease (new variant of Creutzfeldt Jakobsdisease, nvCJD), HallervordenSpatz Disease, Huntington's disease, multiple system atrophy, dull-witted, Frontemporal Dementia, the motor neuron illness, amyotrophic lateral sclerosis, spinal muscular atrophy (Spinal Muscular Atrophy), spinocerebellum atrophy (SCA), schizophrenia, affective disorder, severe melancholia (major depression), meningoencephalitis (meningoencephalitis), bacillary meningoencephalitis, viral meningoencephalitis, the CNS autoimmune disorder, multiple sclerosis (Multiple Sclerosis, MS), acute ischemic/anoxia-induced apoptosis (acute ischemic/hypoxic lesion), the CNS wound, injury of head, arteriosclerosis, arteriosclerosis, microangiopathy dementia (microangiopathic dementia), binswanger (Binswanger ' disease), leukoaraiosis (Leukoaraiosis), retinal degeneration (retinal degeneration), cochlea degeneration (cochlear degeneration), macular degeneration (macular degeneration), cochlear deafness (cochlear deafness), acquired immune deficiency syndrome (AIDS) AIDS dependency dementia (AIDS-related dementia), retinitis pigmentosa (retinitis pigmentosa), vulnerability X-dependency is trembled/ataxia syndromes (fragileX-associated tremor/ataxia syndrome, FXTAS), ophthalmic nerve nuclear paralysis disease (progressive supranuclear palsy on the carrying out property, PSP), striatonigral degeneration (striatonigral degeneration, SND), Nux Canarii albi pon cerebellum degeneration disease (olivopontocerebellar degeneration, OPCD), shy dilatory person's syndromes (ShyDrager syndrome, SDS).
Influence the level of TGF-β 1
Raise TGF-β 1 and effect thereof
For neuroprotective or immunomodulatory purpose, many researchs attempt to increase TGF-β 1 level.Agonist research has proved the infarct size after TGF-β 1 reduces neuronal cell death and deutocerebrum obstruction of artery (MCAO); and on the contrary; the neuronal cell death of increase and the infarct size behind the MCAO have been showed in antagonist research, and this discloses TGF-β 1 and have neuroprotective in cerebral ischemia.Recently further indicated the neuroprotective effect of TGF-β 1 in cerebral ischemia about the research of TGF-β 1 overexpression that in vivo adenovirus mediated in the mouse, the reduction of exporting as neuronal cell death, infarct size and neuroscience proves.In addition, many in vitro researchs have proved that TGF-β 1 is from the neuroprotective ability in the multiple species neurone of (comprising rat, mouse, chicken and the mankind).Especially interesting is to show that 1 pair of various dead inductor/injury of TGF β has protectiveness, comprises Hypoxia, glutaminate exitotoxicity, amyloid beta, oxidative damage and human immunity disappearance virus.The neuroprotective effect of TGF-β 1 is kept the mitochondrial membrane electromotive force, is stablized Ca with it 2+Running balance, the expression that increases inhibitor of apoptosis protein Bcl-2 and Bcl-xl, inhibition Casprotease-3 activate relevant with the ability of inducing Profibrinolysin activator inhibitor-1.
TGF-β is used for immunoregulatory purposes and seriously is subjected to its toxic inhibition in the mankind, comprise overstimulation, Toxicity of Kidney and other deleterious effects that matrix produces.TGF-β has carcinogenic potential, and has been involved in glomerule ephrosis, lung fibrosis, scleroderma and the chronic transplant versus-host disease.In addition, although TGF-β is the very effective immunosuppressant cell factor, some evidences show that the chronic stimulation (in disease-related or the transgenic animal model) that TGF-β expresses can cause or strengthen the autoimmunity inflammation unreasonably.
Our main discovery is that it is the main molecule of oppositely regulating that mainly the CNS stem cell is repaired at physiology with in nearly all CNS pathology to the consistent TGF-β described in the provide protection of above-mentioned CNS: by TGF-β (responding to disease) that microgliacyte produced with low physiological level or higher level by cell in matrix leak out among the CSF.It can contain potential other location that progenitor cells layer region under the epidermis or CNS stem cell upgrade, in precursor cell/stem cell colony of CNS free and directly with through highly regulation and control and the TGF-RII that expresses and TGF-RI interaction.Described discovery is made up of retroregulation, and it causes the low stem cell under high CSF-TGF-β level to upgrade, and vice versa.Unusual and be significantly, the high expression level of TGF-RII and activity are to be positioned at precursor cell/stem cell colony propagation site, are SVZ or hippocampus in our experiment.The unusual signal that also has transmits via buffered soln, for example celiolymph (CSF).Therefore it is to regulate and control circulation fully, and wherein physiology is very similar with the pathology regulation and control, but difference only is intensity (in other words: TGF-β level among the CSF and the TGF-R expression level in the target cell).Individual nosopathology is phenotypic to be characterized as described different the change, as hereditary defect (for example multisystem synapsin disease, superoxide-dismutase sudden change (Superoxide Dismutase Mutation), trinucleotide repeat illness (Trinucleotide Repeat Disorder)) or wound, anoxic, vascular disease or inflammation, or CNS is aging.Yet; the executive of disease pathology always microgliacyte/huge has a liking for the TGF-β that cell colony produces: on the one hand; it has neuroprotective and inhibitive ability of immunity, helps progressively to demote to the acute inflammation damage of soft tissue and the neuron loss that may be caused by disease pathology.Just as two-sided god slave's Si head (Janus Head), same molecular prevents CNS to carry out injury repairing by disturb TGF-β-TGF-R ring on precursor cell or stem cell level by self stem cell/precursor cell indirectly, and then significantly suppresses stem cells hyperplasia.In this case, stem cell be not only derive from CNS those cells of the precursor cell in should considering, and convincing ground is also for attempting to invade from marrow blood vessel separately stem cell/the precursor cell of CNS soft tissue.This is also meaning and is passing through the simple TGF-β level in the soft tissue that reduces, and is deserved with elimination to neuroprotective/immunosuppressive action of CNS, thereby causes being damaged by the serious acute that inflammation and/or direct neural unit apoptosis cause.
Therefore as if the attraction approach for the stable intervention that helps repairing is only intervened in the part of TGF-R level, and do not jeopardize the beneficial effect of TGF-β to brain.Therefore, the present invention relates on the precursor cell/stem cell bank of expressing TGF-R, disturb the antisense oligonucleotide of the biologic activity of TGF-β 1.Described oligonucleotide or comprise medical composition at least a in the described oligonucleotide and can be used for diagnosing/prophylactic treatment/prevention or treatment be wherein neural to be taken place or neurotization has the disease of beneficial effect.As shown in our experiment, it also can be used for therapeutic prevention (for example after apoplexy or head injuries), should be effective before the described hereinafter mechanism.
Term used herein " disturbs (interfering) " and means adjusting, is preferably and reduces or elimination TGF-R and/or TGF-R IIBiologic activity or its expression.Can (be preferably TGF-R by making compound and TGF-R II) direct interaction or combination, perhaps by interacting (for example by interference and TGF-R and/or TGF-R indirectly IIThe compound that biologic activity is relevant) realizes regulating biologic activity.For neurone/hemopoietic stem cell or the precursor cell that improves neurotization or increase CNS recovers (comprise all types of parts or general and transplant (for example in vitro breeding, allos cell)), serve as target TGF-β R I,-R II,-R IIIOr its signal transduction is listed below with the suitable combination thing that disturbs described regulation and control round-robin medicament:
(a) plasmid, carrier or natural/synthetic/mutated viruses, has the oligonucleotide that all kinds modify (PTO for example, LNA, 2 ' F-ANA, albumen-Nucleotide complex body, RNAi, siRNA or mikromiRNA), the methyl methoxy base-, phosphoro-amidate, PNA, morpholinyl, phosphoramidate, tetrahydrobenzene (CeNA), between aggressiveness (gap-mere), ribozyme, aptamer (aptamer), the CpG-oligomer, the DNA-enzyme, examine switch (riboswitch) or lipid or contain lipid molecule
(b) peptide, peptide complex body comprise all types of connexons,
(c) cave in for a short time (caveoli) small numerator modified dose of Lipid Rafts (raft) or film,
(d) modifier of golgi body (golgi apparatus),
(e) antibody and derivative thereof, especially mosaic, Fab fragment, Fc fragment or
(f) carrier, liposome, nanoparticle, complex body or contain any other haulage system of above-mentioned appointment construct can be used for the above-mentioned circulation of target to recover or to improve neurotization.
Yet, most preferably antisense oligonucleotide in the above-mentioned medicament, this is because it early disturbs TGF-R or TGF-R period at the utmost point IIFormation.The major advantage of these molecules is the target-specific that it is high, with and fabulous general and local tolerance; Its utmost point is suitable for being applied topically in the soft tissue or CSF space among the CNS.In addition, it is very stable, and therefore can easily use from the implanted suction system.It also significantly saves cost.
Therefore, in a preferred embodiment of the invention, can be used for disturbing coding TGF-R or TGF-R IIThe compound of genetic expression be antisense oligonucleotide (antisense oligonucleotide).
The generation of suitable antisense oligonucleotide is included in TGF-R gene or TGF-R IIBe identified for the site that antisense interacts and takes place in the gene, therefore can cause and to act on, for example inhibition of protein expression.The site is the zone that (a) comprises gene opening code-reading frame (ORF) transcription initiation or terminator codon in the preferred gene, and perhaps (b) is the mRNA zone of " ring " or " projection ", promptly is not the part secondary structure.In case identify one or more target sites, then select with target fully complementary (promptly fully hybridize and have enough specificitys) to produce the oligonucleotide that will act on.
Therefore, the present invention relates to have antisense oligonucleotide and the stand-in thereof that SEQ ID NO 1 or SEQ ID NO 2 or SEQ ID NO 94 or SEQ ID NO 95 or SEQ ID NO 96 comprise the subsequence of 8 to 50 nucleotide bases.Described oligonucleotide represent SEQ ID NO 12 or SEQ ID NO94 to 96 have the part of 8 to 50 nucleotide bases.In addition, the antisense oligonucleotide that comprises 8 to 50 nucleotide bases is not necessary for SEQ ID NO 1 or 2 or the accurate subsequence of SEQ ID NO 94 to 96.If antisense oligonucleotide be found in SEQ ID NO 12 or SEQ ID NO94 or 95 or 96 in subsequence have at least 80%, be preferably 84%, more preferably 88% and most preferably be 92% consistence, then it is enough.Preferred oligonucleotide has the consistent sequence of subsequence at least 80% that comprises 8 to 50 nucleotide bases with SEQ ID NO 1 or 2 or 94 or 95 or 96, wherein said sequence can with comprise coding TGF-R or TGF-R IIThe gene opening code-reading frame transcription initiation or the zone of terminator codon or be " ring " or " projection " and be not the coding TGF-R or the TGF-R of part secondary structure IIThe fully hybridization of mRNA zone.It means these antisense oligonucleotides has and coding TGF-R or TGF-R IIThe corresponding zone at least 80% complementary sequence of gene, perhaps preferably have and (a) comprise coding TGF-R or TGF-R IIGene opening code-reading frame transcription initiation or the zone of terminator codon, or (b) be the coding TGF-R or the TGF-R of " ring " or " projection " (promptly not being the part secondary structure) IIMRNA zone at least 80% complementary sequence.
Preferably can with comprise coding TGF-R or TGF-R IIGene opening code-reading frame transcription initiation or the zone of terminator codon, or be " ring " or " projection " and be not the coding TGF-R or the TGF-R of part secondary structure IIMRNA zone fully hybridization have 8 to 50, be preferably the antisense oligonucleotide of 15 to 25 nucleotide bases.
The following extension sequence of SEQ ID NO 3 preferably, it can be represented by following general formula:
5′-XCAGCCCCCGACCCATGZ-3′
Wherein X is selected from the group that comprises following oligonucleotide:
ACAGGACGATGTGCAGCGGCCACAGGCCCCTGAG,
CAGGACGATGTGCAGCGGCCACAGGCCCCTGAG,
AGGACGATGTGCAGCGGCCACAGGCCCCTGAG,GGACGATGTGCAGCGGCCACAGGCCCCTGAG,
GACGATGTGCAGCGGCCACAGGCCCCTGAG,ACGATGTGCAGCGGCCACAGGCCCCTGAG,
CGATGTGCAGCGGCCACAGGCCCCTGAG,
GATGTGCAGCGGCCACAGGCCCCTGAG,
ATGTGCAGCGGCCACAGGCCCCTGAG,TGTGCAGCGGCCACAGGCCCCTGAG,
GTGCAGCGGCCACAGGCCCCTGAG,TGCAGCGGCCACAGGCCCCTGAG,
GCAGCGGCCACAGGCCCCTGAG,CAGCGGCCACAGGCCCCTGAG,
AGCGGCCACAGGCCCCTGAG,GCGGCCACAGGCCCCTGAG,
CGGCCACAGGCCCCTGAG,GGCCACAGGCCCCTGAG,
GCCACAGGCCCCTGAG,CCACAGGCCCCTGAG,CACAGGCCCCTGAG,
ACAGGCCCCTGAG,CAGGCCCCTGAG,AGGCCCCTGAG,
GGCCCCTGAG,GCCCCTGAG,CCCCTGAG,CCCTGAG,CCTGAG,CTGAG,TGAG,GAG,AG,G,
And wherein Z is selected from the group that comprises following oligonucleotide:
GCAGACCCCGCTGCTCGTCATAGACCGAGCCCCC,
GCAGACCCCGCTGCTCGTCATAGACCGAGCCCC,
GCAGACCCCGCTGCTCGTCATAGACCGAGCCC,GCAGACCCCGCTGCTCGTCATAGACCGAGCC,
GCAGACCCCGCTGCTCGTCATAGACCGAGC,
GCAGACCCCGCTGCTCGTCATAGACCGAG,
GCAGACCCCGCTGCTCGTCATAGACCGA,
GCAGACCCCGCTGCTCGTCATAGACCG,
GCAGACCCCGCTGCTCGTCATAGACC,GCAGACCCCGCTGCTCGTCATAGAC,
GCAGACCCCGCTGCTCGTCATAGA,GCAGACCCCGCTGCTCGTCATAG,
GCAGACCCCGCTGCTCGTCATA,GCAGACCCCGCTGCTCGTCAT,
GCAGACCCCGCTGCTCGTCA,GCAGACCCCGCTGCTCGTC,
GCAGACCCCGCTGCTCGT,GCAGACCCCGCTGCTCG,
GCAGACCCCGCTGCTC,GCAGACCCCGCTGCT,GCAGACCCCGCTGC,
GCAGACCCCGCTG,GCAGACCCCGCT,GCAGACCCCGC,
GCAGACCCCG,GCAGACCCC,GCAGACCC,GCAGACC,GCAGAC,GCAGA,GCAG,GCA,GC,G,
And wherein X and Z comprise together and are no more than 34 nucleotide bases and stand-in (mimetics) thereof.
More preferably following oligonucleotide sequence and variant or stand-in:
SEQ?ID?NO?3: 5′-CAGCCCCCGACCCATG-3′
SEQ?ID?NO?4: 5′-GCTGATGCCTGTCACTTGAA-3′
SEQ?ID?NO?5: 5′-GCCATGGAGTAGACATCGGT-3′
SEQ?ID?NO?6: 5′-GCAACAGCTATTGGGATGGT-3′
SEQ?ID?NO?7: 5′-GTGCAGGGGAAAGATGAAAA-3′
SEQ?ID?NO?8: 5′-GTATCAGCATGCCCTACGGT-3′
SEQ?ID?NO?9: 5′-GGATCCAGATTTTCCTGCAA-3′
SEQ?ID?NO?10: 5′-GGAGAAGCAGCATCTTCCAG-3′
SEQ?ID?NO?11: 5′-GAGCTCTTGAGGTCCCTGTG-3′
SEQ?ID?NO?12: 5′-GAGACCTTCCACCATCCAAA-3′
SEQ?ID?NO?13: 5′-TAGCTGGCTGTGAGACATGG-3′
SEQ?ID?NO?14: 5′-TTTTGAAACGCTGTGCTGAC-3′
SEQ?ID?NO?15: 5′-TCAGCCAGTATTGTTTCCCC-3′
SEQ?ID?NO?16: 5′-TCACACAGGCAGCAGGTTAG-3′
SEQ?ID?NO?17: 5′-TCAGGAATCTTCTCCTCCGA-3′
SEQ?ID?NO?18: 5′-TGGTAGTGTTTAGGGAGCCG-3′
SEQ?ID?NO?19: 5′-TATCCCCACAGCTTACAGGG-3′
SEQ?ID?NO?20: 5′-GCCTCTTTCCTCATGCAAA-3′
SEQ?ID?NO?21: 5′-TGTCATTTCCCAGAGCACC-3′
SEQ?ID?NO?22: 5′-AGGAATCTTCTCCTCCGAGC-3′
SEQ?ID?NO?23: 5′-AGCCATGGAGTAGACATCGG-3′
SEQ?ID?NO?24: 5′-ATGCTACTGCAGCCACACTG-3′
SEQ?ID?NO?25: 5′-CCTTCTCTGCTTGGTTCTGG-3′
SEQ?ID?NO?26: 5′-CCAGGAGAAATAAGGGCACA-3′
SEQ?ID?NO?27: 5′-CAGCAGCTCTGTGTTGTGGT-3′
SEQ?ID?NO?28: 5′-CCCACTGTTAGCCAGGTCAT-3′
SEQ?ID?NO?29: 5′-CAGCCCCCGACCCATGGCAGACCC-3′
SEQ?ID?NO?30: 5′-CAGCCCCCGACCCATGGCAGACC-3′
SEQ?ID?NO?31: 5′-CAGCCCCCGACCCATGGCAGAC-3′
SEQ?ID?NO?32: 5′-CAGCCCCCGACCCATGGCAGA-3′
SEQ?ID?NO?33: 5′-CAGCCCCCGACCCATGGCAG-3′
SEQ?ID?NO?34: 5′-CAGCCCCCGACCCATGGCA-3′
SEQ?ID?NO?35: 5′-CAGCCCCCGACCCATGGC-3′
SEQ?ID?NO?36: 5′-CAGCCCCCGACCCATGG-3′
SEQ?ID?NO?37: 5′-GCAGCCCCCGACCCATGGCAGACC-3′
SEQ?ID?NO?38: 5′-GCAGCCCCCGACCCATGGCAGAC-3′
SEQ?ID?NO?39: 5′-GCAGCCCCCGACCCATGGCAGA-3′
SEQ?ID?NO?40: 5′-GCAGCCCCCGACCCATGGCAG-3′
SEQ?ID?NO?41: 5′-GCAGCCCCCGACCCATGGCA-3′
SEQ?ID?NO?42: 5′-GCAGCCCCCGACCCATGGC-3′
SEQ?ID?NO?43: 5′-GCAGCCCCCGACCCATGG-3′
SEQ?ID?NO?44: 5′-GCAGCCCCCGACCCATG-3′
SEQ?ID?NO?45: 5′-AGCAGCCCCCGACCCATGGCAGAC-3′
SEQ?ID?NO?46: 5′-AGCAGCCCCCGACCCATGGCAGA-3′
SEQ?ID?NO?47: 5′-AGCAGCCCCCGACCCATGGCAG-3′
SEQ?ID?NO?48: 5′-AGCAGCCCCCGACCCATGGCA-3′
SEQ?ID?NO?49: 5′-AGCAGCCCCCGACCCATGGC-3′
SEQ?ID?NO?50: 5′-AGCAGCCCCCGACCCATGG-3′
SEQ?ID?NO?51: 5′-AGCAGCCCCCGACCCATG-3′
SEQ?ID?NO?52: 5′-GAGCAGCCCCCGACCCATGGCAGA-3′
SEQ?ID?NO?53: 5′-GAGCAGCCCCCGACCCATGGCAG-3′
SEQ?ID?NO?54: 5′-GAGCAGCCCCCGACCCATGGCA-3′
SEQ?ID?NO?55: 5′-GAGCAGCCCCCGACCCATGGC-3′
SEQ?ID?NO?56: 5′-GAGCAGCCCCCGACCCATGG-3′
SEQ?ID?NO?57: 5′-GAGCAGCCCCCGACCCATG-3′
SEQ?ID?NO?58: 5′-TGAGCAGCCCCCGACCCATGGCAG-3′
SEQ?ID?NO?59: 5′-TGAGCAGCCCCCGACCCATGGCA-3′
SEQ?ID?NO?60: 5′-TGAGCAGCCCCCGACCCATGGC-3′
SEQ?ID?NO?61: 5′-TGAGCAGCCCCCGACCCATGG-3′
SEQ?ID?NO?62: 5′-TGAGCAGCCCCCGACCCATG-3′
SEQ?ID?NO?63: 5′-CTGAGCAGCCCCCGACCCATGGCA-3′
SEQ?ID?NO?64: 5′-CTGAGCAGCCCCCGACCCATGGC-3′
SEQ?ID?NO?65: 5′-CTGAGCAGCCCCCGACCCATGG-3′
SEQ?ID?NO?66: 5′-CTGAGCAGCCCCCGACCCATG-3′
SEQ?ID?NO?67: 5′-CCTGAGCAGCCCCCGACCCATGGC-3′
SEQ?ID?NO?68: 5′-CCTGAGCAGCCCCCGACCCATGG-3′
SEQ?ID?NO?69: 5′-CCTGAGCAGCCCCCGACCCATG-3′
SEQ?ID?NO?70: 5′-CCCTGAGCAGCCCCCGACCCATGG-3′
SEQ?ID?NO?71: 5′-CCCTGAGCAGCCCCCGACCCATG-3′
SEQ?ID?NO?72: 5′-CCCCTGAGCAGCCCCCGACCCATG-3′。
Still more preferably following oligonucleotide sequence with and variant and stand-in:
SEQ?ID?NO?33: 5′-CAGCCCCCGACCCATGGCAG-3′
SEQ?ID?NO?34: 5′-CAGCCCCCGACCCATGGCA-3′
SEQ?ID?NO?35: 5′-CAGCCCCCGACCCATGGC-3′
SEQ?ID?NO?36: 5′-CAGCCCCCGACCCATGG-3′
SEQ?ID?NO?41: 5′-GCAGCCCCCGACCCATGGCA-3′
SEQ?ID?NO?42: 5′-GCAGCCCCCGACCCATGGC-3′
SEQ?ID?NO?43: 5′-GCAGCCCCCGACCCATGG-3′
SEQ?ID?NO?44: 5′-GCAGCCCCCGACCCATG-3′
SEQ?ID?NO?49: 5′-AGCAGCCCCCGACCCATGGC-3′
SEQ?ID?NO?50: 5′-AGCAGCCCCCGACCCATGG-3′
SEQ?ID?NO?51: 5′-AGCAGCCCCCGACCCATG-3′
SEQ?ID?NO?56: 5′-GAGCAGCCCCCGACCCATGG-3′
SEQ?ID?NO?57: 5′-GAGCAGCCCCCGACCCATG-3′
SEQ?ID?NO?62: 5′-TGAGCAGCCCCCGACCCATG-3′
SEQ?ID?NO?73: 5′-ATGTGAAGATGGGCAAGACC-3′
SEQ?ID?NO?74: 5′-ATCTCCATGTGAAGATGGGC-3′
SEQ?ID?NO?75: 5′-AACGGCCTATCTCGAGGAAT-3′
SEQ?ID?NO?76: 5′-AACATCGTCGAGCAATTTCC-3′
SEQ?ID?NO?77: 5′-AATCCAACTCCTTTGCCCTT-3′
SEQ?ID?NO?78: 5′-AAACCTGAGCCAGAACCTGA-3′
SEQ?ID?NO?79: 5′-AGGGCGATCTAATGAAGGGT-3′
SEQ?ID?NO?80: 5′-AGTGCACAGAAAGGACCCAC-3′
SEQ?ID?NO?81: 5′-ACACTGGTCCAGCAATGACA-3′
SEQ?ID?NO?82: 5′-TTCCTGTTGACTGAGTTGCG-3′
SEQ?ID?NO?83: 5′-CACTCTGTGGTTTGGAGCAA-3′
SEQ?ID?NO?84: 5′-CAAGGCCAGGTGATGACTTT-3′
SEQ?ID?NO?85: 5′-CACACTGGTCCAGCAATGAC-3′
SEQ?ID?NO?86: 5′-CTGACACCAACCAGAGCTGA-3′
SEQ?ID?NO?87: 5′-CTCTGCCATCTGTTTGGGAT-3′
SEQ?ID?NO?88: 5′-TCAAAAAGGGATCCATGCTC-3′
SEQ?ID?NO?89: 5′-TGACACCAACCAGAGCTGAG-3′
SEQ?ID?NO?9O: 5′-TGATGCCTTCCTGTTGACTG-3′
SEQ?ID?NO?91: 5′-TTCCTGTTGACTGAGTTGCG-3′
SEQ?ID?NO?92: 5′-TTCTCCAAATCGACCTTTGC-3′
SEQ?ID?NO?93: 5′-GGAGAGTTCAGGCAAAGCTG-3′。
Exclude this purport claims category be following two known arrays: 5 '-GATCTTGACTGCCACTGTCTC-3 ' (J.Clin.Endocrinology﹠amp; Metabolism2003,88 (10), 4967-4976) and 5 '-(DevelopmentalBiology 1996,180,242-257) for CATGGCAGCCCCCGTC-3 '.
Especially preferred is sequence SEQ ID NO 3:5 '-CAGCCCCCGACCCATG-3 '.
Therefore, the present invention also relates to SEQ ID NO 3 to SEQ ID NO 93 in any one closely-related sequence.Described in this article sequence is called as " variant ".Can modify antisense oligonucleotide in many different ways.Can in main chain, modify, and be meant oligonucleotide, wherein between its nucleosides in the main chain phosphorus atom partially or completely replaced by other atoms.For instance, preferred modified oligonucleotides main chain comprises phosphorothionate, chirality phosphorothionate, two phosphorothionates, phosphotriester, aminoalkyl group phosphotriester, methyl-phosphonate, phosphinic acid ethyl ester and phosphonic acids C 3-C 10-alkyl ester, comprise 3 '-alkylene phosphonic acid ester and chiral phosphonate, phosphinate, phosphoramidate, comprise have 3 of normal 3 '-5 ' key '-amino phosphoramidate and aminoalkyl group phosphoramidate, thionic phosphoramidate, thionic phosphonate ester, thionic alkyl phosphotriester and boron substituted phosphate, its 2 '-5 ' analogue of being connected and the person that has the opposite polarity, wherein contiguous right nucleosides unit 3 '-5 ' to 5 '-3 ' or 2 '-5 ' to 5 '-2 ' connect.Also comprise various salt, mixing salt and free acid form.
Preferred also is the variant of SEQ ID NO 3 to SEQ ID NO 93, wherein at 3 ' end and/or at 1,2,3,4 or 5 other nucleotide base of 5 ' terminal interpolation.These other nucleotide bases are five nucleotide bases among the SEQ ID NO 1,2,94,95 or 96 preferably, and it directly occurred before or after sequence out of the ordinary.In addition, described preferred variants can have the exchange of 1,2,3 or 4 nucleotide base, and promptly in described preferred variants, one, two, three or four Nucleotide can replace through another nucleotide base.Should notice that these variants also can contain any modification of the disclosed main chain of this paper or base or sugar moieties, for example phosphorothionate main chain.
The preferred modified oligonucleotides main chain that does not comprise phosphorus atom in it has by key between short-chain alkyl or cycloalkyl nucleosides, mixes the formed main chain of key between heteroatoms and alkyl or cycloalkyl nucleosides.It comprises and has the morpholine base key main chain of (part is formed by the sugar moieties of nucleosides); Siloxane main chain; Sulfide, sulfoxide and sulfone main chain; First and second acyl groups (formacetyl) and the sulfo-first and second acyl group main chains; Methylene radical first and second acyl groups and the sulfo-first and second acyl group main chains; The main chain that contains alkene; The sulfamate main chain; Methylene radical imino-and methylene radical diazanyl main chain; Sulfonate and sulfonamide backbone; Amide backbone; The mixture of aforementioned type main chain; And other have N, O, S, P and the CH of mixing 2The main chain of integral part.
Other preferred embodiments of the present invention comprise the oligonucleotide with phosphorothionate main chain or heteroatoms main chain, and especially have-CH 2-NH-O-CH 2-,-CH 2-N (CH 3)-O-CH 2-(being known as methylene radical (methyl-imino) or MMI main chain) ,-CH 2-O-N (CH 3)-CH 2-,-CH 2-N (CH 3)-N (CH 3)-CH 2-and-O-N (CH 3)-CH 2-CH 2-(wherein the natural phosphodiester main chain is by-O-P-O-CH 2-expression) oligonucleotide.The oligonucleotide that has morpholinyl part in the main chain or have the morpholinyl backbone structure or have an aminoalkylamide main chain also is preferred (vide infra).Oligonucleotide also can have sugared stand-in, and for example cyclobutyl moiety replaces penta furanose (pentofuranosyl sugar).
Figure A20058000989000181
Hexanaphthene stand-in morpholinyl stand-in
B is meant can be further through deutero-alkali part, for example purine or pyrimidine group.
Another modification of oligonucleotide of the present invention comprises part or conjugate chemistry that one or more activity, cell distribution or cells that strengthens oligonucleotide are absorbed and is connected to oligonucleotide.Modified oligonucleotide also can contain one or more and be substituted or modified sugar moieties.Preferred oligonucleotide comprise in 2 ' position a kind of in the following group :-OH ,-F ,-the O-alkyl ,-the S-alkyl ,-the N-alkyl ,-the O-thiazolinyl ,-the S-thiazolinyl ,-the N-thiazolinyl ,-the O-alkynyl ,-the S-alkynyl ,-the N-alkynyl ,-O-alkyl-O-alkyl, wherein alkyl, thiazolinyl and alkynyl can be the C that is substituted or is unsubstituted 1To C 10Alkyl or C 2To C 10Thiazolinyl and C 2To C 10Alkynyl.Especially preferred modified sugar moieties is 2 '-O-methoxy ethyl sugar moieties (2 '-OCH 2CH 2OCH 3, be also referred to as 2 '-O-(2-methoxy ethoxy) or 2 '-MOE) and 2 '-dimethylamino oxygen base oxethyl, for example O (CH 2) 2ON (CH 3) (be known as 2 '-DMAOE).Especially preferred also is O[(CH 2) nO] mCH 3, O (CH 2) nOCH 3, O (CH 2) nNH 2, O (CH 2) nCH 3, O (CH 2) nONH 2, O (CH 2) nON[(CH 2) nCH 3], wherein n and m are 1 to 10 integer independently of each other.Other preferably modify comprise 2 '-methoxyl group, 2 '-amino propoxy-and 2 '-fluorine.Other preferred oligonucleotide 2 ' position comprises a kind of in the following group :-OCH 3,-OC 2H 5,-OC 3H 7,-O-ring-C 3H 5,-OCH (CH 3) 2,-OC (CH 3) 3,-OC 4H 9,-OPh ,-OCH 2-Ph ,-NO 2,-F ,-Cl ,-Br ,-I ,-N 3,-CN ,-OCN ,-NCO ,-SCN ,-NCS ,-COCH 3,-COC 2H 5,-COC 3H 7,-CO-ring-C 3H 5,-COCH (CH 3) 2,-CF 3,-SH ,-SCH 3,-SC 2H 5,-SC 3H 7,-S-ring-C 3H 5,-SOCH 3,-SOC 2H 5,-SOC 3H 7,-SO-ring-C 3H 5,-SO 2CH 3,-SO 2C 2H 5,-SO 2C 3H 7,-SO 2-ring-C 3H 5,-NH 2,-NHCH 3,-NHC 2H 5,-NHC 3H 7,-NH-ring-C 3H 5,-N (CH 3) 2,-N (C 2H 5) 2,-N (C 3H 7) 2,-N (ring-C 3H 5) 2,-N[CH (CH 3) 2] 2-CH 3,-C 2H 5,-C 3H 7,-CH (CH 3) 2,-C 4H 9,-CH 2-CH (CH 3) 2,-CH (CH 3)-C 2H 5,-C (CH 3) 3,-C 5H 11,-CH (CH 3)-C 3H 7,-CH 2-CH (CH 3)-C 2H 5,-CH (CH 3)-CH (CH 3) 2,-C (CH 3) 2-C 2H 5,-CH 2-C (CH 3) 3,-CH (C 2H 5) 2,-C 2H 4-CH (CH 3) 2,-C 6H 13,-C 3H 6-CH (CH 3) 2,-C 2H 4-CH (CH 3)-C 2H 5,-CH (CH 3)-C 4H 9,-CH 2-CH (CH 3)-C 3H 7,-C 2H 4-C (CH 3) 3,-CH (CH 3)-CH 2-CH (CH 3) 2,-CH (CH 3)-CH (CH 3)-C 2H 5,-CH 2-CH (CH 3)-CH (CH 3) 2,-CH 2-C (CH 3) 2-C 2H 5,-C (CH 3) 2-C 3H 7,-C (CH 3) 2-CH (CH 3) 2,-CH (CH 3)-C (CH 3) 3, C 7-C 10Alkyl, be substituted C 1-C 10Alkyl, alkylaryl, arylalkyl, O-C 1-C 10Alkyl, O-arylalkyl, Heterocyclylalkyl, Heterocyclylalkyl aryl, aminoalkyl group amino, poly-alkylamino, be substituted silylation, RNA leavings group, report group, insert son, be used to improve the group of the pharmacokinetics of oligonucleotide and/or drug effect characteristic or have the substituting group of similar characteristics.The deoxyribonucleotide base also is preferred.
Also can carry out similar modification, especially 3 of sugar ' position on 3 ' terminal nucleotide or in the 2-5 ' connection oligonucleotide, perhaps 5 of 5 ' terminal nucleotide ' position in other positions of Nucleotide.
Preferred modification can be represented by following structure fragment:
Wherein
R represents any above-mentioned substituting group of 2 ' position, and especially
-H、-F、-OH、-NH 2、-OCH 3、-OCH 2CH 2OCH 3
X and X ' be independently of each other-O-,-NH-,-S-,-CH 2-and
Y represents-O -,-S -,-N (CH 3) 2,-OCH 3,-SCH 3
More preferably wherein X and X ' expression oxygen and Y represent the variant of sulphur.
In addition, pure diastereo-isomerism oligonucleotide or its stand-in or variant are preferred.Especially preferred is Sp-and Rp-diastereomer:
Rp diastereomer Sp diastereomer
Highly preferred also is sequence SEQ ID NO 3 to SEQ ID NO 93, and SEQ IDNO 3 especially, wherein has in the disclosed modification of this paper one or more.The phosphorothionate main chain partially or completely of the phosphorothionate in the main chain preferably, and in described phosphorothionate, Rp and Sp diastereomer are preferred.
Oligonucleotide of the present invention also can comprise nucleotide base and replace.Nucleotide base is four standard nucleotides bases adenine (A), thymus pyrimidine (T), guanine (C) and cytosine(Cyt) (G).Modified nucleotide base comprises other synthetic and natural nucleotide base, for example the 2-propyl group of the 6-methyl of 5-methylcytosine (5-me-C), 5-hydroxymethyl cytosine, xanthine, xanthoglobulin, 2-aminoadenine, VITAMIN B4 and guanine and other alkyl derivatives, VITAMIN B4 and guanine and other alkyl derivatives; Uridylic (U), 6-carboxyuracil, N 6-methyl-VITAMIN B4,5-halo uridylic, 5-halo cytosine(Cyt), 5-proyl uridylic, 5-proyl cytosine(Cyt), 6-azauracil, 6-azepine cytosine(Cyt), 6-azathymine, 5-uridylic (pseudouracil), 4-thiouracil; The 8-halo-, 8-amino-, the 8-thiol-, 8-sulfane base-, 8-hydroxyl-and other 8-substituted adenines and guanines; The 5-halo-, 5-bromo-, 5-trifluoromethyl-and other 5-substituted uracil and cytosine(Cyt)s especially; The 7-methyl guanine; 7-methyladenine, guanozola, 8-azaadenine, the assorted guanine of 7-denitrification, the assorted VITAMIN B4 of 7-denitrification, 3-deazaguanine purine and the assorted VITAMIN B4 of 3-denitrification, 2-thiouracil, 2-sulphur thymus pyrimidine and 2-sulphur cytosine(Cyt) etc., wherein 5-methylcytosine is substituted by preferably, and this is to modify increase nucleic acid duplex stability because shown these.
The variant that preferably has the sequence of any one among SEQ ID NO 3 to the SEQ ID NO 93, one of them, two, three or four nucleotide bases replace through other nucleotide bases or through the nucleotide base of chemically modified.Variant should refer to the sequence of SEQ ID NO 3 to SEQ ID NO 93, wherein for example one to four nucleotide base through uridylic (U), 5-halo uridylic, 5-methyl-cytosine(Cyt) and/or N 6-methyl-VITAMIN B4 replaces.Especially preferred is the variant of SEQ ID NO 3, one of them, two or three nucleotide bases replace through above-mentioned part.
" oligonucleotide " is meant the oligomer or the polymer of Yeast Nucleic Acid (RNA) or thymus nucleic acid (DNA) or its stand-in or variant.Described term comprises the oligonucleotide of being made up of (main chain) key between the nucleotide base of natural generation, sugar and covalency nucleosides and the non-natural with identity function produces oligonucleotide partly.Because desired characteristic, for example enhanced cell absorbs, enhanced nucleic acid target affinity and the stability that increases in the presence of nuclease, so described modified or be substituted oligonucleotide and be better than natural form usually.Though antisense oligonucleotide is the antisense compounds of preferred form, other oligomerization antisense compounds are contained in the present invention, including (but not limited to) for example hereinafter described oligonucleotide mimetic.Antisense compounds according to the present invention comprises about 8 to about 50 nucleotide bases (promptly about 8 nucleosides to about 50 connections), is preferably 9-42,10-36,11-32,12-30,13-28,14-26, and highly preferred be 15-25 nucleotide base.
Especially preferred antisense compounds is an antisense oligonucleotide, even more preferably comprises about 15 antisense oligonucleotides to about 25 nucleotide bases.
Antisense compounds comprises ribozyme, external guide sequence (EGS), oligonucleotide (few enzyme) and hybridizes in target nucleic acid and suppress other shot-catalysts RNA or the catalytic oligonucleotide of its expression.
Term " salt " is meant the physiology of compound (antisense oligonucleotide especially of the present invention) and/or pharmaceutically acceptable salt.By the formed pharmaceutically acceptable base addition salt of mineral alkali is alkali.The example of suitable organic and mineral alkali is for being derived from metal ion (for example aluminium), alkalimetal ion (for example sodium or potassium), alkaline-earth metal ions (for example calcium or magnesium) or amine salt ionic alkali or basic metal or alkaline earth metal hydroxides, carbonate or supercarbonate.Example comprises moisture LiOH, NaOH, KOH, NH 4OH, salt of wormwood, ammonium hydrogencarbonate and sodium bicarbonate, ammonium salt; Primary amine, secondary amine and tertiary amine, for example hydroxide four alkane ammoniums; Than the low carbon number alkylamine, for example methylamine, TERTIARY BUTYL AMINE, PROCAINE HCL, PHARMA GRADE (procaine), thanomin; Aromatic yl alkyl amine, for example dibenzylamine and N, N-dibenzyl-ethylenediamin; Than low carbon number Alkylpiperidine, for example N-ethylpiperidine; Cycloalkyl amine, for example hexahydroaniline or dicyclohexyl amine; Morpholine; Glycosamine; The N-methyl-and N, N-dimethyl glycosamine; The 1-amantadine; Benzyl star (benzathine); Or derived from for example amino acid whose salt of arginine, Methionin, ornithine; Or the acid amides of natural neutrality or acidic amino acid; Chloroprocaine (chloroprocaine), choline, PROCAINE HCL, PHARMA GRADE or the like.
For the compound of the present invention of alkalescence can form pharmaceutically acceptable salt with organic acid and mineral acid.The example that is used for the appropriate acid of this acid salt formation is a hydrochloric acid, Hydrogen bromide, sulfuric acid, phosphoric acid, acetate, citric acid, oxalic acid, propanedioic acid, Whitfield's ointment, para-aminosalicylic acid, oxysuccinic acid, FUMARIC ACID TECH GRADE, succsinic acid, xitix, maleic acid, sulfonic acid, phosphonic acids, perchloric acid, nitric acid, formic acid, propionic acid, glyconic acid, lactic acid, tartrate, hydroxy-maleic acid, pyruvic acid, phenylacetic acid, phenylformic acid, para-amino benzoic acid, P-hydroxybenzoic acid, methylsulfonic acid, ethyl sulfonic acid, nitrous acid, ethylenehydrinsulfonic acid, vinyl sulfonic acid, tosic acid, naphthyl sulfonic acid, sulfanilic acid, camphorsulfonic acid (camphersulfonic acid), pottery acid (china acid), amygdalic acid, adjacent methyl-mandelic acid, hydrogen-Phenylsulfonic acid, picric acid, hexanodioic acid, D-o-tolyl tartrate, tartronic acid, α-toluic acid, (neighbour, between, to)-toluic acid, napthylamine sulfonic acid and known mineral acid of other one of ordinary skill in the art or carboxylic acid.In normal way by want sour contact ionization alkali form to prepare salt with capacity to produce salt.
Handle the salt free alkali form of regenerating with the suitable dilute alkaline aqueous solution of for example dilute sodium hydroxide, salt of wormwood, ammonium hydrogencarbonate and sodium bicarbonate aqueous solution.Free alkali form is different slightly on some physical properties (for example solvability in polar solvent) with its corresponding salt form, but for purposes of the present invention, described salt is equivalent to its corresponding free alkali form in addition.
Perhaps, medical composition of the present invention contains the carrier that allows to transcribe antisense oligonucleotide of the present invention (for example in mammalian hosts).This carrier is preferably the carrier that can be used for gene therapy.The preferred vector that can be used for gene therapy is a virus vector, for example adenovirus, baculovirus, simplexvirus, cowpox, perhaps more preferably RNA viruses, for example retrovirus.Retrovirus carrier even the derivative of murine or birds retrovirus more preferably.The example that can be used for described retrovirus carrier of the present invention is: Moloney murine leukemia virus (Moloneymurine leukemia virus, MoMuLV), Harvey murine sarcoma virus (Harvey murine sarcomavirus, HaMuSV), murine marrmary tumor virus (murine mammary tumor virus, MuMTV) and Rous sarcoma virus (Rous sarcoma virus, RSV).Most preferably, use non-human primate retrovirus carrier, for example (gibbon ape leukemiavirus GaLV), thereby provides with respect to murine carrier host range more widely gibbon ape leukemia virus.Because therefore recombinant retroviral enzymophathy poison defectiveness needs auxiliary to produce infected particle.For example, can provide so auxiliary by the auxiliary cell line that use contains in LTR the plasmid of all structure genes of coding retrovirus under regulating and controlling sequence control.Suitable helper is that one of ordinary skill in the art know.But described carrier can contain the gene of coding selective marker in addition, therefore can differentiate the cell through transduction.In addition, can make its mode that becomes target-specific modify the retrovirus carrier.For example, can realize this operation by the polynucleotide that insert coding sugar, glycolipid or albumen, are preferably antibody.The additive method of the known generation target-specific of one of ordinary skill in the art carrier.Be used in vitro or in vivo other suitable carriers of gene therapy and method are described in document and for known to the one of ordinary skill in the art; For example referring to WO 94/29469 or WO 97/00957.In order to reach the expression in the target organ (for example cerebral tissue) only, be used for the dna sequence dna that antisense oligonucleotide transcribes and be connected in tissue-specific promoter and be used for gene therapy.
In oligonucleotide structure, bound phosphate groups typically refers to main chain between the nucleosides that forms oligonucleotide.The normal key of RNA and DNA or main chain be 3 ' to 5 ' phosphodiester bond.The particular example that can be used for preferred antisense compounds of the present invention or variant comprises the oligonucleotide that contains key between modified main chain or non-natural nucleoside.Oligonucleotide with modified main chain comprises the oligonucleotide that does not have phosphorus atom in the oligonucleotide that keeps phosphorus atom in the main chain and the main chain.Can cause modified oligonucleotides main chain that stability increases for known to the one of ordinary skill in the art, described modification is preferably the phosphorothionate key or one or more bound phosphate groups (phosphate group) are replaced through phosphonic acid ester (phosphonic acids) group or through sulfuric ester (sulfuric acid) group or through sulphonate (sulfonic acid) group or through sulfoxide.Preferred oligonucleotide mimetic is to have showed the oligonucleotide mimetic with splendid hybridization characteristic, and is called as peptide nucleic acid(PNA) (PNA).In the PNA compound, main chain, especially the amino-ethyl glycine main chain of the sugar backbone of oligonucleotide through containing acid amides replaced.Keep nucleotide base, and it directly or indirectly is incorporated into the aza nitrogen atom of the amide moieties of main chain, and (for example referring to people such as Nielsen, Science 254 (1991), 1497-1500).
In the context of the present invention, " hybridization (hybridization) " means the hydrogen bonding between complementary nucleosides or the nucleotide base, its Ke Yi Wei Wo Sen-Ke Like (Watson-Crick), Hu Gesiting (Hoogsteen) or reverse Hu Gesiting hydrogen bonding.Term " complementary (complementary) " is meant accurate paired ability between two Nucleotide as used herein.For instance, if the Nucleotide of oligonucleotide specific location can with the Nucleotide hydrogen bonding at the same position place of DNA or RNA molecule, think that so oligonucleotide and DNA or RNA are complementary mutually in described position.When the correspondence position of capacity in each molecule was occupied by the Nucleotide of hydrogen bonding each other, oligonucleotide and DNA or RNA were complementary each other.Therefore, " but specific hybrid " and " complementation " is to be used to indicate the complementary of enough degree or accurately to match make that generation is stablized and specificity bonded term between oligonucleotide and DNA or RNA target.Affiliated field should be appreciated that the sequence of antisense compounds does not need and its target nucleic acid 100% complementation for the treatment of specific hybrid.The normal function that disturbs target DNA or RNA when combining of compound and target DNA or RNA molecule is when causing the effectiveness forfeiture, but the antisense compounds specific hybrid, and exist the complementarity of enough degree to combine the non-specific binding of (promptly under the situation that treatment is handled) under the required condition in specificity to avoid antisense compounds and non-target sequence.
In other preferred oligonucleotide mimetics, key between sugar and nucleosides (being the main chain of nucleotide units) is all replaced by novel group.Keeping the alkali unit is used for and suitably nucleic acid target compound hybridization.The example of having showed the described oligonucleotide mimetic with splendid hybridization characteristic is called as peptide nucleic acid(PNA) (PNA).In the PNA compound, the main chain of the sugar backbone of oligonucleotide through containing acid amides, especially replace through amino-ethyl glycine main chain.Keep nucleotide base, and it directly or indirectly is incorporated into the aza nitrogen atom of the amide moieties of main chain.
Another modification of oligonucleotide of the present invention comprises part or conjugate chemistry that one or more activity, cell distribution or cells that strengthens oligonucleotide are absorbed and is connected to oligonucleotide.Described part comprises lipid part, for example cholesterol moiety, cholic acid, thioether, hexyl-S-trityl mercaptan, sulfo-cholesterol, aliphatic chain (for example dodecanediol (dodecandiol) or undecyl residue), phosphatide (for example two hexadecyls-outer-glycerine (dihexadecyl-rac-glycerol) or triethyl ammonium-1,2-two-0-hexadecyl-outer-glycerine-3H-phosphonate), polyamine or polyglycol chain or adamantane acetic acid (adamantine acetic acid), palmityl part or octadecylamine or hexylamine base-carbonyl-oxygen base cholesterol moiety.The present invention also is included as the antisense compounds of chimeric compound.In the context of the present invention, " chimeric " antisense compounds or " mosaic " are to contain two or more chemically antisense compounds, especially oligonucleotide of different zones, each zone constitutes by at least one monomeric unit, promptly is Nucleotide under the situation of oligonucleotide compound.These oligonucleotide contain at least one zone usually, wherein oligonucleotide modified with the cell of giving resistance that oligonucleotide increases, increase to nuclease degradation absorb and/or increase to target nucleic acid in conjunction with affinity.The substrate of the enzyme that can shear RNA:DNA or RNA:RNA heterozygote can be served as in other zones of oligonucleotide.For instance.RNase H is a cellular endonuclease of shearing the RNA chain of RNA:DNA two zoariums.Therefore, the activation of RNase H causes the shearing of RNA target, and then the efficient that suppresses of the oligonucleotide of reinforcing gene expression greatly.Therefore, compare, when using chimeric oligonucleotide, use than short oligonucleotide and can obtain suitable result usually with the phosphorothionate deoxy-oligonucleotide of hybridizing in identical target region.Chimeric antisense compounds of the present invention can form the composite structure with two or more above-mentioned oligonucleotide, modified oligonucleotides, oligonucleoside and/or oligonucleotide mimetic.Also can be called heterozygote or gap body (gapmer) at compound described in the affiliated field.
The invention particularly relates to the purposes that the disclosed antisense oligonucleotide of this paper or its variant or stand-in are used for prophylactic treatment and treatment neurodegenerative illness, neural wound, neural blood vessel and neural inflammatory conditions (comprise and infect the back illness).Term " neurodegenerative illness and neural inflammatory conditions " is meant Alzheimer's disease, Parkinson's disease, storehouse Jia Shi disease (CJD), the neomorph (nvCJD) of storehouse Jia Shi disease, HallervordenSpatz Disease, Huntington's disease, multiple system atrophy, dull-witted, Frontemporal Dementia, the motor neuron illness, amyotrophic lateral sclerosis, spinal muscular atrophy, spinocerebellum atrophy (SCA), schizophrenia, affective disorder, the severe melancholia, meningoencephalitis, bacillary meningoencephalitis, viral meningoencephalitis, the CNS autoimmune disorder, multiple sclerosis (MS), acute ischemic/anoxia-induced apoptosis (comprising apoplexy), the CNS wound, injury of head, arteriosclerosis, arteriosclerosis, the microangiopathy dementia, binswanger, leukoaraiosis, retinal degeneration, cochlea is degenerated, macular degeneration, cochlear deafness, AIDS dependency dementia, retinitis pigmentosa, vulnerability X-dependency is trembled/ataxia syndromes (FXTAS), ophthalmic nerve nuclear paralysis disease (PSP) on the carrying out property, striatonigral degeneration (SND), Nux Canarii albi pon cerebellum degeneration disease (OPCD), shy dilatory person's syndromes (SDS).
More generally, the present invention relates to the disclosed antisense oligonucleotide of this paper or its variant or stand-in is used for the treatment of and TGF-R and/or TGF-R IIRise or the enhanced signal purposes of transmitting (for example TGF-β) relevant disease by improving the standard.Antisense oligonucleotide and then inhibition TGF-R and/or TGF-R IIExpression.Antisense compounds can replace antisense oligonucleotide to use, and perhaps can be used in combination with antisense oligonucleotide.Antisense compounds be meant this paper disclosed allow to transcribe the carrier of antisense oligonucleotide or be meant hybridize in coding TGF-R or TGF-R IINuclease, external guide sequence (EGS), few enzyme (Oligozyme) and the shot-catalyst RNA or the catalytic oligonucleotide of target nucleic acid.Described antisense compounds suppresses TGF-R or TGF-R IIExpression.Therefore, under described situation, existing TGF-R and/or TGF-R during the disease IIAmount reduce.
The disclosed antisense oligonucleotide of this paper can be used for regeneration with antisense compounds and is connected the injured nerve path again and is used for the treatment of various neurodegenerative illnesss and neural inflammatory conditions with functional.
In another preferred embodiment of the present invention, can be used for disturbing TGF-R and/or TGF-R IIThe compound of biologic activity be to reduce or suppress the compound that TGF-β 1 is incorporated into its acceptor.The preferred embodiment of these compounds is at TGF-beta receptor (referring to people such as Lin, 1992), preferred pin (neutralization) antibody to TGF-beta receptor II.Term " antibody " preferably relates to basically by the antibody that monoclonal antibody and unique monoclonal antibody formulation are formed that compiles with different epitope specificitys (epitopic specificity).Monoclonal antibody is by for example containing TGF-R or TGF-R by the known method of one of ordinary skill in the art IIThe antigen of fragment or corresponding acceptor makes.As used herein term " antibody " (Ab) or " monoclonal antibody " (Mab) mean comprise can binding proteins specific complete molecule and antibody fragment (for example Fab and F (ab ') 2 fragments).Fab and F (ab ') 2 fragments lack the Fc fragment of complete antibody, remove from circulation quickly, and can have the non-specific tissue bond lower than complete antibody.(people such as Wahl., J.Nucl.Med.24:316-325 (1983)).Therefore, the product in these fragments and FAB or other immunoglobulin expression libraries is preferred.In addition, the antibody that can be used for the object of the invention comprises chimeric antibody, single-chain antibody and humanized antibody.
Being used for other preferred compounds of the present invention is soluble T GF-beta receptor.The fusion rotein of the Fc district that described soluble T GF beta receptor is an antibody and the cell foreign lands of TGF beta receptor.Described molecule has high affinity to soluble T GF-β 1.Therefore, the concentration of free TGF-β 1 sharply descends.According to the laboratory manual (R﹠amp of manufacturer; D Systems, Germany), human TGF-β R will encode IIThe dna sequence dna of 159 amino-acid residue cell foreign lands (people such as Lin, Cell 1992,68 (4), 775-785) are blended in the Fc district of IgG 1, and express chimeric protein in mouse myeloma cell line NSO.
Term " solubility (soluble) " used in the context as this paper acceptor preferably relates to the receptor fragments that only comprises recipient cell foreign lands or its part, and it still can be in conjunction with its native ligand, and for example TGF-β 1.One of ordinary skill in the art can determine these fragments according to the known amino acid sequence of acceptor, and can determine the cell foreign lands of acceptor by using well-known process (for example by computer program (wetting ability mapping)).In the especially preferred embodiment of purposes of the present invention, described soluble T GF-beta receptor is TGF-beta receptor II.
The present invention also relates to be used for differentiate interference (a) TGF-R and/or TGF-R IIBiologic activity or TGF-R and/or TGF-R IIThe expression or (b) method of the compound that transmits of TGF-β 1/TGF-R signal, said method comprising the steps of:
(a) candidate compound is cultivated with the test macro that comprises TGF-β 1 and neurone precursor cell; With
(b) propagation of active TGF receptor expression of calibrating or neurone precursor cell; Wherein
(c) compare with the test macro that does not have described test compounds, (i) inhibition of active TGF expression of receptor or (ii) the disappearance indication of neurone precursor cell inhibition of proliferation have candidate compound with the characteristic of wanting.
The example of these candidate molecules comprises antibody, oligonucleotide, albumen (for example acceptor) or small molecules.Can design described molecule ideally with known technology.The described test macro that is used to screen preferably includes the material with similar chemistry and/or physical property, and described material most preferably is identical.Can be expression library by the compound that use preparation and differentiate according to the present invention, for example cDNA expression library, peptide, albumen, nucleic acid, antibody, little organic compound, part, hormone, peptide mimics, PNA or the like.Recently, WO 98/25146 describes and is used for screening the additive method that the complex body library has the compound of the characteristic of wanting, the described ability of wanting the especially short effect of characteristic, combination or antagonism polypeptide or its cell receptor.Complex body in the described library comprise the compound that is in test phase, record compound synthetic at least one step label and be subject to report the tethers (tether) of molecular modification.The modification of tethers is used to represent that complex body contains the compound with the characteristic of wanting.Can tag decoder to disclose at least one step of described compound in synthetic.For instance, differentiate with according to TGF-R of the present invention and/or TGF-R IIOr the additive method of the interactional compound of nucleic acid molecule of the described molecule of encoding is in vitro to screen with the phage indicating system, and filters in conjunction with calibrating or with (for example) BIAcore equipment (Pharmacia) " in real time " measurement interaction.Can all these methods used according to the invention disturb TGF-R and/or TGF-R to differentiate IIBiologic activity or the compound that transmits of described receptor expression or TGF β 1/TGF-R signal.
One of ordinary skill in the art also know can design, the stand-in of the little organic compound of substrate that synthetic and assessment (for example) can be served as the TGF beta receptor or part.For instance, the D-glucose stand-in of having described hapalosin are showed the similar efficient in the antagonism multi-drug resistance additional related albumen in cytotoxin to hapalosin; Referring to Dinh, J.Med.Chem.41 (1998), 981-987.The gene of coding TGF-β 1 or TGF-R also can serve as the target that is used to screen inhibitor.For instance, inhibitor can comprise in conjunction with coding TGF-R, be preferably TGF-R IIThe albumen of mRNA of gene, and then make the native conformation instability of mRNA, and hinder and transcribe and/or translate.In addition, describe to differentiate the method for nucleic acid molecule in the document, for example simulated compound institute's bonded in cell has through definition or without the RNA fragment of the structure of definition target RNA molecule, it causes the delay of cell growth or necrocytosis; For example reach the reference of wherein being quoted referring to WO 98/18947.These nucleic acid molecule can be used to differentiate the interested unknown compound of medicine and pharmacology, and are used to differentiate the unknown RNA target that is used for the treatment of disease.These method and compositions can be used to differentiate the compound that can be used for reducing TGF-β 1 and/or corresponding receptor expression level.Can the method according to this invention test and the compound differentiated can be expression library, cDNA expression library, peptide, albumen, nucleic acid, antibody, little organic compound, hormone, peptide mimics, PNA or the like (Milner for example, Nature Medicine 1 (1995), 879-880; Hupp, Cell 83 (1995), 237-245; Gibbs, Cell 7 (1994), 193-198 and the reference of above being quoted).In addition, for example can use (for example) bring out with the insertion of the gene of the known targeting vector in affiliated field sudden change identifier number TGF-β 1 the supposition regulon gene and/or in TGF-β 1 upstream or the gene that plays a role of downstream.Described compound also can be the functional derivatives or the analogue of known inhibitor.For instance, described useful compound can be for handling the factor (transacting factor), and it is in conjunction with TGF-R or TGF-R IIOr its regulating and controlling sequence of gene of encoding.Can differentiate with the standard method of affiliated field and handle the factor.In order to determine that albumen is self to be incorporated into albumen or regulating and controlling sequence, can carry out the analysis of standard natural rubber displacement body.In order to differentiate the processing factor that is incorporated into albumen or regulating and controlling sequence, albumen or regulating and controlling sequence can be as the affinity reagents in the standard protein purification method, perhaps as the probe that screens expression library.Also can realize identifier number and TGF-R or TGF-R IIThe nucleic acid molecule of interactional polypeptide, for example (Science 274 (1996), TGF-β 1 described in 2063-2065) as Scofield by using so-called yeast " two-hybrid system ".In described system, TGF-β 1 is connected in the DNA of GAL4 transcription factor in conjunction with the territory.The yeast strain of expressing this fusion polypeptide and comprising the lacZ reporter gene that is driven by suitable promotor is blended in the vegetable-protein of activation domain or the cDNA library of its polypeptide transforms through expression, and described suitable promotor is discerned by the GAL4 transcription factor.Therefore, if by a kind of coded peptide among the described cDNA can with comprise (for example) TGF-R or TGF-R IIThe fusogenic peptide of peptide interact, so described complex body can instruct the expression of reporter gene.For example, can be in this way with TGF-R or TGF-R IIDifferentiate and TGF-R or TGF-R with the gene of each acceptor of coding IIInteractional peptide and albumen.The obvious understanding of one of ordinary skill in the art can further be developed this and similar system to differentiate inhibitor.At last, the present invention relates to compound that method by mentioned earlier differentiates and be used to prepare that prevention or treatment are wherein neural takes place or neurotization has the purposes of medical composition of the disease of beneficial effect.The more detailed ground explain the present invention of following example.
The present invention also relates to differentiate the method for regulating the effect of institute's inductive treatment or prevention/prophylactic treatment by TGF-R-or TGF-RII-system at stem cell/precursor cell colony place.This may especially help to set up the successful treatment in the individual patient, thereby allows (for example) individually administration.Diagnostic method comprises
(a) use at TGF-R or TGF-RII and through the specificity nucleic (iodine, technetium, fluorine 18) of nuclear pharmaceuticals diagnostics or the general of specific antibody that is used for the rare earth element product/paramagnetism compound/iron particle mark of Magnetic resonance imaging through gadolinium salt, perfluoro-carbon or other.In this article, under the situation that does not have enough signal-to-noise ratios, must open the hemato encephalic barrier of subcuticle at once; Although this zone may enough be used for the visual of 3 Tesla machines through height vascularization and contrast gradient, open BBB and may be other help.This can carry out with intravenously hypertonicity solution (for example glycerine) or with VEGF (vascular endothelial growth factor).
(b) have the general of specific oligonucleotide (molecule same as described above) to use to TGF-R or TGF-RII: it can be through following mark:
Gd or 111In-DTPH (5 ' XXXXXXXXXXXXXXXXX3 '-vitamin H)-(SA-OX 26,8D3 or Ak-HIR) (wherein Gd is used for MRI, 111In is used for radiodiagnosis; OX 26 is used for mouse experiment and target mouse TfR, and 8D3 is a mouse anti rat TfR antibody, and AK-HIR is the antibody at human insulin's acceptor).These compounds can only hybridization and signal transmission in those cells of the active mRNA with TGF-R or TGF-RII.DTPH is as chelating construction agent, and Ak-HIR uses insulin receptor that oligonucleotide is shuttled back and forth in different barriers, and the latter is used to stride film and shuttles back and forth under the situation of TfR antibody.Have differentiated hybrid stability in these cells, wherein a large amount of mRNA can use, and therefore can detect significantly stronger signal (SusukiT, people such as Schlachetzki F, J.Nucl.Med.45:1766-1775,2004, Susuki T, Zhang Y, Zhang Y-f, Schlachetzki F, people such as Pardridge, Mol.Imaging 2005,3,356-363).
(c) (doublecortin DCX) has the general application (referring to WO2004067751) of specific oligonucleotide (molecule same as described above) to having two cortins as same tag in (b).
In medical composition, described above-claimed cpd preferably with the combination of pharmaceutically acceptable supporting agent." pharmaceutically acceptable (pharmaceutically acceptable) " means and contains any supporting agent, and it is the efficient of the biologic activity of interferon activity composition not, and the host's nontoxicity to being offerd medicine.The example of suitable medical supporting agent is known by affiliated technical field, and comprises phosphate buffered salt solution, water, emulsion (for example oil/water miscible liquid), various types of wetting agent, sterile solution etc.Can allocate described supporting agent with usual way, and can effective dose to person under inspection's active compound of offeing medicine." effective dose " thus be meant and be enough to influence disease process and seriousness causes the minimizing of described pathology or the amount of demulcent activeconstituents.Can determine to can be used for treating and/or preventing " effective dose " of these diseases or illness with the known method of one of ordinary skill in the art.Can realize the dispensing of suitable groups compound by different modes, for example by intravenously, intraperitoneal, subcutaneous, intramuscular, part or intracutaneous dispensing.Certainly, dosing way is decided on the kind of contained compound in the kind of therapy and the medical composition.In addition, compound of the present invention can form agent, receptor target molecule, solvent, sanitas and/or mixing diluents and dispensing with liposome, mixture.
Preferably infusion solution or solid substrate form be used for the pharmaceutical preparation that activeconstituents discharges continuously, it is in particular for the continuous release of at least a antisense oligonucleotide or its variant or stand-in.More preferably be suitable for the solution of topical administration in brain or the pharmaceutical preparation of solid substrate form.
Can determine dosage regimen by attending doctor and other clinical factors.Know as medical field, any patient's dosage is decided on many factors, comprises patient's the bodily form, body surface area, age, sex, the specific compound of being offerd medicine, dispensing time and approach, therapy kind, general health situation and the other drug of offeing medicine simultaneously.
The present invention relates to comprise the pharmaceutical preparation of at least a disclosed as mentioned oligonucleotide, its variant or stand-in.Replace or except that described at least a antisense oligonucleotide, can have at least a antisense compounds.Antisense compounds is meant to allow to transcribe the carrier of antisense oligonucleotide, the disclosed antisense oligonucleotide of especially a kind of this paper or be meant hybridizes in coding TGF-R or TGF-R IINuclease, external guide sequence (EGS), few enzyme and the shot-catalyst RNA or the catalytic oligonucleotide of target nucleic acid.Described antisense compounds suppresses TGF-R or TGF-R IIExpression, and be preferably and can reduce the TGF-R that forms or TGF-R respectively IIAmount.
In a preferred embodiment of the invention, the disease that can be prevented and/or treated is neural inflammatory conditions, acute ischemia or the wound brain anoxic brain injury of nerve degeneration illness, CNS.The preferred embodiment of nerve degeneration or neural inflammatory conditions is an Alzheimer's disease, Parkinson's disease, storehouse Jia Shi disease (CJD), the neomorph (nvCJD) of storehouse Jia Shi disease, HallervordenSpatz Disease, Huntington's disease, multiple system atrophy, dull-witted, Frontemporal Dementia, the motor neuron illness, amyotrophic lateral sclerosis, spinal muscular atrophy, spinocerebellum atrophy (SCA), schizophrenia, affective disorder, the severe melancholia, meningoencephalitis, bacillary meningoencephalitis and viral meningoencephalitis (the inflammation retarded depression of prevention stem cells hyperplasia), CNS autoimmune disorder (as multiple sclerosis (MS)), acute ischemic/anoxia-induced apoptosis, the CNS wound, injury of head, arteriosclerosis, arteriosclerosis, the microangiopathy dementia, binswanger, leukoaraiosis, AIDS dependency dementia, vulnerability X-dependency is trembled/ataxia syndromes (FXTAS), ophthalmic nerve nuclear paralysis disease (PSP) on the carrying out property, striatonigral degeneration (SND), Nux Canarii albi pon cerebellum degeneration disease (OPCD), shy dilatory person's syndromes (SDS), retinal degeneration, macular degeneration, retinitis pigmentosa, cochlea is degenerated, cochlear deafness.Also can handle the age dependency minimizing (age dependant decrease) that stem cell upgrades.
Description of drawings
Fig. 1: TGF-β 1 suppresses the propagation of adult rodent neural stem cell and precursor cell
A) grow up rodent neural stem cell and precursor cell (NCS) culture through the recombinant human TGF-β of various concentration (0,5,10,50 nanograms/milliliter) 1 processing 7 days.At the 7th day, in hemocytometer, get rid of calibrating and come living cell counting by trypan blue.Data are expressed as the average cell number ± SD from three experiments carrying out in triplicate.B) effect of the neural precursor cell of 1 couple of human foetus of expression TGF-β.
Fig. 2: the effect of 1 couple of NCS of TGF-β is reversible
The rodent neural stem cell of growing up and precursor cell culture were handled 7 days through the human recombinant TGF-of 10 nanograms/milliliter β 1.At the 7th day, dissociated cell was got rid of calibrating by trypan blue and is counted, and inoculate the 1 pretreated cell through TGF-β under the situation that is with or without 10 nanograms/milliliter TGF-β 1.Carried out once described program in per 7 days.Data are expressed as the average cell number ± SD from three experiments carrying out in triplicate.
Fig. 3: the antibody of anti-TGF-beta RII can reduce the effect of 1 couple of adult rodent NCS of TGF-β
The rodent NSC culture of growing up exists or does not exist under the anti-TGF-beta RII antibody (10 mcg/ml) through the recombinant human TGF-of 10 nanograms/milliliter β 1 processing 7 days.At the 7th day, in hemocytometer, get rid of calibrating and come living cell counting by trypan blue.Data are expressed as the average cell number ± SD from three experiments carrying out in triplicate.
Fig. 4: soluble T GF-RII suppresses the effect of 1 inductive NSC of TGF-β inhibition of proliferation
The rodent NSC culture of growing up exists or does not exist under the solubility anti-TGF-beta RII antibody (500 nanograms/milliliter) through the recombinant human TGF-of 10 nanograms/milliliter β 1 processing 7 days.At the 7th day, in hemocytometer, get rid of calibrating and come living cell counting by trypan blue.Data are expressed as the mean number ± SD from three experiments carrying out in triplicate.
Fig. 5: can be with the cell sorting technical point from TGF-β R II-express cell
As the rodent NSC that grows up of preparation as described in the example 1.Express the cell of TGF-bRII with the antibody purification of anti-TGF-bRII.About 20% NSC expressed receptor, and can use the described cell colony of this method enrichment.
Fig. 6: the antisense oligonucleotide of anti-TGF-beta RII in vitro suppresses the downward modulation of adult neural stem cell of 1 inductive of TGF-β and precursor cell propagation
Expression 1 inductive neural stem cell of TGF-β and the effect of precursor cell inhibition of proliferation are handled by antisense fully and specifically and are blocked.
Fig. 7: in vivo handle the blocking-up that to save cell proliferation in the adult brain of 1 inductive of TGF-β with TGF-RII specific antisense oligonucleotide
Fig. 7 proves the downward modulation of cell proliferation among 1 inductive hippocampus of TGF-β toe dentate gyrus (Fig. 7 A) and inferior ventricle district (Fig. 7 B).Can't block this effect with the processing of missense oligonucleotide, and antisense oligonucleotide is handled blocking-up TGF-β 1 effect (Fig. 7 A and B).
Fig. 8: in vivo handle the blocking-up that can stop cell proliferation in the adult brain of 1 inductive of TGF-β with TGF-RII specific antisense oligonucleotide
Fig. 8 proves that the downward modulation of cell proliferation among 1 inductive hippocampus of TGF-β toe dentate gyrus (Fig. 8 A) and inferior ventricle district (Fig. 8 B) can be stoped by carrying out pre-treatment with the processing of TGF-β RII antisense oligonucleotide.
Embodiment
Example
Example 1
TGF-β 1 suppresses the propagation of adult rodent neural stem cell and precursor cell.
(3-4 month big for kill adult female mice (various kind) or Fischer-344 rat; Charles River Germany), removes brain and spinal cord, and places and contain 4.5 grams per liter glucose (Merck, (PAN is Germany) in (DPBS/glu) for 4 ℃ of DPBS Germany).Remove and cover meninx and blood vessel.Under aseptic condition, remove hippocampus and ependyma district, comprise the following and ventricle inferior segment of epidermis from the sidewall of tricorn (SVZ).The tissue that cuts is transferred among the fresh DPBS/glu, cleans once, be transferred to petri diss (Petridish) and mechanical dissociation.Clean cell suspending liquid washing excessive blood off with DPBS/glu, and resuspending is in no Mg 2/ Ca 2(PAA, Germany) contain 0.01% papoid (Worthington Biochemicals among the HBSS (PAN), England), 0.1% Dispase II (dispase II) (Boehringer Mannheim, Mannheim, Germany), 0.01%DNase I (Worthington Biochemicals) and 12.4 mmoles/rise MgSO 4PPD solution in, and at room temperature digested 30 to 40 minutes.Ground cell suspending liquid in per 10 minutes.Collection is through dissociated cell, and resuspending is in containing 2 mmoles/rise in the serum-free DMEM/F12 substratum of L-glutaminate and 0.1 grams per liter penicillin/streptomycin, and cleans three times with the fine grinding thing.At last with single-cell suspension liquid resuspending in be supplemented with B27 (Gibco BRL) (NB/B27), 2 mmoles/rise L-glutaminate (PAN), 0.1 grams per liter penicillin/streptomycin (PAN), 2 grams per milliliter heparin (Sigma, Taufkirchen, Germany), 20 nanograms/milliliter bFGF-2 (R﹠amp; DSystems is Germany) with 20 nanograms/milliliter EGF (R﹠amp; D Systems, NB substratum Germany) (Gibco BRL, Germany) in.In hemocytometer, get rid of calibrating and come living cell counting by trypan blue.Cell inoculation in the T-25 culture flask, and is contained culture in the incubator of 5%CO2 and keeps under 37 ℃.Unicellularly in suspension culture 5 to 7 days begin to form spheroid, and it is agglomerating to continue raised growth in coming weeks.Changed half substratum in per 7 days.The cell in the 3rd to 20 generation is used for testing (Wachs, F.P., people such as S.Couillard-Despres, Lab Invest2003,83 (7), 949-962).The culture of neural stem cell and precursor cell is called NSC in addition.For dissociation process, in 15 milliliters of centrifuge tubes, collect the substratum contain floating neural spheroid, and under 120 relative centrifugal forces centrifugal 5 minutes.Centrifugal fritter resuspending in 200 microlitre Accutase (Innovative Cell Technologies Inc. is by the PAA distribution), and is ground about 10 times with pipette.Subsequently cell suspending liquid was cultivated 10 minutes down at 37 ℃.Regrinding is through dissociated spheroid, and resuspending is in 800 microlitre NB/B27 substratum.Centrifugal through dissociated cell 5 minutes under 120 relative centrifugal forces, and resuspending is in the NB/B27 substratum.In hemocytometer, get rid of calibrating and count aliquots containig to determine the amount of viable cell by trypan blue.With cell (10 5) coated plate is in the NB/B27 substratum of the T75 culture flask that is used for long-term subculture (every flask contains 10 milliliters of substratum).Accutase handles the cell proliferation that is obtained after the neural spheroid of one-level and produces the neural spheroid of secondary.Make the neural spheroid subculture of secondary 7 to 9 days after the neural spheroid cell of coated plate one-level.Similar to the neural spheroid of one-level culture and one-level, the unicellular propagation that is obtained after the neural spheroid of secondary dissociates and produce three grades of neural spheroids (Wachs, F.P., people such as S.Couillard-Despres, Lab Invest 2003,83 (7), 949-962).With 10 4Individual NSC is inoculated in the NB/B27 substratum of 1 ml volumes in 12 orifice plates, and grows 7 days.Inoculate back 2 hours, 3 days and 6 days recombinant human transforminggrowthfactor-(TGF-β 1) (R﹠amp by the various concentration of adding (0,2.5,5,10,50 and 100 nanograms/milliliter); D Systems Germany) comes irritation cell.At the 7th day, by using the Accutase culture that dissociates, and in hemocytometer, get rid of calibrating and come living cell counting by trypan blue.TGF-β 1 in vitro suppresses the propagation (Figure 1A) of adult neural stem cell and precursor cell in the dose-dependently mode.
In the neural precursor cell of human foetus, observe similar action.In 7 days, handle about 50% (Figure 1B) that cell proliferation can be reduced to contrast with 50 nanograms/milliliter TGF-β 1.
Example 2
The effect of 1 pair of neural stem cell of TGF-β and precursor cell is a reversible
In order to determine whether the effect of 1 inductive growth-inhibiting of TGF-β is reversible action, stimulated 7 days with 1 couple of NSC of 10 nanograms/milliliter TGF-β according to example 1 described experimental program.After dissociating, in hemocytometer, get rid of calibrating and come living cell counting by trypan blue, and with 10 4Individual NSC through factors stimulated growth inoculates, and cultivates under the situation that is with or without 10 nanograms/milliliter TGF-β 1 according to example 1 described experimental program.Carried out described dissociating/count/inoculate program in per 7 days.As shown in Figure 2, cultivated for 3 weeks after, compare with previous undressed cell, the multiplication rate of handling cell at the initial TGF-β 1 that does not have TGF-β 1 time growth returns to normally.The effect of this indication 1 pair of adult neural stem cell of TGF-β and precursor cell is a reversible.Can further not reduce cell proliferation with TGF-β 1 long-term cultivation.
Example 3
Anti-TGF-beta R IIAntibody can reduce by the effect of 1 couple of adult rodent NSC of TGF-β
By use as example 1 described Accutase dissociate low algebraically without stimulating 7 ages in days nerve spheroid.Gained single-cell suspension liquid is used for blocking-up and analyzes.With in the NB/B27 substratum of 1 ml volumes in 12 orifice plates 10 4The adult rodent NSC of density inoculation of individual cell.Stimulated preceding 1 hour back 2 hours of inoculation with 10 nanograms/milliliter TGF-β 1, in substratum, add various concentration in and anti-TGF-beta R IIAntibody (R﹠amp; D Systems, Germany).Inoculation back 3 days and 6 days, by add with the 1st day carry out the identical anti-TGF-beta R of program IIAntibody and TGF-β 1 come irritation cell again.At the 7th day, by using the Accutase culture that dissociates, and in hemocytometer, get rid of calibrating and come living cell counting by trypan blue.Interesting is to add anti-TGF-beta R IIAntibody self can reduce the propagation of NSC.Even under used maximum concentration (10 mcg/ml), anti-TGF-beta R IIAntibody only can partly suppress 1 inductive effect of TGF-β (Fig. 3).
Example 4
Soluble T GF-β IISuppress 1 inductive NSC of TGF-β inhibition of proliferation fully
According to the laboratory manual (R﹠amp of manufacturer; D Systems, Germany), human TGF-β R will encode IIThe dna sequence dna of 159 amino-acid residue cell foreign lands (people such as Lin, Cell 1992,68 (4), 775-785) are blended in the Fc district of IgG 1, and express chimeric protein in mouse myeloma cell line NSO.By use as example 1 described Accutase dissociate low algebraically without stimulating 7 ages in days nerve spheroid.Gained single-cell suspension liquid is used for blocking-up and analyzes.With in the NB/B27 substratum of 1 ml volumes in 12 orifice plates 10 4The adult rodent NSC of density inoculation of individual cell.Stimulated preceding 1 hour back 2 hours of inoculation with 10 nanograms/milliliter TGF-β 1, in substratum, add the biological activity soluble recombined human class TGF-β sR of various concentration II/ Fc mosaic (R﹠amp; D Systems, Germany).Inoculation back 3 days and 6 days, by add with the 1st day carry out program identical TGF-β sRII/Fc mosaic and TGF-β 1 and come irritation cell again.At the 7th day, by using the Accutase culture that dissociates, and in hemocytometer, get rid of calibrating and come living cell counting by trypan blue.Interesting is to add TGF-β sR II/ Fc mosaic can be blocked 1 inductive effect of TGF-β (data not shown) fully in the dose-dependently mode.By pre-dispensing soluble recombined human class TGF-β sR II/ Fc mosaic (soluble T GF-β R II) remove 1 inductive growth-inhibiting of TGF-β (Fig. 4) that active TGF-β 1 in the cell culture supernatant liquid can block grow up neural stem cell and precursor cell significantly fully.
Example 5
Can be with the cell sorting technical point from TGF-β R II-express cell.
Present method does not allow quick and believable the separation and purifying of neural stem cell and precursor cell.In order to study the possibility of separating pure neural stem cell and precursor cell colony based on the expression of definition surface markers, we by different technologies according to TGF-β R IIExpression separate neural stem cell and precursor cell.The enough two kinds of technical points of energy are from TGF-β R IIExpress neural stem cell and precursor cell i) FACS-sorting (data not shown), ii) MACS-sorting.Will be under the room temperature through dissociated adult neural stem cell and precursor cell and the anti-TGF-R of 10 mcg/ml IIOne-level antibody (R﹠amp; D Systems Germany) cultivates 20 minutes together.After 1 PBS cleaning step, cell (Dianova) is cultivated with the anti-goat PE of secondary antibody rabbit (1: 500).After 1 PBS cleaning step, (Miltenyi Biotech Germany) uses coupling in three grades of antibody staining cells of the anti-PE of paramagnetic bead according to manufacturer's laboratory manual.(Miltenyi Biotech Germany) uses MACS-system magnetic force sorting cells suspension, and counts feminine gender and the positive cell after the sorting and be dissolved in (Fig. 5) in the culture according to manufacturer's laboratory manual.All of about 20% are TGF-β R through sorting cells dyeing IIPositive.
Example 6
The antisense oligonucleotide of anti-TGF-beta RII in vitro suppresses the downward modulation of adult neural stem cell of 1 inductive of TGF-β and precursor cell propagation.
Described in example 1, prepare, dissociate and the coated plate cell.Subsequently be with or without 10 nanograms/milliliter TGF-β, 1,10 micromoles per liter TGF-β RII antisense oligonucleotides 5 '-cagcccccgacccatg-3 ' (SEQ ID NO:3), positive MODN 5 '-catgggtcgggggctg-3 ' or missense 5 '-situation of catccccggacccgtg-3 ' under 1 week of culturing cell.Oligonucleotide is modified through phosphorothionate, and changes the substratum that contains oligonucleotide every day.Attention 1 inductive nerve trunk of TGF-β and presoma inhibition of proliferation are handled by antisense (SEQ ID NO:3) fully and specifically and are blocked (Fig. 6).
Example 7
In vivo handle the blocking-up that to save cell proliferation in the adult brain of 1 inductive of TGF-β with TGF-RII specific antisense oligonucleotide.
Described example proof i) TGF-β 1 merge to the effect of in vivo neural stem cell and progenitor cell proliferation and ii) TGF β RII antisense oligonucleotide handle rescue to this effect.Therefore, the following experiment of design:
In TGF-β two weeks of 1 ventricle endomixis, then TGF-β 1 merges altogether with oligonucleotide.Carry out experimentation on animals according to European Communities on the 24th Council Directive November in 1986 (86/609/EEC).(Stadt Land) implants two months big male Fischer-344 rats (n=24) to be used for brain inner room infusion as indicated above for model 2001, Alza with being connected in the stainless steel pipe that permeates minipump.Animal receives the reorganization TGF-β (having 500 nanograms/milliliter in the pump) or mechanical brains spinal fluid (aCSF) (each n=8) two weeks in contrast of 0.5 microlitre/hour flow rate.After second week, change pump, and in ensuing two weeks, the combination of aCSF, TGF-β 1 (having 500 nanograms/milliliter in the pump) or TGF-β 1 (having 500 nanograms/milliliter in the pump) and thiophosphatephosphorothioate oligonucleotide (existence 1.64 mmoles in the pump/rise concentration) is infused in the ventricle.Oligonucleotide is described in the example 6.At the 27th day, animal received 200 mg/kg bromo-deoxyuridines (BrdU) of single peritoneal injection.Second day, perfusion 4% Paraformaldehyde 96 in the animal via heart.Handle tissue to be used for as described color development or surface fluorescence immunodetection at 40 micromoles per liter sagittal sections.With being equipped with Spot digital camera (Diagnostic Instrument Inc, Sterling Heights, USA) Leica microscope (Leica Mikroskopie und Systeme GmbH, Wetzlar, Germany) or laser confocal scanning microscope (Leica TCS-NT, Bensheim Germany) carries out the surface fluorescence analysis.One-level antibody is: and rat α-BrdU 1: 250 (Oxford Biotechnology, Oxford, UK).Secondary antibody is: conjugate to fluorescein (FITC), rhodamine X (rhodamine X, RHOX), CY5 or vitamin H 1: 500 donkey α-goat, mouse, rabbit or rat (Jackson Immuno Research, West Grove, PA, USA).In order to count using system and random process.Be arranged in minimum, middle and three 50 microns * 50 microns counting frames counting BrdU positive cells of the tangent plane of high part of SVZ at each.The positive profile that the top focusing surface (eliminating face) of counting frame or sidepiece are got rid of the border is cut apart in no count.Positive profile sum be multiply by the ratio of reference volume and sample volume, with the estimated number of the BrdU positive cell that obtains each structure.Calculate Interhemispheric all extrapolated values, and should multiply by 2 to represent total brain value.Data are expressed as mean+SD (SD).Between TGF-β 1 treatment group and control group, use not in pairs, both-end t calibrating relatively (student t calibrating) carry out statistical study (StatView Software, Cary, NC, USA).Suppose that conspicuous level is p<0.05.Fig. 7 proves the downward modulation of cell proliferation among 1 inductive hippocampus of TGF-β toe dentate gyrus (Fig. 7 A) and inferior ventricle district (Fig. 7 B).Do not block this effect with the processing that the missense oligonucleotide carries out.On the contrary, antisense oligonucleotide is handled (SEQ ID NO:3) blocking-up TGF-β 1 effect (Fig. 7 A and B).
Example 8
In vivo handle the blocking-up that can stop cell proliferation in the adult brain of 1 inductive of TGF-β with TGF-RII specific antisense oligonucleotide.
This example proof is handled the downward modulation that can stop cell proliferation in the adult brain of 1 inductive of TGF-β to the antisense oligonucleotide of TGF-β RII.
With one week of oligonucleotide ventricle endomixis, then TGF-β 1 merges altogether with oligonucleotide.Carry out experimentation on animals according to European Communities on the 24th Council Directive November in 1986 (86/609/EEC).(Stadt Land) implants two months big male Fischer-344 rats (n=24) to be used for brain inner room infusion as indicated above for model 2001, Alza with being connected in the stainless steel pipe that permeates minipump.Animal receives thiophosphatephosphorothioate oligonucleotide (exist in the pump 1.64 mmoles/rise concentration) or aCSF in first week, and receives aCSF, TGF-β 1 (having 500 nanograms/milliliter in the pump) or the TGF-β 1 of infusion (existence 500 nanograms/milliliter in the pump) and thiophosphatephosphorothioate oligonucleotide (existence 1.64 mmoles in the pump/rise concentration) altogether in the second and the 3rd week.Oligonucleotide is described in the example 6.At the 20th day, animal received 200 mg/kg bromo-deoxyuridines (BrdU) of single peritoneal injection.Second day, perfusion 4% Paraformaldehyde 96 in the animal via heart.As processing as described in the example 7 and analyze tissue.Fig. 8 proves that the downward modulation of cell proliferation among 1 inductive hippocampus of TGF-β toe dentate gyrus (Fig. 8 A) and inferior ventricle district (Fig. 8 B) can be stoped by carrying out pre-treatment with TGF-β RII antisense oligonucleotide (SEQ ID NO:3) processing.
Example 9
The pharmaceutical formulation that comprises at least a antisense oligonucleotide
The moisture composite of Three Represents that is used for antisense oligonucleotide:
1. in aCSF: 148.0 mmoles/rise NaCl, 3.0 mmoles/rise KCl, 1.4 mmoles/rise CaCl 2, 0.8 mmole/rise MgCl 2, 1.5 mmoles/rise Na 2HPO 4, 0.2 mmole/rise NaH 2PO 4(pH7.4), 100 mcg/ml rat blood serum albumin, 50 mcg/ml gentamicins (Gentamycin)
2. in 0.9%NaCl
3. in H 2Among the O.
Sequence table
<110〉Regenion GmbH
<120〉the TGF-R signal that is used for the treatment of the CNS illness transmits inhibitor
<130>HPT-P01374WO
<140>PCT/EP2005/001298
<141>2005-02-09
<150>EP?04002846.6
<151>2004-02-09
<160>96
<170>PatentIn?Ver.2.1
<210>1
<211>89014
<212>DNA
<213〉homo sapiens
<400>1
CAGCCACACT?GTCTTTAACT?CTCAGCCCAC?CCACACTGAG?GAGGGTGCCT?AGAGGTTCTA 60
TTTCCAAACC?TTTGCATGTA?TCTTAAAAAT?CTCAATAAAA?TGAGACCTTC?CACCATCCAA 120
ACAGAGCTGA?TATTCTCACT?ACCAGTCCCT?CTCTAATATT?CCTATTTGGC?TGAAAATAAG 180
TAGCTTCAAA?AAGTTTTAAA?AAAGAGATTA?CTTGCAGCAT?TAACACTTCT?TTGTTGATTA 240
ACAAGTTTCC?TATGGAGTTT?TAAAGCTCAT?ACTTTGTTCT?TGTCCTTGTG?GACACAAATT 300
TTCTAACTGC?AAATGGGACC?TTTGTGTCCC?ACATTCAAAT?CCTCTCTAGT?AATTTCTGCA 360
AAGGTTGAGA?AGGCTGGCAT?GATGGAGAGA?ACGGTAACCA?TGAGGAAAGC?TTCTTGGAGT 420
AAAGCACTCC?TCTCTCCAAT?GCAGAGGGTA?AAACTATTAA?CATATAAGCA?AAAGAAACTT 480
GGGCTAACTG?AGACCCTTAA?AGGAGTTCCC?CTTTAGTCCA?ATAAAAGGCC?AACTTCAAAT 540
CTTAACACCA?GATAAGGTAG?TCAAAATCAT?ATTATATACC?CAGAGAATGA?CTGCTTGAAT 600
GGACATTTCT?TACAAGGGAC?CTTGGTTAGG?TGCAGATTTA?ATTCCTAGAC?TGGGGTCCAG 660
GTAGGCAGTG?GAAAGAGCTA?ATGTTTACAG?TGAGAAGTGA?GGCAGCTTTG?TAAGTGTCTC 720
CACACCTTCA?CATTTTGTGA?ACGTGGACTG?GAGATAACTG?AAAACCATCT?GCTATCCTTA 780
CCTGGGGATC?CAGATTTTCC?TGCAAAATCT?CCAAATATTT?ATAAAGTGGC?TTCACTTTTT 840
GAAACGCTGT?GCTGACCAAA?CAAAACATAT?GTTTAGAGTG?CCTGAGGTCA?TAGTCCTGAC 900
AATGATAGTA?TTGTGTAGTT?GAAATCCTCT?TCATCAGGCC?AAACTGTGCT?TGAGCAATCA 960
GGAGCCCAGA?AAGATGGAAC?CCATTGGTGT?TTGTATAGAA?AACTAGAAAA?TCAAGTCAAG?1020
TGTAATGAAA?AAGTAAACAC?GATAAAGCCT?AGAGTGAGAA?TTTGCTCCTT?TTTAGAAAAG?1080
GATGAAGGCT?GGGAGCAGAG?AATAGTAACA?TAAGTGCAGG?GGAAAGATGA?AAAAAAGAAC?1140
AATTTTTCAT?TAGTAGATGG?TGGGGCAATC?GCATGGATGG?GGACATCTGT?TCTGATTTTT?1200
CTGCAACCCA?TGAAGGTAAA?AAGTGGGGTT?CAAAACATTC?AAGGTATTAA?AGATGGGGTA?1260
GAGTTTCTAA?ACTAGGTTGA?GGGAGAGTTT?CTAAACTAGC?CCCCCAGATT?TGGGGCTTGG?1320
AGCTTAAATG?AAAAGTCCAG?GAGAAATAAG?GGCACACAGG?AACCCCGGGA?ACACTGGTCC?1380
TCAAACAGTG?CCACTGTACT?TAGTTCCATG?GCCAGAAGAG?AAGTGCTAGG?CAGGGAATGA?1440
TTATTTTGCA?AAAGCAAGTG?CAATGTGGTC?ATAGCTGGCT?GTGAGACATG?GAGCCTCTTT?1500
CCTCATGCAA?AGTTCACTGT?TTTACAGTCA?GAGAACCACT?GCATGTGTGA?TTGTCAAATG?1560
CTAATGCTGT?CATGGGTCCC?TTCCTTCTCT?GCTTGGTTCT?GGAGTTCTCC?AATAAAACCA?1620
ATTTCCTGGG?AATATTTGAT?GTTTTTCCTT?GTCTCTTTTC?AAGGTATGGC?TATATATATA?1680
GAGCTATAGA?CATATATAGA?TATATATATA?TATATATAAA?ACATAGCTAT?TCATATTTAT?1740
ATACAGGCAT?TAATAAAGTG?CAAATGTTAT?TGGCTATTGT?AAAAATCAAT?CTCATTTCCT?1800
GAGGAAGTGC?TAACACAGCT?TATCCTATGA?CAATGTCAAA?GGCATAGAAT?GCTCTATGTC?1860
ACCCACTCCC?TGCTGCTGTT?GTTTCTGCTT?ATCCCCACAG?CTTACAGGGA?GGGGAGTGAC?1920
CCCCTTGGTT?TTCCAGGAAG?CATCAGTTCA?GGGGCAGCTT?CCTGCTGCCT?CTGTTCTTTG?1980
GTGAGAGGGG?CAGCCTCTTT?GGACATGGCC?CAGCCTGCCC?CAGAAGAGCT?ATTTGGTAGT?2040
GTTTAGGGAG?CCGTCTTCAG?GAATCTTCTC?CTCCGAGCAG?CTCCTCCCCG?AGAGCCTGTC?2100
CAGATGCTCC?AGCTCACTGA?AGCGTTCTGC?CACACACTGG?GCTGTGAGAC?GGGCCTCTGG?2160
GTCGTGGTCC?CAGCACTCAG?TCAACGTCTC?ACACACCATC?TGGATGCCCT?GTAGCGGGAA?2220
AGAGATCCAA?AGGGCACCAT?GAGTTGGTGG?GCTCCGCGGA?AGGCAAGGTG?GCCTGCTGAC?2280
CTTGTTGCTA?TAGTGAGTGC?AAGCAGGGTC?CAAAAGTGCC?TGTGCATTTA?ACATGTGCTG?2340
ACTGAGTGCC?TGCTGCTGCA?GGCCAGCCAG?TTCCATGTGG?AAAGGGTGGT?GGGGGGTTTG?2400
TGCTGGTGGC?AGCTGTGCTC?AAAACCTACC?ATACTTTTTG?GCTCTGGTGC?TATCTGATCA?2460
CAATAGGTCC?TGACAGCACA?ATGATCCTCT?GCTGGGCTTC?TGGGGTACAC?TAACACTCCC?2520
AACACCTGAA?AATTCCCCAT?GTAGTGGCCC?TTAATATCAT?TTCAACACCT?TTCTATTTAG?2580
AGAAGTTCTC?GCTTCACAGC?AAAATTGAGT?GGAAAGTACA?GAGAGTTTTC?ACAAAACCCC?2640
TTCCCCATAA?AGGCACAGCC?TTCTCCACCT?TGACATCATG?CATGCATCTA?TGAGGTACAT?2700
TTGTTATAAC?TGATGAACTA?ACACTGACGT?ATCATTATCA?ATCAAATTCA?TAGTTTACAT?2760
TAGGGTTCAC?TCTTGGTGTT?GTATATTCCA?GGGGTTTTGA?CAAATGTATA?ATGACATGTA?2820
TCTACCATTA?TAGTATCATG?CGGAATAGTT?TCTCTGCCCC?TCAAATTCCC?TGCATTCCAC?2880
TTATTCATCC?CTCCCTCCAT?TCCCCTAAAT?TTCTGGCAGC?CACTGATTTT?GTACTGTCTC?2940
TGTAGTTTTT?GCCTTTTCCA?GAGTGTCATA?TAGTTGGGTC?ATATACACTG?TTCTATTTTA?3000
ACAGGGCTGA?TTACCCCCGT?CAGAATTGTA?TGCAGGCATT?AGCATGGTTT?CATTTTCTAT?3060
AGGCCACACA?TTTTGTAGAG?TGATTCAGTA?GCAGCTTCTA?CGAGCTGCCA?AGGATGACCT?3120
CTGGGATGCT?CCATTCCTCT?CCAACAACAT?TGGGTTGAAC?CCTGTGAAAC?AGCTGCCTAT?3180
GTGGGTCAGG?CATGCTTAAC?TCTATGCCAT?TTCCTAGGGT?TCACCCTAAC?CGAATCAAGC?3240
TCCCATCCAA?GGAGACCATC?CAGGAGATCC?TGCCCAGGAA?GGTGGCAAGA?GTTTTCTCTC?3300
ACTGGCTTAA?TTTTTATTTT?GCATTGCAAA?TATTTTTGTT?ATCATTTCAA?ATCCTTTTTG?3360
GAAATAAAGC?AGGCAGGAGT?TAAGTAAATG?GTCTGATAGG?TGGAAATAGA?GTGTGCTCCT?3420
CCCAATTGTA?AGATCAACAT?TGCTAATGGG?ATCCCTCACA?CAGGTGGCTG?GGAGTGGGAT?3480
GGATAAATCT?CAAAACTACC?TGGGAGAGCT?GGCACTTTTT?CTACTTGTTT?TCTAATACCA?3540
ACAACTTTCC?AAACACACCT?AGGAGCCTAT?CTCTCCCTCC?CCACCCGATG?AGTTCATGAT?3600
GTTAAATTAA?TTGCATAATT?CACCTAATTG?ACAGTATTGA?CAGATGGCCC?TGTTAAGAGT?3660
AGAGTGCTAT?TGTTGGTACA?CAAGTAACAT?TTATTTTATT?CTGGCACTGT?AATTACAGGC?3720
AGTAAATTAA?ATTAAATATT?AAGCATTAAC?TTGAAATCAA?TAGGGCAACA?AATCTCATTA?3780
TGAGAAAAAA?TGTATTATGC?AAATTCTTTT?CAGAATTTTA?TCATCATGAA?TAATGGCTTC?3840
ATTACGAGAA?CTATACAGCA?GAGGAGGCAA?CAGAGTTTGA?AAGAAACATA?ACACTCCAGC?3900
ACATTCTGAT?TTCAGAATTT?ATGCAAAATA?TTCTTACAGT?TTTAGTGTCA?AAGAGGATTT?3960
GCTCAAAACT?CCAGAGAAGC?CTGTGACCCA?CCACAGCCTG?GTTCCCCCTC?GCCAACCTCC?4020
TCGGACTTTA?TTAAGGTCTG?TCTGCTGAAG?TGGCTCTGGG?CCAGGACTGG?CACAGACCAG?4080
ACTTCCTGCT?CCATTTGTCT?TCCCGATTGT?GCCTGATTTG?TTGTTTCTGT?TTCTTATCTG?4140
AATTTGCCTT?GCCCTTAGGG?AAACCAACAA?CTTAGCCTCG?GCCTTCATGG?TTGAGGGAAT?4200
TCATCCAAAA?GAGGCAATAA?AAGGTTTTAG?TCAGTAGAAA?GAACAGTCTT?CTCAGTGAGA?4260
TAGGGCCACA?CTGTTCTCTC?TCATTCTTCA?CTAAGGGCTC?CTTCCTGGGT?GTGTCAGACA?4320
TATAGCTGGT?TCTGACTCAC?TCACAACCTA?TCGTTTTCTT?TTTTCTCTGA?CCATTGCCCT?4380
CATCAAAGTG?CCCCCAAACA?AACAATTTGG?ATCAGCCTCT?TTATGAGTCC?AGAATGACTG?4440
CCCTGCTATG?GACAGCCTTA?GCTAGCATTT?CTTAACAAGG?AAAAATAAGA?GGCCATTAGG?4500
ATGTTCCCAA?CAGACAGATT?TCTCGTTCCT?TCCAGGGCAT?TCTCCTCTTC?TTTGCTTTCC?4560
TTAATTCCAG?AGTGAGGAGT?CGGTCTCCTC?TTTCCCACGC?GTGCTCACTC?AGGCCTCTCC?4620
CAAGTCTGTG?AGCACAGCCT?GCAAACACCT?GTACACAGCC?TTCTGCATGC?CACAGTCACT?4680
TCTCACTACA?GCTGCCTGAC?AAACCCTGCT?TGTTTTGCAT?CTGCTAAGTA?TTTCCTTATG?4740
GAGCTGAAGA?TTCCCAGAAG?AAAACATTTG?GAATCCAGAG?GGAATCAAAT?ATAAACTCCT?4800
GACGTGAAGG?CCCAGGAGTA?AGTAGCAGAG?GCTGCAAACA?AAATGTTTTA?ACCCAGGACC?4860
AAGGGGGCTT?GGAAAATGTG?GCAAATGTCC?TCCGAATGGC?TATTTGTGAA?CTCTCAGAGT?4920
ACATATCAGC?TGGTTGGAGC?CTATAATAAT?TGGGTTATCC?ACTGTATTGA?AATTTGCTTT?4980
ATAAACAAAA?TTTAACAGGG?CCATAGAACA?CAATGGGACC?TTCCCTCAGA?TTTAAGCTCA?5040
ATATTCCAGA?ATTCTCTGCC?ACCTAAGAGG?CAACTTGGTT?GAATCTTACT?GACCTTTGTA?5100
AACACTCACT?CCTTACCTGG?TGGTTGAGCC?AGAAGCTGGG?AATTTCTGGT?CGCCCTCGAT?5160
CTCTCAACAC?GTTGTCCTTC?ATGCTTTCGA?CACAGGGGTG?CTCCCGCACC?TTGGAACCAA?5220
ATGGAGGCTC?ATAATCTTTT?ACTTCTGTGA?AGAAAGCCAG?CAAACACAGG?GTCACTGAGA?5280
ATGGCATGTG?CAGCCAAAGG?AAATGAGCAT?GGTGAGATGC?CTGGCTGGGG?AGCATGAAGC?5340
ACTAAGTAAC?AAATACATAC?GTAATTACTC?TAAGAGCAAA?TTTTAATAAT?AATGGCTAAG?5400
ATAAGAAGGA?AGGAGTGGTT?GGGGAAGGGC?TAGAGAAGTA?TTCAATAAAT?GATTGTTGAG?5460
TACTTAAAAT?GTGCTAGGTG?TTATGCTGGG?GGACACAGTG?GACAACAAGA?TAGAGAGGGT?5520
CACGGAGCTT?AGGTTTTAAC?ACAGGCATTT?TCTACAGGGG?GATATTGCAG?CAAAAGGGTG?5580
AAACTGGTTC?TTGGGAAGTG?GAAAAATCTT?ATGTATTACA?ATGGTTTGTG?AGCCTCCAAA?5640
GGCCCAGAGT?ATACAAAGAG?ATTTAAAATG?TGGTATTAAA?TTTCATGTAG?GTATTGAGGC?5700
ATAAAAAGGA?ATGAAACTCT?GGCACATGCT?ACAACATGGA?TGAATCTTGA?AGACATTATG?5760
CTAAGTGAAA?TAAGCCAGAC?ACAAAAGGAC?AAATATTGTA?TCATTCCACT?TGTATGAAGT?5820
ACCTTGTACA?GGTATATTCA?GAGACAGTAT?AATGGTGGTT?GTCCAGGGGG?CAACCTGGGA?5880
GGAAAGGGTA?GGAAAAGTTA?TCCTTTAAGG?GGTAAAGAAT?TTCAGTTGAG?CAAATTTCAG?5940
TACAGAAAAA?TGAATAATGG?TGATGGTTGT?AGAGCACTGC?GAAGGTACTT?AATGCCAGTA?6000
AACTGTACAC?TTAAAAATGG?TTAAGATGGT?ACATTTTATA?TTATGCCTAT?TTTGCTACAG?6060
AAAAACATCA?TGGAGAGTAG?TGTTTAGAAA?AAAAGTTGTC?TACAGGCCAG?GTGCTGTGGC?6120
TCATGTGTGT?AATCCCAGCA?CTTTAGGAGG?CTGAAGGAGG?ATATCTTGAC?TCCGGGAGTT?6180
TGAGACCAAC?CTGGGCAACA?TAGCGAGATC?CTCTATCTAT?ACAAAATAAA?AAACAAAACA?6240
AGCAAACAAA?AAAAGTTGTT?TAAAAAGGCT?CCTTACGATA?TCACTGATTT?TAAAAAAGGT?6300
TGAGAAATGC?TGTTTTAGTG?GGAAGACAGA?GGGGACAGAT?TAACAACATC?AACAAAATTT?6360
TAAAACGATA?ATTTTCCTCT?GATGGTATAT?TCAATAAAGA?AAATGATAAA?GGAGGAGGTA?6420
ACCCTTCACC?GGGGCCTCAG?GCTTCAACTA?AGGTCAAATT?CTTTATAAAA?ACTTCCTTGA?6480
ACATCCTTAG?GGTCAATCTT?GGTTAGATAT?CCTGGGCAGG?GCTCTATTCG?TGCATATACC?6540
ATATTTTATT?TAATATATTC?ACCTGCTTAT?TTTTCTCACC?TAACTGGACT?GTGAGCATTT?6600
GGGTGCAAGT?TGAGTCCCTT?TCTCATTCTT?GTATTCTTGG?TGCCAATTGC?AAGGGTCTCC?6660
CATGCCAACA?GGCTGTCAAC?AAATGCTTTG?TTGAGTGAGT?GAATGAATGA?ATGAATGAAT?6720
GAATCTTAGA?TTCTCTCCAA?AGTGGCAGTG?CATAAACTCT?GGCCAAACAT?TAAAACAAAA?6780
CACCAATTTA?AATGAGCAGA?TTAATATAGT?GTAAACAGAG?CACAGGACAC?TTAAAAAGAT?6840
AGAAAACATC?CCAGTACTAA?AACATGCCTG?GGCTGAAAGG?AGAGATTGGG?CTGGATTCAA?6900
CACTGTTCTC?CAAAGTAAGT?AGGATCTTTG?GCCTTTAGCT?TCAAAATAAT?CTTATTTAAT?6960
GAGTAAAACT?TTCAATACAT?TTGCACTTCT?AGGTAACGAA?TTGAAGAAGC?TTTCATGGCA?7020
AGATGACATT?TTGAAAAGGG?ACGGCTTGTT?TTTGTTCTTT?GTTCATTTGC?TTTTTTCCCC?7080
TTTTCCAGAA?CTCTACTTGA?ATATTTATCT?TTTTCAGCTT?CACCAAATAG?TAGAGCTGCC?7140
AGGATATTTT?CTTTTTTATA?GTTTTAAATA?CAGGGGAATT?TGGGATGAAG?GCCTCCCATC?7200
ACATTAAGAC?AAACCACAAA?CTATCCTCCT?GTGTGTCATG?CTTTTTGCCT?CAAAGGACCC?7260
AAGCATTTAA?TCCACATTGC?TCTTGGGTGA?GATCTGAATT?GTGATTTGCA?TAGCATTTAT?7320
ACTCTTATTT?TTTTCTTTCA?TTCCTTATCT?TCAACCAGAC?TGTAAATGCC?TAAGGCACAA?7380
GGCAGTGGCT?GAATTTGGTG?TCTTTCACTT?ATCTGCTCAG?TGCCTAAAAT?CGTGCCTTAT?7440
ACGTAGTAAG?AATTTAATAA?ATATGAGTTC?GGTTGAATTC?AAGCAAAAGA?GAAAACTGAG?7500
AATCAGATCT?GGTTCCCAGT?AAGTGTTTAC?TCTCATGTAC?TTCTTCTCTT?CTATAAAATG?7560
AATATACTGA?ACTGAGCTAC?CTCCATGTTC?CTCTTCAGAT?TTATCTTGTA?ATCCAATCTA?7620
ATCAAATATG?ATGCCCCCTT?GGTACCATAC?CTTGAGATAT?ATGTACTACC?ATATAATAGT?7680
AAAGGATAGG?ATTTGTATAT?GATATAAATT?GTTCCTTAGA?TAAGGTACAG?TCCACAGACC?7740
TTCCATCTTC?AATTGTTTTG?GCTTATGTAG?CAGCTGCAGT?TGGTGCCTGC?CAAGGTCCCC?7800
TTGACCAAGC?TAGGGCCAGC?AGCCTACAGC?TGCCACAGGT?GTTGGCTCAT?AAGGGCTCAC?7860
ACCTTCACCC?TTTTCTGGGG?GATTGTCCTT?GGCCAATGGG?AGTTGCCTAT?CCTAGAGATT?7920
CGTGGACATG?ACCGCCTTAC?TCTCAGAGGC?AGCGTATAGC?CGATGACAAA?TTAATGTTGA?7980
AGTTTAACAG?TCCAATTCTC?TTGGCTCTTG?GTGGGTAACT?ATGGTGCAAT?TCACACTCTC?8040
CAGAGCTTCC?AGTGAGATCA?AGCTGAGGTT?AGACCTCTCT?TGAAATACAA?GTTCACTTAA?8100
CTCCTTCCAT?GCCTCTTCCT?GCTTCTCTTA?CTTCCTTCTC?ATGAGAGCTT?ATCCTCAATA?8160
AATCATTGCA?CAAAAGTGTG?TCAGACTCCA?CTTCTAGTAA?AGCTGGCCCA?ACACAGCCGC?8220
CAAGGAAGTG?CTTTCTCCTC?TCTCCCTAGG?CCTTTGTCTC?AGTGAATCTG?CACAATCTGA?8280
CTGTAGCTGC?AAAGCTACCC?TGGGGAAGCC?TTGATGTAGC?CCCTTCTTGT?GAAGGTGAAA?8340
TTACTAAACC?AGGAAGAACA?TTCTGAATCT?CACATTGTAT?TACCGTTACT?CTGATGAAAC?8400
TCCTTTACCT?TTCTAGAAAG?CTTTCATGCT?TTTTCCTTTC?TACCAAGCAT?TTCAGAGAGT?8460
TCTTTCTCCT?CTGACTATCA?ACAACAATCC?CTATACTCAT?GGTCAGAAGT?GACAGAGGAG?8520
GACATGACCA?ACATCAGAGG?AGGAAAATGT?TGGGATCAGA?ATAAACCCCA?GCTGTCAATC?8580
TCATGGCTGA?TAGTCCTTGA?GAACAAAGAC?AAAGTCTTTG?TCCTTGAGAC?TATAAACGCA?8640
GACCCAATTC?ATTCCAAGTC?CTAATCTTCC?TAGTTACAAA?CACTACACAA?TTTATTGTAA?8700
TTTTTTTTAT?AGGTACTCTG?TGGATCAAAG?CAAGTTTCCA?TGGGGAATGA?GAGAAGATGG?8760
CATTGGGCAT?ATTTTTACTT?AAAGAAAAAT?TAATGAATGC?TATTTTAGAA?AGGAAGACAA?8820
AGGCAATAAT?CCCTTCCCAA?AACAAACAGA?CTTATAAATA?GGTTACTTCC?TACTTTTCCT?8880
AAAATCTTGG?AAAGTTGTGA?GACTCCCTAA?TATTCCCAAG?GGATACAAGG?CCTGCTTCCC?8940
ATCTTCGACT?TATGGGTAAT?TTCACAAGGA?AGGGAGGTCA?CGGGTAGTCT?GAAAGGTGCT?9000
GGCAAAAGGA?CTGGCTCCTT?GTGCCCCACT?GGGAGAATTT?ATGACTCTTC?TGCCTCCTCC?9060
TAAGCTTAAA?ATAGACAAGT?CTGGGGAGGG?AGGATCATCA?TTTGACCTAA?ACTGTCATAC?9120
TCTAATCCTT?TAATATTAGT?TTTTCAGATT?AGGAGTACGG?ATGGGGATCT?GCAGTGTGTG 9180
CATGATTTAG?GCTGACCTTT?CTTTAACTTC?TGAAAAATGT?CCTATTTATG?TAACATAGAT 9240
TTTCCAAAAC?AGCTAAATGC?ATGTTTGCTT?TTTTCTTTCT?AATTATGGAT?TTTTGCAATT 9300
CTTCTTTCTT?TACCCTTCTC?TCTCATTTTG?GACATCCTAC?TCCCAACCTC?CATTTTTTTT 9360
TTTCTCATGC?CCTGCAATGT?GTAGGAAGAT?GGTTTAATGT?TTGGCAGTGT?GTATACATGT 9420
GCCTCTCAGT?TAACATCTTT?GATATTCAAT?TGCAGCGATC?AGGCAACATT?GCTCATTTTT 9480
CCTACTATGG?CCATTAAGGC?AATGCCATTC?TCAGGGCCTC?CATTAGGACT?TGTAGGATGA 9540
CCATGTAACA?TGGAGGCCAG?TCCCTCCTGG?AGGGCATTTC?TTAATTGCTC?CTCAGTTCTA 9600
AGTGTCCCTC?AGAATGCCTC?AGATATTTGC?TTTGACTCAG?CAGAAGAAGG?GAAGATCGTG 9660
GCCAGAGATA?GCCTGAACCC?TGCGAGAGGA?GGTTAGAAAG?CAGAAAGCCC?TCTGCCAGCC 9720
AGGTGGGTAC?CAATGGTCGT?TCCTAGGATG?AGACCTCATG?TAACAGAGCC?CAGGCAGTCC 9780
TGGGGAACTG?GACAGAGCTG?GTGATTGGCA?ACAAGTTGAT?GGCCTGAGAC?CTTTGACACT 9840
CCCAACTTTT?TCCCCAGGGT?TTCAGGCAGC?TGGAGACTGG?GATGTTTAAT?CCACTTTGGC 9900
AAAATCTTTG?GGTCCAAACT?GTGTATCTTA?TTTATTTTTC?ATGATGGTGC?TTAAAATATT 9960
TTTATTTTGG?AAAATGCATG?TGATTAAAAC?TATGAAATGA?CTAAACAAAT?ATGTATAAAG?10020
AAATGTAAAT?CTCTCCCCAA?CTCCTAACCA?CTGTTTCTTT?CACAAAAGTG?GCTTAGGTGG?10080
AATAGTGAGA?TTAAAAGTGA?TTAAAATTTT?TCCCTTATTA?CTTGCAAATG?AGCACTTCTC?10140
AATCAATTTT?TTATAAAAGC?CCAGATGTTT?TGCCCTCAAT?TCATTGGGAA?TAAAGGCTTT?10200
GGTAAAATAC?AGTAGAAATG?AATTACAAGA?AAAATGAATC?CCACTTGAGT?GTTGTGGCAA?10260
CATCAAACTG?CTATTAAAGG?CACAAAACAC?ATCTTGGTTT?CTGTCCTTAT?ATTGCAAATC?10320
TGTAACAGAG?AGTTTGAGGA?CCAGCACCTG?CCAAAGACCA?CACTTGGAGC?AACATTGCCC?10380
TAAATGCTTC?TTAAGGAATG?TGAGATGCAT?TTTGACACAG?GAAAAAAGAG?CACAAGTTAT?10440
TAAACATATT?TTAAGGGTTT?CAAATGAGTC?AGACAAAGAA?TATTGAAAAG?GTCTTCAGAG?10500
ACGGGATCCA?ACATCCTCAT?TTTACAGTTG?AGAAAACTGA?GGCCCAAATA?GTACACTGGA?10560
TTCCAGGAAG?AGCATTTAGA?ATTGTGCACT?TTATTACTGT?TACTCTGAAG?AAATTTGCCT?10620
TTGCCTTTTT?AGGAAGCTTT?CATGCTTGCT?CATCTCTGCC?AAGCATTGCA?GAGATTTCTC?10680
CCCTAACCAG?AGCAAGTACA?GCTGGGGCAG?TCCCTGGTAT?GAACATGCCC?TTCCCAAATG?10740
TGACAAGTGT?GTCCCTCCCT?GCCTTGATGG?GGCCCTCCTC?AGCATACAAC?CTTGAGAAGG?10800
GGAACCTTAT?GGGATCTGCT?GGGTGGTTGT?TATTTGTAAT?TTCTAAGCCA?GCTATGCAAA?10860
AAAACAATTA?CAAAGAGCAG?CCCTCTCCTT?AGCTGGTATT?ATTTACCCAC?ATTAAACCCA?10920
AACACTTGTC?CTTTCTGGGT?TTAGGGAAGT?AGATGTGACT?GGTGGTGGAG?GTGAGGTAAG?10980
GATGAGAATC?TCATTTTAGC?TACAGGCATC?AGATTGGGGC?ATAGTTGGCA?ATAGAATTAA?11040
TGCAGTTCCT?CTTTGCACAT?TTGATCAAAT?GATGCTTGAC?CTTGGGCCTC?TCTCTTGTGA?11100
AGAACTGCAT?AAAAAGCAAG?TTCAGGAGTG?TGTGGGCTGA?GTCCAGAGAA?AATGTTACAC?11160
CTGGCTAACC?TATAACAAGA?ACCACCTTTT?TAAAAAAAAT?TGGAATTGCC?TCTAAGAGAA?11220
AAAGCGAAGG?CTTAGAGAGT?ATGACTGAGT?TTAGCACTTC?AAAAGTGGAA?GAGCTAACAA?11280
TATGCATTGT?AAGTATTATT?TGTTGTTTTT?GCCCTGACTC?CTTTAAAAAG?TAGATATGAG?11340
GACTTAGAAA?AGAGATGCCA?AGAGTTTGTG?CCTCACTTCC?TATATCCACA?AAATAAGAAT?11400
AGTCACATAT?GCCCCCTACA?ATTATTCAGT?GTGATGCTGC?AGGGCCAGCT?GCACCGCCAC?11460
CTCCCAACCC?CATTGCACTG?GCTCTTCCGG?TTAGGCTGGC?CCAACTCCAG?GAGGAACAGG?11520
CAGAAGGGCT?GGAGTGAACC?CTCCCAGCTC?GGCCTGGAGC?AGCCCTCCAG?CAAACTGATG?11580
GGAATTGGAA?AGATAAAACA?CCCAGCTTCC?TTTGAGTCAG?GTGGTATGAC?ACTGAGGTGT?11640
GTGTTCTGCT?CGTAGTTATA?CTCCAGTTGC?CCATGGTGGT?AACCCACTTG?ATAAGATATC?11700
CTTTACTGGT?TTCCTTCCCT?TTCCTGACTC?ATTTCCTCAT?TCTCTTACTG?GCATTTCCTG?11760
CAATCTCTTC?CCAAATAAAC?TACTAGTACT?CAAATTCTTG?TTCCAGGGTT?GGAGGCACTC?11820
CACCCAAGAC?ATATGCCTAC?ACAGCAGAAT?TAGTTCATCA?AACCAAGTCT?TTGTCTCACC?11880
CTCAGACTGT?TTCTGAAGCC?AGACAGACGG?GGCTGAACAC?CTCAGAATTT?CCCTGAGTGC?11940
CTCAAACGGC?ATCTTTTCTA?AAAAACCTCT?TTATTTCACT?GCTTGAGAAC?GACTTTCTCT?12000
TACTTCCATC?TCCCTCCCGC?CACCTCTCTC?TGCAGTCTTT?TCACTGATGG?AAGCCACCCG?12060
CAACCGCCCG?GCCCTCGCAG?CTTCTTTTAA?TTTGTCTCAA?AAGGCTCTTA?AGAGAAAACT?12120
ACGCTTGCCT?GTCTCTTCCC?AGTTCCACAA?CCCTCAGAGG?GCAGGTCTCT?GGGACAGCAA?12180
TGGTATTCCT?CGGAAAGTCA?GCATCTGGTG?CACAGCTGCT?GTTTTGACTG?TAGTCCCAAT?12240
GTAACAGGGC?AGCAAAGTTG?TTGATGGTTT?TCCCCAAAGC?AGTACCCCCG?AGTTTTCATA?12300
TCTGCTTTCC?AGACTGTGCT?CCCTTGAAAT?CCAGGAAAAT?GAAGCGTTTC?AATCCTGGTC?12360
TCTCCTCAGC?CGTCTCTCCA?ACGCCTCCTT?TTTTTCTGTC?TCTTTCTTCC?CCCAGCCCCT?12420
TCCCTTTCTT?TTTGGTTCAT?TTGCACTTTT?TTTTTTTTTT?TTTTTTTCAT?CTCACAAGGC?12480
TGCAGCAACT?TGACAATACA?CTAAGGAGCC?CTTCTTGGAG?TTGTGTTGCT?CCTCATTAAA?12540
TACTTGTTCA?GCTGGCTGCT?ACGTGTCAGC?TTCTATTCAA?AGGCCTAAAT?GCTAGGGATG?12600
TGGAAGTCAG?TGTGCTTGCA?GGCCAGTTTG?GCTGGGGATG?ACGAGAGTAT?TTTGCCTGCT?12660
GTGTTCACCA?AAGGGGGCCC?TGAACAGGAC?CGCCTTCACC?CGCCTTCACC?CGCCTTCCAC?12720
ACAACACACA?AACACTTGTA?TGAACACCAA?ACAGACTGAA?AGCCTGGGAC?AGAGATTTCT?12780
TTGTAAAAGA?GAAGCCATCT?CCAGTTCTGT?CCTTGCTGAA?TGGCGATTTC?ATGAAGCTTT?12840
TTCTCCTTTT?TCGTAGAACA?GTAACACACC?AATCACCTCC?TCTTGTCTTG?TTCTTACTTC?12900
AAACAATTCT?GAAAGATTTG?TTTTCTTTTT?TTTTTCTTTT?GTATTCTTTC?AGAGGATTAA?12960
AATGTCTGAA?ATGACAGCCT?CTTTCATTAT?CTATCCCCCA?AGTCTATTTT?TCTTTCTAAA?13020
ATCATCCCAC?CCACCCCACC?CAACTCCAAC?ATTATATTAC?ATAATCTCTT?TGTTCATTAC?13080
CTGTCCCTAA?AATACTGGCT?CTTCACTAGA?CTTCCTGTCT?CTCAAAGAAA?GACACTGCTT?13140
TTTAAACTGC?TGTATCCCTG?GCATTTTAAA?CAATGCCTGC?GACACAATAG?GTACTCAATA?13200
AATACTTTTT?GAGTGAATGA?ATGAATAAAT?ATATCTTTAG?GGAAATAAAG?ATAAAACAGT?13260
TATCTCAAAT?TTTAAGGTAT?CAATACTGTG?ACCTGCTACA?CAAATTAACA?GCCTTGGATT?13320
CTGTTAACAG?GGATTCACCC?AGAGAAGTGA?GGCCATCACT?GAATGTTCCT?CAAACATGTG?13380
ATTGTCTCCT?CAGCTTCTGC?TGGAAGGCTT?CATATCTACT?GCCAGGATGC?ACAGAGTAGC?13440
TCTGACTATC?GTATCCATAC?TGATCATAGG?AATCATAGCT?ACTATTTTTT?TTGGGGGGCG?13500
GGGGGGATGG?AGTCTCGCTC?TGTCGCCCAG?GCTAGAGTGC?AGTGGCACGA?TCTCAGCTCA?13560
CTGCAACCTC?CGCCTCCCGG?GTTCAAGCAA?TTCTCTGCCT?CAGCCTCTTG?AGTAGCTGCG?13620
ATTACAGGCA?CCCGCCACCA?TGCCTGGCTA?ATATTTTAAT?TTTTAGTAGA?GATGGCATTT?13680
CACCATCTTG?GCCAGGCTGG?TCTTAAACTC?CTGACCTCAT?GATCTGCCTT?CCTCAGCATC?13740
CCAAAGTGCT?GGGATTACAG?GCGTGAGCCT?GTACCTGTAC?ATGGCCATAG?CTACTATTTT?13800
AAATACGTTC?TCCATTGGCC?AGGCTAGCAG?TATACCAGGA?ATACTAAGGC?CTGTGAGCTA?13860
CAGAGTCAGA?CAACAGGGCT?TTGATTCCTG?GCTCCACAAC?TTTCGCACTT?CCTGAGCCTT?13920
CAGTTCTCTT?ATTGTAAAAT?GGGATTAATA?ACAGTACAGG?CCTCAAAGAG?TTTTGGTAGA?13980
TTAAATGAGT?TGATGTGTGG?AGCAAGTGCT?TAAGAAGTGG?TAATTATTCC?TTTATGGCTT?14040
TCTTTATCTG?GACCAAATGT?ACTTTCAATA?AGAAGCCTTT?CTCTCTGACC?ACTCTCTTCA?14100
CCTAACTGCA?ACACATCTGC?CGAGGCCCCT?GGTGGAATTT?TGTGCGAAAT?GAAGCTGTAC?14160
CACCTGGCTT?TTGAAGAGCT?CTATTATCAT?CTGTTTATGT?TTTCTCACCT?GATAAAAGTG?14220
AGGCTTCTCC?AGTGTAGTGC?TGTTCTTTCT?CTGTTTTCCC?TGTGCTCCCC?TGCATTCAGG?14280
GGAGACTGGC?TAGTAAAGAA?GTAACTCAGA?AGGATGCCCC?AGAGTCTTCC?TCTTCCTTTA?14340
AGAGCTGACC?TAAGTCTCAT?TCCCTGACCA?TAACACTGCA?CTCCCTGTAG?CCAACCTGGG?14400
CATTCAGTCC?TTTGAGCTCA?CTGCCTTCCC?TTCCTAAGCA?TTTATCACAA?CTGAACCACA?14460
CTTGCCTGTT?AAAAACAGAC?TAGTTAAGTG?TTCCAGTGCC?AGTAAATAGC?ATGAGACAAA?14520
GCCTGGAGGT?AAGACCTAAA?AGACATCCAT?CATGATGAAG?TGATGAACAC?AGAATGAGAA?14580
TGTGGCGTGG?AGGTGAGCTT?GGAGCCTTAA?TATCCATGTT?TATGAGTCAC?TTAAAGGCAG?14640
GCTAGGTGGG?ACTTCACAGT?TTTCTGTGAA?ATCTTCTGTC?CCTAATCCTT?GTATCCTACT?14700
TCATTCAGTT?AGACCTTCTG?CTGCTTAGAA?CATTTTTCTT?CAAGTAGTGA?GTACTGTAAT?14760
GTTAACATCC?AAGAAAGTAA?AACAAATAGT?CACCTCTGCA?ATAGCTCATT?AACAACTGGG?14820
AACAGAGAGG?TTAATGTTCC?ATAGCTTAAA?AAAGTATCAA?TACAACTAGG?GACTCTCTCA?14880
GTACAGGATG?GGGTGCTATA?TCCATATTAC?CAATGGCAGT?CATCCCGAGA?AATCCAAGCA?14940
GCCACACTTA?CTCTCCTTCA?GTGGGTAGAT?CCACTATACT?TGTCATGTAG?ATTAGCTGTT?15000
TTCACTGGAG?ACTTGCATCC?CATCATCCTT?CTGCACACAG?TTGAGGTGGA?CCATACCTCT?15060
TTTTTTTTTT?TTTTTTTTTT?TAGACGCAGT?CTTGCTCTGT?CGCCCAGGCT?GGAGAACAGT?15120
GGCATGATCT?TGGCTCACTG?CAAGCTCTGC?CTCCCGGGTT?CACACCATTC?TCTGGCCTCA?15180
GCCTCCTGAG?TAGCTGGGAC?TACAGGCGCC?TGCTGCCACG?CCCGGCTAAT?TTTTTTGTAT?15240
TTTTAGTAGA?GACGGGGTTT?CACCATGTTA?GCCAGGATGG?TCTCGATCTC?CTGACCTCAT?15300
GATCCACCCG?CCTCGGCTTC?CCAAAGTGTT?GGGATTACAG?GCGTGAGCCA?CCGCGCCCGG?15360
CAGGACCATA?CCTCTTGAGC?AGGCTTCTCT?GCAGGTGCTT?GGTAGCTGGC?TCGATGGGTC?15420
AGATCATAAG?CCTTTCATGT?CACAGAAGTG?GCCCTGATCC?ATGATCCCAC?AAGCACACAG?15480
ACTCAGAGCC?TACAGAGAAG?ATGACTCTGG?AGATCTGGTT?CCCTTTACTG?TCCATCTATG?15540
ATTCATCATA?CAAAGGTAAG?CACATTCCAC?ATTTCCTTTT?TTGAAATAAG?ACTGCTGATT?15600
TTAAAAAAAT?GGTAATTACA?TCTGCTATAC?TGCAAACTGC?AGAAGTTCAA?GCTTAAGGAA?15660
AGACCTTTTA?CATCCTTCCC?TCTTCCTTAT?ACCTTAAAAT?TAAAGTCTAA?CATCAAACAG?15720
GGGGATTCAT?TATTTAATTT?GTAAGATAAG?AAACATATCT?GCATGTGTAA?GTTTTTTAAA?15780
AAGAAGGGAG?AGGAAACAAA?CAACTGTTTC?CTGTAGACTA?CAAGCTTCTT?GAGGTCAAAA?15840
CCTGTCCTTC?CATCTGTGTT?TCTACAAAAG?CTACAGCAGG?GACAACATCA?AGATGAATGC?15900
AGTTGGAGGG?AATCCATCTG?TCTTCAGGCT?TCGTGTACTT?TCCAAAGGAC?CTTTTGAATG?15960
TAAAAGAAAA?GCCTCTGAAA?CTAAGACTAG?GCTGAAAATC?TGTCTTTAAG?GTTTTTGAGA?16020
CATGCCAAAA?AGAAACAAAC?AAAAACCACT?AATGCTTTTA?AAAGAAGAAG?TCAAGGTGGG?16080
AGAAGGAGCT?TACTACGTGA?GTTCACACGC?TTAATCAAGT?GAACGGCTTT?GTGTCAGGAC?16140
GAACGTGAGG?ATGGATAAAT?AACCTTGGTG?TCTGCAGCCC?GAGCAAAGAT?GGGAGAAATA?16200
GGACTGTGGG?CTTAAGATCA?AACGAAATGA?GAACTGGGAT?GGCCTCTTTC?CGGTTCCCCA?16260
GGGCTGTCTC?TTCTTATCCT?AAGGTTATAA?AAGGTTTTTT?GAGACTAGCT?GAATAAACCA?16320
TATCCTGTTC?CTTCCTTGGG?AAAACTTGTT?TATATTCTAA?CTGTTTTTAG?ACCTTGTAAA?16380
ATTTGGTGAA?CTCCTTCCTC?ATTAGCTTAA?ATTCTTCCAC?ACTCAGCAAA?TATCAACAGG?16440
CAAGGGTTTT?AGTCAGTGAT?AACAATGAAA?GCTGGGAGCT?CACCTAGGGC?CTTAATAAGC?16500
TGGCTGCACT?GACAGAGGGA?AAGACAGAGA?CACAATCTCC?AGCTCATGTT?TATAGAATAA?16560
CAGAGTTGAA?AGGATAGGGA?ATGATACTGA?AATCTAGGTA?AATTTATTCT?GACAGTGACA?16620
ACAGCATTGT?CTCTGATACA?ACTCATACCC?GGCTAAAGAT?TCATTTTGGA?ACTGTCAAAG?16680
CTTTCAAGCA?TAAAATTATT?CTCAGTGGCT?GAAACTTGGT?TAAACAAATT?TCACTGTGCA?16740
AGGAAAAACA?AAGTTAACTT?TTGGAAGTGT?TTTGGGGGAA?GAAATCTCAG?TCAAGAAACT?16800
AGATAATAAT?AACTATGTCA?GCTAGATAGG?AAGTGCCATC?CCCATGCGGG?GGTCTCAGGA?16860
AAACATGTGA?GGTTCAGCAG?GGTGCAGGAT?GGGAGGGGGT?GACCCGGACC?CACGCTGGAG?16920
AATTGGCTAT?GCATATTCTG?AACAGGATGA?AGAATCAGAG?CCAGCAGTGG?TGCCAACTGA?16980
ATCTGCCTTG?GGCAAAATGT?TGGGTAGTTT?GGACCAGTGA?CCCAAGCTGT?GGCAACCTGA?17040
GCAACAAAAT?AAATAATGAC?AATACTGGAT?ACTCATATAA?TGAAACAAAT?ACCCCAAATC?17100
CCCTGCTGAT?ATAAATACAT?AATTAGTAAA?CAAAGAACAG?GGGATGGTGT?CAGAAGAGAC?17160
AGATCTTTTT?TAAAGGAGAA?TGCATATTAA?TAAATATAGA?AGGAACAAGA?AAAACAGAAA?17220
ATCTTCCTTA?AGTAAACATT?ATAGTAATAA?TTGTTATAGG?CAGGAATTAG?TCATAGATCA?17280
TCAAATTAGT?GGGTAAATGA?TGAATAAGAA?AGTTCTAGTA?CCTTTGCTAA?ACAGGTATTT?17340
AGTATCTTTA?GAAACAGGTC?AAAGGCATGT?ATTACTTACA?AATGGACAAA?TAGCAGCAGG?17400
TCCCACTTTA?ACCAAAGGAC?CAAATTTAAC?ATTAATAACC?AGACACATGG?ACATCTTATT?17460
CCCCCTGATA?TGACGCACTG?AAGATAGGCA?CACTATCATT?TCTGTGGTAA?TTTTGCCCAA?17520
AATATGTAAT?CTCAATCTAA?TCATGAGAAA?ACATTAGTGA?AACCCAAAGT?GAGAGACCGT?17580
CTAAATAACT?GTCTTAAACT?TTTTACAAGT?GTCAAGGTCA?TAAAAGACAA?AAATCGACTG?17640
AGGAACTCTC?ACAAGGTCAA?GGAGACTAAG?GAGGCATGCA?CATTAGATCA?ATGCGGGATC?17700
CTAGACTGGA?TCCTGTTTCA?GAAAAGAACA?TTACTGGGGA?CTTGGAAGTA?CAAATACGTA?17760
TATGGATTAA?TTAAGAACAC?TGAATCCAGG?TTAATTTGCT?GTTTTTGATA?GCCATACTAT?17820
GGTTTAGGTT?AGATATTAAC?AACAGGCAAA?GTTGAGTTAA?GAGTATACAG?AAACTCCACT?17880
ATTTTTACAA?CTATTTTCTA?AGTCTAAAAT?TATCACAAAA?CAAAAAGTTA?AACATGGAAT?17940
GGAGGCTGGG?TGCAGTGGCT?CACGCCTGTA?ATCCCAGCAC?TTTGGGAGGC?CGAGGTGGGC?18000
AGATCATGAG?GTCAAGAGTT?CGATATCAGC?CTGATCAACA?CGGTGTAACC?CTGTCTCTAC?18060
TAAAAATACA?AATATTAGCT?GAGCGTGGTG?GTGCATGTCT?GTAATCTCAG?CTACTCAAGA?18120
GGCTGAGCTA?GGAGAATTGC?TTGAACCCGG?GAGGCAGAGG?TTGCAGTCAG?CCGAGATTGC?18180
GCCATTGCAC?TCCAGCCTGG?GTGACAGAGC?GAGACTGTCT?CAAAAAAAAA?AAAAGGGTGG?18240
AGTTAGTTTG?GCTTCATTTG?GCAGCCAACC?AGGATGAACT?TGGGTGCACA?GATTTCTCAG?18300
GTGAGACCTA?AGACCCTGTC?TCACCTAAGA?AATAAGAAGG?ACATGAATAG?AAACACATAG?18360
TGGACAGGAG?ACAGCGAAAG?GCAGTTCTAG?TTCAATGAGA?GCTTGCGTTG?GGCTGCTTTC?18420
ATTGGACAAG?CATGCCAGAA?TTCTATTGCT?TTATGTGTCA?TGCATCTGTC?CTCCAAGGTA?18480
CTGAGAAGAG?AGTCAGGAAA?GGGTATAGTA?ATGTAGACCT?CAACTGTTCT?TGCCTTCTGG?18540
ACAACAAGGG?ATAATACTTC?CTAGAACAAT?AGCCTCACCC?TGGCACCCCA?GATGTTTGTT?18600
GCCCATTCTA?TCTACAGTCT?CATGGTCAAT?AGTAGTAACA?GCCTCTAACA?GTGAAAAGGA?18660
CTCAGCATAC?AACTGCAGAG?AAGACATAGC?AGAGGGCACC?TGGGAGGCTA?TGACAGTGTG?18720
TTCAGGGAAA?AATGATCCTA?AAAGAAAAAA?AAAACAGTAG?GTGGCTGAAC?TTGGGGATAA?18780
AAAGAGCAAG?CCAGCTTTTC?AGGAGAAAAG?TAGGTCTCCT?AATCAGTCTT?GCAGGCTTAA?18840
GCAGTAAGAA?GACGGCCTTC?CTCAATAACC?TCTTCACTAG?AATTTTCAAA?ACCTAAACAA?18900
ATATCTCAAA?CAATGATTTT?TTTTTTGCCC?AATAAAACAA?TGTCATGTCC?ATAAAAGTAA?18960
ATTTTGAATC?AAATCTTTTT?CCCAGACATA?ATTCTGAAAA?ATCTTAAAAC?ACAAAGTAAA?19020
AGAAATCAGA?TGCTTATCTG?AATATTACCC?ACATGATCAT?TAGAGATAAT?TCTTATACAT?19080
TTATTAGTAT?TCGTCTCTTG?CCAGATATTT?AAATAACTGT?GAAGAGATGT?GTCAAGAGAA?19140
GAGTAATTAT?ACAAAGGTTT?ATAAAAGGAG?ATACAAAGCT?TTATGCTCCA?AATGTGGCTT?19200
TCAGTTTAAA?AACCTAGGCT?GTTTAGCATA?ACCCCAAATA?GTTCTGGGAT?GGTTGTATAA?19260
TATCAGATCT?CAACTAGCTC?TAATAACTGC?TTTGTAACCC?CTGGAATAAT?GCTCGAAGCA?19320
ACACATGATC?TTATTTTGAA?GACAAGTTTA?CCACTACACA?ATGATGCTGG?TCCACACCTA?19380
CCTCCCACTG?CATTACAGCG?AGATGTCATT?TCCCAGAGCA?CCAGAGCCAT?GGAGTAGACA?19440
TCGGTCTGCT?TGAAGGACTC?AACATTCTCC?AAATTCATCC?TGGATTCTAG?GACTTCTGGA?19500
GCCATGTATC?TTGCAGTTCC?CACCTATAGC?AAAAACAGAC?AGTGAGGCCC?ATCATTTAAT?19560
TCCAGCTGCC?TTTTTATTTT?CACAATATAG?CTGATGGTGG?CCCCTGACAC?GTGCAGAGGA?19620
TTTTTTTAAA?AAATCAAAGT?GCTGTTTTAA?AGAATGAGAA?ATGCACAGAA?AGGTACAGAT?19680
AGATGGTTAT?TTTTTAAAAT?AGATGTTCTC?TCCCTGAAAA?CCCTCTAAAG?ACCATAAACA?19740
AAGCATGCCA?AAATAAGGAA?GTGCCAAACC?CCAGAGCTGC?CTTATCTAAC?CCCATGACTT?19800
ATGTCATCAC?ATTTTTCAAT?AACATCCTTA?CAGATAACCT?GAGAGACAAT?ATTTGTGATA?19860
TTTTAAATGT?TTATTTTTGC?TTTCCAAAAT?TGAATTTTTT?TTTATTCCTG?AAACTCCAAG?19920
ACTTATGGTA?AAAATAATAA?TTGCTATCAG?TTTTGATCAC?TTTAGGACTG?AGTCTTAATC?19980
TTTGTTTATC?CCATGGCACA?TTCCAGTGTG?CAAAGGATAT?AGTACAATTG?CATAACATCT?20040
CTACTAAATT?AAATTGTATA?AAAGCATTTT?CACAGTAAAA?GACCAAATCT?GGATCACTTT?20100
ATAATTTTAA?CTTGTGGGCC?ATGTAGTTTT?ATTTTGACTT?TTAGGCCTGT?GCTAATCTCT?20160
ATGACTGATA?ATATGCAAAC?GTCGGATCCA?TATGAAAAAG?GAAAAAAATA?TTCCAGAGAA?20220
TGGCTCACTT?AAATATTTAG?TGTTGTAGTA?TGTATAAACT?GACTAAATAA?CAATAAAGTC?20280
CTACCTTCCC?AAGGATCTAG?GGAAGCCAAG?TGAGTTGATA?TTATCATTCC?AAGGAATGTT?20340
TCTTATTGGC?ATGTATTAGA?GAATTTTTTT?CTTCTCAAGA?GGTCATTGCA?TGGCTCATTA?20400
CTCTGGCACA?TTAGTCTGTC?CATATTTCGA?TGTTTACCTC?AACACTGCGT?GCGCTGCCAT?20460
GGACACAGGG?CTGACTGAGC?AGTAACCGAG?TGCTTCAAAG?TGTGTCCTGC?CACCTGGCTA?20520
AAGAAGACAG?TGCTGCTCTC?CATGGACTCC?ACTGTGTGAA?AACACTGGGC?TCATCATTTA?20580
TAAGGGATGT?TGTGGTGATT?TCCAATCACC?TTCCAATAGT?TTCTTAGCCA?AAAACATTTC?20640
CATTTTAATC?TGTGAGAGTG?CTTCAAGAGT?GGAAGTGCTC?ACTCAGTCGA?CAAGTACTTA?20700
TTTTACTTTC?AATGTTCAAG?GCATTGTGCT?ACATATCTTG?GGTGACCATG?TGGATGTAGA?20760
TTTGGACTTC?AGGGAGATTG?CCTTCCACGA?TGCTTTTAAT?ACAAAGAAAC?CAACACAACT?20820
ACAGCTAGTA?TAGAGCAGAA?AGGACTGAGT?ACAACCATAA?GAGAGGGAAA?AAATAGAGGT?20880
AAAGTACTAA?CAGTGCTTGA?AACAAAGAAA?AAACATTTGC?TGGAAGAGAA?ATGAGGATTG?20940
ATCCAGGAGG?AAAAAATGTG?CTGAACTGGG?AAGGATTTGA?AGATAGGAGG?AGAAATGCTG?21000
TCCATTAGCA?AAAATGCTCA?GGCAGGACAG?AGCAGAGTAT?GCTCAAGGCA?GACTCCATAC?21060
TTTGGCTAGA?TTCCCTAGAC?CAGTGTCCAG?AGTACAGGGC?TGTTTGAGAT?AAGAGCCAGG?21120
AGATATGGAT?CAAGAGGTAG?GGTGAGGCCA?GGCTCAAGGT?AAAGGGGATC?TAGCACTAGC?21180
TCTAACTTAC?CTGCCCACTG?TTAGCCAGGT?CATCCACAGA?CAGAGTAGGG?TCCAGACGCA?21240
GGGAAAGCCC?AAAGTCACAC?AGGCAGCAGG?TTAGGTCGTT?CTTCACGAGG?ATATTGGAGC?21300
TCTTGAGGTC?CCTGTGCACG?ATGGGCATCT?TGGGCCTCCC?ACATGGAGTG?TGATCACTGT?21360
GGAGGTGAGC?AATCCCCCGG?GCGAGGGAGC?TGCCCAGCTT?GCGCAGGTCC?TCCCAGCTGA?21420
TGACATGCCG?CGTCAGGTAC?TCCTGTAGGT?TGCCCTTGGC?GTGGAAGGCG?GTGATCAGCC?21480
AGTATTGTTT?CCCCAACTCC?GTCTTCCGCT?CCTCAGCCGT?CAGGAACTGG?AGTATGTTCT?21540
CATGCTTCAG?ATTGATGTCT?GAGAAGATGT?CCTTCTCTGT?CTTCCAAGAG?GCATACTCCT?21600
CATAGGGAAA?GATCTTGACT?GCCACTGTCT?CAAACTGCTC?TGAAGTGTTC?TGCTTCAGCT?21660
TGGCCTTATA?GACCTCAGCA?AAGCGACCTT?TCCCCACCAG?GGTGTCCAGC?TCAATGGGCA?21720
GCAGCTCTGT?GTTGTGGTTG?ATGTTGTTGG?CACACGTGGA?GCTGATGTCA?GAGCGGTCAT?21780
CTTCCAGGAT?GATGGCACAG?TGCTCGCTGA?ACTCCATGAG?CTTCCGCGTC?TTGCCGGTTT?21840
CCCAGGTTGA?ACTCAGCTTC?TGCTGCCGGT?TAACGCGGTA?GCAGTAGAAG?ATGATGATGA?21900
CAGATATGGC?AACTCCCAGT?GGTGGCAGGA?GGCTGATGCC?TGTCACTTGA?AATATGACTA?21960
GCAACAAGTC?AGGATTGCTG?GTGTTATATT?CTGATGGGGA?AACAAAACAA?GGAGAGAAGG?22020
AGTTGGATGT?GGTAGGTAAG?TACTGTCAGG?AAGTGGGTTC?ATGCCTGAGC?ATCTATAGAT?22080
TTTAGCATCT?GCATAGTTTT?TGTAGATACG?ATATTGTTAA?TTTTTATTTC?AGGGATGCAA?22140
GTGCATGCTC?GTTCAGCCTT?CCCTGCCTCT?GGCCATCTGT?TCGTCATCCC?CTGCTCTTCC?22200
TTCAAACTTC?AGCTTAAATG?TCACTGCTTA?AGAGAGGCCT?AGAAAAACTT?GGAAAACTGT?22260
CTTATTTTAT?ACATTTTCAT?AGCACCTTAT?ACTTTTCCTA?GGTAACAATT?CAGTACAACT?22320
TAAACTAAAT?GAACTATGAC?TCTACCTCTT?GATTTCACAT?CTGTCTTTCC?CTACTCTTGC?22380
CATCCCCCAC?GGACAGGGAA?CTCCATGCTG?GAAGGTACCA?TGTCTTCTTC?ACTACTGTAA?22440
ACTGCACTTA?GCACACAGCA?GGTCCTCAAT?ATTGCCAAAT?AAAAAGACAA?ACCATTTACT?22500
GAGTGTTATC?TAAGCTCAGG?ACATTGGGAA?CATGAAAAAA?AATGACACAG?CTTCTGCCTT?22560
CAAAAAATCT?GCATGTATGA?CATCTGGTAA?AAACACAGAG?CGTGCCACAG?TTTGCACCAA?22620
AATCTTTGCT?CTTTTTCAAA?CTCCAACTTG?TTCTGCTCTG?ATCAGCATTC?AGGCTACCCT?22680
GGGCCCATGG?GTGACAGGGA?GAGGAGTCCA?TGGAAAGGAT?CTCTTTGGAC?AGTTATCTTA?22740
CATCCACCCA?ACATTCCTCT?TTTCAGTGTG?CATACGAATT?GTAGTTTCAT?GGAACTGAAA?22800
TATTTAATAG?CAACAATGGA?AACATGGCCG?CAAAGGTAAA?ACAAGTTAAA?AATGGAAATG?22860
CTGCAGTTTT?TTGACTTGGA?ATTCTGAAGC?AGGCCCCTGT?GGGCTGACAA?GGAGAGTCCT?22920
TAGCACCAGA?TATCTAACTA?TAATATCTTG?TGCCTCAAAC?TTTGTTTCAT?GTGCTGGCCT?22980
TGTTGGCTCT?GGTGAAATAG?TTTTCCTTTT?TGGAAGAAGG?ACATGAATAG?AAACAGACAG?23040
TGGACAGGAG?AGAGCAAAAG?GCAGCTCTAG?TTCACTGGGA?GCTTGTGCTG?GGCTGCTTTC?23100
ATTGGGCAAA?CATGCAGAAT?TCTATTGCTT?TATGTGTCAT?CCATCTGCCC?TCCAAAGTAC?23160
CCATTAATGA?GCAGGCCTCA?TGCTCAGATC?CTAGAATCAT?TCATTAAATA?TATCACTACT?23220
GAGTGTCTAT?GATGGGCATG?GCACTGCCCT?CAGAGAGTAC?CCAGTAGAGG?ACTTAGGGCA?23280
TATATACAAG?TAAGCAATAT?ATGGCATCTG?GGATAGGGGC?TAAATGTACA?ATGTAATCTA?23340
TATATTAGTG?GAATGTGGAA?AAGCTTAGAG?AAACATGGAA?GGCACAGTAG?CAAAAAACTG?23400
CCTTTAAGTT?GGTCTCTGAA?GAATGGGAAA?AGTCAGTGAT?GAGTGGAAAG?AGTGCTATGT?23460
TAAGGAGAAA?GAATATATGA?TCTACTTAAG?GAAGAGCAAT?TATCCCATAC?TGACCACTCT?23520
GCACCTGCGG?AATAGAAAGG?AAAAAAATGG?GTAGGTGGTA?TGGAACCAAA?CTCCGTGTCA?23580
GAAAAGGATC?TTTTGATTAT?TCATTTGTCA?GTTTTCACCT?ACAGTAGGTG?TTTAAAGAGA?23640
AAAAAAAAAG?TGATGAGAAT?ATAGTCCAGG?TAGAATGAGG?ATATAACCAA?ATTCTCTCAA?23700
GGGGAACCCA?TTACCTAAAT?GATACTGATA?AAGGAGTTAA?GAAGAAATTA?CTTGGGCAGA?23760
TAGTAAGGGT?ATGGAAGTCC?TCGGTAAGGT?GTTTCTTTTT?AATGAAAAGC?AGCCCCAAAT?23820
CATTTTCTAA?CAAAGAGCAG?CCTGTAAAGT?TGAGCTTCAG?ACATAGACAG?GCAAGCTGGG?23880
AGCTTGCACG?GGTGAATGCC?AGCAGGAACT?AAGGACATGT?TCAAGATGGC?AGCTCCATCT?23940
TCCCTTCTCT?TTGTCAGCCA?TGTGTACAAC?AAAGAACAGA?CCAGATGGTG?CTGATCAACT?24000
GGAAAGCCCA?TTTGCATAAT?AAGATTAGGG?TGGGGTGACC?AGTCTTCCCC?ATGCACTATG?24060
TAAACGTCAT?ACCTGATTGA?ACCAATCTGT?GAGCCCTATG?TAAATCAGAC?ACCGCCTCTT?24120
CAAACGGGAC?TATAAAATCC?AGCACATTCA?CCACTGGCCC?GTCCTTTCCG?CTTGGAGACT?24180
CCTTTCTCTA?CAGAGAGAAT?TGTTTCTCTT?TCTCTTCTCT?TCTGCCTATT?AAACCTCCAC?24240
TCCTAAACTC?CTCATGTGTG?TTCATATCCT?AAATTTTCCT?GGCTCATGAT?GATGAACCCC?24300
AGGTTATATA?CCCCAGTCTA?CATAGCTACT?TCAGCATCTG?ATACTTTCTT?TTTTTTTTCT?24360
CGAGATGGAG?TCTTGCTCTG?TTACCCAGGC?AGCAGTGCAA?TGGCACGATC?TCTGCTCACT?24420
GCAACCTTGC?CTCCTGGGTT?CAAGCCATTC?TCCTGCCTTA?GCCTCTATGC?CCAGCTTTTT?24480
TTTTTTTTTT?TTTTTTTTTT?TTTTTTGTAT?TTTTAGTGGA?GACGGGGTTT?CACCATGTTG?24540
GCCAGGCTGG?TCTTGAACTC?CTGACCTTGT?GATCTGCCCG?CCTTGGCCTC?CAAAAGTGCT?24600
GGGATTACAG?GCGTGAGCCA?CTGCGCTTGG?CCCAGCATCT?GAAACTTTCA?TCTAACGAAA?24660
CAGTGAGAAA?TGAAGCTGGT?ACATATCCAT?TTTTAAGGTT?TATGTGTAAT?ATGATTACTT?24720
GTTCTTAAGG?TAAGTCTGAG?TGGAAATGCC?AACTTCCACT?GACTATATAT?TCTAGATGAA?24780
AATCTTGGGT?CTAGTAACCA?GAGAAGTAAC?CCCAAGATAT?CAGAATTCCA?GCAACCAAGA?24840
GGGAAAAAAA?AAATCACCAT?TTTTTGGAAA?GATATATGAA?TGCATTTTAA?AAGTATAGGG?24900
AAAGTGAGAA?AATTTGGTGA?TTGATCCTTA?AAAACATAAA?TTCTTACACT?GGGAGGCTTG?24960
GATTGGGACA?AAGAACAGGC?AAGAGTAGGG?CAGAAATGGG?GTGGGACAAA?GCAATTACAG?25020
AATGATTGAA?TGCAAAAGAA?AAAAAAGATG?CTCTTGTGGA?GATGTATGGA?CTGTCCCTGT?25080
TGTACAGCAA?ACAAAATTAA?GGGGGCAGAT?GAACACAACA?CAAATTCAAA?CACAACAGCC?25140
GATCCAGCAG?TCGGCATTTC?CACTTAGGCT?TACCACTTCC?ACAATGCTCC?CTGCCTGAAA?25200
CTCCACCTCT?ATTATATGTG?GTATCCAATG?AATGTGTTTG?CTTGAAGTAC?CCACTTGTCT?25260
CCGGTCTCTG?TGTCTGTAAC?TACATGGAAT?GTCTTATAAT?CAGAAATCCA?CTTGATTATC?25320
TGATTGCTTC?TCTCCTGACA?AAGCAGGGTA?GTGGCCAGGT?CTGTTTTGAT?CATCATGATA?25380
TACACAGCAC?CTGGGGCAGA?ATGGGGCAAT?TTATGGTATT?CAACAAACGT?TTGTTTTAGA?25440
AGCTGAATGA?TTACTTACGT?GGAATGATAC?TTCTCAAATT?TTTTATATTT?TACAGCAAGG?25500
TTTGACAAAC?TATGGCTCAG?AAGTCCATGG?CCTGCTTTTG?TATAGTCCTA?TGACCTAAGA?25560
ATGATTTCCA?TCCCCATTTT?TAAAGAGTTG?TTTAAAAAAC?AATAAAACTA?AGAGGTTCAT?25620
GCAACAGAGA?TCTTATCTGG?CCCAGAAAGC?CTAAAATATT?TACTATCTGG?CCCTTCACAG?25680
AAAAACTTTG?CTGACCCCTG?TTCTAGAGGT?GTTATTTTAA?TAACCTCATT?GGCAGAATCT?25740
GGAGAGACTT?CACTTTGGCC?AAATGTGAAT?ATGTAGTCAA?TTTTTTTTCA?CATATGAGAA?25800
ATACAATTTG?AAAAAATTTA?AATATTAACT?GCATAATTAC?TTAGCTTTGT?CCTTAATTCA?25860
CTAAAACGTC?CAGATGAAAT?GTTGATTCAT?CATGGATAAT?TTTATTTTAC?AATTCCTAAA?25920
TATCTATAAA?AACAGTCGTA?TTTGCTAATT?TCAATTCCTT?TTTAGCCTAA?AGGAAACACA?25980
AAAACAGAAA?TCCCCTTAAG?TTTATGTGTG?GCACTGACTG?AAGAAGATTC?TAGAAATCCC?26040
CAGTTCAATG?TCAGAAACCA?AAGTTTTACT?TTCTCCTAAA?ATTTCCTGTT?ATTTCTTTAG?26100
AAGACTTACA?CTTAAAAAAT?TTGAGGGGGA?GGAATTCTTG?AATAACATCT?GTCAATCTTG?26160
AAACTTCAAA?GAGGTGGTGA?AAAACTCTAA?CAATAGCAAC?CAGGGCTGGA?AGGAAGCTTT?26220
GGGATGTGGC?TTTATCTAAA?CAGGAGCCAC?CCACACCCTC?TGGCAGTATT?AACCCTTGGG?26280
TTGCTACTAG?AAAACCCAAC?AGCTGTTGGT?GTAGGTACAA?GCCAGCATCT?CCTTTAGTCG?26340
AAGACCAACA?GGAAATGCTT?CTTTTCATCA?GCCGCCAGTT?ACAGAGAAAC?TCATAAACTG?26400
AACACTTACT?AAGTTCCTGG?CTGTGTGCTA?AGGATTTTAT?AGAATATTTA?AATTTAATTG?26460
ATAGAAAAAC?CCTATGAGGT?AGAAACTGCT?ATTATTATAA?ACCCCATTTT?ACAGATAGGG?26520
AAGCTAAAGA?TCAGACAGTT?TAAGTAATTT?TCCCAGATGA?TAAATTTAGG?CAACAGCAAA?26580
GCTGGTATTT?ACAATGAGCA?TTGCCTGATT?GGAGAGACTT?CTGATCTCAA?CCCCATACCT?26640
GATCTCTAAA?CTTCATATTG?GTGAGAGCCA?ACTAAGAATG?GCAATGACCT?TAGGCTGGGT?26700
GTGGTGGCTC?ACACCTGAAA?TCCTAGCACT?TTGGCGGGAG?AATCACTTGA?GCCTAGGAGT?26760
TTGAGACTAG?CCTGGGCAAC?ATAGTGAGAC?TGTCTCTACA?CAAACTTAAA?AAAAAAAAAA?26820
ATTAGCCAGA?CACTGTGGTG?CTTCCTGTAG?TCCCAGCTAT?TACGGTGGCT?GAGGCAGGAG?26880
GATTACTTTA?CTTGAGGCAG?GAGTTCAAGG?CGGCAGCACA?CTATGATCCT?GCCACTGCAT?26849
TCCAGCCTGG?GTAACAGAGC?AAGACCCTGT?GTTTGTGCGG?GCGGGGATGG?GGGGGTAGGG?27000
GTTGCGGGGG?AGGGGAAGAA?TGACTTTATA?TAAGCTCCCA?ATTTGATAAA?GTGTTTTTCT?27060
TTAGTGTAGC?CTGGACTAAG?TGATTTTACA?GCCATCCACC?GACTGACATT?GGCAATTCTT?27120
GTATAATGTG?TCTAAAGGAG?TATATTTTGG?GTATGGGGAT?TATATTCCTT?TGTTCTGAAC?27180
TAAGAACCAC?AGTTTAGTAG?TGTCTCTGTA?AATATGCATC?TTTTTCCTGC?CAGGAAATAA?27240
AAAGTTTTAT?GTGAAGGAGA?ACCCCCAAAT?CTTTTTCTTT?TCTCAGAGCC?TATTCTCATG?27300
GCCTAGATCT?TAGCAGAGCT?CAAAACATAA?TTGTTGCACT?ATTGGGACCT?TCCATGAATA?27360
GTAATAACAT?TGAACCAGAT?ATAGCTCTGA?AGGGCATTAA?AAATAAGGGT?GGAATTTATC?27420
CAAGGCCCAT?AAAAAAATGA?GGCTATAATA?GTAAACATTT?TTAGCCTGGG?TTCCATAAAT?27480
AGAGTTCAGT?GGGTCTGTGA?ATTTGAATGG?GCAAAAATTG?CATCTTTTTT?TATTTTCTCT?27540
AACCTTTAAT?TAAAAATTAA?TATTTCCTAG?TATCAGCTGT?ACCTATGAGT?TTGTTGTTGC?27600
AGACGTCTCA?GCATGTGACT?TACGCTCACC?ATTTAGACAT?TTCAATTGTT?TAGATCTGCT?27660
GCTATTGTTA?TTTAAAGCAT?TATTATAGAA?ACATATATTA?CTATAACACA?AATTCATTTT?27720
TAAAATATTT?GGTCATTGTA?TTTCAATGTA?ATTGGTTTTC?TTTGAAATAC?TCCATGTTCT?27780
ATTTTATGCA?TTTAAAAAAC?ATCACAGTGA?GAAGGGGTCC?ACAGGCTTCC?CTACTTCAAG?27840
AAGTCCATGG?CACAGACACA?CAAAAAGGGA?AGCTCCCTTG?GCAGAGTGAA?GGCATTTGGG?27900
CTCTAGTCTC?TTTTCCAGGA?CTTGCTAGAG?CAGGAATTTT?GAGATTGATG?GGTTTCTCTA?27960
GGAAGTTGGT?AACTAGTGCC?AATGGGAGAT?CTGCCTGGCT?TGATTTGTTG?TGCTGCACAT?28020
GGACAACTGT?GGATGCTGTC?GGAGCTTCTG?TGGAGTGGGA?AGGGAGCTCC?GCAGTGTAGA?28080
ATTTGAGGAG?AAGCCCTCCT?TTGAAATCTT?GTAACAATAA?GAAAGATAAC?TCATATACGA?28140
TGTGCTTTGT?TGGGTTAGGC?ACCGGACAAT?TTATTTTGTA?AACATGATCT?ACTTTATTTC?28200
TCCAATAACC?CTATGTATGA?GTTAGATTCT?CTTACCCCCG?TTTTACAGAG?GAGGATACTG?28260
AACCTTGGTT?GCTTCTACAA?CATTTTTGTC?TACTTAGTAA?ATAAGTATTC?TTGTTAAGTA?28320
AAAGTTGTTC?CTAGTAAGTA?CTCAATAAAT?GAATGCTGTC?CTTTTAATGT?TATAATTAAC?28380
ATGACTTGAG?ACAGGAAGTT?CTTCCTTCCC?CTCAGCTATC?TCTCTTTAGC?ACAGTTTCCT?28440
TCTTTGGATC?TCAGCCAGTT?GCATATATAC?TCTCGCTTTA?GGTGAACATG?CTGGCATGTG?28500
AACATCCTTG?CGGCTAGAGC?TTCACTGCCA?ACTTCACAAG?AATCTCTCTT?GGCATCTGAG?28560
GCTCATTAGT?GCACTAATAC?ACCAAGGTGT?GCGAAAAACT?GTCATCCACG?TCCCTTTCTA?28620
TTGCTCGGAT?AAATTAGTAT?CCCACTAAAT?GTTCACCCTA?AACTCCTTTA?CCGAGTGGAG?28680
GAATTGCCAA?ACTACTTCAA?ATATTAAAGT?AGGAGCCTAT?CTCCCAAATT?CAGCTATGTT?28740
GATTTGCTTT?TTATCAAGAC?ACATTAACTG?ATCCACATAG?GATTTTATTT?ACCAAGTTGG?28800
CCTTAATTTA?ATGCTTTTAT?TTTTTTAACC?AAGTGACTTT?TATTTAAAAT?AGTGGATTAG?28860
GGAGGTTCAG?TTTTAAGTTC?CTTTTAGGAA?CTGGTGTCGG?CATAACAAAG?GACATAAAAG?28920
AGGCTGAGAG?CAACGTGTGT?GTGCGCGCAC?GCGCGTGTGC?ATGTGTGTGC?GCACATGCAT?28980
ACTCAAGTTA?TAAGACAAAT?TGTTTACTTT?TCAATCACTC?CAAAGGAAAG?TATACCACAG?29040
GATTTCCCCT?TGAGGTTTTC?TGCCAGTTTG?TATTTTTTTT?TATGGCATAC?TAACATTTAT?29100
CTTTGGAAGA?CAGAAAAAAA?AAGAATTTGA?CATTTGTCTT?TAAAAAAATA?TTTATGTAAC?29160
AAGACTCTGA?CATTTGCAAA?TGGCTCCTTA?TTTGCAACTA?AGTCTGGCCT?CTATGAGTGA?29220
CAGAAGTGAC?TGGAAATTTT?CAGAATTATT?AAATGGATCT?CACAGTTCAT?TGTTAAGGAG?29280
ATAGCTTGGT?GGTATGGAAA?GAACAAAAGC?TTTGAAGCCA?CTCAGATGAT?TAAAAAAAAA?29340
TGGGGGGAAG?ATATGGTGCC?TCACACCTGT?AATCCCAGCA?CTTCGTGAGG?CTGAGGTGGG?29400
AGGATCACTT?GAGCCCAGGA?GTTTGACACC?AGCCTGGGCA?ATATATTGAG?ACCCTGTCTG?29460
TATAAAAAAA?AAAAAAAATT?AGCTGGATGT?GGTGGTGTGG?GCATGTAATC?TGAGCTACTT?29520
AAAAGGCTGA?GGCAGGAGGA?TCACGAGCCC?AGAAGTTCAA?GACTGCAGTG?AGCTATAATG?29580
GTGCCACTGC?ATTTTAGCCT?GGGCAACAGA?ACGAGAACAT?CTCCCCCTGC?CCCCCCAACT?29640
CCCCCCCCCA?AAAAAGTTAG?CCCTCTCTTC?CTCTTTCCTT?TCTCCTAAGG?GTATTTAAAA?29700
TAATATACTT?GGCCCAAGAG?CACAGTATGG?CCCTCAAAAC?TAGAGAAATT?ACTCTGATTT?29760
CTCTCTTGTG?AAAAAGAATT?CATTCCAAAA?TAAAACACAG?ATACAGAAAA?GTGCATAAAA?29820
CAAGTGTCTG?GCTTAGTGAA?TTACTATAAG?ATCAACACTC?TTGTAACCAC?TGGTCAGGTC?29880
AGAAAATATA?ATTTTGCTGG?CCACCCCAGA?AGTCTGTTCA?TGTTCCCCAA?CTCAATCGGA?29940
GATCCCTCCC?TTCCTCTAAA?AAGTAATCAC?TATTCCTGGC?TTTTATAGTT?ATCATTTTCT?30000
TGAGCTTTTA?AACTTGTTTT?ATCATCCAAG?TATGCATCTG?TAGTCGTCTT?GCTACTAATA?30060
TGACTGAATA?CAAATGGCAA?ACCTTGCTTT?TTTGCAGAAT?TACTGTTTTA?AAAAAACTTC?30120
CTACAATAAA?AACACCAGAA?TCTTTAAAAA?ATGTTTAATC?TGAATTAATC?AAATCATCAG?30180
ACAAATCTAC?AAAGTGCCTT?TATAAAGTAC?ATGAAATGGT?CTGACCTATT?CAAATCAAAG?30240
TCAATGTCAT?GAAAACCAAA?AAAACACACT?GTAGAGGCAA?AACAATCAAT?TTTAATGTGT?30300
TGTCCTTGAC?TGGATTCCGA?ATTTAAACAA?TAGACCCATT?AACCTTGAAG?AAATCTGAAT?30360
ATGGACTGTA?CTGTATATAT?ATTTAGATGT?ATATATGTGA?ATGTATCTGT?GTCTTAGTAT?30420
CTGTATACAC?ACACACACAC?ACAGAAAGAG?AGTGAAAGCT?AAGCACTCAC?ATATATGCTT?30480
CATATTGCAG?AGTTCAAAGA?TCTTGCCATC?ATTTTCTGTA?CCTTTAAAAA?TTTTGTTGGC?30540
ATGTTACATA?AAGAATAACT?TGTCACCTCG?TTATTCTAAG?TGTGCCCGCA?GACCAGCAGT?30600
CATCAGCATC?CCCTGGGAAC?TTACTGGAAA?TGCAGAGTCT?TAGCGCTGTC?CTCAACTAAC?30660
TGAATCAGAA?TCTACATTTA?AAAGTTCTCT?CAGTGATTCA?TTTACACATT?CAAGTTTCAG?30720
AGGTAAATTT?TATTCTTGCT?AAACAGTTTA?GCAAAAATAA?AGTTAAGTTC?TTTGGTACTC?30780
TGCCATAGAG?ATGCTTTCCT?CCTACAAAAA?ATTTCTTAGT?GGAATTGTTT?GCAAAGCTCT?30840
GGTACAGCTG?TATTCAGCAC?TAGCCAATGA?GAAAATGGCC?CATGATAATT?TTCTAGTCAA?30900
TTAACTGGTG?GAGGAGTGTA?GAATGAGATA?TGCTTCCCCA?TCCATCATCC?TAGTAAAAAG?30960
CACACCAATT?TAGGCAAACA?ATAAAAAGTC?ATTTCAATTA?AACAACAAAA?GGACAGTAAG?31020
CTCACTAGCA?ATGAAGGATT?TAATTTAACT?TCTAGCTATT?GATAGCACTG?TTTGACATTC?31080
TGGATATATT?TTGAGAGTAT?TTTTTCCTCA?AATGATGAAA?GAAGTCTTCT?CTCCAATCAA?31140
TGTGGTTGTT?TTATTCCAAC?TGCACATATT?TCAGAACAAA?GCTATTCGCC?ACCTCTCCTA?31200
TCCCATGGCA?CAGTCTCCTT?TGTATTATTT?CCTTCTTATC?TCTCTCCCAG?ATGGAAAAGC?31260
CTTGCATGTA?TTCTAATCCA?GTATGATAAT?CTCTTTCTAG?AATACCCATG?AGAGGTAGAG?31320
GTGAAACCTC?TGCCTGAAAA?TGTTATGGTA?GAAGGACATC?ATTCCTTTGT?TATCATTCCA?31380
TAATCAAATC?ACAATATTTC?TAACTGCAGA?TATATTGGGA?TAAAGTCTAA?ATATTGGGAT?31440
ATGTTTAAAA?TTATTCTTTA?CATTAAGTCA?AATGTAGCCT?CTGTGTGCTT?CTATTATTGG?31500
TCCTTCTGCT?GTTCTCTAAA?GCAAAAAGTA?ACAAAATGAA?TCCGTTTTCT?ATGGGATGAG?31560
AACTATTAAA?CTCCTGCTGG?ATATGAAACT?CACAACCCCT?AGATCATTTC?ATTTTCAGGT?31620
TGAACAGCCA?TGTTTTCCTC?GGTTACTTTT?CAAGAGATAC?ATTGATGAGA?CTCTAAAGTC?31680
TGACAGATTT?ATCAGACCCT?AAAATCAGCC?TGCCCAGCAT?ATAGCGCCCA?ATAAATGCCA?31740
GGACCTTTTT?TCTAAGGGTA?AAGTGATCTG?TTCTCTGAAA?CCACGCTTGC?TATTTAAGAT?31800
TCTTCATCAT?GTGTTTTGAT?AGACACAGAT?ATAATACTTG?GAATATAACT?TGTGTAGCAA?31860
AGATTACAGC?AGGACTCTCA?CCTCCTCTTC?CACCAAGTGG?AGTTTAAGGC?TCCTGATGGT?31920
TTGTTCTTTC?TGTTTTGTTT?TGATTCTTTC?AGCCAGATCA?TCCTGATTTC?AAAATGACCT?31980
TAACTCACCT?CTAAACCCTG?GGGTCTTCAT?CACATGAGCA?GATTCCCAGC?CAGTGTTTTG?32040
ACAAGTGCTC?CTTTGCAATC?GATTGTTTGA?ACCTATATGT?CTGATTTTAC?ATCTACCTGT?32100
CAAGTTTTAG?AAAATTGGTC?ATTTCAGGCC?ATTAAAACCC?TGATTCAGCC?TTTGCTCTTT?32160
TAGGCATCCC?TTCCACTGTG?CTTTTCACCC?TTTATGTTCC?TCCTTAGGAT?ATAGATTCCT?32220
GCTACTTCTC?TTGCTCTGAC?TTTAAAAGGA?GGGCAACCAA?CATTAGGAGG?GTGCCTACAA?32280
GGTACCAGGC?TTTGTCCAGG?AAATGATGAC?ACATCTGTCC?TCCCACAAAG?AGAGTTTCAC?32340
ACCTGATATA?TGTTCTTTGG?AACAAGATTT?TTTTTCATTT?TCTTTTCTGT?GTTATTGCAG?32400
TTTTCTGACT?ACTAAAAGCT?TAGGTTTTGT?TAGGATCCCC?ACACCTGCCC?TGATTCTTTA?32460
ATTCTTTTTC?TGGCTGGCTG?TCTGAATTAC?ACCTTGTACT?CTGTCTAGGG?GCCCTCATGT?32520
TCTCAGGAAA?CCTGAAAGCA?AGGTACATTT?CTTAAGTTAT?TTCAGGATGC?TCTCCAACAG?32580
GGAGACCAGA?TCGCTTTGGA?AAAGCATATT?CATTATTCAC?AATACCTGTT?AGGTCACCAG?32640
AATACATCCT?CTCTCTCTCC?CTGGCTTTCC?AGGTGAACCA?CAGGCTTCTG?CAATTCCTTC?32700
CCACCTGAGT?TTCTCACCTC?CTAAAATCAT?GCACACAGCC?TCCCTGGTCC?CTGCCTTGTC?32760
TCTGCCAAGG?CAGTAGCACC?CAAACCTTGC?CATCCAACCT?TTTGGACACA?TTAAGGTTTA?32820
AAATGTGCTT?TCCTTTAACG?TATAATTTAA?TCAGTTTTAA?AAGCTAAGAT?GCCTATTCCC?32880
AATGAGGCCG?TTGACCTTGT?TCCAAAGCAA?TTGCTTGTAA?ATTGTTGTAG?AAAACAAAAT?32940
AATATCCCCT?CTTAAAGTGT?CTTGCTATTC?CTCCAAGGAT?GGGGTAAAAC?AGGTGTTGGT?33000
TTTTCTCCTC?CTCTAACCTT?CGAAGGCATA?ATTTTGGCTC?CTTCCTGTGG?TAGCTGCCAT?33060
TCTTTAATTG?TTACCGTCCC?TTTCCAGGCT?ACAGGGGGAA?CGTGACGAAA?AATATAAAAA?33120
GATTTGGCAG?AACAAACTGT?CTTGAGTCCA?GTGGTTCCCA?ATGTGGGCTG?CATATTAAAA?33180
TATCTTGAAG?AATTAAAAAA?TAATTCCTGA?TACCAGGCCC?CAGACCAATT?AAGTCAGAAA?33240
CTGCAGGAGT?AAGACCCAGT?TAATGAGTAG?TTTTTAAAGC?TACTCAGGTG?TTTCCAATGT?33300
GCAGCCAAGC?CTAAGCATAA?CTACATCAGC?CTGGTGGAAG?AAACAGGTAT?TTCGAATAGG?33360
ATGGGGCCTG?GAAAATGAAA?GACATGGGAA?TAATTTTAAT?GACTACATTT?CAGAGAAATT?33420
GT7CTTGACA?TTGGAACCAA?CTATATCCTC?TAATTAGGCA?ACAAAAGGCA?TATATATGTA?33480
TATTTTTAAA?AGTAGATAAG?CAAATATAAA?TTATTTCTCT?AAAAGTTAAC?ATGTTTTTAA?33540
AAAAAAGCAT?AATTTGTAAT?GGCAAAATTG?ATATTTTCCA?CAACAGGTAA?CATGCAGGAG?33600
CGATTTAGAA?TACAAAAGGA?CTTTCCAAAG?GCAAGTCATC?CAGATGTCCA?AATGGTGGTG?33660
AATACAGCCT?CTGGAGTATA?CGTGGGTGGA?AATAAAAGTC?AATTTCACAG?TGGTTAGCCA?33720
CCTCCCTGAG?CCTTTTTTTT?CCCCTGGTGG?GACACTGAGA?CACTCGCAAA?GCAGCAAAAG?33780
GTCTCAGTGG?ACCCTTCTTG?CCATTACTCA?TGGGTGTGGA?GTTTATGGAA?CACATGGAGG?33840
CCGCAGTGGG?AGAGACCTGA?GGCTGCAGAG?GAACCACCCG?AACCTTGCTA?CAGCACCAGC?33900
AGTATGGGTC?CGACTGCTTT?CTTGGCCACT?CATATCCAGT?GGATGGAATT?TGAGACAGCC?33960
TGTGTCCATA?CTAGATTCCA?CTCTGCTGAT?TCATACCAGA?ATGAGGTTCT?AGAGTACAAA?34020
TATTCACAAC?CAGAAAGCAC?ATCTGGCCTC?AGTGCAGCTT?TGTTTACTTT?GCTACTTAGG?34080
AAAAAAAAAA?ATCTTGAAAA?GCGAGTTGCT?TTTGCCTTAA?TTCAGTTCAA?ATACATTCTA?34140
AGCTTCCTTC?AACTGAGTCA?CAGTGTCCTC?TATCATGCAA?AATCTTTATT?ATTTCCTTGG?34200
CCAGACATAG?GGCCATATTG?ATGAATTCCA?AGTGTGCTTT?CTAACCAAGG?CTGGTTCACA?34260
ACAAAAAGCT?GCTTCAGCTC?TGAGTCATCA?CCTCAAATAA?CTGATTTCTC?TTCTCAGGAA?34320
TGAGACTAGC?AACTTTAATC?CATAATTTTC?TTCCTCTTCT?AACAACTTTT?CTCAACCATA?34380
TTTCCACACT?TATTTTTTCT?TCTGCATTTA?GACCAGAAAG?TAAATCTGGT?TTGTTTCTTT?34440
TGAAACAAAA?ATGCACAGCT?GGAAAGCCAG?CTATTTTGAG?GCGTGAGTGC?ACAGTTCCAA?34500
GGCAGCATAC?CTAAAATCCC?CCAGAGCTAC?CAAAACACCA?TTTACTCTTT?TCATTTCTTA?34560
CATGCAAGAA?CTAATCATTT?CCCCAAGAAG?CCAGCTCCCT?GGTGTTGGAG?CTGAACAAAC?34620
ATAAAATGAG?ATTTGGGAGA?AAGAGGGCAG?CATTTCTAAG?ACTTCCCTTA?CTCGGAAAAC?34680
AACGGAAGTC?AACAAAATGC?TCAATGCATG?CGATCAGTAC?ACAGAGTGGG?TTTGCTGGAT?34740
GGTGTAAAGC?AACGACATTA?AGGACACAAT?GGGTCCAGAG?GGAACCAGCT?GGCTGAGATG?34800
TTCTGCTAGC?AAGTTAAACA?TAGACAGGAA?ACCGCGTGTC?TGATACTGTA?AAAAAATAAT?34860
TTGTCTTCCT?GCCAGAGATA?GGCTAGCAAA?CCAAAAAGGC?TGTTTTCACT?TAAAAGAAAT?34920
GCTACAACAA?TGAGAGAGGA?AGGAATGAAA?CTTTGTGGCT?ACAAGAAGTC?TTCTTCTCTG?34980
CCCCTCTCTC?AACATCTCAG?GTTAGAGGGC?ACACATCACC?ACACTAAATG?CTAAAGCCTG?35040
CACATAGCTT?GCGAGTCAGC?AACGTGCACC?ACTGGGCATA?CATCTTATGG?TCTGCTTCCC?35100
TATTTAACCA?CATAGATTGA?ACTTTGAGTC?AGAAGTGGTT?ACTCAAGTCC?TGGTTTCTAA?35160
GCTAGCAAGA?TATAATTGAT?TTATTTACTT?ACAGTCCTAT?CCCATTCCCA?AAAACAACAA?35220
CAACGACAAC?AACAAAAAAC?ACAGTGAAAG?AAGATACAGT?CAAGACAGGA?GCTATAATTA?35280
TGACAAATGG?AATATAAATG?TGAGAAAACA?GGGTAAAAAC?TGGTAAGCAA?GAGTGATATT?35340
AGTATGCTAA?ATGTGTAGGT?ACATATTTGC?TAGAAGCATG?ATTCAGATTT?GACTCTAAGC?35400
TTTTCTGGTA?GTTAGCATTT?GAGAGAGAAA?CACAAAAACC?ATGAATATCT?CTATCAGGGG?35460
TTGGCCTGAG?CCCTGTTTTT?GTAAATGAAG?TTGTACTGGA?ACACAGCCAC?GTCCAATCAC?35520
TTACACACTG?TCTGTGGCTG?CTACCACAGA?AGAGTTGAGT?AGCTGTGACA?GAGACTCTGC?35580
CCTGCAAAGC?TGAAAATATT?TACTATCTTG?CCTGTTATCA?AAGAAGTTTG?CAGACCCCTG?35640
CTCGGTATGC?TTCAAAGTGT?CCTTAAGATC?AGAGGCAAAC?AGGTCGTCAT?GAGGAGAACA?35700
CCTTTCTAAA?ACAGAGAGCC?AAAATAAATG?TCTCCTGGCT?TCCTCATGAA?GATAACAATA?35760
CAATGCAGTG?AACAGCATCC?TCCACATTCT?TTACAGTAAA?CATACCACTT?TGATTCACAG?35820
GACTCCTTAT?AATGGGGAGC?ACCTCAATAG?GACTCAGGTG?GAGGAATTTG?CAGGGAAGAG?35880
GAGAATACAT?GACGTTGGTA?CAAATCTCCT?CACTCATCCA?GCTAAAGGCA?AAGATAAGAA?35940
ATTTGAATCT?AGTGGAACAG?TAATAACTAT?TTACAGTCAA?AATTCATTAA?GTGCTCACTC?36000
TGTGCCAGGT?GCCGTGCCAA?GTTCTCTACA?TAAATAAATA?CATTTATCCT?CAAAATAATC?36060
CTATTAAAAG?TATTCATTAT?TTCTACTCCC?ATTTTTCAGA?GAGGTAAACA?AGTAGTTACC?36120
CCAAGAACCA?AGAGCTTACA?CACGGCTGAG?CTGGGATCTG?AACACAGGCA?ATCAGCAGGG?36180
AAGCCATGCT?CTCAGCCCTG?CCCTCTGTTG?TCTTCCCAAC?AGATGAGCAT?CTTACTGGCC?36240
ATCGTTTATA?CACATCATTT?CTCACGGACA?TGGAAACAGT?GTCAGCCTGA?GGTTGTGCCT?36300
CTTGCCAAGG?ACATGCTCAG?TGATGGGTCT?GGGCTGCCGT?TTGGCAAACA?GAACAGGTAG?36360
CCTCTTATGT?AAGTTGTGCA?GCCTCCCATG?GGTTAAGACT?GATAAAAAAG?CAAACACACC?36420
ACCACCACGG?GAATGTGGAA?GGGTAAGGGT?ATTCCTTCTA?TAAGAGACAA?GATTATCTGG?36480
TTCTTCTATG?ATTCTCCTAC?GGACAAAAAG?TGAGGAACAA?ACTATGAGAT?CTTGGAAAAT?36540
CCCAGCTCCT?CTCTGGAGAC?CCACTTTTTT?GTCATTAAAA?TGAGAAGTCT?GGAGGAGCCA?36600
ATTCACGGGT?TTCACTTCAT?CATAAAAATG?TAATGAGTCT?ATGAAACAAG?ACAACACACC?36660
TGAAAGTAGT?TAGCACAGGT?GCACACATTC?AGAGTAGGCT?GCAATCCAAG?GCAGCGATCA?36720
TCACTATAGT?TGTTCTATGA?GTTCCCACAG?CCTAGGCCAT?GGGCTTGCCA?CCACCTTGCC?36780
TACATTTCAA?TTGGAAAAGG?GGTGGGACCC?TGGTCCTGCA?AACAAACTAC?TGAAAGTCTA?36840
GGACTTGGGT?CCAATGCTAT?CCCTTTCCTA?TATGGCCCCA?GTGCCTCTCA?TTTTCTAGAA?36900
TAAGCAGTTC?AGTTCTAAGT?TAGCAGGAAA?AGCAAGATGG?CCAAGATCCA?GTCATTTGGG?36960
AGCTGGAAGT?GGTCCAGCAG?CATGCCTCCC?TTCATCCTCC?TTGGCTTACC?ATCTTGTTTT?37020
CCACGTACCC?ACCTTCAGCA?GACAATCTTA?GCAAACAACC?CAAGAATGAA?CTGATTCAGG?37080
CCAACTCTTC?TTAGAACCAC?ACTATTACTC?TCCAGGGCTT?TCCAAGGCCA?CCAAACATCT?37140
CCTTCATTGA?TCCAGTTCAA?AACAGTATCT?TGTACAATGC?ATCTTGAAAA?CATTCGCAAA?37200
TGTCTTCTTG?TTTTGGGAAA?TATTAAGGGA?TAGTCCCACA?GATAAACTAA?TACAAATACA?37260
ATAAACTAAC?ATGAACATGA?TCACAGAAAC?AAAAGAAATG?CTTACTGAAA?AGGTGTCTGA?37320
TTTTCTCCAC?ATTAAGATCC?ACACCAGAAC?AACATTTGTG?GAGTATATTT?AAAAAATAAA?37380
CTATTGTCAC?TGCTGAAAAA?GACCCACATG?CCACTGGAGA?GCTCTGTTAC?ACAAGCTGAC?37440
TGAGTAAAGT?ATATTTAGTT?CATTTCCAAA?TGACCAGGCT?TTAGACCAAA?TTTATTCCTC?37500
ATGGGCCCAT?TAGCTCAGGG?AGTTACCAGC?ATGAAGTTAA?TAAGACCTCC?ATCTCTGGTT?37560
CCATCCCTAC?CTGGTGAGTT?CACACCAGTG?CTTCTCACAC?TTCAGTGTGC?AAACAAATCA?37620
CTGAAGGCCT?TGTTACAGGC?AGATGCTAAT?GCAATAGGCC?CCAGAGGACC?CAAGGTTGTG?37680
CAGTTCTAAT?AAGCTCCCGG?GTGATCCTGC?TGCTGCTGGT?CTAGACACTT?TCAGTAGCAA?37740
CGGTTTATAC?CGTTCAGAAG?AGGTATGTGT?CTTGGTGTAG?AGTGTTCTCC?TTAATCAGGG?37800
GAAGAAGAAG?TAAGAAAGGA?TGCACCTACT?GTGTGCCAGC?CACTGTGCTG?GGCGCTCCCA?37860
AGCATCATCT?CCTTAAATCC?CACAACAACC?CACAGGTACC?ATTTATCAGC?ACTACTTGGC?37920
CAATAATGGC?GCAGTCATTC?AAAGAGAAGG?CCTTGTGGCC?CAAAGCAAGC?TTTCCATGGA?37980
AAAAATGAAG?AGGGAATGAA?TCCCTTTGGC?AAGTACAGAA?CTGCGATTAC?CCTAATCACT?38040
TATGTGAAAG?GCACTTGTGG?GTTGTTTCAG?TTTTATTTAG?CTGCTTCCTG?CTGTGATTCT?38100
GAGTCAAAAC?AGGAACAACG?TGTCTAATTT?GTAATATTAT?CCAACAATGA?CAGGGATGTG?38160
GTTAGCTTTG?ATTAGAAATT?CTAGACTCAG?CATGCTCCCC?TTGCCTCTGT?GAAGGCATGT?38220
GGAGAAAAAG?AGAAACTGGA?TGAAACAGGG?ATTAAAGCAA?AGTGAGCCCC?TCCAAAACCT?38280
TGTGGTGTGA?TATGTAGGTA?TCCGAATGCT?CAGTTTATGC?ACCACAGTCA?GCACTCAACT?38340
ACAAAACTTC?AGTGTTAGAA?CAGACCGAAG?GCTACACAGG?CCTGGTTTCC?TGCATTCAGA?38400
CAAGCACAAG?TCACCAGCCC?TCTATAAAAA?GCCCAACTAC?TGCTAACAGC?TAACAGACAG?38460
TGACATGTCA?GGCAACGTTG?CAAGCACTTT?ACATGCATTA?ATCTACTCAA?TCCTCACAAC?38520
ACCTCCCACC?CGCTTTGTAT?TTCCATTTTA?CAGATGAAGA?GACTGAAGCA?TGGAGATGTC?38580
AAGTCACTGG?CCCAACATAG?CAGAGCTAAT?AAGCTGTAGA?ATAAGCCTTA?AATCCAGGAG?38640
ATCTAGCTCA?TTCTTGAGTA?TTACACTAGA?CCGTTTCTCT?CTTACCTAAA?CCAGCAGAAA?38700
TCACCTCTTC?GCTCAGTGTT?CCACAAATTA?AATGTCTGAC?TGCACTTGGA?AACCATTTAT?38760
GAAATGAATA?AAACTGAGTT?GTTGTGTTTG?ATTCTTACAG?GTTCAGTGAG?AGATCAATAA?38820
CCATATCATG?TCTTTGCAAA?GTGGGGATGT?CATTGGCAAG?TAAACAGCAT?GGCTATTTGC?38880
TCAGGATTCC?TTCCTCTCCT?ACCTCCTGTG?CTGCTGCCTT?CAGTCCTGGT?GCCCATCAGG?38940
TCTCGTCTGA?CTGACAGCTG?TCACCAGGCC?ATCCATCATG?ACCAATCCAA?ACAACTTCTC?39000
TTCTAATTGG?AATTTTATAT?GTTGGTTAGT?ACAGGGATAG?ACTCTGATTT?CCTTAGAATT?39060
CTACACAAAA?TGTTCTGGCA?GGAGGGAATC?TTCAGAGACT?GGGAGGGAAG?CATGAATGTG?39120
AGAGAACAGT?TGTGCAGTGC?AGACCCCAGC?CCCATTCTAG?TTGTTTCTTG?ACCCCTGCCT?39180
GCCCTTGGTC?ACTGTAGGGA?GGCAGGGGAA?CTGGCACTAG?GCCCCACTGA?GGGATTCCAG?39240
GGTTAAGGGT?AGGTACCCGG?TTCAAAGAAA?AAAACAGCAA?GGTTTCTTTA?ACTCTTTCAT?39300
TCTAAAAACC?ATGATCTCAG?TCCTCTGAGG?AAAGGGCATC?TATGACACCA?GTGTCTGATG?39360
TCAAGATGTT?ACCGTGTTCC?TCTGCCTCTA?CAGACAACCA?AGCCTCATTT?ACAACAACAA?39420
CAAAAGGAAC?AAATGTTAAA?TCTCTGCACC?ATTTTGTCTA?GATGTTTGAA?TTTGTCTAGC?39480
ATTTGAATTT?TTTATCATAT?GCATATATTA?TCTCTTTGGA?AACATACAGA?GATATAAAGA?39540
GAAAGAAGGA?AATAAAAAGA?GGAAAAAAGG?AAAGAATTAA?AAAAGGAAAA?AAGGAAAACC?39600
TTCACAGGTT?TTAGTGCCTT?ACATATCCCA?TTATAAATCC?TAGCTTTGAT?ACCCACTAGT?39660
TGTTTGATTG?TAGACAAAGT?GTTAAATTTC?TCTAAGCCTG?GTTTTCTCAT?GCATAAACAG?39720
GGATCCTAAC?AGTGCCTACT?CGCATGGGGT?GGCTATAAGA?TTAAATGAGG?TCATGCTTGG?39780
AAAGGGCTGA?GCTCCCTGCA?CAGCGACAGT?ATGTTTTCTC?TGAATATTAA?CTATCATTAA?39840
TAGTAGCACT?AGAAATAAAG?ATCCATACTT?AAAATCTTGT?GGCTCAACTT?TTTTTTCTTA?39900
CATATTAAAA?AAGGTAGATG?TACATAATTA?TCATCCATTG?TGTAGCTGCA?GATCAGGAAC?39960
TTGCCAACAA?GAGTACTGTA?CTACTAATAA?TACAGCCACA?ATGCACTTCA?TAGCTTTTGT?40020
GTTCACCACC?TTGTTGGACT?TGGAGTAGAC?AAATCAACAT?TAAGAGTTTT?CATTCTGGCC?40080
GGGTGTGGTG?GCTCATGCCT?GTAATCCTAG?CACTTTGGGA?GGCTGAGGCA?GGTGGATCAT?40140
CTGAGGTCAA?GAGTTTGAGA?CCAGCCTGAT?CAACATGGTG?AAACCCCGTC?TCTACTAAAA?40200
ACATAAAAAT?TAGCCGGGCA?TGGTGGCAGA?TGCCTGTAAT?CCCAGCTACT?TGAGAGGCTG?40260
AGGCAGGAGA?ATTGCTTGAA?TCCAGGAGGC?AGAGGTTGCA?GTGAGCCGAG?ACTGCACCAT?40320
TGCACTCCAG?CCCGGGTGAC?AGAGTGAGAC?TCTGTCTCAA?AAAAAAAAAA?AAAAAAAGTT?40380
TTCATTCCTC?AAGATAAAGA?AGAGATGGTG?GCAATAAGGG?GAGAAATGGA?ATATAAAATG?40440
TTGCTCCTAA?TGTCTGCTGT?TTTAGGTGGA?AGAAATATCC?CACCACACAG?AAAAGAGATG?40500
CTTAAAAAGC?AAACACCCCC?TACCTTCTGG?AGCATTTTAG?AAGACTCTGA?AATCACCCAG?40560
ACATTTGAGT?CGTCAGCTGT?GAAAGGCTTC?CTGTACTGTA?CAGTGAGAAA?TTGTCTTTAT?40620
GCTTATTATC?TCACTTCATA?AGAAAGTCTG?AGAATAAATA?AGAGGAAAAA?TATGAGGGAT?40680
GCCCATGATG?ATCACTTGAG?TTGAAAGACT?CTGAAAATGG?AAGTCATTAG?TATCTGAAAG?40740
GCTCATAGTA?AAATATAAAA?TGCATGATAT?ATTTTGACAA?AGATATTCAA?TGATAAAATA?40800
TAGATCCAAC?TTGCAGGCCA?TTTATCAACT?TTTGTCCTTT?TGGAGGAAAT?AAACTTGTCT?40860
ACTGTAGACA?AGCTGGTATA?CAGAAGGAGA?GAAAAGTTTC?TTCAATGCTA?GTAAACATGC?40920
CTGGGTATTC?TACTGTCAGA?GATTAATTCC?TTTGGCTTAG?CCTAGGCCTT?CTTTTAAAAG?40980
GTGATCTACT?TGAAGAAAGC?TGACCTGGTA?AGTCAGAATA?TCAGGTGTTA?CCATGTTTCA?41040
TGTGATTAAA?CTATTTAGAT?TTCCCTCCTA?ACTCAAATCA?CATAAAGAAC?ATGAGGCCAA?41100
GCACAGTGGT?TCATGCCTGT?AATTCTAGCA?CTTTGGGAGG?CCAAGGCAGG?TTATTCACCT?41160
GAGGTCAGGA?GTTCGAGACC?AGACTGACGA?ACATGGTGAA?ACTCGTCTCT?ACTAAAAATA?41220
CAAAGATTAG?CTGGGTATGG?TGGCACACTC?CTGCAGTCCC?ACCTACTCAG?GAGGCTGAGG?41280
CAGGAGGATC?ACTTGAACCT?GGGAGGCAGA?GGTTGCAGTG?AGCCAAGATC?GTGCCATTGC?41340
ACTCCAGCCT?GGGCGACAGA?GTGAGACTCC?GTCAAAAAAA?AAAAAAAAAA?AAAAACAACC?41400
AGAAAAGAAA?ACGAGAGAAA?TGGACCATTT?ACAGGATGAG?GATGAGAACA?TAGGAAGGAA?41460
GAGTAATCTG?GAAAGCGTTG?CCCTGACAAG?ATGTGCATGC?CTGCCTTCAG?TTCACTGAGA?41520
AGTTGGCCTG?GGGGATGTTG?GACAGGAAGA?TAGGGAGAAT?GGCAGTAGGT?GAAGGACACA?41580
GGAAGAGAAC?AAGCTGGATC?TGCAGTGCTA?CTGAGCACCA?AACACGAAAC?ACGAGGACAC?41640
ATAGCTTCTC?GCAGGTGGAA?TGCACATGGC?CGCAGAGATA?GGGTGTAGAG?CCAGCATTTG?41700
TATTTCAAAA?AGATTTTTTA?ATTAAATCAG?ACCTATTGTT?GACTAAACTA?ACATTTACAC?41760
TACCACGCTG?GTAAAATTAA?AAGACTTATC?CATTCCCAGT?GTTGGAGAAG?GTACACGGAA?41820
ATCCATATGC?TTACATCCTT?TTCAGGAGGA?GAATAGTTTA?GTAGTGCTTA?TTCAAATTTA?41880
AAATACACAT?ATTTCTAATC?TAGAAATTTC?ACTTCTGGCA?ATCTGCCTTG?CAGAAATATT?41940
AGCACAAATG?CATGAGATAT?TTTTACAAAG?ATATTCAATG?TAGCATTAAG?TGGAAAAACT?42000
GAAGACAATC?CATCAACAGG?GACATGATAA?GATCCATCGT?GGGAGATAAT?ATGAAATTCG?42060
AGACTAAATT?AAAAGATGTA?CAGTATATCT?ATGTGTTCTA?TCTTGTTTAG?AAGGAATTGT?42120
AAAAGTGGTT?GGGTATAAAA?AAGTGTTGCA?AAATAATATT?TATAGTATGA?TCAGATAGTT?42128
GTACTGAAAG?ATGGATGAGT?GGATGGAAGG?ATGGACAGAT?GGATGAAAGG?AGGGAAAGAG?42240
AAAGGAAGAC?AGGGAGAGAT?TGGGAGAGAG?GATGGAGTGG?GAGATAATAT?GAATGAATGA?42300
TAGAGACGTG?TGTGCATCTA?ATACATTGTC?AATACAGATG?ATCTGTTGCA?TTGGGAGTGA?42360
GGGGAGGACG?AAAATGTACT?TTCATTTTTA?ATTTTCACAC?ACTGTTGGAT?TGTTTGAAAT?42420
TTTTGATGAC?GAGCATATAC?TACTTTTGTA?ATTAAAAACC?ACTGAATTCT?CTTCTTATTA?42480
AAAATTGAGG?GAATAGTGTA?TGCCTTCCTT?TCAAGCTGAG?TAAACGCTGA?ACTTCAAAGA?42540
TGGAGGCTAG?TATCTAATCT?ACTCTTCTCC?TGGCTCTAGG?GGTAAACTTT?GGCTTATTAT?42600
TTCCTCTCTG?TATTGCAATG?TTTCTCTCAA?ATGGGATCGA?TGACAAGTAC?CCTAAAGACA?42660
AATCCTGGGA?CTATGTACAA?GAAACAACAT?CAGTTATAAA?GAAAGTCCTC?CTCCAAGATT?42720
AAACAACCCC?ATCCAAATCT?TTAGAACAAT?AGTTACCAAA?TTTTAGCTGC?ACAGAATTAC?42780
TGGGAGGGCT?TGTTAAAATA?CAGATAGCTG?GGGTTCACCC?TCTATGTTTC?TCATTTAGTG?42840
GGGCCTGAGA?ATCTGCATTT?ATAACAGGTT?CCCAGGTGAT?ACTGATGCTG?GCTGCTCAAG?42900
GGGCCGCACT?TTGAGAAACA?CTGCTCTAGG?TGAAAGAAAC?TATTTGTCAA?AGACAAATAA?42960
TAATGTTTGC?CCCAGTCAAC?CATATTTGAT?GAGAACCAGA?ACAAACCCTG?CTACTCCCCA?43020
AGCCCCTCTT?TCCACCAGCT?GAATGAGCTC?CTAATCCACT?GTATGCAATC?CACCACAGGA?43080
GGAATGTGCT?CTATGACACT?GCAGACCAAG?GATACAAAAA?ATTGGCACAG?ATCTCAGGTC?43140
CCACACCCTT?AAGAGAAGAA?AACTCACCTT?CTGAGAAGAT?GATGTTGTCA?TTGCACTCAT?43200
CAGAGCTACA?GGAACACATG?AAGAAAGTCT?CACCAGGCTT?TTTTTTTTCC?TTCATAATGC?43260
ACTTTGGAGA?AGCAGCATCT?TCCAGAATAA?AGTCATGGTA?GGGGAGCTTG?GGGTCATGGC?43320
AAACTGTCTC?TAGTGTTATG?TTCTCGTCAT?TCTTTCTCCT?AGAGTGAAGA?GATTCATTGG?43380
AAGCGAGGGG?AGAGGGAGAG?AGAGAAAGAG?AATAAATGAA?TAATATGGCC?TCCAGACAGA?43440
AAGGCAATCT?GGAATACTTT?TCCTTCATGA?AGTTGTTCCT?AACAACGGCA?GCTGGTTCCT?43500
GTTCTCCAGC?ATTCGCAGGC?TGTCCTATAG?TCTCCTATGC?TTTTCTACTC?TTTTCTGTTT?43560
TTCCTTTGTT?TATTCTTGGA?ACCCATTTGT?GATTATAAAC?ATCACCTGGA?GCAGACAGCG?43620
TTCCACGGGG?CAGTCCTGGT?GGAGAATTTT?ACATATTTAA?GTCTTAATTA?AATCATTAAA?43680
GGGGAAGACA?TGGAAAAAAA?GAACATTCCT?AGGTACTCAG?GATAATTTTA?AATCTTCCAT?43740
CCTGAATGTA?ATGCAAACCT?CACATCACAC?CCCTAGTTTA?ACTGGCAAAA?TCTGTCCTGT?43800
CTAGCTATAC?TGTTTTCAAA?GAGCATGCCT?GGGGAAATAG?TCACAGTTCC?TCTTTTTTTT?43860
GTTTGCTGGG?CCCCAGAGCA?TTGCGTGTAA?AGGGTATACT?CCTTGTCAAC?AGCTGGTTCT?43920
GCTGAGAAAA?ACGGGAAGAA?ACATCGCAGA?TAAAGAACTG?CAGTCTTTCC?CAAATTACAG?43980
AAAGGAGCAA?TTCAGAAAAA?ACAAACAAAC?AAAAAAAACA?AATAAATAAA?AGAAATGGAA?44040
AAGGATGTCA?GGGTGTTCTT?CATTTACAGT?TCAATGAAAT?ATTTTATGCT?GTCATAAACT?44100
AACTACTTTG?ACAGTATCAC?TTCATAGCAC?ATATTTGAAG?ACTAATTTAG?CCCAGGGCTC?44160
AGAGAATTTC?TCACATAGCA?TTTTCCTTGG?GCCCTAGGAA?ATGCTCAATT?GGCCGTCAGT?44220
GTACATTAGA?TTTTTAAACA?ACATGATTAA?TGCCCACTAT?TATAATTGAA?CAAAAGAACA?44280
TTTTGGCTCT?CTTGGAAAAG?GGTATCACCT?CTCTATCTAC?CTCCCTCTGC?TCCCTCATGA?44340
ACATACTATC?TTGGATGACT?GTCCAACAAG?GCTAGTCTGA?CATCCACCCT?TTCACCTCTG?44400
TCCTTTTTAG?ATGCAAAATA?CCTGTTGTCT?TGAATCGCAT?TCTCTCTGTC?TAGAGAGGGA?44460
GCGGAAGGAA?GGGCTAATCT?GGTCCAGTCA?GTTTTGCTAG?AGTAATCTTC?TATGAAGATT?44520
CTGAGTGCAC?ACATGAGCCA?ATGCATGCAT?GTACTCACTC?ACCAATTTTC?CCCTAATCCT?44580
CCCTGCCCCA?TGCACAAAGG?CTCACTGCTC?ACAGCAAGGA?AAACGGAAGG?CAGGCTAGAA?44640
GCAAGAAGCA?GCTAAGACAC?AGCTTGCACC?TATAAAAGAT?GCGGGGCCAT?CCCCACGAGA?44700
GAAAGAGCAA?CTTTGACCAA?TACCACTTTT?TTAGTGCTTA?AGTCAAGGAC?ATTAAAGGAC?44760
AATATGTTGA?CAAAGGGATA?AGGGCAAGGG?TATGGGTTAG?GACAATCCAG?GCAGGAATGG?44820
TGCCAGTGTC?AACATCCATG?CAGCCCAGAG?TTGACTCCAG?TGGAGGTACA?TGTGTCTGCT?44880
TGTGAAGGGG?CTCAAGGGTT?CTTAAACTAG?AATTCCGAAA?GACACAAGAG?GAGCAAGGCT?44940
TTGCTAAGTT?GGTCCCTGCT?GTGACAGGAA?GAGTGACAAG?CAGAATAATT?GGTTGAGGGT?45000
GGCTATCAGG?ACACCAAATG?AAACTAAATG?AAAGTTGGCA?TGATCATACA?ACAAATGATG?45060
TATAATTTGG?AAATCTACCC?ATCTTTAACC?CCAAAGCTAC?TTGGCAGTCT?TCAAATCAGC?45120
TGTAGTCATG?GAACAAGAAC?ACCTTCCTCC?CTGCCCCCAC?AGTTTTGTGT?GTGTGTGTGT?45180
GTGTGTGTGT?GTGTGTGTGT?GTGTGTGTAG?GTTGTTTTTG?GTTTGGGTAA?TAAAACGAAG?45240
GTATGCTGTG?CCCACAGAAA?GGCATGGTCT?CTTTTCCTTG?TGACGCTTAT?AGAGGCCTAA?45300
GAAGGAACTG?TGAGCCATGA?AAGAAAGCTG?CTCTATAATT?ATTGGGCAGC?TCTTCCAGAG?45360
CCTCCGGTTT?TCTACCTCTT?AGCTACTGAG?AGAACTAACA?TCACAGAGAG?AAAACAACTG?45420
TAATACTTGA?GACCTGGTAA?AGCCCTTAAC?TGCTTTCTCC?ACTCACTCCT?GTAACAGCCA?45480
GGCACAGCTA?ACTTTTCAAA?CTCTTTTTGG?ATATAGCTGA?GCATAGGAAA?GGTAAATACA?45540
AAGAAGTAAA?TACGGACTTC?TTTTTTTGTC?CTGCAACATT?TGCTCTGAGC?CACTGAAGAG?45600
GTTGTCAATT?TCCACTGAAA?GAAGAACCAA?CATGATAAAA?TTAATTTTGG?AGGCTGGGCA?45660
CGGTGGCTCA?TGCCTGTAAT?CTAAGCACTT?TCAGAGGCCG?AGGCAGGCGG?ATCACAAGGT?45720
CAGGAGTTCG?AGACCAGCCT?GGCCAACACA?GTGAAACCCC?ATCTCTACTA?AAAATACAAA?45780
AAATTAGCCA?CGTGATGGTG?GTGTGCACCT?GTAATCACAG?CTACTCAGGA?AGCTGAAGCA?45840
GGAGAATCGC?ACGAACCCGG?GAGGCAGAGG?TTGCAGTGAG?CCCAGATCAC?GCCATTGCAC?45900
TCCAGCCTGG?GCAACAGTGG?GAGACTCCCT?CTCAATTTAA?AAATAATAAT?AATAATAATT?45960
TTGGTTATAA?AATATTTCTA?TCCTTGGAGG?CAGCTTAAGC?ATTTTATATG?GAATGGGCAC?46020
ACAACTGACA?TTAGTTAAAT?GAATGAATGA?ATGAATGAAT?GAATGAAAAA?ACACTAAAAC?46080
TGATTAAAAA?AACAACAACA?CTGAAATCTA?CAATCATAGT?AGAGCCTTTC?AGTTTCCACA?46140
CTGGCTATTT?TTACAATAGC?CTCCTGTCTT?AGTTTAGGTT?TCCTGGAAAC?AGACCTTGAG?46200
GCTGTGAGAG?TTCTGTGCAG?GAGGTTTTTG?GAGATGCATC?TGTAAGCGAC?TAAAGGCAAC?46260
AGTATTGCAC?AGAAGGAAAA?AGCTAAACTA?TAATGCAGGT?TGCAGCAAAG?GCCTCAGTGA?46320
ATGCCTTGGA?AACTCTGAAA?ATGGGATGTC?CTTCAAAGAT?GTACCACATT?ATGGCAAAAT?46380
AACCAGGAAT?TTGTTTCTCT?GCATCAACTA?GCCATGGGAT?GATGGCTACC?CATGAAAAGT?46440
GTCCAACGTG?AATGAGGCAG?CTCCCATCAC?TGGAGGGAAG?GCTCAGCAGT?GATCCTTCAA?46500
CAGCCAACAC?TCCCAGGGAA?TGAGTGCCTT?GGTCATGAAG?GAGGATCAAG?GAGGGCACTA?46560
TAGCGTACCC?TATACTTCCC?CTTCTCATTA?TCAACACCCC?TGGCTTCACG?GGAGAATTTT?46620
CTTTGGCCAG?CACAGGTCAA?AATAATGTTC?ATTGTATTTA?CCCTTTATAG?CTGGGACACA?46680
GAAAAGACAG?GGAGGCCTCC?TCTCTTCGAC?ATGCTCACAT?TTTTTTGAGG?CTAGCAAAGC?46740
CTCTATTCTA?GAGAGACTTG?ATTCACATTT?AATGATTTGG?GCTTGTATTA?CTGGTCAGGA?46800
AAACAAAAAT?CTTAATTAAA?AGAGCCTTTT?TGGGTTGCAA?AAGCAAGTGC?TCACACCACC?46860
GTAGATATTT?AAGAAACCAC?GGAAGGAAGC?TTTGAGGCCA?TCTAGTCTGG?TGTCTCAATC?46920
TTTCCTGCAT?TCTATTTGAC?ATATGGTCAT?CCAGCCTCTC?CTGAACTTCA?CTTGGTGCTT?46980
ACAGAAAAGG?AAGCCTGTTC?TGCTGTTGGG?AAACCATGAT?TGTGAAAATG?TCTAAACTTA?47040
TGCTGAGCAC?AAGTCTGCCT?GCCTTGCAAA?TGTTATGGAT?CCTCCCTCTA?CCCTTCAGAG?47100
TTATGCAGAA?TATGTTTATT?ATATTTTCTA?CCTGAGAGCC?TTTCAATTTC?ATCAGCAGAA?47160
CCCACGATCT?CTCTTCACTG?TACTAACCAT?GTCTAATTGC?CCAGGCCATT?CCTCAGACAG?47220
CATGATTTCT?AGGCCTCTAA?CCACACTGGT?CCCTCTCCTC?TGAACACATT?CTTTGTCCAA?47280
ATCCTTTCTT?TGAAAGCGTT?ACCTAGAAGT?GGACATGGAC?AGGTATCATA?TCATATTGGC?47340
AAGTATGTCA?TGACAAGTCT?TTGCTGTTAA?CATTCCTTCA?GTTCTTAAGA?AACCAGTTCA?47400
TCCCGTGGTA?TGTACAGAAG?TTTGCAAGGT?TTCCAGATCT?ATCATCAAGG?CTAGCTTTAC?47460
ATGGTCTAGG?GGTCTCAAAT?GACTCATTCC?CAAAAAAGGG?GGAGAGATAT?TTGGGTTTAT?47520
ATTCTTGTTT?GTCAACTAGC?CAGGAGACAC?ATAAGTTACT?TTTTTTAAAA?TGGCCAATAA?47580
ATTAAAAACA?TCAGAATAAG?TCTGCAAAAT?GTCATATCTC?ATTAATGAAT?TTATGTACTT?47640
TTGTAAAATT?ACAACTCTTC?TAAAGATCAA?GGTTATTTCT?TGTTCATGCT?CACAATCTAT?47700
AACCATGAAT?TAATCAAATG?ATTCATGAGT?ATCCACTGTG?TATGTATAAT?TATTATTTGA?47760
GATGTATGTA?TGAGTTGGAG?GGAATGAGAG?AGAGAGAGAG?AGAGAGAGGA?GAAAATGTGA?47820
TCCGATAAAA?ATATATAGTT?CTGGTCGGGC?ATGGTGGCTC?ATGCCTGTAA?TTCCAGCACT?47880
TTGGGAGGCA?GAGGCGAGTG?GATCACCTGA?GGTCGGGAGT?TCGAGACCAG?CCTGGCCAAC?47940
ATGGTGAAAC?CCCGTCTCTA?CTAAAAATAC?AAAACTTAGC?CAGGTGTGGT?AGTGGGCACC?48000
TGTAATCCCA?GCTACTCGAA?AGGCTGAGAC?AAGAGAAACG?CTTGAACCTG?GGAGGTGGAG?48060
GTTGCGGTGA?GCCAAGATTG?TGCCATGGCA?CTCTAGCCTG?AATGACAGAG?CAAGACTCCA?48120
TCTCAAAAAA?AAAAAAGAAA?TATGTAGTTC?TGAGCTGAGA?GAAAGAAGTC?ATATCTATCC?48180
CAATGGTTAT?ATGAATAATA?TAACCAGAAT?TTCTGACTAA?AAAAACAGGT?TGTTTTTGTG?48240
GTTCTCCAAG?TAGATTCCCC?ATTTTTGGCT?GGTAGTTTTC?TCTTCCAACA?GCCAACCTTT?48300
CATCACCTCT?TCTTCCAGAC?CTGAGATTGC?CTCAAGAGAA?CAAAGCTCCT?GGTCTCACTA?48360
TGGGGTGCTG?AGGAGGTGTC?GGTTAAATGA?CTACTAAGCG?GCAAATCCCT?CTTCTTGATA?48420
CAAGAAAGAG?TTTCCAGATT?TATTATATTA?AAGATCATTT?TATGATCTTT?ACATTTATCA?48480
TGATCATTTT?ATAATCATGA?TACGTTTATA?TACCCACATA?AACGTACACA?TACATGCAGA?48540
GAACACCCCT?AGAAACTACA?TTTAATAATC?GAAAGAGAGA?TGGTCTAAAG?GAAAGGGAAA?48600
TGGAACAGGT?GTTTACATTT?AGGAGACAGA?GATACACTGA?CTGTGTGTAC?TATGAGAATA?48660
CATTATGTAA?AAAGGGGAAA?AGAAAGAATA?ACTTCTTAAA?AGGCTTGCTT?ACCATACAGC?48720
CACACAGACT?TCCTGTGGCT?TCTCACAGAT?GGAGGTGATG?CTGCAGTTGC?TCATGCAGGA?48780
TTTCTGGTTG?TCACAGGTGG?AAAATCTCAC?ATCACAAAAT?TTACACAGTT?GTGGAAACTT?48840
GACTGCACCG?TTGTTGTCAG?TGACTATCAT?GTCGTTATTA?ACTGAGGAGA?GAGAAAGATA?48900
TATTAAATGA?TTATCCAACT?GCCAGGCAGC?CTGCCAATGA?ATTCCTGAAG?ATGTTATGCA?48960
ATTTCAAATG?AACTTGATGT?CATGAGAATG?AATCTGAAGA?AAGGCAAAAT?AATTCCTTCA?49020
CATCAGATTA?GAATTATCTG?GTGTATGCAA?TTTGTAATAA?AATCCATTGT?ACCGTGGTGA?49080
GGGGTGGTGA?GGGGTTGGGG?TGGTTGAGTA?GCCATTTGCT?TTTGTCAATG?GTTGTCATAA?49140
GGTCCACTTT?CTACAAAAAT?CTTATCATTC?AATAAAGAAA?CCTAGATGGG?CCCACTGCAT?49200
AGTACGGAGT?GCTGGGCCCA?CAAATAAAAG?TACCCTTAAG?GAAATTATAG?TTTAGCTGGT?49260
GAATAAGACA?GGAAACAGAC?CAAGTCAGGG?TGACCCAAAA?TAGAGGGCAG?CACAGAGGAT?49320
GTGGGAGCCA?GGCGAGCATC?ACCGCTCAGC?TGGGCAGGGA?GGCTATAACC?TCACAGAGTC?49380
ATGAAGTGCC?ACACCAAAGG?AGGAACCGTT?GCTGGAGGCA?CAAGATTTTG?CCGCCATTTT?49440
CCTGACCTAC?TCCTGAAAGA?GCTATAAGGG?TCTTCTTTTC?AAGGGACTAG?TTCTACTGAT?49500
CTCTCTCTGT?GTTTGAGGCA?AATCAATTGA?TTAACTAACA?CTTACTGAGT?GCCTCCTAGA?49560
CACAATCCCA?AGCATTGGTG?AGGCATTGGA?GTTATGATCG?CAGCAAATAA?AAGCTGAATC?49620
CACCTCAGGA?TCTGCCTTCT?GTACCTCTCC?CTTATCACCA?CCATCACCAA?TCTCCTGCCC?49680
CCTTCTGGGA?AGAAGCCAAG?TTCATTCCCT?CCTCAGGCCT?TTCACTTGCT?ATTACCTTTG?49740
TTTAGCTTCC?TGTCACTTTT?CTGATCTCTG?ATCAAATGCC?ACCTCTTCAT?CCTATAGCAA?49800
CTCTGTTTTA?TTTATTGTCT?GCACAAACTA?TCTGCATCGC?ATACTTGCTA?ATAATCTATC?49860
CACAAAAATG?TAAGCTCCAT?GAAACTTTCT?CCACCTCACT?TACCTACTAT?ATCTCCAGTG?49920
CCAGGAAGAG?AACCTTTCAC?ATAGCAGGCA?TACAAAAATG?TTTATTGGAT?AAATGAGTGA?49980
ACACAGGATG?AATACAAGGA?GTCCATGTTT?GGCCCTTGAT?GCCATGTAGG?ATAGGATACA?50040
GAACTTCTTC?ACTCAGATTA?GAGAGGAATG?TGATTATAAA?TGTGATATTC?ATTCACATTT?50100
ATTCAATAAA?ATATGGAAGA?CAGACTATTC?TTTGCAAAAT?ACAGGCTGCA?AACTAGGGGC?50160
AGTTCAAATA?AAGGTGTAAC?ACCCCATTCC?CCATTTTCTT?CCTCAATGAG?ATGGTGATGA?50220
TGTTTAAGAC?ATGAGTTTGG?ACAGTCAGTG?AAGTATGACA?AGGCTACTAG?GCACTCAACC?50280
AGCAAACATG?AATTAATACT?TACATGCTAG?ACTAAGAAAC?ATTAAGCACT?TAGACCGCAT?50340
GGGGTGCTGG?AACAGTTGCT?GGGCCACAGA?AAGTTGTGAG?GTACTTTTCC?AAGGCATAAC?50400
CCTTAGAGAG?GCCTAAGAAA?AGCCTCATGT?TCCCTCTGCT?CTTGCCTAGA?GAGGAACACT?50460
TTCAATGCCT?TTCCACAGTC?ACTCTCTGTC?CTGTGAATTT?TAGGATTCTG?TCATAGATAC?50520
TTTGCCCTGC?AACTGTCTTT?GTAGCTTGGG?CATAGCACCT?GTTTCCTGGG?TCTCTAAAAA?50580
TATAAACGTA?TATAAATTTA?AGATTTGCTT?TCTTGTGGTA?ACAGTAAATA?TAGAAGAAAA?50640
AAATAAAGCC?ATTCATCCCT?CTCGGGCCTC?AAGTTCATTT?CAGGAAGTTT?ATTTTTAGGT?50700
AACAAGCTAT?TTTGAAATTC?TCAGTGTCTC?CCAGACCAAG?AGCTCTATGC?TTAGCTAAAA?50760
ATATAGGCAG?AAATACTCTC?TGAACTGTGT?GAAATTTGGG?AGAAACACAA?CAATTAATAT?50820
GTATTTTTTT?CTAACATGGT?TATACTTGGA?TCAATTTTTG?AAACAACTAA?TAACACTTTA?50880
GGTTTCTTTA?ACATTGTTTA?AAGCAAAAAA?AAAGTGAAAC?CACGTTTTGT?TTATTTCATA?50940
CATACGTATT?TTTTGTATAG?AGTATGTTTT?GGACAAGCAT?CTATTTGCTG?ATTAGGAAGG?51000
TTTGTTGTTT?GTAAATATAA?AACCAAATTT?CCATTACTTG?AAATTCAGTC?TTCCAACATC?51060
TTAGGATTTT?AGCTTAGATT?GGTGGTTATC?AACTTGGAGA?GCATGTTGAA?ATCCATCACC?51120
TGAGGAAATT?TAAAAAATAC?TGAAGGGGTC?CCACTCCCAG?ATAGTCTGAT?TTAATTTTTC?51180
TGGAAGGTAA?CTGAGGCATC?AGGATTTTTA?GAAGCTGCCC?AGATGATTCT?AATGTGGAAC?51240
CAAGGTTGAG?AACCCAGACC?TATAGTTAGT?TGGAAAAAAC?ACAATAAACA?GAAAACAAAA?51300
CAGCAACCCC?CCCACTCCCA?CCCCACCACC?ACAAACACAT?ATACAACTTA?TGCTGCTGAG?51360
GGGACAGCAC?CTGGATATAG?CTGGAATTAG?TTCCCTTGTG?AAAAACATGC?ACCTAAGGAG?51420
AGGTGATTAG?CTCTTTCACA?CCTCAGATAG?AAATTCTTCT?CCGTGCTGGC?CAGTCCTTTT?51480
CTAGCAAAAC?CTTAGAAACG?TGAGAATAGT?GACAGGAGTG?AGCAGCGATA?GATAAGACAG?51540
AAATGAAAAC?AGATGAGATG?GGTGCTGGGA?GCAGTGGTGG?CCACAGATGT?ATTGACAAAT?51600
GCAAGTGGTT?TAAGTCCGAT?GCTTGCAGAA?CACAATCAAC?AGGGAAAAGA?AAAAAGGACC?51660
ATTAGAAGAA?AGAAAGGGAG?AGAAAGGGAA?GAAGGATGTA?GGGAGAGAGA?GAGGAAGGAA?51720
GGGAGGAAGG?GAAACAAGGA?GGGAGGGGGA?GGAGAGAGAA?AGAGAGAGAA?GGTCCACCAA?51780
TTTGCACAGC?TCCAGGAGCA?CCACTGTAAC?GGGGCCCCTG?GCGAGATATA?ATACATGTTA?51840
CTTGATGGGT?AGACCCAACA?AGAGAAAGCC?TTTCCATTGA?ATGTTGAAGA?AAAGCCAAAC?51900
AAGCAACTGT?ACTGCATATA?GACACAGGCA?TATGGTGGGA?AGGGCAGTGT?ACAATAAGAA?51960
TTTGCACATG?CTGAGCACCC?ACTGTATATG?AGGAAAGTTG?CCTAAGATAC?AGCATATTAC?52020
TTCACAAGAA?CCCAGCCAGG?GATGCCACAT?TTTTCTCCTT?GTTACAGCAG?AAGCTACCAC?52080
TGCAAGAGCT?TAACCAGAAT?TTTTTTTCAA?AAGCCTGTAT?GCAGGACATG?TTCAGCACCA?52140
GCCATCGACT?CCCTATTAGT?TGACCCTAGG?AGACTCCCCA?CCTTAACAAT?TCCAGGTAGC?52200
CCTTGAGGTC?ATATACATTC?CAACCTTTGT?TTTAAACCAG?TATTCTTTTC?CTCTATATGA?52260
TATAGGTCCT?CAGGTCCTTT?TATGCATACC?ATATGTACTG?GTGGAATAGG?TAGTTAAGTT?52320
CAGAGGGCAA?AGCTACTCTA?AACCTTTGCT?GGAGTCACCT?AAGTTTGATA?AAAGCCTTAT?52380
GAACACACTT?TGGAGTTGGG?GAAAAGAAAC?AAATACAAAA?TTTGTAGATC?ATCTGAGAAG?52440
GTTTGCAGAT?TCTCTGAGGC?CCGTAAGATC?CAGTTAAGGC?ATCCCAAGCC?AACCCCGGAA?52500
TCCTCAAGAG?TCACTAATAA?CATGCTAAGT?GGTATACTGC?TGGTCAGAGT?GGGATGAGGG?52560
CCAGTGGGAG?GGAAGGGTAA?CAGTCATTTG?CTGTATGGGA?CATTGCATCT?GTGCACTCCA?52620
AACCACAGGA?AAAGATGTTA?CCAGCCACGA?CCTCAGATAT?CAAACAACAT?CTCCTTACGT?52680
TTAATACATA?ATGTTTAAAA?AGCCAAAGGA?ATGGGAAGGA?AAGTAAGTGC?ATACATGTGC?52740
ATAGCTAGGA?ATAAAGATAT?TCCTCTAAAC?AACGATACAA?AACCCACCTA?ATTAACCCTA?52800
TAGCAAACCC?TAACCCAACT?TCAACATTAC?TTTTAATCCA?GATTGTTATA?TTAGTCTAAG?52860
TCTCTCTAGT?TAAGATATTC?TTATATTAAG?GCAGTATATA?GTCAGCCTTC?TGTATCTGTG?52920
GGTTCCACAT?CTGCGGTTTC?CATCAACCGT?GGATGCAAAA?TATTTTTTTA?AAAAAATTGA?52980
TGATTGTGGC?TGTACTGAAT?TATGTACAGA?CTTTTTTCTT?GTCATTATTC?CCTAAGCAAC?53040
ACAGTATAAC?AACTATTTAC?ATAGAATTTA?CATTGTATTA?TGTATAAGTA?ATCTAGAGAT?53100
GATTTAAAGG?ATATGGGAGG?ATGTGTGTAG?GTTATATGTA?AATATTACAC?AATTTTATAT?53160
AAGGGAGTTA?AACATCTGTA?GATTTTGGTC?TCCTCGAGGA?GTCTTGGAAC?CAATCCCCCA?53220
TGGGTACCAA?GAGATGACTG?TACTTCGATT?CCTATAGACT?CTCTGTGAGC?AGCTAACCAT?53280
CTTTAGAGAA?TTTTCTACCC?CTAATAGGCA?AATTCGTTAT?TCATAAAGTT?CTCCAGAAAG?53340
AAGTTCCAAT?AAGAATATCT?GTCACCTAGA?AAGCCATCCA?CTAAAGGAAG?TGAACATGGG?53400
TAGCATCTCT?CAGCATATGA?TAGTATCACA?TGGCCCATAA?TATTTCACTT?CTCTTCAAAT?53460
AAGCCCATGA?GTAATATCAA?AACCTTCACT?CTAGGTCATA?CCACCTTCCC?CATTTTATCT?53520
CACATTTTCC?CCACACTCAC?TGCCTACAGA?CAGAGGTTCC?AGGTCTTGAG?AATATGAATT?53580
GACTGCTTAG?CTGTGTCTAT?TTCTGGAACT?GTACTATTGT?CTTTGAGGGT?CAGATGAGCA?53640
GCCTAATAAG?ATTTAGACTT?ATTTCAGATA?AATATTAGAA?ATTCTGAATA?TGACCTTAGT?53700
CCAAATCTTT?GAAATAGTGT?CTATTATTAG?CTGAACCATT?AGGTAAAATC?TCAAGGTTTA?53760
ACAATAACCA?TAAACACTTG?TCAGAAATGC?ATTCATGTAT?CACTGAATTC?ATGCATTCGT?53820
GTATCATTGA?ATTCATGTAT?CTACCGACTG?TTGTTTTCTG?GAGTGTTTTT?TGTGGGGGGA?53880
AACTCAGAAA?TTTATTTGTT?CTACAAATAC?CTGTGGATGT?CTTGATTAGT?GTTATATATT?53940
CATAGTAAGA?CCACTGAAAT?TGACACAATT?AAATAACATC?TCAAAGAATA?ATCCATGGAA?54000
ACTGGTGGAT?AGAATTTACT?GTTTTAGAGT?ACTGCTTCTC?AAATATTAAT?ACACAAGTAC?54060
TTTGGGAATA?TTTTTAACCT?GCAGGTGTAG?CATAGTGGTA?TTGTGGGGGC?TGGCAAGTCT?54120
GAAATTTATA?GGGCAGACTG?GCAGCCTGGG?AACTCAGGCA?GAAATCAATG?CTGCAGTTTT?54180
GAGGCAGTAT?TTTTTCTCTC?AGAAACCTCA?GCTTTTGCTC?TTAAGGCTGT?TCAGTTGATT?54240
GGATGAGGCC?CACTCACATT?ATAGAGAATG?ATTTCTTTTA?CTTAAAGTCA?AATGATTTTA?54300
GCTGTTAATC?ACATCTACAA?CATACCTTCA?CAGCAACAAT?GAGATTAGTG?GGCACCAGAA?54360
CCTAGCCAAG?TACACACGAA?ACTGACCTTA?CAGATAGGAA?GGGAGCTGCT?GCCCTGGGTG?54420
ATGCCAGCCC?ACTATATGTT?GAGTGGGAAG?GCTGTGGAGA?ACCCAGTTTT?TAATAATTGT?54480
TTCCCTTTCT?CCAGTCATTT?TGGAGTTAGT?GAAATTAAAT?ACCTATTCTT?CACCTTTTTA?54540
CAGGCATTTC?TCATCTTCCA?GTTCTTTCCA?TATGCTTTTC?TCTTGAGCCT?GACCTCTTAA?54600
ATGATTGCAA?ACCCAGAGGC?CCTGATCACC?ATATGGGCCC?AGAATTGAAA?GACATGTTCT?54660
CTGAAAGGAG?GTTTTTAATT?GCCTGCAGCA?TTTCCGAGTC?AGATACTGAG?GCAGCCATCT?54720
GGCAGAAAGC?CGCTGTGGCC?TGTGATGCTA?GCAACAGCAG?CTCCGACCCT?TGAGACAAGG?54780
TGGGACAAGG?CTATTGGCTA?GTCACACACT?TCCTCCCACC?CAGAACAAAG?AAGAAAGTCA?54840
AGCAATCTGA?GAGGATTCCC?TGTATAATTC?TTCAGGAAAG?ACATCCCCAA?GCCAATCAGA?54900
TACCTTGGCC?AATTACTACA?ACCAACCAAC?CAACCAAACA?AACACCTTGT?GATTAAACCA?54960
AAGATAGGAA?CATTTTAGGA?ATAGTTCTTT?TTGCTGAACA?TCTATTGCAC?ACTCTAATTG?55020
GAACTTCTAA?TACAATACCT?TCTTTTTAGT?TTTTAAAAAT?GTGTTTGAAC?CCTAATGCTT?55080
TATCTAATTA?TACCTTGAGA?GAAGAGAGGT?ATCGGGCTTT?CCTTCAACTG?ACAGTCCACA?55140
TGGTCTCTGG?GGTACCAAGG?TCAATACTAG?AGATACCATC?ATTTAGCTAA?CAGGGAGACT?55200
ATGGCGTGTG?CAGGAAGAAA?ACAGAGACAA?GTGACCTGAA?GGCATCAATT?CTCCTTCTTA?55260
TGCAAATATT?TTTGTAGTAA?TAATACTTTA?AAACCTTTCA?GAGATGACAA?AGTGAATACT?55320
CTAAAATCTC?TGTGAAATGA?CAATGCCTTA?TAATTCTTGC?TTTTAAATAG?TAAGTATTCT?55380
ACAAGTGCCA?GAAGAATTAA?TGCCATTTAA?AATCATTATC?AATGCTTATT?GGAAACAAAT?55440
AACAAATCAT?ATGAGTTCTC?TATATTGTGT?TAAAAAAACG?CTACTTTAAA?TATTACTTCC?55500
TGATCATATC?ACCAGAGAAT?AAGCTCTAAA?AGCGAAGCAT?GTCAACCTCA?TTGCTAACAA?55560
GTGAAATGCA?GATTAAAAAT?GCATACCATA?TTTCACCTAA?CTCATTTTGA?AAAAGATCAA?55620
TAAGTCAGAT?AACACAGTGA?GCTGGGTAAA?GTATGGGGAA?ACAAACATTC?TCATAATGCT?55680
GTGTTGTAAA?CAGGTATAAC?ATCTCAGGAG?TACATGTTAT?TGATATCAAT?CAACACTGCA?55740
AACGCAAATA?GCCTTTTGCC?TCGCACTTTC?GCTTCTAAAA?ATTTATGATA?TTCATTGATA?55800
AATTCGCTGC?AGTGTTGTTT?GTAAGGACAA?ACAGGTTTTT?TTTTTAACCA?CTCATCAAGA?55860
GAAGACTAGT?AAAATAAATT?AGACAAATCC?AAACAAGGAA?CACAACGCAA?CGACTAAAAA?55920
GCAGAGGGCA?GCTCCATGTG?GCTATCTTTA?TAAGTGTTGA?AGCCCAGGCT?ATAGCATTCA?55980
AGAAAATAAG?CAAGGTAGAG?ACCAATGTAT?AGAGTTACTT?GGGCTGGGTG?TCTTCTATTG?56040
CCCTTAGAGA?TCAGTTCTCC?ACCCTTGGTC?ACCAGACTGT?CTGCCCCAGG?AGGCTCATCT?56100
TTATGGACTA?CATCAACCGG?CTCTCTTGCC?CTCAAGCTTC?CAGTAAGTTT?GGCCAATGGG?56160
GTGACCCAGC?GGTATCTAAG?GGAAGCAATG?AGGAGCACAT?TTAAGGTATC?TGTGTTCTGG?56220
CTCCCTCTGT?GGAATCTTTT?CCAGCTGGCC?AAGTCCCTCA?CTTGGAGGTC?ACAGGTTCTC?56280
TTCAGGAGGT?CATTTCCAAG?ATTTACTTCT?TCCCTCTCCT?TGCCACTTTG?GGCCTAGCAA?56340
GTCAACATAG?CAATTACTAG?TCCTAAGTAT?CTGCACTATG?GTTTCTCCCA?TTTTGTGGTG?56400
GTTTCCCTTG?ACTCTATCCA?TACCTTTGTA?AGTACTTGTT?TTACTAAACT?CTCCTTAAAT?56460
CTCCCTAATT?TGAGGGTGCC?ATCTGCTTGC?AACTGGAACC?CTGGTTGACA?CACCACCATT?56520
TCTGTTTTGT?TGTTATTGCT?TTTATTGCTT?TTTTTTTTTT?TTTTCAGACA?GAGTCTTGCT?56580
CTGTCACCCA?GGCTGGAGTG?CAGTGGCGCG?ATCTCGGCTC?ACTATAAGCT?CTGCCTCCCA?56640
GGTTCACGCC?ATTCTCCTGC?CTCAGCCTCC?CGAGCAGCTG?GGACTACAGG?TGCCCAACAC?56700
CACGCTTGGC?TAATTTTTTG?TATTTTTAGT?AGAGACGGGG?TTTCACCGTG?TTAGCCAGGA?56760
TGGTCTCGAT?CTCCTGACCT?CGTGATCTGC?CCACCTTGGC?CTCCCAAAGT?GCTGGGATTA?56820
CAGGCTTGAG?CCACCACGCC?TGGCCTGTTA?CTGCTTTTTA?AAGGGAATAC?ACACACACAC?56880
ACACACACAC?ACACGTGCAC?ACACATGCAT?GCTTATATAT?TTAGACGGTC?TCTGGGAGTA?56940
GATGCAAGGA?CATGAGAATC?AAACATTATT?TGGCCCTGTA?AAAGGAAAAT?AAATAGGTAG?57000
AAAACTGAGG?TTGAGAAGCA?ACTTTTTATT?TCATACCCTT?CTGTTACTTT?TGAATTTTCT?57060
ATTATTTTTC?TGTACTTAAA?AAATGTTTTC?ATTATAAATG?AGCAAATGCA?AGGCAGATTC?57120
TGTCATGGCA?GATGCATGCA?GCTTTCATTC?AAGTGACAGC?CCCACATAGC?CTCTGGGCAC?57180
CAGGATCAGA?AGTGGAGAAA?CAATACCTAA?TAGGGAGACC?ACCATGTGGG?CAGAAAATAA?57240
AGAGATAAGC?TCAAAAGCAT?CAATTTTCCT?TTTCATGCAC?ATGTTTTTGT?AATACTAATA?57300
TAGTTTTTAA?AACCTGTCAA?GAATGACATA?ATCAATACTC?TAAAATCTCT?TAGAGCAGGA?57360
AATAATTCTA?GTAAAATACC?TAGTACGGGC?CGGGTGCGGT?GGCTCACGCC?TGTAATCCCA?57420
GTACTATACA?CACACACACA?CACACACACA?CACACACACA?CACACACACA?CATACATATA?57480
TATTTTCACA?CTGAAACTAC?CTACCATCTG?GCCAACAATT?AAGGATATCA?AATGTCTGGG?57540
ATACTCTCCA?CACAACAAGA?CATCTAAAAC?AAACACCAGG?TTGGTCCCTA?CCCTCCTATG?57600
GCTTATATTC?TAGTTTGAGA?GGCAACATTA?ACAACGGCAA?CCTCATGTGA?ATCAGTTACT?57660
TGCCTTTAAA?TGCAAACATG?AGGTCAGAAA?TGGAGACAGA?GCTGATACGG?GAAGTGTGTG?57720
TGTGAGTGTG?TGTGTTTATG?CATTTATGTG?TGTGATTTCC?TCATTTGGAC?TTGTTCAACT?57780
GAGGGAATTT?AGCTTTGTAG?GTTTGAGTTT?CACTAGCATT?TTGGCTCATG?AATTTAGTAG?57840
TTTGCTATGA?TTGCTTTAAG?AAAACTGCAT?AAACATAAAT?TTGTATTTAC?CAAACAAATT?57900
AAGGGATTAA?GGAATGATTA?CTTGTGTCTC?AAATGAATTC?ATCCAATGAG?GTACTTTAAA?57960
TTGAAATCTT?GGCTGTACCT?TTAAACTCAA?ATTTTTTTAA?ATGCAATTTA?CAAGGAAGTT?58020
TTTTTAGTCT?TCTACGGAAT?GAAACAAGCT?GTAGCTGAAC?GGAAAAATAA?TTGGCTTTCT?58080
CCAGTGACAA?ACATAAAATA?ACTGAGCTGG?AATTTCAATT?GCATCCTTTC?CTATTTAACA?58140
CTTACCAGCC?CCAATGACCC?CAAATAAATC?CTAAAAATGC?ATACTTGGTT?TTCTTGCTTT?58200
CTTGTATCAT?TGAAGAATGA?AGTACAATTT?GAGTCCCCCC?AACGCTTGCT?GAATTTTCAT?58260
TTATTTTTCT?GTTTTTTGTT?TGTTTTTGTT?TTTAGTGGCA?GGGGACCTCT?CTGAGATACA?58320
GGCCACATAA?CAGGAGACAA?AATCTAAACA?TTTAAAATGA?CTCTTGCAGG?TGGAAATATC?58380
TACACATTGT?TGCCAAAGGC?AGTATTTCAG?AATTCTAGCA?CTTGTGCCAT?ATTCAAAAAG?58440
CTGAAACAAT?TGTAACTTTC?TCAATCATGC?TCTTTCAGCT?CTAATAGGAC?CCAGTGAATA?58500
AAACAAATTT?CTGAAAGCTG?GGGAGAAGCA?AGCAGTTTAT?AGTAAATACT?GTCATCAATA?58560
CATGAAATTC?TTAAGTTTTT?CATTGATAAA?GCTCACTTTA?ACAGTGCCTT?TATCTGGCAA?58620
AGACTGACTG?CAGGGACTAT?GAGATGAGTC?AAAAACCAGA?ATGTAGGGTT?TGGGGCTGAG?58680
AAGAACAGGA?AGCCAGTTAA?AAAAGTTAAG?CCATATAAAT?GCAAATGGTA?TATTAGATCA?58740
AGTGAAAGAG?TAGAATGGAG?CACTATTTCA?TGAACTCTCA?AAATAATAAC?TTTATGCCTC?58800
TGCTGAGAAG?TGCTTTAAAG?TTGGTACTTT?ACCTAAAGTG?ACAGCAACTG?AGAAAACAAT?58860
TCTCCCTCAG?TTGACAGGAC?TTGGAGTGCT?GTAGCAACAA?GGAAATAATT?TATTATTGAA?58920
AATAAAAGAT?GATTAAATAA?CTCTCTTGGT?GATGGTCAAA?ACATTGGTAA?ATGGCACAGA?58980
CTGATAGAGG?CAAGATAATG?ATACACGACT?GACGGAGTTT?TACAACATTC?CAATTCAACT?59040
AAAGTAATTT?GTTACTTACC?AGCAAAATTA?GTCAACCTAA?ACGAAAATGT?GCTGCTTTCT?59100
GACAGCCCTC?ATATTTAAAC?CCTTGAGGGA?AGGGGGACAG?GATAAGACAT?GGTCCTTTCC?59160
TCAAGATCTT?TAAGTTCTTC?TAGGGAATTT?TTAAAAATGC?ACGAAATGAT?TTTCATCAAA?59220
AGAGCTTTGG?AAATAAGGAT?GGTCTAAATG?AAGATGTGCT?TTTTAATTAA?GTTATTCATT?59280
TAGGATTTAA?ACAATTCTTT?ATCTCAAAGT?ACTGAGGCAG?CTTAATGGAA?AATGCAGAAA?59340
CTAACACAAA?ATCTGGTAAG?AACAGATTTT?TAAAAGATAG?TGACTATTAG?AGAATCTGAA?59400
AAATCAGCCC?CTGAAATGAA?CCATTTGCCT?CAACTAAGCA?TGGGATTTGG?TCCGAATATC?59460
AATGTTCTGT?GAGAGCAGAA?TTTTCACTGA?TAAATTTCTC?CGTGGAGGCT?TTTGCTTCAG?59520
TTTTTCAAAA?TATGCTGCGG?GGTTCTTGTG?CATGCCTGGT?ACCTGAAAGG?TTTTTCAATT?59580
ACAGTTTTAT?TAAACATGTG?AAAATATTGG?TCAAAACAGA?TGATTTCCAT?ATTTTCTCTG?59640
GAAAAGGGCC?AGAGTACTAC?CATATTTGGG?AAAGGCATCC?CTTTAAAAAG?TAATATAACG?59700
AGGTCCAAGG?CGCTTGGTTT?CTAACAACCA?AATAACTTGG?GCACAGACTG?AGAAGCTAAA?59760
GCAGAAATTG?CTACAGTGGG?TACAAGAGCT?GGATACAGAG?CACAGATGTG?TTCTGTTTGG?59820
CCTGAACTCT?TTTCTTTTTA?AAATATAAAC?CAAGTTTTAA?AATTCAGAGA?TTTCACATGC?59880
AAAACTGGTT?TTCTAATTCC?ACTTAAAGAA?ATAAAAAAGA?CTTGGAAACA?GTGGGCCCAC?59940
ACCATCCCAA?GACAACAGTC?AGCTGACTGT?GAGCTGAGAT?GCTCCTCTTG?AGAAAGTCTC?60000
TGTGTCCTCA?AATTTGCCTC?CTCCCTGACA?CTCCTTCATG?TCACCTACTC?CCCTGCCAGG?60060
CCCCTGTGGC?CACCTGAATG?TTTACAATTA?ATGATTATTT?CACCTGCACA?TTCAATTCTC?60120
TCTTCTAATA?TTAGGGTTTA?ACTAGAATGC?AAAAAGTCAT?GATTTAACTC?TCTAATATGA?60180
ATATTTTTAA?CATGCATGTA?ATTCTCTAAT?GTGTATAATC?ACATTTCAGT?TCAAGGCCAG?60240
AGGACATCTA?CTTTAGAAAT?CAGATCTATG?TGATGTTAAT?AATTATTATT?ACCATGATCA?60300
TGATTTATCG?AATGCAGACC?AAATGCTTAG?TCCAGTATTA?AGTACTGTGA?TGATTATTTC?60360
ATTTACTTAT?CACAACCACC?ATGCAATTTT?GTCATTAACA?TTTTATAGAT?GGAGAAATTA?60420
AGGGTCAAAG?AGATGAAATA?ACTTATCATA?TCATATCAAT?GAGAGAAAGC?AAATAAAAGA?60480
CAAAGCCAAT?GGTGACACAC?AAGCCCTCAT?CCTTCCTGAT?ACTCCACAAT?GAAATAGATA?60540
TTCCATCAAA?AAGTTTAAGA?GTAGAACTTT?ACACACATTC?CAGTACAAGG?CAAAGACACA?60600
GGTGTGACTA?CTAGGAGTTG?AAGAAAGTAT?ACAAGGGGTG?GGGAAGCAAT?AAGTTTCTTA?60660
GACAAAAGCT?TTGGTTCTTT?GTAATTACTT?CACTTATTTT?AGGAGACATA?TATAATAAGG?60720
TCAGCTTGGT?GAAGCCCAAG?AGTTTTAAGG?TAAAAACTTG?AGTGTGAATT?CAGGCTCTTA?60780
CATGTATTAG?CTGTGGGCCA?CTTAACTTCT?TGAAACCTCC?ATTTCCTGAT?TTATGAAATC?60840
GTCCCATGTA?GGATCATGAT?GAAGAGCAAA?CATGCTTGAA?GTACCTGTGA?AAATCCTCTA?60900
GACAGTAAAA?AATGCCACAC?AAGCATTCAC?TTGCTAGAAA?GGTAACATTC?CATGCAATGC?60960
TCTCTCACAC?CAAAGAAAAT?TGCAGGAAAC?AAATGACAAG?ATAAGTATGA?GTTTGGTAAA?61020
TCTATTCCTA?CTCATCAATA?GAATGTAGCA?GTTTGATGAC?TTCTAAAAAA?CCTTTCAGGA?61080
AATTTGAATG?AATAGACAAA?TTGAAATATA?ATAATTTTTT?GTTACCACTG?TGCCCTGATG?61140
CTTTCAAATA?TACAATGGAA?TCAATCATCG?TTACAATAAA?GTTGCCAAGA?GTGTTTAGGA?61200
TCTAGAACCA?AATAATCTGG?TTTTGAAATA?TTGTTCATAA?CCAGCATAGG?TCTGGCAAAC?61260
AGGCAGTAAC?TTGAGAATCC?AGTTCAATTT?TCAAATCCTC?TGCTTACTCC?TGCACATTTA?61320
TCAGGCGAGA?GCTGATCTAC?TTTGGCTTTG?AGACACTTAG?TGTGTTATTT?CGCAACATGC?61380
TAATAAAATT?AGTAAGTTTG?ACATGCAGAG?ATGGGAAGGC?AATGATGTGT?CTTAAGATTG?61440
TGGAATTCTA?AAATATTGAA?ATAAAATCAT?GTTTGGCTTA?CTTTTCAAGG?AAATAAAACT?61500
GCTGTACTTT?CATTCACAGC?TGATGAAAGA?ATTACAGAAG?AATATGGGCA?ACAACAATTG?61560
TAGTAGATTT?TTAAGTACCT?AGTTAAAAAG?TGTTCTGGGC?CATCCAGATA?TATGGAAAGC?61620
AATATTCCTT?AATCTTCTCT?CCTGGAGCTC?ATTTGCTCAC?GTAAAAGTTA?ATTATAAAAC?61680
ATTGCTATAT?GACTTCTACT?GGAGGAGAAT?TCACCATGCT?GGGAATGGCA?GCAGGTTGCA?61740
GTGGAGAAGG?CTCTGAATCG?ACCATGAGGG?GGCTTTGAGT?TCAAGGGCAA?TTACCCAACC?61800
ACTCTCTGTG?CCTGTTCTCC?AACCAGTCAA?ACAAATGGGT?TGGACATGAT?GAACTTAAAG?61860
GTCCCTTTCA?TTTTGAAAAA?TGACACAAAA?AGGACAGAAA?GACACATTCA?GATTCACTTT?61920
GGTTTCTAAG?ATAACACCAA?ACACTTTGAA?ACTTCCCCCT?TCATGTTTTT?CAAGCAGAGG?61980
AAGTAAAAAA?AAAAAAAAAA?AAAAAAGAAA?GAAGTTGCAA?GTATTGTTAA?GGCTTCTAGA?62040
AAGGACAACA?AAGGGCAGGA?AATTTGAAAC?AAAATCTGAG?AATCTGCCCT?TAAACTGGGC?62100
AATTTTGCTT?GTTTTCTCAC?AGTGCAGTTA?GATGAAAAAG?TGTAAGGTTG?ATCTTCGCCT?62160
TTCCTGGGCA?TTACTCATTG?CTGTCATGAC?CTTGATGCAA?TTTGCAGTAA?ACATCATAAA?62220
GGTCTCTCTT?GTGGTGAGTA?GCTGCAACTT?TTCTGATGCT?ACCTCCTGTG?ATTAAAATAT?62280
CTACTCCCGG?CCTGGCACGG?TGGCTCACGC?CTGTAATCCC?AGCACTCTGG?TAGGCCGAGG?62340
TGGGTGAATC?ACGAGGTCAA?GAAATCAAGA?CCATCCTGGC?CAATATGGCG?AAACCCCGTC?62400
TCTACTAAAA?ATACAAAAAT?TAGCTAGGGC?TTGATGGTGC?GTGCCTGTAG?TCCCAGCTAC?62460
TCAGGAGGCT?GAGGCAGGAG?AATCACTTGA?ACCCAGGAGA?CAGAGGTTGC?AGATGGCCAA?62520
GACTGTGCCA?CTACATTCCA?GCCTTACGAC?AGAGCAAGAC?TCTGTATTTA?AAAAAAAAAA?62580
AAAAAAAAAA?AGGCTACTCC?TTTCCAAGTC?CTAGCAATCC?CACTAAGGTT?GGTAACTTAG?62640
TCTGTTTGGC?TGCCATACAA?AATATGTGAG?ACTGGGTGAT?TTATAAAGGA?CAGAAATTTT?62700
TCACAGTTCT?AGAGGCTGAC?AAGTCCAAAA?TCAAGGCACT?GGCAGTTCTG?ATGTCTCGTA?62760
AGAGCCCCCT?TTCCTGCTTC?CAAGATGGTG?CTTTGTTGCT?GTGTCCTCTA?GAGAGGACCA?62820
GTACTGTGTC?ATCACATAGC?AGAAAATGGA?AGGGCAAAAG?GATCCAGGCT?GGTTACCTCC?62880
AGCCCTTTTA?TGTGGGACTA?ATCCACTCAT?GACTTAATCA?CTTCCCCCAA?ATCTCCGTCT?62940
CTTGATACCA?CCACAATGGG?GATTAAGTTT?CAACATAAAT?TTTGGAGGGG?AGACATCAGC?63000
CACAGTAGTT?GGTGAGAAAA?AAGGACAGTA?TTTACATAAT?GACAGTTGTC?AATGGGCTGT?63060
GGAAAAGTCA?AGATAGATTC?CAGCAGTGAT?TTTAAGATGG?AAAATGAGAA?CCATGCACAC?63120
AGTCTTCAAG?GTGCAATCTT?CCAACATAGT?TCTGGAACAC?AGCTGGCTCC?TTCCATCCAT?63180
GGGGAATGAC?CACATTTGTG?TGCTGAAATA?ACATTTAGTA?CTAGAGATAA?AACTGGAATA?63240
AGTGATCTAA?ACTTTGAAAT?GTTTTGAATG?ACCTTTGGCT?ACAAAGTCAA?ATTATAATGC?63300
TTTCTATTTC?TTAAGACAAC?TCTTTATGGA?AGTTCTAGTA?TGTACCTAAC?TTTGGCACCT?63360
TAGATTTGCC?CCACACTGAA?TCTTATCTAT?TAAACCTATC?TCATTCTGGG?GTGAGAACCC?63420
AGATGTGTAA?AATCGTATGG?CCAGAGGTGA?CTGAGAAGTG?CATTTTGACT?ATGTTTCATA?63480
GTCTTTTATC?CATCTTAGCA?TAATCTTTTT?ACCAGCACCA?GTGGAGTTGT?GAACTCGCTC?63540
AATTTCTTGT?GATGTCCAGT?GTAAAAATGT?ATGCCTATAA?ATGTAACTCT?TAGAAAGAGA?63600
AGCAAAAATG?AGAAACCATG?GGGGAGGAGG?GGAGGAAATG?ACAAGCACAG?TCTGTTTTTA?63660
GGACACTGTA?CTTGCTGTTC?CCTCCAACTA?GAATGCGCTT?AACCCAGAGA?TCTGCCTTCT?63720
TCATCCCGAT?TTCATACCAA?TTACTGCTCA?AATATCACAT?TATCAAAGAT?GCCATTCTTG?63780
ACAACCGCTT?CTAAAATTAC?AAGCATCTAC?CATTGTTCTC?AGACCCTCGC?GCTGTACTTA?63840
TCTGCTGACA?TGTTGATAGA?ATCTTGTTTA?TTAGCTTGTA?CACATGGACT?TTAATTCACT?63900
CTGTATTCCC?CAAATCTCAA?ACATTGGCTG?GCACACGGTG?GTTGGTACTC?TATAAACACT?63960
TGGTGATGGC?TTTCCTATCC?CTAAGTCCTC?CAAAGCCAAG?TTTCATACCT?CTTCCTTAAG?64020
TTCCAAAGGA?AACCTTATCT?GCAGAAAATT?AATGCATATT?TGCTGTTGCT?GGATAAAGAA?64080
TAAGGATATA?GTCACAGAGA?AAAAAGGACA?TGTTGAGGCC?AGGTATGGAG?GGTATAAACA?64140
GTTGGTGAAG?AGTTTTAAGC?TCAAGGCCTA?GCCTGTCTAA?CTTAGCAATA?AAAGGAAGTC?64200
AGTTCTGAAG?TCAAAGAGAG?TTCTTCTTTC?CCCACTGGGA?GGAGCTGGTT?CATGAAAGTG?64260
GAGGGCCAGA?GCCAAGAGAA?CTCTCCCAAG?ACACATTGTT?CAAAAGTCAA?GGGCATAATC?64320
TAGATAGAGC?TACACAGTAG?CCATGAGGAC?ACATGGATTT?ATAAATTTAA?ATTAACTAAA?64380
GTTAAATGAA?ATCATACATT?CAGTTCCAAG?TCAGACCAGC?CATTTTCAAG?TGCTTAATAG?64440
CCACATGTGG?CCAGGAATAG?ACAGGATACT?TTCATCATTG?CAGAAAGTCC?TATAGGACAA?64500
CACTGATCTA?AAGAAATTCA?AAAGGACCTG?CGTTCCTCGG?CTTCTGAGGA?GATCTGAAAA?64560
CGAAGGCCCA?GAGGGAAATG?GAAGGAGAAG?CAGGGCAGAG?CTTGAAAAGT?AATCGCATTG?64620
GAAAGGGCCC?TGACTGCTGG?CTTGGATGCC?TTGTGTAATT?AAAGTTCTAT?CCCAACTTCT?64680
TAAGGAATGA?GTCTCGTATT?AAATGACTGG?CTGTCTGTAG?TGTCACTGCT?GAGGTAGGGA?64740
GAGAAGACAA?TTAGGGACAA?GGAGTAGTGT?TCCATGGAAA?ACACGTTAGC?TATGAGTGGC?64800
AGCAGCAAAA?GGTCTCAGAA?GTGAGAGAAA?TGGACCCAAC?TAGGTTTGCA?ACAAGCTGAA?64860
ACCTGTAAAG?GCTCATGTCA?GCTGGCACAA?CCTCTCAAAA?TGCAAATCCC?TGAGCCCAAG?64920
ATAAATGTAA?GGCTCGTCTG?ACTCCTAAGG?TATCAAGTAA?TTCTTATTAA?GCCCCATTTC?64980
AATGACTGAA?ACCTAATGCA?GAGCCCAGGC?ACACAGATTA?AGTTTCCAGT?CAAAGCCCAC?65040
ACAAGCCTAA?AGAAAGGAAA?TTAACATTTT?AGAGAAAAAA?AAAAAAAAAA?AAAAAAAAAC?65100
CCACAGGCTT?TTTCAAAGGC?TTTTTTTTTT?TTTTGGAGGA?TTTAAGTCAC?AGCATGCCAA?65160
ATAAAGGTGA?GTTTCTAGGA?GAATACAGCA?CAGAGGTGAC?CAAGGTGGGT?GAAATTTATT?65220
CACAGGGGAA?AATCCAAATG?CCTTCAGGGA?AACCACTTTT?GCAGGGTTCT?TCTGATAAAT?65280
ACTGAACCCA?ATTAAAAGCA?TCCCTTCAGG?GCAAGTTTTC?TCCTAGGAGA?TTTCTATTGG?65340
CCGCTTTAAC?TTCCCTTTCC?CCAGAATTTC?CAGGAGAAGT?TTGTAACGGT?TTATAATCCC?65400
TACCACTCCA?TGCTCATAGA?CTTTAAGCAT?ATTTTTCTCC?CACAAGGCAG?TACTATTTTT?65460
ATAATCCTTT?TAAGATTAAA?ACTAAAAACA?CAGATGATTA?AAAAAAAAAA?AAAAAGGCCT?65520
GGCTGCATCC?TCCTACAATA?AAGTATTATA?ATTGCAGTGC?ACTACTAAGT?AGTATTTCCA?65580
CAAACATTAG?ACTATCTGGT?TTCCAGGACA?AAGAAACAGC?CTATAATTCC?AAAGCACAGG?65640
AATGGAAAAG?TACAAGTAAT?TTAATCTGTC?CCACTGTGAT?TATAGGTGCT?AAGAAATTAC?65700
CTGAACGGAC?CTCTTTGGGA?CTTGAGAAGA?ATGGGGACTT?TAATGATGCT?CCATAACTGC?65760
CCTATTCATT?ATGATACCCA?AGAGCCACCT?GTGGCTATTT?AAATTCAAGT?TAACTGAAAT?65820
AAAAATATAT?CTATATTTGA?AATTCAGTTC?CTTATTTGCA?CCTGCTACGT?TTCAAGCCAC?65880
ATGTATCATC?TAAGATGGTC?TCAGACCCAC?TGTTCAATAG?AACTTCCTGC?AAAGGTGAAA?65940
ATATCTTATA?CCAGTGCTGT?CCTTAAACCT?TAACACAGCC?GAGGTATAAG?ATATTTTCAT?66000
CTCTGCAGAA?AGTTCTATTG?AACAGTGGAT?CTAAGACCAT?CTTAGAGAGA?TAATTACATA?66060
ATTTTTCCCA?ATTTCATAAT?AGAGATTATG?AAGTAACAGC?CTCCAAAATA?CAGGGTTTTT?66120
AGGCTACTGG?CTACCTTCTA?CACTCAGGTG?AACTTTTTGT?AGTGGTTTAC?ACATGTGTAC?66180
CAATTGCCCT?CATCTCCCCA?GTTTCAAGTA?CATTAAAATG?GCATTAGATG?TAATAAAATA?66240
CATGCCACTG?AGACTCAGCT?CAATTGAAAC?TTGAGTTTCT?TCAGAATTCC?AAACGATGGT?66300
GCATCTCTTT?CTGAAACCTG?AAGTGGGGAC?TTGTCAGGAA?AATGTCTATG?AGGGAGGCCT?66360
AGGAAAAAGA?AGGCATTTTC?CAAAATTAAT?AAATTTATTT?CCTTGTTTTT?TGTCACACCT?66420
TATTCCAGAG?GTGTCTCTAG?GCTACTGTGT?GCGGAACGAG?GTCTGGACAG?AACCTAATGA?66480
TAAATTGGGG?GATACTGAAA?GTCCTGGCAC?TCTAAGGAGC?TTCCCCACAC?ATCTTTAGAT?66540
TTTTATTTCC?CATGTGGGAA?AAAAAGAAAG?GGATTTCCTA?TCTTCCCATC?ACAAACTCCT?66600
GGCTTTGCAG?TGGTTTTATT?ACGTCATTCC?CCTAGTTACA?ATCTGCCAGT?GACTCAGAGA?66660
ATTTAGCCCA?AACTGGCACT?TAAGGCTCCC?ATAATCTGAT?TACCTTTCTG?CTGAATAACT?66720
CCTTTTATCA?GAAACCCTTT?GACCTGATAA?TTGCTGGCTT?TCCTACCACC?AAAATTTCTA?66780
CCTCCCTACC?AGATCTATCA?GGTGGATTTT?AAGGTCAAGA?AGAGCATGCC?CAAGGCAGCC?66840
TGCTCAGCCC?CTGGAAGGAG?TTCAGTGCCT?TCACTGTTGG?CTGTGAGGTT?TACGTGATGG?66900
AGGGAAGAGA?CTCCAAGAAT?GGTGTCTGAA?AGGATGCCTG?GTGTCTGATG?CTGCCCCTCA?66960
GGAGTGGTCC?AAGGTGGTTC?AAATACTGCC?TGCTTTGGCC?ATGGCTGACA?GAGCTGAAGA?67020
ACTGCCTCTA?TATGGTGTGT?GGACACACAC?CCCAGGCAGC?CACTTGCCGG?CTTCCCTCTG?67080
TTTCCTTGAA?GGAAGTGGAG?TAGCATGGCC?CTGGGGCTAA?CAAGTGAACA?ATAGTGCCTG?67140
CCTTAAATCA?TACCCAGCCT?TTCAGACCCA?GGTCAAGTGT?TTTCTCTTTT?GGAAAATCAT?67200
CCATTCCCCC?CACTACCAGC?CCCACCAAGA?GTACTCTGCC?TCCTCCGGTT?TTGGTTTTTA?67260
ACCATCTTTA?CTGTGAGGTA?TGCTTTTAGA?TAGGCCTGTA?TTTGCTCTGT?TCTGCAGATG?67320
AGTTTCCAAA?ACCTTCTAAA?ACCTTGCTCA?TATTTGTTAT?GCTGGATTTA?AAGTCAACAG?67380
ATGGGAGTTT?TCAACCCAGT?AAATGGAATT?TCTTTGCTGT?GGGAAATCAA?GTACTTTGAC?67440
CTCTCTGGTG?AAATTCTTCA?TTTGTAACCT?CACTGGGTTA?GGCTAGATTA?GTGTTTCTCA?67500
ACATGGTTCC?ACATCGGAAT?CATCTGGGGA?TCTTTTAAAA?CAATAATGAT?GCCAAAGTCC?67560
TACCCCAGGG?CAATGAGTCA?GAACTTCTAG?GTGCTTGGCT?CAGGCTTTGG?AATTCTTTTA?67620
GAAGTTCGCA?GGTGATCCTA?ACGTGCAGCC?AGGGTTAGAA?AAATAAACTG?AGTTCAGGAA?67680
GGGACTTATG?CTACATGGAC?TGGAGAATTC?AATAGGAAAA?AATGTAGTAG?TTAGAGATGG?67740
GGCATGGTAG?TACTGGACAG?AGGCAGTCAG?GCCCATAGGT?GTTGCTTCTC?ATCTTTGCCT?67800
TGAGCTGTAA?CTAGAAAAAC?TGCAAACTGC?ATTATAACCA?GAACATTATT?ATATACATAT?67860
ACATGTACAA?TCAAGCCCAA?CCCAATTAAT?TTTCTCATAT?GACTCAAACT?CTAGTACCAT?67920
TTGGAGATGA?GGCAGGAATC?ATAAACATAA?TTGGCTGCAG?GGCATTTAGT?TGCCATTGTA?67980
TAAATTCTTC?CTGAAAAATA?ATTTTAGATT?AATTTTTAAG?TGTGGATTTT?ACAATTTCCT?68040
ATCTTTTTAA?AGGGTGGGAA?TCCTTTGCCA?ATTCCCAAGA?GGACAATAAG?CTTAAAGGAA?68100
GATAATGTCT?GAAAGATCTG?AGGACCAAGT?TTCCTGAGAA?AGCTGTATTT?CTAAAGTTTT?68160
GACCCTACAA?GGCAACATTA?AAAGTAAGTT?CAAGGAAACA?AATGTGAGAA?AGCATATCTC?68220
CCTTTAGATA?ACCTAGCAAA?GAAGTTAAGA?AGGGAAATAG?TTCCTTAGAT?CAGAATTAAC?68280
AGTTGTGGAT?AGCCTTCCCT?TCAGAAAATT?GCAATGCTAA?ACAGACGTTA?CACAAGCAAT?68340
ATATCCCTGC?AACTTAATTT?CTCTTCCTAG?GATCTTTAAT?ATTTTTCTTT?TTTTATTCCA?68400
TTAAACAAAT?ATATATTGAG?CATCACCTAT?CCACCAGATC?TGAAGAAACA?CTATTTTTAA?68460
TATGTTCAAA?ATTTGAGTCT?TTTCTTGATA?CAATAACATC?TGCCTTAACA?GGAATCAGTA?68520
TGTAAAAATT?ACAGTTTTTA?AAGAATTATA?TAAAAGGTAT?TATTCCAGAA?GACTTGCTAT?68580
GGAATCCCTT?TTAAAAAGGG?CGTTCAGAAA?AAGGTAACAC?TGAAATTTAT?TACAGTTTGA?68640
AGAAAATCAC?TCCAATTATA?AATCCATGAA?CCCAGTCATT?GTTTAATGAA?GCTCATCTTT?68700
GCTGGAAAAT?CCCCACTGAG?AACAAAGCAT?CACAATGATC?CACACAGTCC?TAATCAAGCC?68760
CACTGGAAAA?ATCACCCTGA?AGAACACTGG?TGGAAAACAG?AAAGAAGTCC?ACACCACAGT?68820
GTGAGAGCTA?ATTTAATGTG?TTCTTCAAGA?AAAATTAAAT?AAAACAATAT?6ACTCAATTT?68880
TTCTTTTATG?TTGCAAGAAA?AATAACATTT?ATATAAAGCT?AGTAGTAGAA?AAGCAGAAGT?68940
ATAGCTTAGC?TTTCTATGAT?GGCAAGTGAA?ATAGTTTCTG?CTAATCAAAG?TGATTCTTTT?69000
TTTTTTTTCC?TTTGAGACGG?AGTCTTGCTC?TGTCGCCAGG?CTGGAGTGCA?GTGGCACGAT?69060
CTCAGCTCAC?TGCAACCTCC?GCCTCCCAGG?TTCAAGTGAT?TCCCTTGCCT?CAGCCTCCCG?69120
AATAGCTGGG?ACTAGAGGCA?CGTGCCACCA?CGCCCAGTTA?ATTTTTGTAT?TTTTAGTAGA?69180
GACGGGGTTT?CACCATGTTG?GCCAGGATGG?TCTCAATCTC?TTAACCTCGT?GATCTGCCCT?69240
CCTCGGCCTC?CCAAAGATCC?GGGATTACAG?GTGTGAGCCA?CCGTGCCTGG?CCATCAAAGT?69300
GATTCTTAGC?CATTTTCTTT?GAAAATGTCA?GTCATAGAGG?TAGGCTCTGT?TGCTCTTCAA?69360
TGTATACCTT?CTTTTATATA?AAAGCAATTT?GACTAAATAT?TAGATGTCTG?TGTGAGTCGT?69420
GTTCTGCTAC?TCAAAACACT?TCTTGTTCTG?TTCTTCTCTA?TATTTTGTTT?ATTTGTTTGT?69480
TTTTTGAGAT?GGAATCTTGG?TCTGTTGCCC?AGGCTGGAGT?GCAATGGCAT?GATCTCGGCT?69540
CACTGCAACC?TCCACCTCCT?GGGTTCAAGC?GATTCTCCTG?CCTCAGCCTC?CCGAGTAGCT?69600
GTGATTACAG?GCGCCCGCCA?CCATGCCCAG?CTAATTTTTG?TATTTTTTAG?TAGAGATAGG?69660
GTTTCACCAT?GTTGGTCAGG?CTGGTCTTGA?ACTCTTGACC?TCAGGTGATC?CACCTACCTT?69720
GCCCTCACAA?AGTGCTGGGA?TTACAGGCAT?GAGCCACAGC?GCCCAACCTC?TTCTCTGTAT?69780
GTTTATTCAG?ACATTCATGT?TTAAGAATTT?CTGAGAAAGG?AAGCCAAAGA?TAATAATACC?69840
TGACCTCTAT?GTCTATATGA?TGAAGAAGTG?CACTTCCTAT?GTAAAGATGC?CCGTATTCCT?69900
GATTAGGTTA?AGCAACTTGA?AGTTCTAGTG?AGGGGCAAAA?CTACAGGACT?GCAGAAACTG?69960
GCATAGCCTT?TTACACATGG?CAGCATTTGT?CTACTGATAA?TGGTGACACA?ACCTCCAAGA?70020
GGGCAGACCA?CACGGTGTAT?TAAAGAGAAG?CTGTCCCCAT?AAGAAAAGGG?GAAAAGTAAA?70080
ATGACTCATT?ACATAGTTTG?AAATCTCTTA?TGATGGGTGG?ACAAAACCCT?CAAAGAAGAA?70140
ATTCTCCAGT?CTTAAATTGG?GCTTTTAATG?TTCGAGGCAA?GAACAAGTCT?CCTGATGAGT?70200
ACACTGCCAT?CGCCTCTTTA?ACAATTTAGC?TATGAAAATA?TGAAAATACG?AGGAGACTAT?70260
AGATTTTTAT?CTTAGATTTA?CTTACAAATT?AAGCAGTGAG?GGAGCATGAC?TAAAAATAGA?70320
AAAATGATGA?AAAGATTAAT?TAATGATACT?TTACTATGTC?TCAGTGGATG?GGCAGTCCTA?70380
TTACAGCTGG?GGCAGATGAT?TTCATCTTTC?TGGGCCTCCA?TTTCCACATC?TGTAAAACAG?70440
GATAATTATA?TCCATCTCAG?AGAGCTGTTT?TTAAAATTAC?AGATGACAGG?AAAGTGAAAC?70500
TGTTTTGAAA?ATAATGAAGC?TTTCTATTAC?TGTGAGATTA?TTAAAAGATT?ATTATAACTA?70560
GACATGGTCA?ATATGTTTTC?TTCAAAGTTA?TCAGACTAGA?CATTTTTCCC?TCTGGTGATC?70620
TTTCACCCAT?ATGTCTCAAT?CATACTGAAA?TTATTCAAAT?CACTTCTTTT?TTCTGTTTTC?70680
CTGGTACTAG?TTTCTCTTTT?TCTTTTTCTT?TTTCCTTTCT?CTTTTTTTTT?TTTTTTTTTT?70740
TTTTTTTTGA?GACAAAGTCT?CGCTCTGTTG?CCCAGGCTGG?AGTGCAGTGG?TGCGATATCG?70800
GATCACTGCA?ACCACTGTCT?CCTGGGTTCA?AGTGATTCTC?CTGGCTCAGC?TTCCTGAGTA?70860
GCTGGGATTA?TAGGCGTGTC?CCACCACTCC?TAGCTAATTT?TTGTATTTTT?AGTAAAGACA?70920
GGGTTTCACC?ATGTTGGTCA?GGCTGGTCTC?AAACTCCTGA?CCTCGTGATC?CGCCTGCCTC?70980
GGCCTCCCAA?AGTGCTGGGA?TTACAGGCCT?GAGCCATTGC?ACTGGCTGGT?ACTAGTTTTC?71040
TATCTGCCTG?AAGAAGTACG?CAAATGACTA?TTTTCATGAC?TTTTTTTTTT?GCCTTTAATA?71100
TTATTTAACA?GCTATTTTAA?CAATGAAAGA?CATTTTACAT?ATTCTCAAAA?GGTATGTACC?71160
AAAGAAGGGT?GTGGGCAGAA?ATGTTCACAA?AATCAGGACC?TTTCATTGCA?TCTTGGTGAC?71220
CACCAATAAA?GTACACAGAA?ACCCATAGTG?AACTGAGGTC?TAAGTGGCTG?CTATCAACCA?71280
ACACAATCTT?GAACTGCTGA?GTCTGATCAT?TTCATTTTCT?TAAAACTTCA?GGACAGTTCA?71340
ATTTAGAGAG?CACAAGAGTG?AAGTTAGCCT?CCCTGGTCAT?CTAAAGCAAC?ATGGGAAGGT?71400
AATTTAAGAA?AAGTGACACC?ATATCAATCA?CTTTCCCAAG?CTTTTCAGGG?GCTCACTCCA?71460
AAGACTTTCT?TGATGATAAA?TTTTATTAAA?GTGCTGATCA?TAATCAAAAC?AGTACATTGT?71520
ATCAGAGGTC?AAGCATTGTT?TTTCACTTCC?CTTCCCAGAA?CTTATTAAAG?ATGTACCTCT?71580
GAAGAAAGAC?ATAAGGAAGA?ACAAAATTGT?TTTGACTCAC?AGAAAATGGC?TTACACAGAC?71640
ATCTAATACT?TAGTCAAGTT?GCTTATATAT?ATGAAATAAG?TTATACCTTG?GGAGTAACAA?71700
AGCCAATAGG?CTTGGCTCAT?AGGGGGCTAA?CTACGGCTGC?AGCAGTTATT?CAAGAAGTTA?71760
ACATATTCTC?TCCTGTCCCC?TGAAGACACC?ACAGGCATCT?CAGTAATAAA?CTGATAACAA?71820
CCAATACTCA?AGAGTTTGTG?AAAATGCTTT?GTAAAGTGCT?GAATAATGTA?AGTGATTATC?71880
TACTTACCAC?AAACGTCCTC?ACCAACATCA?TCATTAAAAT?CTTGAAAGAT?AAGTGCTTTT?71940
CAGTAGTTTT?GAGAGTGAAC?CAATGACATG?CTAAATTAAA?AGCATTATAT?TTCAACCATT?72000
TCCAATAAGT?GCCACAGAAT?ATTAAGACTT?AAGAATATTA?AAATTCTGGT?CAGGTGCAGT?72060
GGCCCATGCC?TGTAATCCCA?GCACTTTGGG?AAGCCGAGGA?GGGTGGATTG?CCTGAGGTCA?72120
GAAGTTCAAG?AGCAGCATGG?CCAACATGGC?AAAACCCTGT?CTCTACTAAA?AATACAAAAA?72180
TTAGCCAGGT?GTGGTAGTGG?GCACCTACAA?TCCCAGCTAC?TCGGGAGGCT?GAGGCAGGAG?72240
AATAACTTGA?ACCCAGGAGG?CAGAGGTTGC?AGTGAGCTGA?GGTCGTGCCA?TTGTACTCCA?72300
GCCTGGGTGA?GAAGAACAAA?ACTCTGTCTC?AAAAAAAAAA?AAAAAAAAAG?AATATTAAAA?72360
TTCTTATTTC?ATCTCCTTTT?CCTCTATAGA?TAGAGCAGGT?AGGGCACTAC?CAGTCCAAAT?72420
CTATGTAATG?TGATGTCAGT?GGTAGCTCCA?GAATTCCCAT?AGAGGAGTGG?CTACATGGGT?72480
GATGATCTGG?CTGAAAGGGA?GGCAGGCAAC?ACAGCTGGAA?GCTGTGCTTG?CACAAGAGAA?72540
CACTACTTGT?GGTACCTAGA?CTGCATGTTT?ATTCAGGATG?GATGGGGACT?ATGGTGGACG?72600
AGAAGGCTGA?AGGCCAAATT?CAAGACCATC?CTTAGAAACC?CACTCCTATT?AAGCACCCAG?72660
GTAAGAAAGG?CCTCATATTT?AAGTCTCCTT?AGCATGTATC?ATTTTAACAG?GGCTTTCCAA?72720
AAAGTACAAC?CAGGGGTCAC?CTTTGCAATA?TGGGATTATT?TACCCTCAGG?TAGGTAGAAG?72780
AGTATCTTCA?GCCACTCTTC?ATTGCACCAA?GACCCCTTCA?GCCATCCCTA?TTCCAGCAAT?72840
CCCAATGACT?GAAATCATCT?ATGACTCATA?AAGAGAAAAG?GCAGGAGTGA?CAAAAAATTG?72900
TCCTGCGTGA?GATGGTGTGA?TTTACTTTAT?GACTTTGCCT?GGTCTCTATA?GTCATAATGC?72960
ATTGAGCCTT?CTGCAAAAGA?TTCACACATG?AGAGAATAAA?TGAATCAAAG?GCAGAGCCAG?73020
TGATGGATGG?AAAATTAACC?TTAACACCCA?CACACCACAG?CTCCCCAAAA?TTCACAGAAA?73080
CTAAAGACTG?CAGACAGAGC?AAGTCTCCAC?TGTAAAGAAC?AATTTACACA?AAGCAGATCA?73140
TACGAGATTT?TCCATAAGCC?TATGGTTCTG?TCAAACAATA?CTACAGGTGG?CTTTAAGCCA?73200
TTGACATTTA?CACTTGGTGG?TGAAAAGCCA?TCTGGGAGAA?AAAAAAATAG?CACTCCCCGC?73260
CTTGGATCTA?AAAGCAAGTT?TCCTCGGCCT?TTAAAAGCAA?TGAATTCCAA?ACAGCAACAA?73320
ACAAAACACA?TAAACAGAAT?TAGTGAGAAT?CTGTGCTAAG?AGCTATGGCA?AAATCAGACA?73380
GAAGTTTCTC?CCTCAAAGAG?TTTTCATTCT?AGTAAGAGTT?TTGTTTTGTT?TTGTTTGTTT?73440
TGAGACAGAG?TCTCACTCTG?TCGCCTAGGC?TGGAGTGCAG?TGGCGCGATC?TCGGCTCACT?73500
GCAAACTCCG?CCTCCCAGGT?TCACGCCATT?CTCCTGCCTC?AGCCTCCCGA?GTAGCTGGGA?73560
CTACAGGCAC?CCGCCACCAC?GCCCAGCTAA?TTTTTTGTAC?TTTTAGTAGA?GACAGGGTTT?73620
CATCGTGTTA?GCGAGGATGG?TCTCGATCTC?CTGACTTCGT?GATCCGCCCG?CCTCGGCCTC?73680
CCAAAGTGCT?GGGATTACAG?GCATAAGCCA?CCACGCCTGG?CTAGTAAAAT?AGTTTAAAAC?73740
ACACAGAGAC?AGCACAGGTA?GCTTGGCAAA?CAAGGTCATA?TGAATGAGAA?TGCAAGGCTT?73800
GTCGGAGAGG?CTATGGGCAG?GAAAAGGAAT?CACAGTGGGA?TGGATAATCA?AGGAAGGCCC?73860
ACTAGAAAAA?GTAACATTTA?GACCAGGCGT?TATTTCAAAG?GGTGGAGCCG?TTGTAGGGCA?73920
CAAATAGAGA?ATGGTAAAAC?TTGGGGGGAG?GTGGTGGAGA?ATGGTCACAA?GCTAGGAAAT?73980
TTGTAAGCAA?AAAGGATGTG?TGAGGCAGCT?GGGTTCAAGT?GGAACCAGGG?CATGAGGGAT?74040
GTGAAGGGTG?GAATAGATGA?TGGGCAAGAG?GTTTGGCTTC?ATCTGTGCAC?GTAGTCATCA?74100
AACTGGTCCT?GTGTCCCATC?AGCACAAGGC?ACTCTCTTAG?GAGCCAAGGG?ACACTGAGGC?74160
AGCCCCCATG?CTCAAAGAGA?AAGGGAAGGC?CATGTGATGA?TCTAGGATTC?ATAAAATCCA?74220
TGGAAGGCTT?TCTAACAGAG?GCCAGCTATT?CAAAATGCCA?TCTGGGGGGA?GATTTAACTG?74280
AGGGCAATGC?CTGTGTTATT?GACAGAGAAA?GAACAAAGGG?TGTCCATAAG?CAGAGACCAA?74340
TTAGGTGATT?TTTACAGATG?ACAAATATAA?GAGTTCAGGT?TTGTGTTACG?GTAGCATAAT?74400
TCAAGGGCAA?AAATAAAACC?AAATGGTTAT?AGATTTTGCG?TAACTTTTCT?GATGGATAAC?74460
TTAAGATTTG?ATGCAACAGG?AATCACCATG?AGATATGAGT?TGCAATGGAA?AGTTTTTATG?74520
TTTTTTTTTC?TTGCCAAGTA?TAGTTCAGAT?GTCAAAGGCA?AAGAAAAAAA?AGTCAGAAAA?74580
TAAAATTATT?TGGAAACATC?AGAAACTGCT?TGTAAGGACT?GGTTATTGTG?GCTACTGTTA?74640
ATTAAGAGCA?TTAATAACTG?ACAGGGACCC?ATAATTCTGG?AAGACAAAAG?TAACTAAGTC?74700
ACAAAAAGCT?GCCTTATGAT?ATTAAAATAA?AGGAGCAAAT?CAATGAAAAA?GCCTACAGTG?74760
GCACTCTCAG?AAAAGTCTAA?AACAAATGTT?GAGCAATTCA?AGAGAAATTT?ATTGGGTCTT?74820
CACTGAGCAT?CAGACAAATA?AGTTCCTCAA?GACAAAAGAG?GATTAAAAAA?TGTTGAAGAG?74880
TAAAACCACT?TCCTGAAAAC?CTGTCATCGA?ATCATTAATT?TATTGGGTAC?CTACTTTGTA?74940
TAGAGCAGAG?TGCTACCTAT?TTTAAGAAAT?GCTGTGGTAT?AATAGCTCCA?GAATGAATTA?75000
GGGCCTACAT?ATGTCAAGGC?AATCTGTGAG?TAAATGCCTA?ATGAGGTAAA?CATGATTAAT?75060
GCAGTGAGTT?CGATATAGAA?ATGGGTCCTT?GGGGCCGGAC?ACGATGGCTC?GTGCCTGTAA?75120
TCCCAGCACT?TTGGGAGGCC?GAGGCGGGCG?GATCACGAGG?TCAGGAGTTT?GAGACCAGCC?75180
TGACCAACAT?GGTGAAACCG?TGTCTCTACT?AAAAATACAA?CAACAACAAA?ATTAGTCAAG?75240
TGTGTTGGTG?CACACCTGTA?ATCCCAGCTA?CTCAGGAGGC?TGAAGCAGGA?GAATCGCTTG?75300
AACCCAGGAG?GCAGAGGTTG?CAGCGAGCCG?AGATTGCGCC?ACTGTACACC?AGCCTGGGCA?75360
ACAGAGCGAG?ATTCCATCTC?AAAAAAAAAA?AAAAAACAAG?AAAGAAAAAA?GAAATGGGTC?75420
CTTGGGTTCT?ACAGTTCACC?ATGGTCAAGG?GATGGACAAT?CAGTGGACAA?AAGACTCATG?75480
AAGGATGACT?GGGGAAACAG?ACTGGTTAAA?AACTGACTCA?TTTAGTTGAC?TTGCTACCAG?75540
TGCCTTCTGT?CTTCTGCTAG?CTTTAGTTAA?AACGGCTTAG?GAAGAGTCAA?AAGACTCTCA?75600
TAAAACTAAG?CCAACTCTTC?CTTGAATTCT?CCTCTTCTTT?ATTGACAGAA?ACAAGCCTGA?75660
TGTGATCCAC?TAAAACCACT?GCAGATCATT?TGGCTACTCT?TTGGAACATG?CTTTAATGCT?75720
ATTACAGCAG?TGTTTTTCAA?ACTGCTATGT?GTACAGGAAT?CACCTGGGGA?CCTTGTGAAA?75780
GTGTACATTC?TGTTGCAGTA?GGTCTGGGGA?GAGGACCCAC?AATCCTCATT?TCCAATAAAT?75840
TCTCAGTGAT?GCCAGACCTC?CTGTAAGCGG?CAAGGTATTA?GAACATCTTC?AGTTGCTGTT?75900
ATCAGAAGAT?GATAGGAAAC?CATCATTTTC?GGGGTCAGAA?TGCTGGAGCT?CAAGCTTTGG?75960
GCCTTGATGC?ATATAATAAC?TCATAAAATG?TAATATTCAG?GAAGGAATGA?GGCTCCTAAA?76020
GAAGTGAGAA?AGTAGAATGA?ACAAAGGCCT?AAGAGAATAG?AAATGTATTC?TAACAATATA?76080
AATTATAAAA?ATAAAAGTAA?GAGTGCCCAG?GGGTATTGAG?ATTGTTAGAT?TATTTTATAA?76140
TGATATAACT?TAAGGGATTC?CAAAATAATG?AACATAAAAT?GTTATTATTA?GATTTTTTTC?76200
CTTTTCACAT?ACTTGAAGGA?CAAATTATAT?CATATTGTCT?TTTTTTCTTC?CCCAATACTA?76260
TGAGCGTTAG?AGAATGAGAC?GCAAATCCGA?TATGTAGTAA?CAAGGTAGTC?ACTCACAGCA?76320
AAAGTTGAAA?GATTCCTAGT?CTACGCTAAC?AAGTGTCTGC?AAACTCTACA?GAAATGCAAT?76380
TAGAGGTTGC?GGCAGCTACT?CCCCTGCCTA?AAACAGCAGT?CTGAAAACTG?CCAATCTGTT?76440
GCAAATTCTG?TCTTTTCTGA?GAATATTTTA?AGAAAAGTGG?TAGAGAAATA?TTTGAAAGGC?76500
AACAGAACAC?TAATTATATC?TAGACAAGTT?TCCTTTTTTT?TTTTTCCCAA?AAAATATGAA?76560
AGTTCCTTTA?GGCTTTACAT?CTCCTAGGCA?TAGCAAAGCA?TTTCATAACT?TTCTACCTTA?76620
GGAAAAATTT?TCACAGACAT?TTTAACCAAT?TCAGAGGAAG?GGGAGAATGA?AAATACCATA?76680
ATTAACCAAA?GAGGAATAAT?ATTACCACCA?AAACCAAGTA?AGCCTTTTAT?TTAGGAAGGA?76740
GTGAGCTCTA?GCTGAAGTAA?ACATGCTATT?TAGTCAGGAT?GTATGCTCAG?ACACCTGTAG?76800
TCGGAAATTT?TCAAAATAGC?TATGGTTTTT?TTTCTTCTCT?TTTTTTAATA?GTAGTCATCT?76860
CCAATGAACA?CCAGTGGAAG?TCTGTGGTAT?TTCTCAGTTC?TGACCTGTCA?TGACTTTTGT?76920
TAGTTTTCTA?TTTTGATTAG?CTAAAGATTT?TCTAACTCAA?CTTCAATGAT?TTATTCTACT?76980
AACAAAATAG?TACAGGGATA?ACAAAGAATG?AAATGTTTCA?GAAGAGAAAA?TACTGGAAAT?77040
CTTATTTAGT?CCAATTCTTG?TCACTGTATA?GAAGGAAAAT?GAGCCCCAGT?GGGAAGAAAG?77100
ACAGCCTGGT?CACCCAGACA?CCTAGATTCC?TGGTACAACA?TACCTTAGTC?TTTACCAGCT?77160
GTCTCCTAGG?TAGAGTCCTT?CTAATCTCAA?ACTAAGGGTC?AGAGCTAGGT?TATCTTTCAT?77220
CCAAGATGAA?GGTTTGTGAT?AATTACATCT?TTGCAACTTC?TTTTCTACTT?GGCATGGGGC?77280
TCTAAAGTAG?GAAAATGATG?AAGGGTTTAG?CTAAACCTGG?AGGAAAAATA?TTTTGGTTTT?77340
GTGAAATAAC?AATGCAGATT?TCAGTCTCTG?TTTGCAATGG?GGGGAAGGAG?GAAGAGGCAT?77400
TTTTTAACAT?TTATTTTCTA?AACCAACAAA?CAAATCCTAC?CATTAGTCAA?AGACTCAGGT?77460
CTTTGGAATC?TGAAGCTTGT?AAATTTCAGG?GGCACTCTTT?AAGAAGAAGA?ATACAAAATT?77520
AAGAATAAAG?TGAATATAAA?ATTAAGAATA?AAGTGAATAT?TTATTTAGAA?TTAAAATGGC?77580
ATACAGGCCG?GGTGCAGTGG?CTTACACCTG?TAATCCTAAC?ACTTTGGGAG?GCAGAGGTGG?77640
ACAGGTTCCT?CTGAGCCCCA?GTGTTCAAGA?CCAGACTTGG?TACATAGTAA?GACACCATCT?77700
CTACAAAAAT?TAAAAAACAA?CAAAAAACAA?AAAACTGGCC?GGTCTTGGTG?GTGCATGCCT?77760
TTAGTCCGAG?CTACTCTAGA?GGACTGCTTG?AACCTAGGAC?TCCAAGGCTG?CAGTGAGTTA?77820
TGATTATGCA?ACTGCTTTCC?AGACTGAGTG?ACAGAATGAG?ATCTCATCTC?TGGAAAAAAA?77880
ATTTTAAATA?GTATCATACA?AACAACAAAT?TTTTAAAAGC?TATAAATACT?ACAAATATGA?77940
AGTGTTTAAA?AAACAAATAT?TTTTATTAAC?TGATTGCCAT?ACCTCTGAAA?TAATTCTCCT?78000
ATATTTTTTG?GTTGCACACT?CTTTGATCAT?CTCTTCCAAT?AACATTTTGC?AATATTCTCT?78060
ATTGAGAGAA?TAGAAAAATA?ATTCAGTCTT?CCCTTTAGAA?ATGTAGATCA?GAATTTGTAA?78120
TTTATTCTTG?AATAATTTGG?AAAAGTTCCT?TTCAGCTTCA?TAATTCATTA?CAGGTAATGT?78180
CATATAAATT?TTTTGGATTG?ACTTCAAATT?TGGAAAACTT?TTATCAGGTT?TCTTTTATAT?78240
GTGAGCTGTA?AGATTCAGGG?CACTGCAAGA?TTTCGTAGTA?TTTGACTTGA?TGACACTTGT?78300
TAACCACATT?GCCAGGGCCT?CTCCTAGAGC?CAGGAGATGG?ACCTATACCA?GGGTATAGGT?78360
AGCCTTGAAG?GTTAAGTTCA?AGCACTTCAC?AGTAAATCCA?CCTGAGCCTG?GCATTTATAT?78420
CCTCAACATA?TTTGATGCAT?CTGTGAAGTC?TCCCAGTCCT?TTCAAATAAA?GTGCCTGTTT?78480
TACTCAGAAT?ACCTAAACTT?CCTGATGGCA?TAATTGTTCC?ATGATTCAGC?CAAGACTGTA?78540
TCACTTGAGG?TATACACTTC?ATTTTTCCAT?TGAGATCACA?AGACAGGCAT?GATGTTTGAC?78600
TACCTGGTGT?ATAAACCGAG?TGTTATTTTA?TTACACTAAG?AAAATGCAAT?GGGATAATAT?78660
ATGAAGAATG?CTAAAACACT?AGAAAAATGT?TGGATATTAT?TATTTCTCTT?AACCTCTAGT?78720
CTTCCAACAC?CCATGCTATA?ATGGACAAGT?AGTTTATGTC?AATTAAGGCA?GACTAGTCTC?78780
AGTACAGTAT?AACAATTAGG?AATCTAGATC?CCCAAACCAG?ACCATCTTGG?TTCCAACCCC?78840
AGCCTAATCA?TTTTCTAACT?AGGTGGACTT?AGGCAAATTT?ATTGACTCTG?GAGGATTTAT?78900
AATAAGCATA?ATATAACCTA?CCTTCTAAAG?TTGTTTTGAG?GGTTAATACA?CCTGAAGTAC?78960
TCAGCATGAT?CCGTGCAGTA?GCAAGACCTC?AATAAGTGGT?AGCTACTATG?ATTATTGGGA?79020
AATTAGTCCA?TGAAGTCTCT?TGAGAAAAGC?TACAGGGGAA?ATAAGCCCAA?TTTCATTTCC?79080
CTATGTAGAA?AAGTTTGCAG?GATTTGGGCG?TGACAGGTAG?TCATCCACAA?AGCAGCAGTG?79140
TTATCGCCCC?ATAGGAAATG?AAGACTTCGT?AATGATTTAT?ACTTTAATAA?AGAGCTGCTG?79200
CAGCATATAC?TGAAAATATG?CACCCAACCC?ATATCTTCTT?TCAAAGGCAT?TCATGTTGGT?79260
TCAACCAAAT?CCCTAGTTCT?CTAAAATGAA?GTTTTGACAA?TCTTATATCT?TCTAAAGCAC?79320
TGAGAAGCCT?TTTTCCTTGT?TTTCTTTAAA?GAGGCTTGAG?AAGAACCAAG?CCTTTTTTTG?79380
GTTCAAATAA?AATATTTACA?ATAGGAGGAA?AAAACATTCA?GATAAACTTC?ACCTTGCCCG?79440
CCTGGTGGTC?TCTCAATACA?CAGAAGAAAT?GCAACTAGGG?CACTAGGAAA?TCTAAAAAAA?79500
AAAAAAAAAA?AAGGAAAGAA?AAAAAGTATA?GAGCTAAAGT?TCACTTCAGG?ACAACGCAAA?79560
CTAAGAAAAA?CTACATTTCC?CAAAGGAAAT?AGAGCACTAT?GTCTACAAAG?TAACTCATTT?79620
TTTCTTTAAT?GTTCAATGTT?GTCTATTCCA?GGGAAAAAAT?GGTACAATTA?ACCAAAACTT?79680
ATTTCTACCC?AACATCTCTG?CAAAGGAATG?TTGCTGCTGC?AGATCCACCC?CCAACATGGG?79740
AAGGCCCAAG?GCAAGTGAGC?AAATAGAGGC?CCATGTACCA?TAAGTCAAAA?CATTTAAAGT?79800
TACAAATCAA?GCTAGCAAAC?TGCTCAATAA?AATAGGTGTT?ATCCTTCTAC?CTAGACTGAC?79860
AAATATATCT?TTTCAATGTC?TTGGAAGACC?AGGTACAACT?TTAGAACTCC?TACAATGTTC?79920
ATAGTCCTTC?CACAGAAATG?GGTGGTTTAA?AGAGAGACAT?CATCCTGAGC?CCTGGTAATC?79980
AATTTGCCTT?CCTCCCCCCT?GCCTGCTCCA?TCCTACATCA?AGAGGGGCCT?TGTGATATGT?80040
GGACACCCAA?GCTCGCTCTC?TGTCTCTCTC?TCTCTTTCTC?TCTCTCTCTC?TCTCTCTCTC?80100
TCACATACAG?ACACACACAC?ACACAGAGCT?ATCCCTTAAA?CAACCCTCGT?GCAGAGATTG?80160
CACAACCAGT?AGCAATGACA?GCCTTCAGGA?AGATGGCTTC?AAGGATCCAT?GCAAACTGCA?80220
GATACCAGTT?CAGGGCCTTC?TGGACAGCGA?ATGTGGGTTC?CCACATAACC?AAATCATGGT?80280
CTAAAAATGA?AAAGAGAGTA?AGACTGGAAG?GCCCAAAAGT?CACCTCACCC?CATAGGCATG?80340
GCTCTGACCA?GAGAAGAATG?ACAGCAGAGT?ACCATCTAAG?GCCCAGGACA?GAGGCCAGTT?80400
GTGTTCATAT?ACTAGGTCTA?TATTTTAGTT?GTAGAGCTGA?AAAAAATTGG?AGGAAAATAT?80460
TCCCTCAGAA?AAGAGAAGAA?AAAAAAAAAA?AAAAAAGAGC?TGCATGTCTT?GACCTTTCCC?80520
AGATAGAATC?TCCCCAGTCA?TAGGTACGGG?CCCTGAAGCT?AAATCTCATC?TAATAATGAT?80580
AGCTTCAAAC?CTACAAACAA?AACACAGATG?CTAGGGAACC?CTTAAGAGTC?TAAGCAGGAG?80640
GCCATAAGTA?GACTAAACTG?ACTACACCCA?AGAGGATAGT?TGCTACTTGT?TGGGTGCTAA?80700
GACCTAGAAA?GCTGACTGTG?GCAAGTAAAA?GGCAGAAGTA?CTCCTGATGT?AATGGGTGAG?80760
GAAGAGAATC?TTAACCTCCT?ATAAGTTTTC?AAATTGTCCC?CTTCAAAAGT?CAAACTGTCC?80820
CCTTCTTCTT?TGTTATGTTG?GATAAAGTCG?GCTCTTCTTG?CCCTCATCAG?CAGTTGTACA?80880
CGATTGTACA?CAAATGATTG?TCCTACACAC?TCAAAATTTG?GGGTTTACAA?TACACATCTT?80940
TGCAAATGGG?GTATGTCCAA?CTGCTATAAG?TGGCCAAACC?ACAGGTCACC?CACCATGAGT?81000
CCTACCACTA?AGACACCATT?GTCAAACTGT?GGGCTGTAGA?GTTTCCTTAT?GCAAAGAAAC?81060
TCTGCCTTAT?CTTGATTTTC?TGTGGTACAA?ATGTAGTCAG?GAAGGAGGCA?GATAATGCAA?81120
GCAAACCAAA?TCAATTAAAT?CAGGAGCACT?GAACTGATGA?CATTAGATGG?TAAGCTTCCC?81180
CTCTCTCAAA?TCTGATATCC?ATTCACCCCT?CTTCAGCCTC?CCTCCCAACA?CACGCATACA?81240
CACATAGAGA?CCACACGAAA?GAACCTAGCA?GCATGCAAGC?ACAAGAAGCT?TGGGCCACAC?81300
ACTCATACAT?GCACCCAGGC?AAAACTCCAG?AGAGACCCTG?AGCAGGATCC?ATCTTTCCAT?81360
CCATAAAATA?AAGATAATAA?AACTTATCTT?GGAGATTTCT?TCCTAGGATT?AAATGAGATA?81420
CATAATATCA?AGTGGCTGTC?TCAGGGTAGG?TTCTCAAATG?TTAATTGTCT?TTCTCTTCCT?81480
TCTCCCTGAG?ATGAGACAAT?TTGCCTGTCC?AGCATTCCAA?ACCCTTTGGC?ATGCCAAGCA?81540
AAGAAGTATG?AGTCATTATC?TTGCCTCAGT?CACAAGCAAC?AAGTACCTGT?GGAGCAAAAT?81600
ATTACCAGGA?AAGTAGAGAG?TGCAAAAGAA?GCGGTGAGCA?TTCTTGCTGC?GAATGCATAT?81660
CTGTTCTACT?GAAAATCATA?ACTTAAATCT?GCTGAAGTTG?TACATAAGGA?CCTGGAGGGT?81720
AGAAGCTAAC?AAGGTAACAG?AGTTATGCTT?TTATGTGGAA?CTTGGCCAAA?TAATGCCATG?81780
CTGTAGCCAG?GAAGTATGTT?TCCCCTGCAC?CCTATTTAAA?ACTGCTTTGG?TGGTTTGCAT?81840
CAGACCTAAA?TAATATCCAC?GCTACTCTAG?AGTAGGCAGT?GGTGGCTACA?AGACCACACT?81900
TCCCTTCAAC?CAACGCTGCT?TCACCCTTAT?AAACCAAAAC?ATAAAACCCA?ATGAAAAAAG?81960
AAACTTAAAA?AATAAATTTA?GATTTTAGCA?CTTCATTCGT?AATAAAATTC?TCTTTCCGAC?82020
ACCCTTCTAT?GAAAAAAAAA?AAAAAGAGGA?ATCAGTATCT?ACTGGATAAT?TCCTCTGGTG?82080
ACTTTATTTA?AAATTTTGCA?GTGGCTTTCA?AGGCCCTACA?CTGATTCAAA?ATTTATGGCT?82140
AAAGGAATTG?CATGAAAACT?TCTAGCAGCT?TTCCATCATG?TTTGTCAGAA?GTTGAAACAT?82200
CTTTTTCCAT?ATTTCATGAG?AATACAAGAA?CCAATTCCAT?ACTTCAAAAA?CAGTCAAATT?82260
ACTTATTGTG?ATCAGAACTA?AAACTATTCT?AACTGAAAGT?AAAGATTTTA?CTATTTGGAC?82320
CAAACACCTA?ACAAACAGTG?ACTGCTTAGT?TAAATGCTCG?ACCTCAGTTG?CATTAGATAC?82380
AGTAGGATGA?AGTGGAGGCT?CAGCTCAGCA?CTTCCTGGGT?GCTAAATGAT?GTGTCAGGCA?82440
CTGCCAGAGA?TCCCAGAGAT?AGAAAACTGA?ATAAGATTGA?GAGGATTAAA?GGTATAATGG?82500
GCAAGAGAGT?TACGTAAAGA?TATGACTTTG?GCTTGGTATT?GTTACCAGCT?AAGTGAGAGG?82560
TCTGTATCTC?ATAGGAGACA?TTTACCTCAA?ACTGGGACAT?TCAAAGCAGG?TTTCCTCAAG?82620
AAGATGACAC?TTGAACTACG?TCTTAAAAGA?TGAGTGAAAA?TTAGCCAGGT?AGCAGGAGTT?82680
CCAGACATCC?TGAACAAAGG?AACAGCTGCC?TAAATTGCTC?ACATTGTGTG?TATGTGTAGT?82740
GACACAAATA?GACTGGGAAA?ATGTGGGCTG?TGGTGGGATG?TGAAGCAGCA?GAGTCAAATG?82800
GGAACCAGGT?CAGAGGCCCC?TGGTAAGCCC?AATTAAGGAG?TTAATAGTAA?TAACAGAAGC?82860
TGATATTTAT?TGAGCATTTA?CTATGTTGCA?GGCACCATGT?TAAATACTTT?AAAACAATAT?82920
TTTATTTAAT?CCTCACCATA?ACTCCATAAT?CCTCATTTTA?CAAATGAGAC?CAGGGATGAC?82980
TAGTAGGTAA?AGCAACTACA?ACAGGCTACA?CAGCCAGTAC?ATGGCAAGTG?GGTCTGGAAC?83040
CCAGGACGGC?CTGATTCCAA?AGTTTATACC?CTACACTCTT?CTACCACCAG?CCTATCCTCA?83100
AAGAGAGCAC?TAAATGAACG?CATTGGGTCC?ATCATGCTGG?CTATGGAATG?GAGAATGCAA?83160
TTAAAGGCTG?CCCAACTGGG?GCTCCGTGAC?AAGGCAGGGA?TAGGAAAGAG?ACAACAAATT?83220
GATTCAAAAA?TACATTCAAT?GGGACCTAGA?AGGAAACATT?CAACATGCAC?ATCCTCCTAG?83280
TGCATACAAC?AACAAAAAAA?AATGAGGCTT?TTGAAAATGA?GGTGTAGAAA?ATAAAACACC?83340
AGTATTCCAT?AATGCTTTCA?AATATAAACA?GTTAAAACAC?GTATCCTTTT?CTTTACTTAT?83400
AACATGCTCC?CAGCTGTTAA?ATTCAATGGC?AAAGACCAGG?TCTGTCTTAT?TCATCTGAGA?83460
TGGTATCCCA?GGTCTGAGCA?TCCTGCCTGG?CAAGAGATAC?TCAATAAATA?TGGTTGAAAA?83520
GGTAGAAGAA?AAAATGCCCA?GTTTTTGCAA?TGATATCAGA?GGTGCCTTAT?TGATCCAGAG?83580
TTAAAAACTA?ACCTTACTGA?AAAAATTAAA?AAGTCATGTT?CATAACTGAG?TAGAAAACAT?83640
GTAGTAGTTA?TGTTGACTAC?ATAGACAACA?GTCATCATTA?GGGAATGCTA?CATTGAAAAG?83700
AAGGCAATGA?GTTCAAAATG?TGATTAGTAT?TTTGTATAAA?TCATAACTCA?TTAAAAATAA?83760
GATGTTGAGT?GGCCTAAAGG?TGGAAATGTG?TTTTTATGAG?GCGGAAAAAA?AGCACGAGTA?83820
GACTGAAGAT?CAGATTTGGG?GCCTAATGAT?GTCTAGTCTC?TTACCCTGAC?AAAATAAGCA?83880
GGTTATTAAA?GTGATGTGAA?GAACCTGATC?ACTATGACAC?TTTTACAAAT?TCTTTGTCCT?83940
CAATAAGAAT?CTATCTACTT?CCAGGAACCT?GAAAAGTCAT?ATTTTTCAGA?CCTGAAGAGT?84000
TATTGTGCAC?TTTACAGTTT?TCCCCAAAAG?AGTCATTTCT?TAATTTTGAT?CATTTAGGAA?84060
GAGTGAATCT?ATTAAGTCAA?AAACGAAGAA?AAAAAAACTT?TCTATTTCTT?AGTGAAATTT?84120
GTTCTTTTAT?TTAAATCCTT?TGCATACTAC?TAAACAGAAG?TACAGAAGCT?ACTAAACAGA?84180
AGACAGATTT?TTGGGCCTTT?TTAGGTGACG?TAAAAGGAGC?TTGTTGTTTA?TTAAACAATC?84240
TCATTACCTG?ATATATTATC?TTGCATTAAG?ATATTTTGAA?AAAATGTTTT?CAGTTTACCA?84300
ATTACGTTAG?AGAAATTCTG?AAACTATTTA?CTTACATGAA?AAATTAAAAT?GTAAGTAGAA?84360
TTAGGTTTCT?CGTCTTCAAT?ATATCTGTCT?TCAACCATTG?GCCAACTTTG?AAAATTTAAT?84420
TTGAATCAAA?TGAATACAAA?TTCAAAATGA?TTCATTAATT?CAACCATTTT?GAAACTTCAG?84480
TTCTATAAAA?ATATGAAATC?TGTGGGCCTT?GTAAAACTGT?CTAAATACCC?AAATAAAAAG?84540
CCACCACGTT?TTTAAGCTAA?TTGTTTAAAA?GTGTGTATAT?TGATGAAATG?AAAGTGACTC?84600
GTGAACTATT?GGGTCTGGAA?TTTGCAAATC?ATAAACCTTA?TCCTTGTAAA?CAGAACCTAA?84660
CTAACAACAT?CAGGGCCTGC?TAATTTCCTT?CTTTTATAAT?CTGGAACAAA?AGTTGTAATG?84720
ATTTTTAACA?TCCACAGAAA?ATTAAGGGTG?CCATTTTAAA?TATTTATTAG?CAAAATGTCA?84780
CTTAGGTTTT?AAAAGTCTGG?AGGAAAATGA?GAGACAATTG?AACATTCTGG?TACTGCAATG?84840
CAGGAAAAAC?GCCAAGAACG?AAACACTAAG?ATTTTATTAA?AACCATAGGA?CTCAAATGTG?84900
TGTCAAGACT?TTTTGCTTGC?AATAGTGCCT?CTTCCTAATT?TGATTAAAAG?CTTCCATCTC?84960
CATGCCACCT?TCAATGTATG?CCATAATTTT?TAAAAAGTTC?CCAATCCACT?TCAAACACTC?85020
TAAAATTTAC?AACTGACCGT?GATGCGCATT?TTTTCTAGAC?AAACCTAAAG?GTAAATCTGC?85080
CCATGTCCCT?GGATAAATAA?AATGAGTGCC?TCCGGGTGAT?GTGGACTGTC?AACTCCTCTA?85140
CATTTCATCC?AAAGTCTACA?TGGGTCATCT?CCAAGTCACC?AGAAGAGCCA?GGGGAAAGGA?85200
GGGGAGGGGC?ACGATACGTA?AGATGTTAAA?CATGAAGATG?ATGTAAAATT?ACCCAGATTC?85260
AAGCTGGCCA?TTTTACAGAT?GAGGAAACTA?AGGCCCAGAA?AAAGCTCTAT?GACTTGCCCA?85320
AATACTCGGT?TACCCAGACC?ACAGCTGCAG?ATACTGTTAT?TTGGATCATA?GCTGCAAAAA?85380
GTCTAACTTT?TGGCCGGGCG?CGGTGGCTCA?CGCCTGTAAT?CCCAGCACTT?TGGGAGGCCA?85440
AGGTGGGCGG?ATCACGAGGT?CAAGAGATCG?AGACCACCCT?GGCCAATATG?GTGAAACCCC?85500
GTCTCTACTA?AAAATACAAA?AATTAGCTGG?GCGTGGTGGC?ACGCGCCTGT?AATCCCAGCT?85560
ACTCGGGAGG?CTAAGGCAGG?AGAATCGCTT?GAACCCAGAG?GCAAAGTTGC?AGTGAGCCGA?85620
GATTGCGCCA?CTGCACTCCA?GCCTGGTGAC?AGAGCGAGAC?TCCGTCTCCA?AAAAAAAAAA?85680
ATCTAACTTT?TGAAGTCTCA?GAGGTTTTAC?ACTTTCCATA?ACAAATAGTT?AAGAACCCCC?85740
ATTCCTGCAT?GCATATATAT?ATTAATATTA?TATATATTTA?TATATATAAT?TATATATATA?85800
TTTATATATA?TATAATATAT?ATATATATTT?TTTTATTTTT?ATTTTTTCCT?TAAAAACCTT?85860
CAGAGACAGC?GATCAGGTGG?GTAGCCTAGT?TAGGATTTTA?ACCCTTCGGT?TTCCAACAAA?85920
CGATAATTGC?ATAGAACCAT?CAACTCCCTG?AAGACAGGAC?TATCTTGTTC?CAGGCAAAAT?85980
CTACAGCCTC?TAGCACCCAG?TAGGCATTCA?GTGAGGGATT?CTCGGTTTCA?CCTGAGCATC?86040
TCCACTCCCT?ATCCATCCAT?GCCAAGGCGT?CAGTGGAGCC?AGCTAACTTT?CTTTTGGAAA?86100
TCGATTATTT?TCTTGAAACT?TGTTTCCAAA?AACTCCGGGC?CAAGAAGCCG?GCCTGAGGGA?86160
AAGCGTGGCC?GTCTCCAGGA?GCTAAGGACT?GAGGAGCTGG?CCTTTTGAAC?GGGTGGCTCA?86220
GAAAGAGCTG?GGTGGGCACG?CGGCATCGCC?ATGGGCGGAG?TGGCCCAGGT?GCGCTGGCTG?86280
CTTTGGCAGC?TCAGGCTGCC?GCTCCGGGCC?GCTGCTCCCC?GGCCGCCTTC?AGATAACCAA?86340
CTTCTCAAAC?TTCCCTTTCC?GGGGGTGGGG?GCTCGCCTCG?AACGCGGCCA?ACACAACGCC?86400
TTTCCTGCTC?GCACAAAGGG?GACCAAACGT?GCCCCGCGCC?CCTTGCAACT?GAACTTTCCT?86460
TCTCTTTTTC?AAGAAAAACT?CACAATCCCT?GCAGCTACGG?GAGTCGGGCT?GCGTGAGTGT?86520
CGCGGGGGAA?ACTTTCCTCG?TTTCCGCCCG?GGGGCCGGGT?TGCCGGGCCC?GACTGTCAAG?86580
CGCAGCGGAG?AGGCGGGGAC?CCCAGGAAGA?CCCCCGGCGC?CCCGCCGAGC?CCGGGCTGGG?86640
GACCACTCAC?CCGACTTCTG?AACGTGCGGT?GGGATCGTGC?TGGCGATACG?CGTCCACAGG?86700
ACGATGTGCA?GCGGCCACAG?GCCCCTGAGC?AGCCCCCGAC?CCATGGCAGA?CCCCGCTGCT?86760
CGTCATAGAC?CGAGCCCCCA?GCGCAGCGGA?CGGCGCCTTC?CCGGACCCCT?GGCTGCGCCT?86820
CCGCGCCGCG?CCCTCTCCGG?ACCCCGCGCC?GGGCCGGCAG?CGCAGATGTG?CGGGCCAGAT?86880
GTGGCGCCCG?CTCGCCAGCC?AGGAGGGGGC?CTGGAGGCCG?GCGAGGCGCG?GGGAGGCCCC?86940
CGGCGGCCGA?GGGAAGCTGC?ACAGGAGTCC?GGCTCCTGTC?CCGAGCGGGT?GCACGCGCGG?87000
GGGTGTCGTC?GCTCCGTGCG?CGCGAGTGAC?TCACTCAACT?TCAACTCAGC?GCTGCGGGGG?87060
AAACAGGAAA?CTCCTCGCCA?ACAGCTGGGC?AGGACCTCTC?TCCGCCCGAG?AGCCTTCTCC?87120
CTCTCCTCGA?CGTCCAGCCC?CTAGCTCTCT?CGTAGCTGCC?AATCATGTTT?CCTAGACCAG?87180
CCCCTCCGAG?AGCTTTGGCC?GACTTTCAGC?TGCCCCTCAC?CGCCCTCCCA?CACCACTCAG?87240
GAGTTCCTCG?CTCCAAGTAT?TTACTCAAGA?ATGACTAAGT?GCACACAGTT?CACAAAGTAA?87300
CAACAGAAAA?CGTCCACGTT?TTCCCTAGTA?GATCAGAACA?TCTGCCGCCT?CCCCTCAGCT?87360
TTCTTCAGAT?TGCTCCTAGG?TGCTTTAGAG?ATGCGTTTTC?AAATTGCAAG?TTGAGATCCA?87420
GGAGTGAATA?CTCCAATCTA?TTGAGTCGCG?AGCACATTTC?TTTCCCAAAT?AAAATAGTAA?87480
CGGTAAATTC?TACTTCATTA?AATTTGTGCT?TCAGTTGTGT?CTATATGCAT?GTATGTATGT?87540
GCATACACTG?TCAAGTTGTA?AAATGTTTTT?CTTTAGGTCG?AAGTCTAGAG?GTTTTTCTCA?87600
AGTTTTAATG?TACATATTGA?TCACCTGGAA?ATCTTATTTA?AAAATGCAGA?TTCTAATTCA?87660
GTAGGTCTAG?GAGGCAGGCA?GAGATTCTGC?ATTTCTAATG?AGCACCTGGA?TAGAGCGTCC?87720
CATTTTGCAC?CGCCTCTTCC?CGGGACTGAG?TCAGTGAGTA?ATTGTAAATG?ATCACCTATC?87780
ACGAAGTGAT?AGTGGTGGGA?AATGTAATTT?TCAGAATGTA?TAGAGTATAG?CAGAAACTGT?87840
AAAATTAAAA?GTGGGTTGGG?AGTCACCTGA?ATGCTTGTGC?TTTTATTCCC?TTAATGCAGG?87900
TGAAGAAAGA?GAATACTTAC?CCTCTCATGT?GCAAACGGGG?TAACATGGGA?GCAGAACAGC?87960
ATAAACTTTC?AAATTTCCTT?TCTTGCTAGG?GCAACCAGAT?TTGCCCAAGA?CATTCCTGGT?88020
GTACATGTTT?TGTAGTTTAA?ATATTAATAG?AACCCCCTTT?CTCTTTCAGA?TATGTCCTGA?88080
TTGGATAATA?AACTATGTGA?TCAACCTACT?TCCCACTCTC?AAAGATATGA?TTCTGTACAG?88140
CCCTCTGGTC?AGTAGATCTT?CTAGCAATTC?ATTTAATGAA?TTCCTTTACC?TGAGAGGAAG?88200
ATTGCAGAGG?CAAGGGTTTG?TGCCAGGGTC?TCCAGGGAAT?AAAGGTAAAT?AGCCCTCCCC?88260
CAAACCCAAC?TCCCAAATCT?TTCCTGTCAT?TCTAAGTGTT?CATTTGCTTC?ATCCTGGAAT?88320
TTTAACTCAT?GCTCCACCTA?GCACCCAAGC?TGCCTCTGGA?TGTTTTGCCA?CTTCCCAGTA?88380
CTCATGTTGA?AGATGCAGAA?AGTGCAGTGA?AATCAGGAGG?GCTAGGCATC?TTCTTTCCCA?88440
CCAATTAATT?GCCTTGCCAA?AGCTGGAGTG?ACTTTGTCAA?TGGAGGAAGA?TTGAGTTCCA?88500
AATCTTCTCC?CTATTCCCTC?TTCTGCCACC?AGCCCATGCC?ACTGCCATGG?CTTGTGTAGG?88560
AGTCTCCCAG?GAGTCACCCT?CAGCCACGGC?CGTTCTGGGC?TCTTTCACTC?AGTTTCTCAA?88620
ACGAGAGCTG?AATTCAGCTT?TTCAAAATAC?AAAACTAGTT?ATACCAACCC?TCTGATTAAA?88680
ATCATTTAAT?GGCTTCCCAC?TGCTCTTGAG?ATAAAGAGAA?GATAAAAACC?AGATCCTTGA?88740
ACGTGTCTTC?AAGCCTCCAA?CTCTCCCGTA?AACTTTCATT?TGGCTTCTCC?TTGCTTACTG?88800
AAAGCCTTCT?CCAAATTTCG?TGAATATGCC?TCTGTAATCC?TCCTACCCTT?TATGCTTAGA?88860
GCCTTCCCCA?GTGTGGACTT?CCTTCCTCTG?ACCTTTTTTT?CTTCACCCAG?CCAACTCCTG?88920
GTCTTCGTGG?ATTGAATCAT?AACTTCTTTG?ATGGGCAAGC?TTTCCCTCAC?CTCCATGAGT?88980
AGATCTTGTA?TTACACGTTC?TCTTGGCACC?ATAT 89014
<210>2
<211>4636
<212>DNA
<213〉homo sapiens
<400>2
tttttttttt?ttttttctag?gaatgggaac?aggaggcagg?atgctcacct?gagtattttg 60
ctttattcaa?tctaataaac?attttattta?tgtaaaagac?aaacaatgca?tagaataaaa 120
ataagtgctt?gagacttttg?atataaaaag?agtatatagc?attcacattc?ctattttaat 180
acatgagtac?agctgaagtg?ttccataaaa?gaataaaact?ttccctttat?gtatagtagt 240
gaaaaaagtc?agtattttta?ggaactacag?aatgttattc?cttggtcttt?tttcttgaat 300
aagaaaaaaa?aacataaaca?aaacaagcca?cagtatcctc?tgacactaca?ttccagttta 360
tgctgataac?ccagaagtga?gaatactctt?gaatcttgaa?tatctcatga?atggaccagt 420
attctagaaa?ctcaccacta?gaggtcaatg?ggcaacagct?attgggatgg?tatcagcatg 480
ccctacggtg?caagtggaat?ttctaggcgc?ctctatgcta?ctgcagccac?actgtcttta 540
actctcagcc?cacccacact?gaggagggtg?cctagaggtt?ctatttccaa?acctttgcat 600
gtatcttaaa?aatctcaata?aaatgagacc?ttccaccatc?caaacagagc?tgatattctc 660
actaccagtc?cctctctaat?attcctattt?ggctgaaaat?aagtagcttc?aaaaagtttt 720
aaaaaagaga?ttacttgcag?cattaacact?tctttgttga?ttaacaagtt?tcctatggag 780
ttttaaagct?catactttgt?tcttgtcctt?gtggacacaa?attttctaac?tgcaaatggg 840
acctttgtgt?cccacattca?aatcctctct?agtaatttct?gcaaaggttg?agaaggctgg 900
catgatggag?agaacggtaa?ccatgaggaa?agcttcttgg?agtaaagcac?tcctctctcc 960
aatgcagagg?gtaaaactat?taacatataa?gcaaaagaaa?cttgggctaa?ctgagaccct?1020
taaaggagtt?cccctttagt?ccaataaaag?gccaacttca?aatcttaaca?ccagataagg?1080
tagtcaaaat?catattatat?acccagagaa?tgactgcttg?aatggacatt?tcttacaagg?1140
gaccttggtt?aggtgcagat?ttaattccta?gactgggtcc?aggtaggcag?tggaaagagc?1200
taatgtttac?agtgagaagt?gaggcagctt?tgtaagtgtc?tccacacctt?cacattttgt?1260
gaacgtggac?tggagataac?tgaaaaccat?ctgctatcct?tacctgggga?tccagatttt?1320
cctgcaaaat?ctccaaatat?ttataaagtg?gcttcacttt?ttgaaacgct?gtgctgacca?1380
aacaaaacat?atgtttagag?tgcctgaggt?catagtcctg?acaatgatag?tattgtgtag?1440
ttgaaatcct?cttcatcagg?ccaaactgtg?cttgagcaat?caggagccca?gaaagatgga?1500
acccattggt?gtttgtatag?aaaactagaa?aatcaagtca?agtgtaatga?aaaagtaaac?1560
acgataaagc?ctagagtgag?aatttgctcc?tttttagaaa?aggatgaagg?ctgggagcag?1620
agaatagtaa?cataagtgca?ggggaaagat?gaaaaaaaga?acaatttttc?attagtagat?1680
ggtggggcaa?tcgcatggat?ggggacatct?gttctgattt?ttctgcaacc?catgaaggta?1740
aaaagtgggg?ttcaaaacat?tcaaggtatt?aaagatgggg?tagagtttct?aaactaggtt?1800
gagggagagt?ttctaaacta?gccccccaga?tttggggctt?ggagcttaaa?tgaaaagtcc?1860
aggagaaata?agggcacaca?ggaaccccgg?gaacactggt?cctcaaacag?tgccactgta?1920
cttagttcca?tggccagaag?agaagtgcta?ggcagggaat?gattattttg?caaaagcaag?1980
tgcaatgtgg?tcatagctgg?ctgtgagaca?tggagcctct?ttcctcatgc?aaagttcact?2040
gttttacagt?cagagaacca?ctgcatgtgt?gattgtcaaa?tgctaatgct?gtcatgggtc?2100
ccttccttct?ctgcttggtt?ctggagttct?ccaataaaac?caatttcctg?ggaatatttg?2160
atgtttttcc?ttgtctcttt?tcaaggtatg?gctatatata?tagagctata?gacatatata?2220
gatatatata?tatatatata?aaacatagct?attcatattt?atatacaggc?attaataaag?2280
tgcaaatgtt?attggctatt?gtaaaaatca?atctcatttc?ctgaggaagt?gctaacacag?2340
cttatcctat?gacaatgtca?aaggcataga?atgctctatg?tcacccactc?cctgctgctg?2400
ttgtttctgc?ttatccccac?agcttacagg?gaggggagtg?acccccttgg?ttttccagga?2460
agcatcagtt?caggggcagc?ttcctgctgc?ctctgttctt?tggtgagagg?gcagcctctt?2520
tggacatggc?ccagcctgcc?ccagaagagc?tatttggtag?tgtttaggga?gccgtcttca?2580
ggaatcttct?cctccgagca?gctcctcccc?gagagcctgt?ccagatgctc?cagctcactg?2640
aagcgttctg?ccacacactg?ggctgtgaga?cgggcctctg?ggtcgtggtc?ccagcactca?2700
gtcaacgtct?cacacaccat?ctggatgccc?tggtggttga?gccagaagct?gggaatttct?2760
ggtcgccctc?gatctctcaa?cacgttgtcc?ttcatgcttt?cgacacaggg?gtgctcccgc?2820
accttggaac?caaatggagg?ctcataatct?tttacttctc?ccactgcatt?acagcgagat?2880
gtcatttccc?agagcaccag?agccatggag?tagacatcgg?tctgcttgaa?ggactcaaca?2940
ttctccaaat?tcatcctgga?ttctaggact?tctggagcca?tgtatcttgc?agttcccacc?3000
tgcccactgt?tagccaggtc?atccacagac?agagtagggt?ccagacgcag?ggaaagccca?3060
aagtcacaca?ggcagcaggt?taggtcgttc?ttcacgagga?tattggagct?cttgaggtcc?3120
ctgtgcacga?tgggcatctt?gggcctccca?catggagtgt?gatcactgtg?gaggtgagca?3180
atcccccggg?cgagggagct?gcccagcttg?cgcaggtcct?cccagctgat?gacatgccgc?3240
gtcaggtact?actgtaggtt?gcccttggcg?tggaaggcgg?tgatcagcca?gtattgtttc?3300
cccaactccg?tcttccgctc?ctcagccgtc?aggaactgga?gtatgttctc?atgcttcaga?3360
ttgatgtctg?agaagatgtc?cttctctgtc?ttccaagagg?catactcctc?atagggaaag?3420
atcttgactg?ccactgtctc?aaactgctct?gaagtgttct?gcttcagctt?ggccttatag?3480
acctcagcaa?agcgaccttt?ccccaccagg?gtgtccagct?caatgggcag?cagctctgtg?3540
ttgtggttga?tgttgttggc?acacgtggag?ctgatgtcag?agcggtcatc?ttccaggatg?3600
atggcacagt?gctcgctgaa?ctccatgagc?ttccgcgtct?tgccggtttc?ccaggttgaa?3660
ctcagcttct?gctgccggtt?aacgcggtag?cagtagaaga?tgatgatgac?agatatggca?3720
actcccagtg?gtggcaggag?gctgatgcct?gtcacttgaa?atatgactag?caacaagtca?3780
ggattgctgg?tgttatattc?ttctgagaag?atgatgttgt?cattgcactc?atcagagcta?3840
caggaacaca?tgaagaaagt?ctcaccaggc?tttttttttt?ccttcataat?gcactttgga?3900
gaagcagcat?cttccagaat?aaagtcatgg?taggggagct?tggggtcatg?gcaaactgtc?3960
tctagtgtta?tgttctcgtc?attctttctc?catacagcca?cacagacttc?ctgtggcttc?4020
tcacagatgg?aggtgatgct?gcagttgctc?atgcaggatt?tctggttgtc?acaggtggaa?4080
aatctcacat?cacaaaattt?acacagttgt?ggaaacttga?ctgcaccgtt?gttgtcagtg?4140
actatcatgt?cgttattaac?cgacttctga?acgtgcggtg?ggatcgtgct?ggcgatacgc?4200
gtccacagga?cgatgtgcag?cggccacagg?cccctgagca?gcccccgacc?catggcagac?4260
cccgctgctc?gtcatagacc?gagcccccag?cgcagcggac?ggcgccttcc?cggacccctg?4320
gctgcgcctc?cgcgccgcgc?cctctccgga?ccccgcgccg?ggccggcagc?gcagatgtgc?4380
gggccagatg?tggcgcccgc?tcgccagcca?ggagggggcc?tggaggccgg?cgaggcgcgg?4440
ggaggccccc?ggcggccgag?ggaagctgca?caggagtccg?gctcctgtcc?cgagcgggtg?4500
cacgcgcggg?ggtgtcgtcg?ctccgtgcgc?gcgagtgact?cactcaactt?caactcagcg?4560
ctgcggggga?aacaggaaac?tcctcgccaa?cagctgggca?ggacctctct?ccgcccgaga?4620
gccttctccc?tctcca 4636
<210>3
<211>16
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>3
cagcccccga?cccatg 16
<210>4
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>4
gctgatgcct?gtcacttgaa 20
<210>5
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>5
gccatggagt?agacatcggt 20
<210>6
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>6
gcaacagcta?ttgggatggt 20
<210>7
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>7
gtgcagggga?aagatgaaaa 20
<210>8
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>8
gtatcagcat?gccctacggt 20
<210>9
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>9
ggatccagat?tttcctgcaa 20
<210>10
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>10
ggagaagcag?catcttccag 20
<210>11
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>11
gagctcttga?ggtccctgtg 20
<210>12
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>12
gagaccttcc?accatccaaa 20
<210>13
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>13
tagctggctg?tgagacatgg 20
<210>14
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>14
ttttgaaacg?ctgtgctgac 20
<210>15
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>15
tcagccagta?ttgtttcccc 20
<210>16
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>16
tcacacaggc?agcaggttag 20
<210>17
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>17
tcaggaatct?tctcctccga 20
<210>18
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>18
tggtagtgtt?tagggagccg 20
<210>19
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>19
tatccccaca?gcttacaggg 20
<210>20
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>20
agcctctttc?ctcatgcaaa 20
<210>21
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>21
atgtcatttc?ccagagcacc 20
<210>22
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>22
aggaatcttc?tcctccgagc 20
<210>23
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>23
agccatggag?tagacatcgg 20
<210>24
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>24
atgctactgc?agccacactg 20
<210>25
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>25
ccttctctgc?ttggttctgg 20
<210>26
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>26
ccaggagaaa?taagggcaca 20
<210>27
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>27
cagcagctct?gtgttgtggt 20
<210>28
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>28
cccactgtta?gccaggtcat 20
<210>29
<211>24
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>29
cagcccccga?cccatggcag?accc 24
<210>30
<211>23
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>30
cagcccccga?cccatggcag?acc 23
<210>31
<211>22
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>31
cagcccccga?cccatggcag?ac 22
<210>32
<211>21
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>32
cagcccccga?cccatggcag?a 21
<210>33
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>33
cagcccccga?cccatggcag 20
<210>34
<211>19
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>34
cagcccccga?cccatggca 19
<210>35
<211>18
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>35
cagcccccga?cccatggc 18
<210>36
<211>17
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>36
cagcccccga?cccatgg 17
<210>37
<211>24
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>37
gcagcccccg?acccatggca?gacc 24
<210>38
<211>23
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>38
gcagcccccg?acccatggca?gac 23
<210>39
<211>22
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>39
gcagcccccg?acccatggca?ga 22
<210>40
<211>21
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>40
gcagcccccg?acccatggca?g 21
<210>41
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>41
gcagcccccg?acccatggca 20
<210>42
<211>19
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>42
gcagcccccg?acccatggc 19
<210>43
<211>18
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>43
gcagcccccg?acccatgg 18
<210>44
<211>17
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>44
gcagcccccg?acccatg 17
<210>45
<211>24
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>45
agcagccccc?gacccatggc?agac 24
<210>46
<211>23
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>46
agcagccccc?gacccatggc?aga 23
<210>47
<211>22
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>47
agcagccccc?gacccatggc?ag 22
<210>48
<211>21
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>48
agcagccccc?gacccatggc?a 21
<210>49
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>49
agcagccccc?gacccatggc 20
<210>50
<211>19
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>50
agcagccccc?gacccatgg 19
<210>51
<211>18
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>51
agcagccccc?gacccatg 18
<210>52
<211>24
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>52
gagcagcccc?cgacccatgg?caga 24
<210>53
<211>23
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>53
gagcagcccc?cgacccatgg?cag 23
<210>54
<211>22
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>54
gagcagcccc?cgacccatgg?ca 22
<210>55
<211>21
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>55
gagcagcccc?cgacccatgg?c 21
<210>56
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>56
gagcagcccc?cgacccatgg 20
<210>57
<211>19
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>57
gagcagcccc?cgacccatg 19
<210>58
<211>24
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>58
tgagcagccc?ccgacccatg?gcag 24
<210>59
<211>23
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>59
tgagcagccc?ccgacccatg?gca 23
<210>60
<211>22
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>60
tgagcagccc?ccgacccatg?gc 22
<210>61
<211>21
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>61
tgagcagccc?ccgacccatg?g 21
<210>62
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>62
tgagcagccc?ccgacccatg 20
<210>63
<211>24
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>63
ctgagcagcc?cccgacccat?ggca 24
<210>64
<211>23
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>64
ctgagcagcc?cccgacccat?ggc 23
<210>65
<211>22
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>65
ctgagcagcc?cccgacccat?gg 22
<210>66
<211>21
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>66
ctgagcagcc?cccgacccat?g 21
<210>67
<211>24
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>67
cctgagcagc?ccccgaccca?tggc 24
<210>68
<211>23
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>68
cctgagcagc?ccccgaccca?tgg 23
<210>69
<211>22
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>69
cctgagcagc?ccccgaccca?tg 22
<210>70
<211>24
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>70
ccctgagcag?cccccgaccc?atgg 24
<210>71
<211>23
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>71
ccctgagcag?cccccgaccc?atg 23
<210>72
<211>24
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>72
cccctgagca?gcccccgacc?catg 24
<210>73
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>73
atgtgaagat?gggcaagacc 20
<210>74
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>74
atctccatgt?gaagatgggc 20
<210>75
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>75
aacggcctat?ctcgaggaat 20
<210>76
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>76
aacatcgtcg?agcaatttcc 20
<210>77
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>77
aatccaactc?ctttgccctt 20
<210>78
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>78
aaacctgagc?cagaacctga 20
<210>79
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>79
agggcgatct?aatgaagggt 20
<210>80
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>80
agtgcacaga?aaggacccac 20
<210>81
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>81
acactggtcc?agcaatgaca 20
<210>82
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>82
ttcctgttga?ctgagttgcg 20
<210>83
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>83
cactctgtgg?tttggagcaa 20
<210>84
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>84
caaggccagg?tgatgacttt 20
<210>85
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>85
cacactggtc?cagcaatgac 20
<210>86
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>86
ctgacaccaa?ccagagctga 20
<210>87
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>87
ctctgccatc?tgtttgggat 20
<210>88
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>88
tcaaaaaggg?atccatgctc 20
<210>89
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>89
tgacaccaac?cagagctgag 20
<210>90
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>90
tgatgccttc?ctgttgactg 20
<210>91
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>91
ttcctgttga?ctgagttgcg 20
<210>92
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>92
ttctccaaat?cgacctttgc 20
<210>93
<211>20
<212>DNA
<213〉artificial sequence antisense oligonucleotide
<400>93
ggagagttca?ggcaaagctg 20
<210>94
<211>1512
<212>DNA
<213〉homo sapiens
<400>94
ttacattttg?atgccttcct?gttgactgag?ttgcgataat?gttttcttaa?tccgcaatgc 60
tgtaagccta?gctgctccat?tggcatacca?acattctctc?ataattttag?ccattactct 120
caaggcttca?cagctctgcc?atctgtttgg?gatatttggc?cttaacttct?gttcacaaac 180
aacttttctc?atttcttcaa?ctgatgggtc?agaaggtaca?agatcataat?aaggcagttg 240
gtaatcttca?tgaattccac?caatggaaca?tcgtcgagca?atttcccaga?atactaagcc 300
cattgcatag?atgtcagcac?gtttgaagga?ttcaaaatgt?ttcatattta?tggaatcatc 360
gagaacttca?ggggccatgt?acctttttgt?tcccactctg?tggtttggag?caatatcaat 420
ggtatctgtg?gctgaatcat?gtcttactgc?cagtcctaag?tctgcaatac?agcaagttcc 480
attcttcttt?accaagatat?tctttgattt?caaatctcta?tgagcaatgg?ctggctttcc 540
ttgggtacca?acaatctcca?tgtgaagatg?ggcaagaccg?ctcgccgtgg?acagagcaag 600
ttttatcatt?ccttccacag?taactgtgta?tctgtttaag?taatcaaaaa?gggatccatg 660
ctcatgataa?tctgacacca?accagagctg?agtccaagta?ccattgtctt?tattgtctgc 720
tgctataaat?cccaggatgt?tttcatgacg?taacattaca?gtttgataaa?tctctgcctc 780
acggaaccac?gaacgttctt?ctctagagga?gaatatctta?acagcaactt?cttctccccg 840
ccactttcct?ctccaaactt?ctccaaatcg?acctttgcca?atgctttctt?gtaacacaat 900
agttctcgca?attgttctct?gaacaagcaa?tggtaaacct?gagccagaac?ctgacgttgt 960
catatcataa?attaagtctt?tcaacgtagt?accctctgaa?ataaaagggc?gatctaatga?1020
agggtcctct?tcatttggca?ctcgatggtg?aatgacagtg?cggttgtggc?agatatagac?1080
catcaacatg?agtgagatgc?agacgaagca?cactggtcca?gcaatgacag?ctgccagttc?1140
cacaggacca?aggccaggtg?atgactttac?agtagttgga?agttctattt?tattgcaatg?1200
gtcctgattg?cagcaatatg?ttgtagtcac?agacccagtt?tttgaagagg?gtgcacatac?1260
aaacggccta?tctcgaggaa?ttaagtcaat?ttcagctata?cacatgctgt?tgtgtataac?1320
tttgtctgtg?gtctctgtga?cagagacaaa?gcagagccca?tctgtcacac?aagtaaaatt?1380
gtcttttgta?cagaggtggc?agaaacactg?taacgccgtc?gcccccggga?gcagcgccgc?1440
cgccgccgcc?gccgccgccg?ccagcacgag?gaggagcagc?cggggacgcg?gagcagcgac?1500
cgccgcctcc?at 1512
<210>95
<211>2308
<212>DNA
<213〉homo sapiens
<400>95
aaacactata?ggttttaaca?tagagacttt?cagcaattct?actcatttcc?attagaaaga 60
cacagaagtg?gcacttactg?gtatagtaca?atcccatttt?gaaggcatgt?aatgttctga?120
ataagtgaaa?gaacaataat?agtatacaaa?atacaattgc?atgaattatg?ttcctcacta?180
ctatatgagg?tcatttttag?actcaagata?agagttttat?aagtgttagt?tttaagatcc?240
tgaaaaacta?tagaacagta?cattcaaagt?ctgaatcaag?gaaactctag?tggttcagaa?300
tcctctgaga?atgtactaac?caggagtaaa?tcactttctt?tagtaataag?acatgtttca?360
ttgtaattca?gcaatccaac?tcctttgccc?ttaaagatga?tctccagcac?agcagagtta?420
cctaaagtta?agaccagcaa?tcatcttttt?aaaaaacaag?ttttgttaat?aaaaaataaa?480
ggtagactac?acattttctg?tcctgggaaa?gaagcgttca?tagtgcacag?aaaggaccca 540
catggctgtt?tcctgggtcc?aaagaaatcc?tgggaagttt?ttaattgact?ttattacact 600
gctgcaaaag?gaagcaatat?ccttctgttc?cctctcagtg?aggtagaaca?attgacctcc 660
caaattaaaa?cccaggagca?gatctgaaga?aaaaaggaga?gttcaggcaa?agctgtagaa 720
ttacattttg?atgccttcct?gttgactgag?ttgcgataat?gttttcttaa?tccgcaatgc 780
tgtaagccta?gctgctccat?tggcatacca?acattctctc?ataattttag?ccattactct 840
caaggcttca?cagctctgcc?atctgtttgg?gatatttggc?cttaacttct?gttcacaaac 900
aacttttctc?atttcttcaa?ctgatgggtc?agaaggtaca?agatcataat?aaggcagttg 960
gtaatcttca?tgaattccac?caatggaaca?tcgtcgagca?atttcccaga?atactaagcc?1020
cattgcatag?atgtcagcac?gtttgaagga?ttcaaaatgt?ttcatattta?tggaatcatc?1080
gagaacttca?ggggccatgt?acctttttgt?tcccactctg?tggtttggag?caatatcaat?1140
ggtatctgtg?gctgaatcat?gtcttactgc?cagtcctaag?tctgcaatac?agcaagttcc?1200
attcttcttt?accaagatat?tctttgattt?caaatctcta?tgagcaatgg?ctggctttcc?1260
ttgggtacca?acaatctcca?tgtgaagatg?ggcaagaccg?ctcgccgtgg?acagagcaag?1320
ttttatcatt?ccttccacag?taactgtgta?tctgtttaag?taatcaaaaa?gggatccatg?1380
ctcatgataa?tctgacacca?accagagctg?agtccaagta?ccattgtctt?tattgtctgc?1440
tgctataaat?cccaggatgt?tttcatgacg?taacattaca?gtttgataaa?tctctgcctc?1500
acggaaccac?gaacgttctt?ctctagagga?gaatatctta?acagcaactt?cttctccccg?1560
ccactttcct?ctccaaactt?ctccaaatcg?acctttgcca?atgctttctt?gtaacacaat?1620
agttctcgca?attgttctct?gaacaagcaa?tggtaaacct?gagccagaac?ctgacgttgt?1680
catatcataa?attaagtctt?tcaacgtagt?accctctgaa?ataaaagggc?gatctaatga?1740
agggtcctct?tcatttggca?ctcgatggtg?aatgacagtg?cggttgtggc?agatatagac?1800
catcaacatg?agtgagatgc?agacgaagca?cactggtcca?gcaatgacag?ctgccagttc?1860
cacaggacca?aggccaggtg?atgactttac?agtagttgga?agttctattt?tattgcaatg?1920
gtcctgattg?cagcaatatg?ttgtagtcac?agacccagtt?tttgaagagg?gtgcacatac?1980
aaacggccta?tctcgaggaa?ttaagtcaat?ttcagctata?cacatgctgt?tgtgtataac?2040
tttgtctgtg?gtctctgtga?cagagacaaa?gcagagccca?tctgtcacac?aagtaaaatt?2100
gtcttttgta?cagaggtggc?agaaacactg?taacgccgtc?gcccccggga?gcagcgccgc?2160
cgccgccgcc?gccgccgccg?ccagcacgag?gaggagcagc?cggggacgcg?gagcagcgac?2220
cgccgcctcc?atggtcccgc?cgccaccgcc?tgtggcccgg?cccggcccgg?ccgcgccgct?2280
gcctcacccc?agcaaacctc?gcctcgcc 2308
<210>96
<211>48775
<212>DNA
<213〉homo sapiens
<400>96
cctaggatgg?gcagtataaa?caactgtgtt?tttaaatgac?aaaattatta?ctctaatcaa 60
atttatctgc?agttatcgac?agtaatcatg?atccatccca?ccttttaagt?ttctttcatt?120
ttcaatatca?gccaattgtg?gtttatcaaa?ccatccctag?ccaaaaaagg?aattaactgc?180
agtaatacgt?aaagtcaatt?tagaactaaa?ctccaacttt?aaaaaaattc?cctgattcat?240
caaaagtaca?ttttatccac?ttaggtaaga?aaagtataat?tgtaactcaa?tctttgattc?300
aataaaaaat?atcttcagca?aaagtggata?accttacatg?aaagtgagaa?atcatgtatt 360
acaactttaa?atcagacaac?ttttggtata?ttcttaaaat?tatataaaaa?tagttttagt 420
gataaaatgc?attggtcccc?tggatttcat?aaagcagatc?tggtaggctt?agaaatggcc 480
caaaaacaac?aacaaaaaaa?aaaaaacaaa?aaaaaaaccc?ccacaaaaaa?agtacctgat 540
cacagaatta?gagattatta?ttaaacaagt?aatacaacac?aactataaaa?acaaacctct 600
caaactcatt?catttgcttc?aatgaaatta?tggtaactac?agaaaaaaac?tcaactttgt 660
agtcaaaata?gtaacctcta?agcatttttc?ccatgatgtt?tttaaacaca?tgaaattgac 720
actaaattcc?tatgtaatat?gtcactcatt?ctaaaattac?tttggtttta?agatcaaata 780
gtctttcaaa?tttattctac?gtataagaga?taagacatta?tcagaatgca?actcattcag 840
tgtaaatggc?cactttctct?tcctgaccaa?aatactgtat?gggttactct?gaccctgtat 900
cggggaactg?atagcactat?aaagtcgaag?tcttgcctca?gagctatgat?agttttttct 960
cccctcagaa?taagatcaca?gtgataaaag?gacttcgaaa?actgtaaaag?ccctgcagag?1020
acttcatagc?attggaagta?aaaaccagtt?attataagct?agtttcaact?taatgtaaga?1080
agaccatgac?aagtttgctt?tcaatatttg?accaaagaca?tctgtaaatg?gagaaaaacc?1140
tatactcaga?atgttcttta?gctaccacct?ctcccaagta?acaagggtgc?actgaatgca?1200
ttacataaat?tacatgtaag?cagttgcaat?gtacgcacac?ataaggaaac?actgaattaa?1260
aagctgcctt?cctcaaagtg?tagtgagacc?tcaaaaccac?actagctcta?acctcagtta?1320
caaagacaga?ggatccaccg?aacgtttact?cctacataca?taacaaatgt?gactttcttg?1380
cacatctgtt?atctattcaa?attattaact?accttcgcct?tcctagaaaa?aggcctatta?1440
tttaatatta?accatattct?aattttaaat?gtaattcatg?tcttaaaaaa?taagtctttg?1500
aacagataaa?gaaaaaaatg?gcttacagaa?taccacataa?cttttcacaa?gcagctagac?1560
agactttccc?ttttagaaaa?attagtctgt?atgctacaaa?tattaaagta?ctataagcat?1620
ctagagtgcc?acttgatttt?ttaaaagtat?acttagacaa?cacaattaaa?atgcaaaagc?1680
ttgatgtgag?aatattcaaa?catgaccatg?ctaataattt?actaattaat?gccacttcat?1740
ttctttagtg?gcttaagcac?attttggtag?gagaaaggca?ttttcagaat?agaataccaa?1800
atgacatacc?acaaaaaccc?ttccaaaaac?aaaacagaaa?aagtttgggt?tacccagata?1860
aataagcttt?ttgaattcaa?acactatagg?ttttaacata?gagactttca?gcaattctac?1920
tcatttccat?tagaaagaca?cagaagtggc?acttactggt?atagtacaat?cccattttga?1980
aggcatgtaa?tgttctgaat?aagtgaaaga?acaataatag?tatacaaaat?acaattgcat?2040
gaattatgtt?cctcactact?atatgaggtc?atttttagac?tcaagataag?agttttataa?2100
gtgttagttt?taagatcctg?aaaaactata?gaacagtaca?ttcaaagtct?gaatcaagga?2160
aactctagtg?gttcagaatc?ctctgagaat?gtactaacca?ggagtaaatc?actttcttta?2220
gtaataagac?atgtttcatt?gtaattcagc?aatccaactc?ctttgccctt?aaagatgatc?2280
tccagcacag?cagagttacc?taaagttaag?accagcaatc?atctttttaa?aaaacaagtt?2340
ttgttaataa?aaaataaagg?tagactacac?attttctgtc?ctgggaaaga?agcgttcata?2400
gtgcacagaa?aggacccaca?tggctgtttc?ctgggtccaa?agaaatcctg?ggaagttttt?2460
aattgacttt?attacactgc?tgcaaaagga?agcaatatcc?ttctgttccc?tctcagtgag?2520
gtagaacaat?tgacctccca?aattaaaacc?caggagcaga?tctgaagaaa?aaaggagagt?2580
tcaggcaaag?ctgtagaatt?acattttgat?gccttcctgt?tgactgagtt?gcgataatgt?2640
tttcttaatc?cgcaatgctg?taagcctagc?tgctccattg?gcataccaac?attctctcat?2700
aattttagcc?attactctca?aggcctacaa?gaaaatataa?aaaaaaaaat?taatgcatgc?2760
accattttcc?attggtctgg?ataagaattt?ttacgtgtaa?attttctttt?taaatgacat?2820
atacacttgt?tattgtttaa?gcattatttg?taatagcaaa?tgagtagaaa?ttacataaat?2880
ttccatcaat?agggtactgg?tgccagtgct?ggaaagcagg?tggacaaaga?gtgactcatt?2940
tagcaaacct?gaaaaggccg?aatcctaaac?cagagctggg?caaagcaaag?aagaaatctg?3000
acctcacact?gaaattttaa?gtttgtactt?tgaagtattc?acatcaaatt?tttctttctt?3060
tttttttttt?ttgagacagg?gtctcactct?gccgcccaaa?gtggaatgca?atggcatgcc?3120
ctcagctcac?tgcagccttg?acctcccagg?ctccagcaat?cctcccactt?cagcctccca?3180
agtagatcaa?atttctaaaa?gacaaaatct?agcagcactc?tcatttatta?aactatgtca?3240
catgcaaatt?ccttaagcat?gctgaaatac?attttattta?tttgggcctg?gagatgtgat?3300
tttgttggag?gtagcaagct?ctcttgctta?tcagaggttc?tgctgagtcc?tacaatagtt?3360
taagacgtaa?aatcaactac?tgaactgaac?agctttttat?agccttttta?agctacaaat?3420
cttcaaacct?ggaggaatat?gctctgcttc?accaatattg?taatagtaac?agctagcaat?3480
taaggagagg?ttaaataaaa?ttcatcttac?gaatctttaa?atttacaatt?acaaaaacgt?3540
ttctaaaact?ttttgttaga?gctgaagttg?agcagctcag?atactgctgg?aaaaaagcat?3600
tttccctaaa?ttcctggtta?acggttatct?gggcaatcag?atgaataaaa?cggaaaatca?3660
tttgaaacac?ctttgtaatc?accttatctg?agttcctcac?cttgcaaagg?gatattaaag?3720
tccagagaac?taaagggatt?tgttcagagt?cagacccttg?aaatggtagc?caggctggtc?3780
tagaatacag?ggctcctcat?tcatgtccgg?taactgtcta?gtgttctggg?ttgccccggc?3840
tgaagggagg?cattcattta?aaaatatgtg?ccttagttcg?cccggcagat?ctaaactatg?3900
ttctgataca?ctaaaggcca?ctgcaaatgt?tccatggccc?tttcaatgtg?cttacaattg?3960
aatatgaaaa?ccaaattatt?ctgtttttaa?acattggttt?gactgctatg?aaaaagaaaa?4020
ttcttaaaga?aaagttttcc?ttaaagaaaa?gtagcaaact?tttgcttact?aagcagaagc?4080
agtttagaaa?attgcctaat?atcaaaaaga?aatactcact?tcacagctct?gccatctgtt?4140
tgggatattt?ggccttaact?tctgttcaca?aacaactttt?ctcatttctt?caactgatgg?4200
gtcagaaggt?acaagatcat?aataaggcag?ttggtaatct?tcatgaattc?ctgtatcagt?4260
ttaaaaaaaa?ttaaattttg?atgaatttat?tcagctaatg?ccaaggcatt?aaaagatcac?4320
ctgagagacc?tattacagtg?tttcattact?aaagtaggta?tgtggaacag?agattacagc?4380
tttctctatc?tcatccacat?ctgtatccac?aagccacttc?cctgagttga?tattccaccc?4440
acaccttgaa?actaagtatt?gccatgagat?caataaagcc?tatttgaaat?gacagtaaac?4500
tatgagctgt?gatgaccaga?ttgacatttt?cccctagaac?cctattgtgc?agcaaatgag?4560
attctattct?gtaagtgcac?aggctctcac?ttgcacaggg?atatatatac?cctatcagtg?4620
agacttgaat?cttatgaggc?aagtttaagg?tgccaagtcc?ctttctctac?ttgcatctgt?4680
caataatata?tcctatttac?tacaatacag?agaaatactc?tgtccctcac?tgcttcaaaa?4740
acctaaggca?ctaggtctca?gccaagtcta?ggtccccaag?cctaagagac?tgtttcctga?4800
gtaaacatta?aaagtactcc?atctaaaaag?ctagaagtta?aaacaaacta?actctagaat?4860
acaacacaat?ggtaacataa?ttgtattctg?tgtatgtaac?tgtaactatc?aagttggaga?4920
aaataaccac?aatctcaaag?aaaaaaaata?agtttgacac?ccaggtacat?gctagaaaca?4980
gcttcctagg?tgagcctctc?aagcagctgt?ccattctaaa?gaactatatt?ccaatataac?5040
aaggggttgg?gttctgatga?gtctccagat?tcaaatggaa?acaggaagag?aatacactag?5100
gctagagctg?tgcatgtgca?caccatggca?ctgtcccctc?ccaaaggttt?catcgccttt?5160
gttttctctg?gcactcggtg?acatcctgtt?tcagataatg?gactgtacat?aatttcattc?5220
aattaaaaaa?agaagacaat?tcttgaacaa?cttctgctca?tgacaaacta?ctgggggaga?5280
ggagagcaat?ttaccaccaa?tggaacatcg?tcgagcaatt?tcccagaata?ctaagcccat?5340
tgcatagatg?tcagcacgtt?tgaaggattc?aaaatgtttc?atatttatgg?aatcatcgag?5400
aacttcaggg?gccatgtacc?taaaaaaaat?ttgcaaaaag?aactttgaaa?atcatcccct?5460
tactgccata?tttggatgaa?cctcctttca?gacatttctt?tatacataga?catatgtaca?5520
caatattaca?taacaaatat?tagactcaag?aaaaatatta?aatatccaca?ctggtttgca?5580
cattaatgat?gtcaactaaa?tcccacaaaa?tgctaaaata?gcagtttcac?actatctgcc?5640
tcatgatctt?ggtttccaat?gaaagacata?cataacaatt?gtgactgtta?aaggtgtcct?5700
aatgtacacc?acctatacac?gtactaggta?gaaaccatgc?attttaattt?agaagtcttc?5760
tcactgagga?tgaaaggaag?ggcacgaata?tactccaggg?aaaaaaataa?tagatacaaa?5820
agaatgccag?tcctcatact?gaagcttcaa?aaacctacca?aaattatggg?tcaggaccca?5880
cagagaccta?cagcaaccac?tgacaaggac?cccttagctg?gttgagaatt?gagagtcatc?5940
tacggccata?ccaccctaaa?cacgcccgat?ctcgtctgat?cttggaagct?aagcagggtc?6000
gggcctgctt?agtacttgga?tgggaaaatt?gagagtcccc?agggaatcca?gaaatctcaa?6060
aattatacat?gcaatttgaa?tagactaatg?ctgctggctc?tccagctgtc?tccaaggcca?6120
agacagtagt?ttgaaaaaat?gctgtgacag?cttgtgataa?ggggtttggg?tcagaaatgc?6180
ccaggttcaa?atctcagctc?ttcggcttat?catccacatg?aagctggcca?tattatttaa?6240
cctcctcaag?gtggtttcct?catctgtgaa?ttaaagggta?ataacaccta?cctaattaag?6300
ttcttttgaa?gactcatgga?ctcaacaaat?atctactgag?gatctaccat?gtattaggca?6360
ctgtgatgga?tgctgggaat?acaaggctgc?tctcaagcag?cttgcaccta?atagaatata?6420
taggcaaata?aataaacagt?tacaacataa?cgcataagtg?cctcaacggt?cccagttcag?6480
tgtgctatga?cagtccctgg?cagggactcc?taagattttt?gaggactaga?aaaaacttcc?6540
tacgggaaag?gtgggtatga?ggctgagaaa?cagtagggta?aagtatgctc?caggagacag?6600
catgtgcaaa?agttctaaga?aagcaagaaa?ggcatatttt?taggaactga?aatatgaaaa?6660
tagcagggct?agctactgca?cagtatttga?gaagggatta?aatgaggtaa?tatacgtaaa?6720
agacctatta?gacgattggc?acatagtagg?tgccctataa?acgttagtta?ctactgttat?6780
tataattaac?atgcctaatg?atattttctg?gaagggcaac?ctttcatcag?caggcatctt?6840
tttaagtcag?gtaactctgg?cttcagagca?ggcaagacca?tgagatcttc?ttacctgttg?6900
gcaatctaat?aaagtgcaag?tttaagctga?gtttcagcaa?tgatatgtat?atatgaaaga?6960
gaagggaaaa?aaggtgattt?cagaagatat?taaatatagt?tgttcaaaag?tatacctttt?7020
tgttcccact?ctgtggtttg?gagcaatatc?aatggtatct?gtggctgaat?catgtcttac?7080
tgccagtcct?aagtctgcaa?tacagcaagt?tccattcttc?tttaccaaga?tattctttga?7140
tttcaaatct?ctatgagcaa?tggctggctt?tcctaaagaa?tcaaaaatta?aacatgactg?7200
cttaaaaggt?aataccaatc?acaactcaca?tctttaggtt?caaaagtctc?ttctcccaac?7260
ccaaattatc?aaagcatttc?agcccacatg?acctacaata?cttacgggca?ttattaaact?7320
caagtgaatc?actacaccaa?aagtcactga?atttatattt?ctttaaagaa?aatgtggaca?7380
ataacatgct?ttaaaagatg?aacaactcaa?agactggggc?aaaaaaaaag?ttatcagttt?7440
atctgttggt?gccttatgaa?ttctttttaa?gaaacttagc?catagactga?tattccagca?7500
gcccaggaac?caagcatgta?gaacatcact?tccctatcaa?ctgcaatgta?ctcagtatta?7560
agtatattat?ctttgatgct?aaccactaga?aaatgttatt?aaaaaataat?aattataatg?7620
tggaaaacct?ggaaccttca?tacactgctg?gcaggaatgt?aaaatggttc?aggcacttta?7680
agaaaatagt?atggcagttc?ttcaaaccat?taaatagagt?tatcatatga?tacagtaatt?7740
caactcctag?gtatataccc?aagataactg?aaaacatgaa?actacataca?acttgtacac?7800
aaatgttcac?tgcagcatta?gctacaatgg?ccaaaagaaa?caaaccaaat?gtccatcaac?7860
gaacggatat?atgacatatg?ccatatccat?acactgaagt?attacttagc?catcaaaatg?7920
actgaagtac?tcatacgtgc?tacaacataa?atgaaccttg?aaaacatgct?aagtgaaaga?7980
agccagtcac?aaaagaccac?atattgtatg?attcatttat?ataaaatgtg?cagaataagc?8040
aaatctacag?acaaaaagga?gcagttgttg?cctagggcta?aggagtttgg?gaggaaaggg?8100
gagtgactgc?tagtggctac?agggtttctc?tttggagtga?agatattcta?aaattgactg?8160
tagtgtttgc?tggctgtaca?actcttgagt?attctaaaaa?ccactgaatt?ttacacttta?8220
agtgggtgaa?ctttatgatg?tgaattataa?ctcaataaaa?ctgttacaat?caataataat?8280
aataactaca?aagatggagc?taagatgtga?actagcactt?atgctgtatg?taaagtgggg?8340
agtgggggag?ccattgggtt?gcaagtggac?aactgctaga?gcagagagat?atactggcat?8400
ctgaaatccc?acatgcacaa?aaactacagc?atacaaatgt?cataactaaa?acttagtatt?8460
taatttttca?actgtaaaac?tatctcatgc?agtctcctta?tctcaaggtc?aaatataatt?8520
attagatggc?cagataacag?ttacctagca?tgttgatgtt?tacaaagcac?tttcacattt?8580
catttgatac?tacacataaa?aatatattca?gttggacctg?aattctgaaa?ctgagatcct?8640
caaaaatcat?aagattgaat?gctactttta?agaactcaaa?aaaaatcaca?gttttgttac?8700
aacgactaga?gaatctctaa?acaaatttcc?agattcctag?ctctacctga?aattttgaac?8760
tgaaagataa?aatgttctca?tctaaaaaat?ttgttttaaa?tatctccagt?taggccacct?8820
actgtttttg?tttttgtttt?tttttctgag?acagggtctc?tctctattac?tcagctggga?8880
gtgcagtggc?atgatgtctg?ctcactgcag?cttcgacctc?ccaggctcag?gtaatcctcc?8940
tacctcagcc?ccctgagtag?ctgggactac?aggtgcatgc?caccatgccc?gactaatttt?9000
ttgtatgttg?gtagagatgc?ggttttgtca?tgttgcccag?gctggccatg?aactcctgag?9060
atcgggcgat?ctgcccacct?cagcctccca?aagtgctggg?attataggca?tgagccacca?9120
ggcccagcct?ccaccttcta?ttttcataga?cattattcat?gaaaatttaa?agcttaaata?9180
atagaactgc?ttatagaatt?accttgggta?ccaacaatct?ccatgtgaag?atgggcaaga?9240
ccgctcgccg?tggacagagc?aagttttatc?attccttcca?cagtaactgt?gtatctgttt?9300
aagtaatcaa?aaagggatcc?atgctcatga?taatctgaca?ccaaccagag?ctgagtccaa?9360
gtaccattgt?ctgtaaaaca?gaattaacat?ttcggttggg?ctgcagacca?tttatgattt?9420
atttgttcaa?tggttattac?tttttactct?caatcctgag?tcacacactg?caatataatg?9480
ccaccttaag?tctgtatttc?cttcacattt?tcttctacat?tgtttgtttt?atacttttat?9540
gtacacatcc?tttagttcct?cagagtaagc?ccctcttctt?gagataaggc?aagtataatt?9600
aatcccattt?aagagacaaa?gatggtgact?tttttgagtc?ttcacagata?attggtatca?9660
gagctggcac?tcttaagtgc?ctagaaaaat?ctctgggtcg?ggttgggtgc?tcagtggctg?9720
ttcctggaag?gagagaaggt?taaaaaaaag?gaaggaacag?agagggaagc?aaggaggtga?9780
gaagtctccg?gagaccagtg?tggccacagt?gggaatggaa?gagtatggga?caaaactgaa?9840
agtgagtttc?aacaagaaat?gacaagcttt?agtgacagat?tgtgtacaca?gttcacaaag?9900
acgcaagaca?agatgattat?gattccaagg?ttgctagctt?agaaaaacag?aaatagtgat?9960
acctctaaca?catggggaag?ctgaaatagg?aactgaaatg?tcaggagcaa?aactggaaaa?10020
gctgggacta?aactcaaaca?acgaggaacg?tgggttccaa?aatttcctct?gtaagccaaa?10080
acacgagttt?aaaacatgtt?ttctcatagg?aataatggta?aagacactag?ctaggctcct?10140
aagctagact?ggtccacgac?aatctaattt?aacctagaag?tagctggaaa?accacatgct?10200
taattaagcc?atgaagaaaa?aaagcattac?aacattagga?gacagcacaa?tccagtaaaa?10260
gatggacgct?tagagtcatt?ctaacctggt?tggaatccac?ggcctgcctg?ttactgacaa?10320
ggagcctgtt?tctcctttta?tacaagaata?aagtcttact?ttgtaagact?gttaagattt?10380
aaaaaacgga?atgctagatt?ctttaggtaa?gaagtacata?aactgtgctc?tttctttccc?10440
tgctggttgt?aaaccaaaag?aaaaaatcca?tattgacatg?aaacagcttc?tattttgaag?10500
gtatttggtt?gaagaagaaa?accaactctg?attagaagag?attaagaaag?gaatagaaac?10560
ttttcagaag?attctggagg?agatttctgg?gtacatttaa?aaggacttag?tattaatttg?10620
ttcttcatga?actttataaa?ctgattctga?ccaaactcgc?acccttgctt?ttccttgata?10680
taggcacatc?actagcttat?ttgcatgcct?cttaaccatt?actgaatttt?gaaaagctca?10740
caaatacaag?aaacaaagtg?gaagacaggc?agatggaaga?aagggaaacc?acaggttatg?10800
gacaagatag?aaggaaggtt?atatgtaagg?ggccataaat?ataaagggct?gccgggggtg?10860
gaattaacta?aatcaggaga?agataaagga?actgaggtgg?aggggctagg?ctcagagaaa?10920
gtacattaac?ccctgacaaa?gaagaaagaa?ggggagtagg?gaagagccag?tagggtcagc?10980
tagttcccat?ggtgaccacc?agatgacagc?atcagcctgg?ttagaagttc?agggcacaga?11040
ctcaccaaca?ttttgtgctg?ctgtgtttgt?aacttggaat?gtgacaaaat?ccagaccctg?11100
ggtgaggttt?aagctttcaa?atggagattt?gagagttgcc?aacatggtag?agtttgaaac?11160
catgaatgtg?gctatgttct?taaggaagaa?attaccactt?ataaaatcag?taccttcata?11220
tgaaccagtg?agaagagtaa?gagttgagaa?aacaaagaca?actatgaaga?agtaagaagg?11280
aacaaggaaa?gtctagggtc?atcaaacaca?gtaaataaag?aaaaggttgt?tttaagagtt?11340
gggggaggaa?ataaatggtg?ataaaggcag?aaacgaaaat?gagaactaag?gatttggtca?11400
gactgattac?tattttttgt?tttgttttgt?tttgttgttg?tttttttttt?gagacagagt?11460
ctccctgtgt?cgcccaggct?ggagtgcagt?ggtgcgatct?cagctctgac?tgcaacctcc?11520
acctcccagg?ttcaagcaat?tctctgcctt?agcttcccaa?gtagctggga?ttataggcac?11580
ctgccatcat?gcctggctaa?tttttttgta?tttttagtag?agatggggtt?tcatcatctt?11640
ggccagccag?gctggtcttg?aactcttgac?ctcgtgatcc?acccaccttg?gcttcccaaa?11700
gtgctgggat?tacaggcgtg?agccactgtg?cccggcctgt?tttgttttta?acttaagagg?11760
tattacattg?tcaggtgcca?ctgataatcg?ctacctacat?tcatcatata?cctcactgcc?11820
ccgtcttaat?caaacactat?acacctccac?atatgatgca?ataggatgta?tataatatcc?11880
ttagtatgta?ttttgagaaa?accaataaaa?ctccaattag?gtttagcttc?taaatctaac?11940
taccagtttt?cagaaaagat?agaagaacaa?gttaagagac?actatggaaa?tgcaatcagc?12000
aaaatccaga?atgtgatagg?cccttcagga?taaacaatcc?aatttcttca?acaaataagc?12060
tgcgagagga?gaaaaaagat?gaagggggga?cctaaatttt?aagacacata?agagaaatat?12120
caactaaata?taacttgtgg?acttagaatc?ataatttgaa?taaataattt?ttttaatagg?12180
agacaattat?agaattgaac?ctaactggat?atttgataac?atttaaaaaa?ctgacaatgg?12240
tagtgtggtt?gtttcataaa?aacatttcct?catcatttga?agatacaaat?tacattttat?12300
aagtgtttac?agatgaaaac?atattgtctg?ggaccagctt?caaataacac?agttagggca?12360
gagtaggtgg?gatcagacat?caattatgat?tggcagtgac?ctgacaactg?ttgaagctgg?12420
acgatgaggg?atcactgtaa?ctactctgct?tttctacata?ttggaaattt?tctacaaata?12480
aaagtcaata?acaaaaaaaa?gcagtacatg?cttgtaaata?aatttgaaaa?cccagagaag?12540
ctaaaagaaa?aataataaaa?atcacccata?attaccaact?gaggttaaac?actgttaata?12600
tttgaataaa?taaatattgc?tgaagtaaat?ggaaggtggg?agaaggaaaa?agatgactac?12660
aggtctggcc?aagctaagag?ataatgacag?catttttttt?tttttttaaa?taggaaagct?12720
gggaaataca?tttgattcag?gggtagggat?gacaagagtg?gagctgaaac?acaagtctct?12780
gacagaggca?gtaaaaatag?gaatcgtggg?ggctgggcac?agtggctcat?gcctgtaatc?12840
ccagcacttt?gggagggtga?ggtgggtgga?tcacgaggtc?aagagatgga?ggccaacctg?12900
gccaacatgg?tgaaacccca?tctctactaa?aaatacaaac?attagctggg?catggtggtg?12960
cacgcctgta?gtcccagcta?ctcgagaagc?tgaggcagga?gaaccacttg?aacccaggag?13020
gcagaagctg?cagtgagccg?agattgcacc?actgtactcc?agcctggcta?cagagcgaga?13080
ttccatctca?aaaaaaaaaa?aagtaggaat?catgggcata?aaggtattaa?cggaagctaa?13140
gaaagtggca?gcagcacagt?ctaaggtcac?tgcttgcagt?ccccactcat?tctgactccc?13200
tgctgacagg?cttccttcct?tcttcagcat?ctgacctgac?actgggcctc?aggcaccagc?13260
atgataggca?gaaaagtgtc?cgtacagtta?ccagggtggt?tgaagaaaca?atttatctct?13320
ttgagtttgc?cagaagattc?atctatttag?cccttggcaa?ctcagaacac?tgacaagtta?13380
tttttactct?ccccattaat?aaggtcaata?gtccatattg?aaacatccta?ctggtcagga?13440
agagattaaa?aggaaacagc?tatctgagcc?ctattctcaa?aattttgagc?aagtttatat?13500
atcttttcta?tatcatgagt?actctcaata?actaactgcc?ctaaactaaa?ccaacaaagt?13560
acatggcttt?ttaaaatagc?tcttttatat?tttataaaac?attaagagat?tttaggaatg?13620
ctatcaagag?tcaagaaaat?cttgaagaag?ttcctagttc?taaaagttac?taatatattg?13680
tattcgactt?aatgggtcta?atctacatga?gagacatcta?tgtctcatct?actttgatga?13740
tggttagtca?ccatatctgt?aaagacttaa?agagatcttg?ttatatataa?cataaggaaa?13800
agcaaatgtt?acagaccttt?attgtctgct?gctataaatc?ccaggatgtt?ttcatgacgt?13860
aacattacag?tttgataaat?ctctgcctca?cggaaccacg?aacgttcttc?tctagaggag?13920
aatatcttaa?cagcaacttc?ttctccccgc?cactttcctc?tccaaacttc?tccaaatcga?13980
cctttgccaa?tgctttcttg?taacacaata?gttctcgcaa?ttgttctctg?aacaagcaat?14040
ggtaaaccta?aaggtaaaaa?taaatagtac?tcaacacaat?caacaatatt?acatgtttca?14100
aacatcatga?taggcactaa?tgagtgaccc?agaaaactga?tactttaagc?tatcccttta?14160
ggaatttatc?tcactgggga?gatattatat?ttgcaataaa?ataactaatt?aaaaaaggaa?14220
aataagataa?taaatataat?aaaagaatcc?agaaactcct?gctagagggt?caaggtaggc?14280
tttgtaaaag?taagttgaat?tttgactatc?ccttaagtac?ggtggttagg?caggaagaat?14340
gtgcaggcaa?aggtagaggg?aaatgaatga?cacattttta?gggaagcagc?ttgggcaatc?14400
agagagagga?tatatgtggc?aaagcagtga?aaagagaaag?taagctgtca?ccagaagatg?14460
aagagtactg?aataccaagc?tcaaaataac?caatgaagag?ctttaggtaa?aagaggaacc?14520
tttaaagatt?tctgagaaaa?agggccatgg?ctggaagcaa?gataatttta?aaatcttatt?14580
ttagaaagat?gaatctcgta?acagtttcac?tgatgggagg?aaaaaaggat?gtgaacgcag?14640
aaacacagaa?gtaaattctg?gctttttgat?aagtcagtaa?aaatcaccac?agaaactatt?14700
tcaaggaaag?caatttactt?gctgacaact?ggctacatag?acaacactag?tatcttgaag?14760
aacaaggcta?agtaacttac?cttggtaatg?gagcactgtt?tttccactaa?tggaacttgg?14820
ctttctccaa?aatatgtatt?tttaagtatt?gccatactta?cttcatttaa?aagggtttac?14880
taacttacct?gcaacattta?agtggcacta?tatgtgagac?catcacttaa?tatcctatcc?14940
accatccggt?aagtgtcatt?ttaaattaca?ttgacactaa?caaagaaaat?gccagtgtac?15000
atcatgttcc?tcactcatat?cttatttata?caatctatgt?acatataaat?tggtgtcatt?15060
tataatctat?actcaaagct?gcttactaga?tcaaattaac?ccaatgacag?taaatgaaat?15120
tatctgctct?ctttggttcc?ctgatgtgaa?atgcttataa?atccaaacgt?taaatcttta?15180
aagcgatcag?aagctcttct?tcttaagttt?ctcaaacggg?tcctttcttc?ctcttgctct?15240
accctcccca?cctcctgtaa?agtagttagc?agtataacta?taaataactg?tttgtgttta?15300
taaggaggct?gctagttaga?aacagatctg?tcagaaatcc?ttatttaaat?catagagctc?15360
tttcgcacta?tgtataatca?attctaatta?tgttgtttag?tgtagatact?aatttattac?15420
attttatgaa?agccttgtag?agggccacac?cacagactta?aaagtacact?taagagttaa?15480
tttcaggaga?ctaatctgga?aattgcaaag?acaagtaata?aaaaagaaaa?aggaatcaca?15540
aacacaaatt?ctgaaaacac?ctgacaggtt?caggacttgt?gtaaatggta?tggtcaagaa?15600
aggccaacag?gacgaggaaa?ggttttgtct?tcccctttat?cactggattc?tagatgtcaa?15660
ttaaaattaa?aaagcaaatc?ttgatccact?gtattatcta?tattggatta?cttcacatga?15720
atagttgagc?atttttaaaa?agttaacaat?tggccaggca?cagtgactca?cacctctaat?15780
cccagcactt?taggaggccg?acgtggttgg?atcactagag?atcaggagtt?caagatcagc?15840
ctggccaaca?tggtgaaacc?tggtctctaa?taaatataca?aaaattagct?gggcatggtg?15900
gtgcacacct?gtaatcccag?ctactcagga?ggctgaggca?ggagaattgc?ttgaacccgg?15960
gaggtgaagg?ctgcagagag?ctgagatccc?accactgcac?tccagcctgg?gcaacagagt?16020
gaaactccgt?ctccaaaaaa?aaaaaaaaaa?aaagtaacaa?ttttcttcta?aagacaaaac?16080
tgaataggcc?taatttagat?ctctatattc?tctgctctac?tcttctgtac?ctttagaact?16140
gtttgagaga?aaacttcaaa?agggaaacag?ggactccaca?gctttacatg?cagtgaacag?16200
gaaataagac?ccgaacaaca?tgcatatatt?acaagagctc?ataagctgca?cacgccataa?16260
caaacactgg?cctagaagac?tcacttacaa?aagctggcac?atatgcacat?gtgcacactc?16320
acacacttgg?cgtacagctg?ccagaaccca?gctcttcatt?gtattccctg?aagttcccaa?16380
gttaaaagca?cagtctttag?aggtagagac?agggcctttc?cttaattatg?gtcacggtac?16440
taagtaataa?acatatgaat?tcagaatgtg?aaatgcttat?accttttcct?caattaatga?16500
aagaactaaa?aacagagtat?tacaaacaca?cagtttactt?attcacaggc?actagtctca?16560
tgcctaaggt?ggcattaagg?atttataatg?aatagaaggg?aaacagatgg?cattttctgc?16620
tattattcac?cagaagatgg?cttctgcctg?gataggtttg?gagggaattc?agtacacaat?16680
gaactatgac?aggcaaagga?ggccttaaac?taagttttgt?acaatgtggt?caactgatac?16740
tgtatgttag?atttttcctc?caagtatgtt?ttcaataaga?gtaacacttg?tcatttggac?16800
ataactctac?aatttaccaa?gtgctttcat?gcaaacattt?tgtcttgctt?gaactcacaa?16860
caatccaatg?atgtgcacag?aatccatcac?tttcatttta?aagatgaaat?aactcaagca?16920
tgagacattg?gttaactgcc?caaagccaca?gagctagcaa?gcaatgcaga?caagtttttg?16980
cagggtaagg?catcaaagga?gggagagaag?ctttcagaga?acagagagct?atggtccctc?17040
atggatctag?aaatatatat?atatatatat?atatatatat?atatatatat?atatatatat?17100
ataatggaaa?cagaattatt?ccattgtttc?tcatgtttat?atcttaaaag?gttaatgaag?17160
atattcttat?ccagtaatca?actgccaccc?acccaccaat?tcctttaatc?agttaggtgg?17220
gcttattcca?ctgtggcaag?tggcatgagt?gctgtgtctt?tccggagtat?aagtttagaa?17280
acaagagaac?aggtttgagg?gattaattcc?aaatatctgt?agccatcctg?attttctgtg?17340
actctggtcc?ttgattatca?cagttttgag?caggatgact?tccagaatga?gcaaaatctt?17400
tttgaagatc?tgaactgaga?ataaatggga?agtcccagga?aagctctaaa?ataacctctg?17460
tccaccaggc?ctgcctaaag?actatcacac?cttcagtact?aagactgctt?catctaagtc?17520
caaactctca?ttgtcttcct?tgcacaactg?tttcaggaat?ccctaagctt?gccttctggg?17580
acgtgagctc?cagtgcgagc?ctgtgtgtgt?cctagtagtc?aaggagagag?ctctcttatt?17640
gaatacatat?ggccaaattc?tatagaagaa?taattcaggt?aataaaatca?gtttcttcat?17700
tcttaaatga?atggatatgc?atacatacca?atatatattc?atttccttaa?aataaataga?17760
catttgtcat?tatatgagct?ttctgcaaca?ttagatgtga?ttttatgctt?cagaattata?17820
ttcttaccca?gtcacaactt?ctgctttaac?attcctttaa?tatcactcaa?ttataaaatt?17880
agtgaaaatt?tttttttttt?ttttttttta?gatggagtct?gtttcccagg?ctggagtgca?17940
gtggtgcgat?ctcagctaac?tgcaacctcc?accccccagg?ttcaggtgat?tctcctgtct?18000
cggcctcccg?agtagctggg?actacaggcg?catgccacta?cgcccggcta?atttttttgc?18060
atttttaata?gagatgggct?ttcaccaaaa?ttagtgaaat?tttcattata?tacgctttac?18120
aaattttcac?tttattcatg?aatttagccc?ttatttgaag?atgactcata?cttttcaaag?18180
gatagtacat?ctcatttaaa?agtcttaaca?aaccacttga?agtgttttta?tcaacagtat?18240
gggttccata?tttttgatga?ggaaacagaa?gcccaaagag?gaaacatgtt?ctaaccaagg?18300
ttatacagcc?aatcaatgac?aaagcttgcc?ttgaaaccta?gatctattta?ttcttcacca?18360
agtgtcaaat?tctaaaaaca?caggggatag?gagtgttcct?ctcttaatat?ttttccaaac?18420
cacatacatg?caagaaaaag?taaaagataa?ccccctttca?gtttaaacat?gaagcactgc?18480
tatgccaaaa?tccaccttgg?gatgactctg?acaattagct?catctacttc?tgatgccaca?18540
aatatcaaca?aatagaactg?agaaaagaaa?acgtcattag?gggccaaaac?tacattaaat?18600
aagaaggtgg?ttagacattt?ttctcaagtg?agaaaatgac?ataagagttc?attagtttaa?18660
ttttaaaaaa?ccaggcctat?acgaaagaca?atttcatata?atgtttaaaa?agtaaataac?18720
cttcacaatt?ctgaatacat?ttctgtcatg?cctgttttca?aatgtaaaca?tcaagctgct?18780
aaacaatcct?gaatagaatg?ggttagctgc?agatcatgtg?aatatctttg?accttcagct 18840
tcatctatat?gagaataatt?gttcttatcc?tttctacctc?acagtgatga?aaagcaaatt 18900
agattataca?agtgagaacg?ctttgaaatt?tataccacca?tggagctgac?ttattgattc 18960
gctttaacag?ttaaagttaa?gttccaatct?attttaaacc?agccacagtc?atatatacat 19020
caagcttaaa?gatttttatt?aggttcaaac?ctgcaatatt?atttatacta?tctcacattc 19080
tagcaagttg?gcttattaga?aaactaataa?aataagtatc?gcttaatttt?aaaaagatgt 19140
cttaggaaaa?aggagaaaca?attatgttac?ctgagccaga?acctgacgtt?gtcatatcat 19200
aaattaagtc?tttcaacgta?gtaccctctg?aaataaaagg?gcgatctaat?gaagggtcct 19260
cttcatttgg?cactcgatgg?tgaatgacag?tgcggttgtg?gcagatatag?accatcaaca 19320
tgagtgagat?gcagacgaag?cacactggtc?cagcaatgac?agctgccagt?tccacaggac 19380
caaggccagg?tgatgacttt?actgaaaaag?ggcctcgagt?gaaataaaca?tcaacaacga 19440
caaaaacact?gtaggtggca?acccccattt?tcccaatcct?acacaattcc?tgcagctggc 19500
cactgccacc?acttagccaa?agagcctcat?tacagcagtt?tacagggctc?aaacccagaa 19560
caagtgaatc?agtcttctcc?cactaggcct?ccttttatgc?acaccagctc?tgtcagcacc 19620
cacttactcc?tgtattcttc?agccatcatt?acaaggccaa?ctgccgccaa?tatcatagga 19680
ccttccccac?ttatcacatc?aggtcactaa?taccaataac?ctgtaacaat?acctattaac 19740
atctccttaa?aaatcatatt?ttttttaatg?tttggcttgt?cttcttgttc?caaggccagt 19800
acatgctcat?agcaagaaaa?acaacaacaa?aaaaaacaac?aaaatatcaa?aacaagcgaa 19860
aaaaaaaacc?acatacatct?tcatcacttc?taaacaactc?acatttcagt?atatatctct 19920
ccaccaattt?tttttttttt?tgagatggat?tttcactctt?gttgcccagg?ctggagtaca 19980
gtggtatgat?gttggctcac?tgcaacctcc?gcctcccggg?ttcaagcgat?tctcctgcct 20040
gagcctccca?agtagctggg?attacaggca?tgtgccacca?cacctggcta?atttttgtat 20100
cttaatagag?acggggtttc?accatgttgc?tcaggctggt?ctcgaacccc?taacctcaag 20160
tgatccacct?accttggctt?cccaaagtgc?tgggattaca?ggcatgagcc?atgcccggcc 20220
aataggtcca?ccaatttttt?aaaggcagaa?catatctttt?actttttttt?tttaacagag 20280
tttgcatata?tatacttttt?atactatctt?aacctcctgg?acttttaagt?ccagatcatt 20340
ttcttgtaac?ttctattaat?aattaagatt?ttctggttgt?ttcagaaaat?tacaattatt 20400
ttgacattca?tcctgagtct?tactggttta?ctgcttacca?ccatttcttt?catatcacat 20460
ctttcccatt?cttaagatct?tcagtagatt?aatctcttat?catacagaat?cctatttcta 20520
gtaatttctt?tcaggaagag?tccatgcacc?cttgtacact?gaacttagtt?gtggcaagaa 20580
ggctgttgcc?tttgtatatg?aaaaatcttg?gcctatttca?agaattttag?gtgatcgtaa 20640
aaatgttcca?tttgcccttt?gatatttaag?cagaaaatct?gaacctgttt?ttttttttca 20700
ccttttacag?gtaaccaatg?tttatgtgtg?ttaaatgctt?atataattct?tttattcttg 20760
aaattgatac?tttttattat?atgtgtttgg?attaatattt?tttcattaat?tttgcctggt 20820
attctgtctt?ctttatgatt?tcatgccttt?ttctggaatt?ctgataataa?gcatattgga 20880
tcatctaaat?ctgttcccta?tatctcttaa?tatgctcacc?aactgtcttt?tctctgaatt 20940
gtaacacagt?ttcttaaaac?ttgtcccaaa?cttgactata?aaattatggc?atccagtctg 21000
ttgttcgctc?tcaatagtgc?atttttaaaa?acattcatca?gttgggcttt?tcttctgaaa 21060
gcaaccttta?acaactgtga?aatgttctca?tttcatagtg?aataactgaa?aatagaccct 21120
gtactgtttg?aaagttcttc?cctatcatgt?ggtaaaccta?tttcacagga?tgacatctaa 21180
tctatctagt?tcagactact?tcttttgaac?tcctaacttt?tcattggtaa?ttttttgctg 21240
tttgcttatc?ctagagctgg?aaatgagaag?tttatatatg?ttcattagaa?acatgagaaa 21300
taaggtgact?tcttcacaag?gttttgtaaa?tatctattca?gatatttcaa?gctcaaatga 21360
tggaaatggg?aaattctgga?attatccttt?tctttgccac?attataactg?cagatgcttt 21420
catcaaagtc?acaaagatat?tgtagtccga?ccaaccctta?ccacagggga?gctgcattat?21480
catgctgaac?aggtggagga?ctggcctttt?ccttctgcgc?tacagcagtg?cttcctcctt?21540
taattagcac?aaggcctgga?ccaactttga?gtggagagtg?agcaactgtg?tctgctcctc?21600
tgagcactga?agccaggtgc?ttcctaaaag?ggaactgaga?gtttgccccc?ataccctaac?21660
ctcacccccc?aaatcctttg?tctaagttat?tggctggact?tttcgatgac?taacctttct?21720
tatatggcta?gtcaattctt?tactagtctg?gtgtcatctg?tactgtaaat?tgcagaagtt?21780
cctcacaagt?gctggcatgt?gggtggcatt?ctaccattaa?tcccactagc?attaatacag?21840
gttgccctca?tttttatatt?cctttgggat?ctggggaaag?aggtaagagt?taaatacatg?21900
tgctcagact?tccatattaa?accggaatct?taaaattaaa?aagtttatga?agtcttcaaa?21960
ctgctggttc?tgccaggaaa?ttttatttat?ttatttatta?tctttttttt?ttagacagag?22020
cctcactctg?tcacccaggc?tggagtgcag?tggcacaatc?ttggctcact?gcaacctctg?22080
cctcccaggt?tcaaagattg?ttgtgcctca?gccacccaag?taggtgggat?tacaagcatg?22140
tgccaccatg?cccagctaat?ttttgttatt?ttagtagaga?tagggttttg?ccatgttggc?22200
caggctggtc?ttgaacttct?ggcctcaagt?gatctgccca?cctcaggcct?tccaaagtgc?22260
tgggattaca?ggcatgagcc?accgcaccca?gccccaggaa?attttaaatg?taaactacag?22320
gtgaaggacc?aaaaatctag?aaatcatgta?taattaattt?acgcaaaaag?atcataaaac?22380
aagctgaaat?tacaaaatga?aaacatctag?actgttaagt?gctgctctga?atccccactc?22440
attaaaagac?tgtgattgct?ttaaaagata?ggagcattat?acaaggaaga?agaaattcac?22500
tctgagaaca?aagtagagac?aatctgaaga?tgttgttgtg?ggctttgtca?gagtttgctt?22560
ttatctatcc?ttttaggtat?aacagacctc?agaggaagtc?caccctggaa?ccaccttctt?22620
aaacaacaca?tacccaggag?gcaggatctt?ggttactctt?ataagtctgt?aacaatggac?22680
aagtcacttc?ttgcctctaa?acggaatgag?ctggattaga?caatttttat?gatcccttcc?22740
agttctaaaa?tcacagagta?tgaagagttt?ttcttgtagt?atctaggaaa?aaaattttat?22800
acaacttacc?agtagttgga?agttctattt?tattgcaatg?gtcctgattg?cagcaatatg?22860
ttgtagtcac?agacccagtt?tttgaagagg?gtgcacatac?aaacggccta?tctcgaggaa?22920
ttaagtcaat?ttcagctata?cacatgctgt?tgtgtataac?tttgtctgtg?gtctctgtga?22980
cagagacaaa?gcagagccca?tctgtcacac?aagtaaaatt?gtcttttgta?cagaggtggc?23040
agaaacactg?taacgctgga?aaaagagaaa?gattcttaga?aaaaatctca?aggttaacag?23100
tttgaaatta?tccaatattc?acctctaata?atacattctt?gatcctatta?tcacacaatt?23160
tctatgcact?gtttgttgct?cttagaagca?aaaaacaact?atttgttgct?cttagaagtt?23220
tcaaattata?ttaagaacca?catacacgtg?gaagcccaag?gaaatgtagc?aacatttgga?23280
cccaggtttt?ttcctgaagt?tttttgcttc?caagtataga?aaaattttgt?tatgttcaat?23340
ttcatcaaag?caaggcaagc?atttgccttc?ccattagaaa?caaagtacat?ttaaatttgt?23400
aatggttata?cttttttttt?tttttttttt?tttttaccag?gcccaaacta?aacattcaca?23460
tactcctcct?ttgagaagca?atgtgtgaaa?acactaccac?ccattaagtg?taggctaatg?23520
ccatttcagt?ggctttctgg?ataatggagt?aacggaaaca?gatttgtact?gagccagaca?23580
ctctctattc?cccttggtgc?aaaccctaaa?aaagacatgt?atattctggc?caggactggg?23640
gcattctctt?agggaagcca?agcagactac?acctgtaaca?atacatacat?gctccaacca?23700
cataggcaac?ctaactacag?aaatgactgg?cagcaaaata?ctagcttcat?gcccacttgt?23760
atctacttga?tctttatggc?tcaaccccag?gagtgacctc?tttagggaag?ccttctaatt?23820
atcaccaaca?ccttctcata?cacacagata?caccttcaac?catgctctct?gatgaagtta?23880
agtgctctcc?aaaacacata?ctgcttacca?gaattgctag?ttttgttttt?ctttctccta?23940
tgaaactgta?aactccttga?ggccagatac?ctgtattagt?catttctgtc?aatctgccat?24000
ctaacaccat?gcctcatgca?cagcagcatt?caaaaaatac?ttgttgaatc?acaatgatag?24060
aatgtgtgca?taatttcacc?atggtcacat?gaaattgcaa?agcacagaca?tgttcttaaa?24120
tccaaacatt?ccaattactt?gttggcaaag?gaataaaaag?gagtctaggt?acacggaatg?24180
gccatctatg?acgtgaacag?caaggtccac?tctacctaga?aaaggagtgg?ctaggcagac?24240
aggggcagga?tagacagagc?taactccctg?aagagctaac?ttgctgtaca?agaaagggtt?24300
aactcagcag?gactgagttg?ctcaaaccct?gcatattccc?aagaaagact?tgtcttcaaa?24360
actggccttg?gctggctcct?ggtagatgag?ctctgaacct?ttggaatatt?ctccctgata?24420
agaatatttc?tgtatgcctg?aggccttggg?tcacatggta?ccaattttgt?cagacagctt?24480
attctaacaa?tgtgatttac?agtgaacacc?tattactgct?ggggggccgg?gtaggagaag?24540
tctgaggggc?tgaagcctgt?catgcagatg?ctgcaagcct?aagtgactga?ccaacagtaa?24600
aaaccctgga?caccaaggct?caagcgaact?tccctggttg?acaacttcgt?gcatgctgtc?24660
acacattgtt?gttgagagaa?ttaaggccat?ctatgctatg?ccactggaat?gggacacctg?24720
gaaacctgtg?tctgatttct?cctagacttc?accccgggtg?ccttttgctt?ttgctgatgt?24780
taactgtatg?gttttgctgt?aatacactat?aaccatgact?gtaacagctt?ttctgagtcc?24840
tgtgagtcct?tctagcaaac?caagtctgag?gatggccctg?cagactccca?actcacttgc?24900
tcaactcaaa?ttcaggaatg?tcaggttctc?cctcaagtag?ctgtttcttg?gttgctggct?24960
taattcacat?acttgtctat?tatctttaca?gaccagtaaa?gttttacctt?aatcattatt?25020
aaaaacgctt?tctttattca?tagacaggtc?agctatttgc?ttcctaagta?tgaaagaaac?25080
tcaaggaaat?gacaagaaag?agacacaatc?gtaataaaga?ctgctaaaag?agacagtaat?25140
tattcatgac?aaggtgtgat?ggtgatggct?gtctgggtat?gatttcctaa?ggaggaattc?25200
tgaaccagga?attcatggac?tggcttcaga?ggtacatgaa?tcccataaaa?ctataagcca?25260
aatgttatat?gtatttacat?tttcaaggaa?aagctttcca?agtcaatcac?aatggagtct?25320
gtgacccaca?aagcattaaa?actaccaccg?aaggacattg?tcataattct?ctcctaaatc?25380
ctctttactc?atgattagtc?attcaaccca?tgttttctaa?gcattacttt?tatcagttac?25440
tctaccaaaa?gcttagcaca?caaagattaa?taactaatgg?tcacagcact?tgaagagctc?25500
caatgacaag?tgaaggagaa?cactgtaata?caatgtggta?accgctatac?ataaaaaata?25560
ttgccctgaa?tactctccca?gttctcagat?caccatggct?cccctatgct?gatgagataa?25620
gggctaaaca?cctagcctaa?caagactttt?agtttggggt?tccaatttac?ttctcacatg?25680
gcaaatgcta?tctagggcca?cacacctctc?accattataa?taataatgtc?tttcatgacc?25740
ttggtcttta?catataccat?ctctctgtct?agtttaaacc?tatcttctta?tctgactcat?25800
cctttaagac?cctatttcaa?caggatcttt?gccattatgt?gctctaaacc?tcgcccttac?25860
cttcacaata?attggtatct?cctttcaata?tgttccatag?tgctctttgc?atacctttag?25920
aacagcacaa?atcaatctat?ttatagcttg?ctgttaaagg?gtctttcatt?gcctcaggaa?25980
gggccaagct?tgttttgttt?ttcacatctc?tgaatcctgg?ctccttagat?agtgatcaga?26040
aaaatatttg?ctaaaacaat?gtctcccaaa?tatgctggga?gaaaaaaagg?atgtataagt?26100
tgggtacaag?gtttgagaac?atattttcac?ttcaaagata?atctaaaaac?aaggataaac?26160
attcaagatc?atgagtagcc?actgtctcaa?cactggcact?aggctttcac?tgctgcttct?26220
tcagctgtgt?gaagatcccc?ttcaggccaa?atgtccttgt?ggcacactac?acacagcata?26280
agtttcatgg?tcattgtaaa?agaaagagta?aaaaataaag?ggaatttgaa?tcgaccatat?26340
ggcaatacag?gcatggcatg?catattcaaa?agccaatagc?ctaacagcca?ataccatata?26400
tgtactttat?tatatgcaag?tgctatatgg?gtcctacatg?tgtagtacaa?tttgcaaaca?26460
tttgttagca?gtaaatataa?ttgtaggtat?gcaatgtttt?tccattctca?tttccagcaa?26520
taactggttt?agaaaatcat?ttaatgaaga?tttcaataat?gtcaagatat?taaccttatc?26580
ttccaatgaa?caaaatggat?gacatctcag?taaaacttat?aagcctgtat?ttgaggaatg?26640
cttgctgtca?agtgttttgg?ttaggtatga?tgtctcatcc?tgaacttacc?aacaaggcct?26700
tgaagtcatt?aatgccctcc?tgcataacat?tactgatgag?aagaggcact?actcacagct?26760
tttattatca?ctgaagttaa?aatacagaaa?cacatttaaa?atggaattag?acctaaagct?26820
atttttttct?actgcaaaac?ctaaacatca?tctgtcacat?ggaataattg?tattcatttg?26880
aattttgttt?ttttttgtag?ttgtctttgt?atttaatttg?cagatttggt?ttatagtggt?26940
gtatgagcca?agaacataag?ggttttatat?ctagtttcat?gtctacagaa?tttaagtaac?27000
attatgaaaa?atacactctg?tacttctcct?ttcaaagagg?tcattacatt?acggtaaatt?27060
tgaaaaagtc?agtactaaag?ggtttttctt?aactactctt?tcaatcagaa?gaggtcacta?27120
gacaaataaa?aacatcaaga?taacacaaag?cttaactagg?taaagatttc?tctcttcagg?27180
gaattaaaaa?attccatttc?accacttgaa?gtcagtcttg?attgactaca?agactgctgt?27240
tatgtgatac?ggcaagatcg?tttagggaaa?aactaaaata?agaacttaat?tttttccatg?27300
aacatgagtt?ttaattgcca?tttttttaaa?aaattcaaat?ttattttatt?aatagataga?27360
tttggcccct?ggatactgcc?ccccccaacc?ttttattcaa?ctaggtttta?aatttttaaa?27420
cgcatataca?tggcaaaatt?tcaatctaaa?aaacgtaaac?gaagacacct?ccttccgcca?27480
gcccaaagcc?caagttctcc?tcactctgca?acacatcacc?ttgactcttt?catttaattc?27540
tgcaattatt?cactaagcat?ctctatatgc?caggtacagt?gtgggctatg?aggtgcagag?27600
atgagtaaga?caaggtattt?gcacttgagt?agttcactag?ggtggaaggg?aaaggcatta?27660
aacagataat?taaaatcctg?agtcctgaga?agaatgatca?aagtgtttct?actctgctgc?27720
ggtagaagag?attatcaaga?aaagcttcac?cagcattcaa?gtcagaactt?ggagaatatg?27780
tacaatttgt?tagatagata?agggtgagaa?agctttcctg?actgggtttt?ctttctcagt?27840
ggcaggattt?catccttagt?ggctggcata?ccaagtaaga?tgatcaaatt?taaattgttc?27900
aagatgctaa?ctacgatgtt?ttatttcatc?aggaaaataa?acataatacc?tctctgacct?27960
atttcatcat?ctgagctaat?caaatgagat?actgtacttt?attaacacat?ttggaaacga?28020
acataaatga?ttatataaac?acacagaatt?atcccatatg?ataaatggca?ttgtgccaat?28080
gtggttttta?ttcgtaggcc?accaaaggta?aacttcttcc?caaaagtagt?gacaaaattc?28140
cactgtagaa?tcccagacta?acagaaccac?atgaaacttt?gaatatcatc?taggcaattc?28200
agttctgtca?ttttattaat?gtagaaacca?aaacttaaga?aaagcaaaac?aattttaaaa?28260
attttaaaaa?gaaaaccaaa?aaaccaaaat?gatttataca?aatattctac?ccagattaca?28320
ggcggatgtg?aatcctcact?atattatcac?cagcccacga?gtgaaaccta?cgcaactatt?28380
tgctatacca?ctatccccat?gctaagtaac?cctgaacttt?aaagactccc?aggtggacct?28440
gatttggttt?agactcctac?agttttgact?cttctgcttg?atagcaaaaa?taagaaccaa?28500
atcccctgtt?taggaccttt?ctactacact?gtccaacttt?gtttccatgc?cccagtcttt?28560
aacagtgggc?atagctttct?taatcttgag?atgcacattt?ctctaagctt?tacatttcta?28620
aaatctgaat?acaatttaca?atcaaagtaa?aaagaaaact?ccagcctcca?gactgaaagg?28680
ttaagacatg?atgggttgtt?gtaacctatg?tatgtgcaaa?cttggctata?catagaaaag?28740
attacaagtt?gagtatccct?catgcaaaat?gctcaggacc?agaagtgttt?tggatttggg?28800
atttttttca?gattttggaa?tatttgcata?tacataatga?gacatcttgg?gaatgggacc?28860
caagtctaag?tataaaattc?attcatgttt?catatatgct?ttatatatat?agtctgaagg?28920
taatttaata?taatatttga?aataattttg?agcatgaaac?aaaggtcatg?ttaagtactt?28980
atgtgcagaa?ttttccactt?gtggcatcat?gttggtgtgc?tcaaaaggtt?ttgaatttca?29040
gattgggatg?tttgacttgt?attcacttca?ccatcactgt?aattatttgt?cttgatagct?29100
cccttgcaac?tataacttag?gttaaacaag?gatttcagtg?tgattcagca?ctaaaaggaa?29160
aagctactgt?gtacacagaa?aattatatca?gaaccatgcc?aggaaataca?attactagca?29220
gtgaaatttc?caaatattgc?agaataaatc?agaattttca?aagtttgcag?atgttagcat?29280
ggtgacagtt?agtaccaaag?gaagtgacat?gaggaaaaag?agacaacagg?acccttgggg?29340
ttattattca?tggtattata?gtatcggggt?aacaactctc?ggggtaacat?atcccaagtt?29400
gagatcttgg?ctcttggtcc?caatataaag?gatttccttg?gttgcctcat?ttcagtacgt?29460
ctcgaggtca?catatggaag?cactattaat?tctatctaat?gccagggcta?cccagggtta?29520
attcacaagc?ccatatgtct?tgctagaaaa?gctgagaggt?aaacagttgt?gtatagtatt?29580
aatatatgga?acagatattt?ctatcaccct?tgttaaagaa?ataaaaatta?gcaccgaaac?29640
cttgtcttcc?caggcttagt?gtgtcatcat?ctacacaacc?tacccgtagt?ctttttatgc?29700
atacgcttga?atactctttc?ctttttcaac?ccttgttact?ggccctctcc?agccttctat?29760
cacccatctt?cctccagttc?agagctcaac?tgaaatctct?ctttgaaatt?cactagcaat?29820
gcccttctgg?tcaaattcaa?tattcttttc?aaaacgtttc?aggatatgag?acagagtacc?29880
accctttctt?tattagtttt?tatatgacac?taaacttccc?aaacttactt?tgcacttggc?29940
cctttggtac?atctcagatg?tacatctcca?agcctcttgg?ccttttacct?gtgctccaag?30000
cttgtatttt?aactacatcc?aggaaacact?ctgcttggct?tacttatcta?tgcaaagtca?30060
agcagagtgt?tgtaatccag?ttttttcatc?actctgactt?tgctggtgat?gacccttatt?30120
ttcctcaccc?tacccactac?agcacaacta?tacttttctt?cgcagtgaga?gtatttccaa?30180
atattacaaa?catgtaccaa?caggcaagta?aaagacctaa?catgcacaat?gtcctttatg?30240
cagtttgctt?cactacagct?gaaagcagat?cacatcactg?ctggcaaagg?tgaaggcaaa?30300
agttggaagt?tatttaaaaa?aaactttcag?ggactaatgt?cagccccttt?tatcatccaa?30360
cctattcttc?taccccagtt?cttctgagta?atctgcctta?ccccttttct?ccattctcaa?30420
cacatgcccc?cttctcaagg?agacgtgtcc?tcttttctcc?ctcatccagc?tttggagtaa?30480
agcatactat?atagattctc?cttttctttt?tattaaatat?gttgcttatc?tctgtataca?30540
tggctaaaac?cctgacctcc?aattccctcc?agcctactat?cctaggtttt?gttcctcaaa?30600
atactcagtt?cttctcaatt?caaccctcct?ggggctacct?tgcagcagta?atatcaaagt?30660
aagcttgtca?aaatagagaa?caccatataa?tgtacataaa?attttcctct?agtccagata?30720
atatttcacc?cctgaattta?gggcatcaga?ataaacgcct?gatttttttc?cagataaatt?30780
ccatttactt?ctgccacttt?taaagaattt?aagatgcatt?gtttatcatt?taacccacat?30840
cacatcttaa?aagaacaggg?cactcccaaa?ttcacaagct?cttgtttttc?cacattatct?30900
tcattttcca?gtctcctagt?ttctatggaa?ttagccaata?taatgttaac?tgatatcaga?30960
gaaaacacac?taagaatagg?ctgcccaaat?ggcaagatgg?gatttaacag?ggtaactaat?31020
acaaaggctt?tcacttagat?tcgaaataaa?tcacacaagt?acagcataaa?gatctggtta?31080
gcagatctga?ggagtttaac?aacacatttt?agaagagtca?gagcctttaa?aaagtatctt?31140
ttaatccatc?aattctacta?cttacagttg?tctgaggaaa?caataggtga?gagcaaaaat?31200
ctaaacttgc?agatgttcat?tacagtattt?tatgattgaa?aacaacctat?gtgaatgaca?31260
atacaatgac?agaatgaatc?cttatacaat?cataaatgaa?agactatata?gccattaaaa?31320
ctggtatttt?agaagcatgt?ttaaggacaa?gggaatggtc?ctactactaa?agggcaggaa?31380
gtaaagctgt?atagtgtgat?tacaattaca?gtcctgtcaa?gtgaccttgt?ttttgttcca?31440
cttcaatgag?ttgaggggat?attttaatat?acagagcaga?tgtgcacact?ttgccttacc?31500
ccaggccctg?aaaagaaatg?gagaaacttc?tatgtctaaa?ggtgagtgct?aaaacaataa?31560
ccaaatttct?tatttcctct?caatctaagt?atgcttttac?acagtttctt?attagatttt?31620
aatttgacta?gtgggtaggt?attataagga?tatggtagtt?aagttgatgg?aactcagaga?31680
cagaaaaact?taagttaaaa?tcctatcttt?gccagtcagg?cactgagtaa?tcctgaggaa?31740
gtcacttaac?ttatttgaac?ctaaatttct?tcaacttact?tcctaaattt?ataacatact?31800
aacaaacagt?accaatctca?gaaggtttga?gggttaatga?aataacatac?atagaatact?31860
tagcacagtg?cccagcacat?aataaaatgt?tcaaaaatta?gtttatgcac?tttttcaaca?31920
agtatttctt?tggagctcct?attacgtgcc?agtctctggt?ctagatgcta?gacagagaat?31980
cagagctaat?gttgagacag?ctctggtagg?caatactgac?acagaacaca?atataaacca?32040
tatgcatata?caacagtgaa?tgttcatggt?acctatcagc?tctttctcct?tcataaatat?32100
tcatacagtt?tttcaacaat?atgactgaac?agacctggct?caagaacttc?actacagtag?32160
cagtaggcac?acacagaaag?tatattttca?gttccaaccc?aaattaacag?tgtagggaca?32220
cacccagtgt?gtatatgtaa?tatccctaat?aaataagtta?atatctaatt?agccataaaa?32280
tgttcatgct?ggaaggaata?tgaacagaaa?tatcagatcc?cagctccttt?agagatgaag?32340
aaacagaaat?gtcctaacag?ttacatcaac?ataatctaga?tttattccaa?aagtacacaa?32400
agaaaaaaag?gattacttga?taatctacag?tgatttccac?ccctactccc?cacaacccct?32460
cacgtaggac?aaaaccgaaa?atttcaacct?ttccctttgg?aaagcacgag?tggctgtagg?32520
agagactggc?ttggttgcac?agataataag?gtgtaataat?gaacgtaaat?gaaagtggct?32580
gatcatcctg?ggctagggga?atgacataca?aaacagaact?gtggtagaga?aggaactgtg?32640
gtaagagaag?gaagtggtaa?ccactcccag?ctgccattga?ctcggggcag?aggagagcaa?32700
tacctgggcc?agcaaacagc?gaaagatctg?ttggagccac?agttgaagaa?atgaactgat?32760
ggtcctgggc?agttagtaat?tttagaagca?gaaagcaagg?cctgaacacc?ttttctcaga?32820
acacaacagt?gaatgtaacc?tgtgtaggaa?gaaagaaaaa?acctttagga?ggatagagat?32880
aattaggatt?gagattcctg?ccctcagatt?cacaatgcag?agaacacacc?actgataaat?32940
gatgatgcaa?agtgcacaga?tcagaggaca?gaaaagggag?atttctctga?aatatgacac?33000
ctaaactaag?acttaaggaa?agctagtgaa?gaaaggaaag?tcattttagg?tagaggatat?33060
acaaaaacat?tgtacaaaag?atgccaaaat?aaaagtttga?gccaggtgtg?gtggcacgca?33120
cctgtagtcc?cagctatttg?ggaggctggg?gcacaaggat?cacttgagcc?ccaggagttt?33180
gaggctgcag?tgagccatga?tcaggccaca?gcactccatc?ctgggcaaca?gagtgagatc?33240
ctgtctcaaa?aaaaaaaaaa?aaaaaaagaa?agaaaacagt?aagggagttt?ggcagtttag?33300
gtgatgtaaa?caaaaacaaa?aaaactgata?aaattcaaca?gctattcatg?atttttaaaa?33360
atcttagtaa?actgataaaa?ttcaacagct?attcatgata?tttaaaaatt?tcagtaaatt?33420
gcagaattta?aaaaaaattc?tgaaataatc?agattaaata?aaaggcataa?aagtaggcat?33480
tacatttaat?gttgcatgac?tgtcattttc?ccttgaaatc?acaaataaga?aagagatatc?33540
catcactact?tctcaacatt?gtattagaag?tctgagtgta?gtaagtcaga?aataaacaaa?33600
aggaagatag?actggaaaga?cacagaacta?tcattacttg?cagaggacaa?ctatgtacat?33660
ggaaaatcca?aaagtgacct?acagatcaac?tattagaatc?aattagtcaa?tctagcaagg?33720
tcactaatat?aaggttactc?actataccaa?aaaaaattaa?attaaaaaat?cattcttaaa?33780
ccagtaataa?atagaaaacg?ttttttaaaa?atctaaaaac?taggaataaa?cctaacaaaa?33840
gacaggtaaa?gacctctgca?gagaaagctt?aaaaaatatt?acttattgat?agaaattaca?33900
aaggagataa?aataaaattt?taaaatgtat?ttataaatgg?agaaaagtga?caagttccta?33960
actggaagat?tcaatactgt?aaagaggtca?atattccata?aagtgatctg?tagattcaat?34020
aaaatcaaat?cagaatcccc?acagggtttt?tttattcagt?gggaactgac?aagttgattc?34080
tgaaatttat?atggaaaaac?aacatcgcaa?gaataaccaa?agcaatcttt?gaaagactta?34140
acactactcg?atatcaagac?tcctaacatc?ataataatta?agacagtatg?gtaatggcac?34200
aaggacaaat?gggcaaacag?aacagagatt?acagagaaac?agaccctcac?atatacaacc?34260
tcttgattta?tgatgaaggt?gattgtacac?tgggggaaaa?aaggttttac?caataaatgg?34320
ttctgagtca?accagatatc?cgtattttaa?aaataataaa?aatctcatac?cataataaat?34380
aaccaactcc?agatacatct?caatgtgaga?ggtaaaacca?atcttttaaa?tgaaaacaca?34440
ggaaaacatt?tttaaaacat?ttgggtcaga?aaaagtaagc?aaacaggatt?ctaacttaaa?34500
gcaaaaaatt?gaaggccggg?cacggtggct?cacgctgtaa?tcccaatact?ttgggaggcc?34560
gaggcaggca?gatcacctga?ggtcaggaat?tcgacaccag?cctggccaac?acggtgaaac?34620
cccatctcta?ctaaaaatac?aaaaaaaaaa?aaaaaaatag?ccaggcgtgg?tggcagatgc?34680
ctgtaatccc?agctacacgg?gaggctgaga?caggagaatc?acttgaaccc?aggaggcaga?34740
ggttgcagtg?agccaagatc?gcgccactgc?attccagcct?gggtgacaac?agtgagactc?34800
cgtctcatct?gaaacattca?tctcccttgt?caaacaaaat?accaaagcaa?agcagttaaa?34860
ttgtggttgc?agtctcctag?aagaacacag?ctgaattgaa?ccaagcaagg?acagaaaagc?34920
ccaccaaaag?gaaggagctt?ttgtattatt?tctatatttg?catttttata?atatttttaa?34980
tcattaaatt?ttggactccc?ttggagccta?aagatataag?catctagtgt?tgactgaact?35040
cctttcaggg?aaacatttgc?cctttgagac?taaactatgt?gtatatgaaa?acttaggctt?35100
gagatgtact?gtaaccaagc?taataaagtt?ttcagacctc?aaaatctaca?tgccgagact?35160
tggcattagg?aatatgggtt?tccaattgct?ggtagcattg?atacagtagc?atcatggcta?35220
ctgaagaaag?tggggggttg?gttattaaaa?gataaggatc?tatcaggctc?agaggcataa?35280
gggtcttgat?gttatttata?ccttggataa?ctgatgatac?aacaccgaag?actatcttgc?35340
agaattatga?aatctatatg?taagtcaata?atcactagtc?tctagataat?agtttagaat?35400
ggttcacagg?tgattatact?catttcttcc?ataagatttt?cctttttccc?agttacagag?35460
actaagctaa?atcagatgga?agcacccaat?tgcttagggc?aactacgcta?tttcctcagg?35520
gacacaccat?ctgtttgcaa?tgcacagcta?attctgagcc?tgttggtcct?cgcagagttt?35580
tcccttaaga?cttctgcctg?atgcctaaaa?tcccttaaaa?ctcctccctc?ctttcccttc?35640
tcccatggta?aggcaagagc?aggctggatc?tgacaaaact?taaatgatag?atgagatcta?35700
cataaaatac?ttatgtggcc?tttttttttt?tttttaagaa?taaagtgaag?aaacaattat?35760
gatcatgggg?agaaagaatg?tgagagcaga?aaggctcaag?tttatacatg?catcgaaata?35820
agagggaaga?aaacaaaagg?acaatgcacc?atggaaagaa?ggaaagcaaa?ataatggaaa?35880
gggagaaaaa?aggagcatct?cttcctagga?aagtaatcta?caatgctgtg?ttaatctgcc?35940
aacgctttgg?tgggactggc?aatcagaaat?tgtctttcct?cactgacaaa?catgaccaga?36000
ctctggcccc?tgatttgtaa?tttttttccc?aaatgtaaaa?tgagacaaaa?taactaaaac?36060
tactttaact?tgtttatttt?gataaaataa?ttatatataa?ttattgttga?aggaaatcta?36120
caatacacaa?tcttgggtgt?ttttatttaa?atctatcaca?cattgaataa?caaaattaaa?36180
atgtcagttt?ttcaactgga?gaaagtactc?aaatcaacaa?ccacgtgctg?aacaaagaga?36240
cccaattaga?gcacattata?gtttgatttg?gaaatgaata?catcaagcaa?aaaataaaaa?36300
acccatacat?atatcgtgtg?cttgcataca?aatgaaaggg?cagttgctgc?ttttctatct?36360
ctgtatgtct?tttcaagttt?aactctatcc?tccatgttca?gtgctcccaa?atatctatat?36420
tagtcctagt?ttctcgcaga?aaaagccatt?cgtttttgcc?ttttccctgg?ggacctattt?36480
gtaattcaat?gcatatttaa?gaatcttata?atgtagaaat?gtaacaggat?gcctgaagaa?36540
ggtgtcctag?aactataaat?atacactatt?atgtaatcag?tgaggtttac?acctaggaaa?36600
tctagatgga?atggttttcc?tgaagcaaat?gaacaaaaat?aaggaggttc?agtcttggtg?36660
gtgagaacaa?ggaaacactg?gaacagacct?gaagtagtac?agcaactgca?gaaaaaagga?36720
aaagtgaatc?cttacaaatc?atgagtgata?aacccgaatt?gttcacttta?tttttcaatg?36780
gcccatgtac?aaagacttct?ataaaagctt?ctgctcaaga?acagagagaa?gcttgttttt?36840
cccaatgaaa?tcagaatgct?tctaaccaca?gaatgccctc?atgctaatgt?acgtgcctat?36900
cttttccatg?aatactggga?ttactgtgag?accagtacag?tagggccaca?ctctcagata?36960
agtgtggtct?ctcctaaagt?aatcattccg?aacgtccatt?actcagaaat?gaagcagttc?37020
ttcaaacaag?aaacccaagc?aaagacactc?tggatcttac?tgacttgcac?ctgtttgaag?37080
gtaaatgtct?ggctctgcct?ttggtagcag?tactctgatg?aagtgtatca?aatggagaca?37140
caccaaaaga?taagggcatg?agaaaaatgt?ctttgtaagc?cagactaaat?agtttcatgt?37200
tgctctctat?tcattatcct?ccagctttta?gcaaagcttg?atttaaatgt?cctagcctta?37260
catcagctgt?tccattggca?ttagggaaag?actaatgtgt?tcatacttgg?atcagagact?37320
taaactggag?aagaaagatg?gaggcagcag?cactaaattg?aaccctcaat?acgtgttaaa?37380
ggggaagcct?cagaacaaga?atcagattat?tgccagatcc?agcaataacc?ccttaccact?37440
tggagattct?ccctgtatga?caatcttggc?atttggggct?ccactttatt?aaggaaggtg?37500
gcagtctcct?catgaattct?cgataggcaa?tgagatctat?gcaaattatc?agtcttcctt?37560
acttgccttg?gttaccagaa?aactcagagc?taagtattgt?gttcaacttc?taaagctttc?37620
ctcagctaaa?cttacggata?attgttctct?ttttctttcc?ctttttgact?tactgattct?37680
tatcttttgt?ggtcagtaga?tttggtctta?ctgaatttgc?tattatttca?agcttccaaa?37740
atcctttttt?ggaaaatgac?caaaataaaa?gccaatcaat?ggataaacta?acttttctcg?37800
tataatacag?gagcaacaag?atactgctca?tcttgaagcc?atgaatccta?gggatattta?37860
gactatattt?ggctaaaacc?agtaagcaag?gaagcttgga?ttatgcccaa?aagtacagaa?37920
ttttagagga?gaaacagagc?ttagagataa?acaagtccga?cctcctacct?aatgtaagaa?37980
attccttcta?caatttctca?gacagaaggt?tatctagcct?ctgcctgaat?agttccaggg?38040
tgacagggaa?catactacct?tacaatgttc?cattttgaca?gctatggtag?agagtcattc?38100
cttacattga?gctgaattct?gcctttcagt?ctaccaatta?attctagttc?ttcattacac?38160
agacatgtat?ttcttctttc?agaagacatt?ctttcactta?tttaaatata?taataattcc?38220
cctttattga?acacctactg?gtgtcaggct?atgtactaag?tgtaaatact?actgtacact?38280
atcttcacaa?cgatcaggta?aattaggaac?tatcctcttt?tgaaaagtga?gtcacagata?38340
cactgattag?actctaatta?cagccagata?tgttggtgct?tatatactac?tcctataaac?38400
aaatatttca?ttaaatttct?gacaaccaag?tcacatgaat?ttaatctgcc?ttcaaaactg?38460
aaagaaaaac?ttaagttaga?tcaatccaaa?tagaaaaaga?gagatggtct?agggatacaa?38520
ctgcaccagt?gtttggttca?ttgagaaaaa?caacaggaaa?agcatttaaa?aggatagcca?38580
tcagggagct?ccaggagata?gtaaagctga?cacctgtaac?atcagcaacc?atgacctgag?38640
gcctaggccg?caagcaggaa?acttcctctc?ttttatctca?gccaagaacc?acactcccaa?38700
aagatcaaac?gcattactgc?agagaaagca?gcactgtctg?aaggttaatt?tcaatacaac?38760
cagaagatca?caagtaattc?tgaatatata?catctttact?aagagaggtg?ggggaaaaat?38820
agcatgaacc?tgcaaaacag?gaaagaacca?tatcccagca?aacggaccag?gactccagat?38880
acaagctagg?acttcagggt?ctaaataaaa?actccattta?aggtagcgtt?ttaggacact?38940
agaatcctcc?tacccccaaa?agagaaagac?agagagagag?agagagaata?tgaggtgaat?39000
gctagatgct?agtagccatt?tctttgctta?aggtgctctc?ccatttccaa?ctaggttcca?39060
ttttttttta?atctttgctg?actactgagc?aattttattt?ggctaccttc?acctcaaact?39120
caacatgctt?aaaccagaat?tcgtctcccc?ttaatcctcg?tgccaaatta?ctcattaagt?39180
taaaggcatt?atccagccta?aaaaagcttg?gagtcattct?tttttctttc?atggagtcac?39240
tctgaatttc?tgtactccac?ctctttacag?ctaagaccta?ctgccactca?acaaatattt?39300
actgagtgcc?taggatgcac?caggcacttt?ccatacactt?gagatacatt?agtgaacaaa?39360
acgaagacat?ccactttcac?aaagcataga?atgataggaa?ggagacaata?aacagtaaat?39420
aagtacatat?gataagtaaa?taaatacagt?atgttagaag?gtattgttac?agagaaggaa?39480
agcactgtag?gatgatgaca?atattttaaa?aggtggcagg?ataagcctca?ctgagaaaaa?39540
ggtgtcatct?gagcaaagac?ttgcaggagg?tgagggagga?agccatgcag?gtatgtgagg?39600
gaagagcaca?caagcaaggg?aacagccaca?cacaggccct?actactaatt?cctctgattt?39660
ctttgtttca?aatgtcatac?agtcaccatt?tcaccccgtt?ctcaatgcca?tcaaaccaac?39720
tgggtagcca?ccctgatcca?ttccctctgc?ggcacaatta?gacattcttt?ttccacatta?39780
aaaccactct?cctgattttc?aaggcccata?attctctgag?cccacccttt?acaccatgaa?39840
cttccatttc?tcctcttaga?aatcctgaaa?cttagaatgc?tctttctcca?cacatgccat?39900
cctctccagc?caagaagtgc?ctcctttcca?ccacacatcc?actcaaagcc?ctatcctcct?39960
gcaaggcaga?gagatcaagt?cctacctcct?ctgtaaagca?gtccctgtgg?ttgctagtac?40020
tgagtctgta?gtcatatttc?ctcagcatca?attttttcaa?aagcaagact?gcctcttact?40080
tttcctatat?ttctcatcat?gttgatcact?actaaatatt?tgctaagaat?agatgagcta?40140
tttcctctgt?aaactgaagc?tctttcctct?gtaaactgaa?gctgtttgtc?aatttaaaca?40200
cttttattag?ctttcataaa?ctgctgaaat?agaatgatta?aagaatggtt?tgttgctgtt?40260
tttttgtttg?tttgtttttg?ttgagatgga?gtttcactct?gtcgcccggg?ctggagtgca?40320
gtggcgcaat?ctcggctcac?tgcaaactcc?acctcctgag?ttcaagtgat?tctcctgcct?40380
cagcctccca?agcagctggg?attacaggtg?cctgccacta?cgtccagcta?attttttgtt?40440
atttttagta?gagacagggt?ttcatcatgt?tggccaggct?ggtctcgaac?tcctgacctc?40500
gtgattcgcc?cacttcggcc?tcccaaagtg?ctgggattac?aggtgtgagc?tactgtgccc?40560
agcccaagaa?tggtttttta?tactcaaaaa?aaaaaaaaaa?aaaaaaaaaa?aaaaagcatg?40620
ggtgcaggat?atgccaaatg?ttaataatgg?ctggtgatgg?tttttttcct?ttctctaata?40680
caaattttca?gtcctgtgct?tatgtaactt?ttagaagaaa?agaatttgct?atgaatatat?40740
gtataaatca?atacaaatag?taagtgatca?actatcactg?gactcgtcag?gaagattcaa?40800
attacctaaa?aatataatgt?taaagaaaga?ctgttagtat?ctgaatggcc?tgcagttgca?40860
aagaaatagt?aaaactgtaa?tcaaggcaat?ctgaagcaaa?ttctcatggt?ttgcaaaaaa?40920
gggaaaggaa?actttcctgc?tgaagtggct?ctaacaatgt?atttactcta?tatgaaagga?40980
gcatggacgt?acgtgacccc?atcataagta?gaggagcatt?tgtataggaa?aagagtacat?41040
accctggagt?gcttaactga?aggctccacc?tttcattaac?agcataactt?cagtttcctg?41100
gtctataaaa?tggaaacaaa?gagggtcttc?tttcatagat?atgaactagg?ttccaatctg?41160
agcaaaattg?tgtcaattct?gcctgcccag?gcagatgggg?tttatggtaa?tacaaaatca?41220
tttgagtctc?agtggctgaa?ctactgttag?tctacatctg?tgccattcaa?agcagtgtct?41280
ttcttttata?tatatattta?cgattagacg?atgaaaaaat?actaacacct?ttggataatg?41340
tttagagttg?aaaagaatct?tggggtagag?ccgatgttat?caaaacctac?agttatcttc?41400
tgagcactgg?tcacctgtat?ctgggaacaa?atgggcttaa?gagtttggaa?attaagcagc?41460
aaataagtaa?gaagttttgg?tactctatac?aactaccatt?caaggttggt?tatgagaact?41520
aaatgatgcc?gtattagcca?tggtcaaaga?aaaaaaaaga?gagaagagag?aattaaacga?41580
gacaagacag?atagaatatg?tagcatattc?ttgcaaccct?tcaagaaatt?tcaaagcaac?41640
ctgtgtgtat?actttgcaag?tcaatttttt?ttaagttaga?ttagaaattg?ttctttgagg?41700
gagcagcttt?ataaaagact?tgatctgatc?tataaaattg?gaccataaaa?ccaactgaac?41760
ttagtccact?agtatttaag?aaagtgatgt?ctgagatgaa?taattacaag?tctaccaacc?41820
aattttcttc?atgatgaaga?agggtagcca?taagaaactt?acctggaaag?caaacaaaac?41880
acataaaatt?ggatctaatt?cagagtggta?aacaatttta?atgtttatgg?agactgcctg?41940
gatttgacat?tgagaaaatt?cagctaagaa?tggcattaaa?tgtaatccta?agtattggag?42000
ttaggctggg?tcaaaactga?ccataaattc?tgagaagact?ccaaaacttt?tcctcaagct?42060
agttctatgg?gacaaagcat?taaaaaatcc?ctgagaaata?tgccagcatc?tgccctcaat?42120
tccaaaagca?ggaagcaaag?atgtgaccca?atcacatgat?atcaaaccac?agtccatctg?42180
ttcagagaac?tctgtgttac?gtaagccatg?accaaggaag?aactgcaaaa?ggcaagaggt?42240
gtgtcgacat?ttgcaagggg?ctctgtggtt?tgaagagaca?cgttctcaca?tcagaagggc?42300
catccatagg?ataatggcat?tttcaaaatt?ccatttatta?cacatgaaca?tatttggtgc?42360
aataaaatga?cactacaaga?atggtgttga?gtccctgtaa?ctgctcaact?aaggcctaga?42420
accttttgac?aggggtcttc?cctacatgag?cggccctcct?cacaggaaca?agatttatct?42480
tcctcttgat?tatttttatg?tcaattcctc?tcttaatttc?aacaacaaag?cggatcatct?42540
aatattctaa?accaaagcct?tctaactaca?ccccaattca?attaactgta?cttactcaag?42600
accatcttcc?aaactactat?aggcctactt?ttctcaatca?ataagtatat?accaggtcct?42660
tttatcagca?attaaaaaaa?aattgacctt?ttccttgaga?actttaaggc?tttaatcatt?42720
ccccctccct?tccaccttta?gaattcactt?ttcataaatt?ctgtgaagtt?caaggcctac?42780
ttcacttaag?gaagtcactc?atcccttcgt?ggatgccaac?cacctatccc?aaccctgtcc?42840
cactcccacc?tccaagtcct?tcacatttta?aagcaccata?tagggcacaa?gatatggaat?42900
cagaaaatca?aagttcctgt?ctctgttctg?cccctgtgcc?accctaagaa?attcacctga?42960
gtcgtttttt?catctgtaaa?ttgaagtgat?aatatactta?ggacttccac?catttgaatg?43020
cctagtccta?ctgggcatcc?cataatgtta?ttctccctca?ctcattccac?tttgattact?43080
tttatgtttt?gtttccagct?atgtactata?gcttttagga?ttggggaaaa?aatgatagag?43140
gttaatacat?ccaaattcca?cagtacagaa?taaggaacct?aactctgaag?agtaacttgc?43200
cagtcagtca?gtaaaagcct?tgtttcctcc?cttggagtag?gccccaggac?agttggggac?43260
acaacttcaa?aagaactttc?acactcatca?aatccccctc?tgaattctac?ccacccttca?43320
aagtcagtgt?aagtcctaaa?gtgtccaaga?agcctccccc?aatcattcca?gcttacacta?43380
atcatttccc?tttttgaata?ctaatgcctc?cctatagaaa?tgatattaaa?aatatttaac?43440
aactggcact?acaagggtac?caaccaatca?gaaaggatgt?ttaaccaaaa?cacacatggc?43500
ccagtgggaa?ctgcttattg?aacatcagtc?ctgctcttta?gcaacaacac?agaatagcaa?43560
cctcaaactc?aaataccact?ttctcatgtg?atcttcacaa?tctcatgaat?taggcaaaag?43620
taggtattgc?cccattttct?gcataactgc?tggtgaaggt?aggacaaata?accaattgct?43680
ttcaacacgc?catacaactt?ttcctgatta?tttatacgga?attacaagtt?aatattgcat?43740
aaactggact?tacataaaac?agtataaata?ttaaaggaat?gctcaaatag?aaatcaacaa?43800
gcatttatgt?ggaatagaat?ataaaacaca?gtgctaagtt?ctgaggccac?aaaagaaaga?43860
aatggcatga?atcttgtcct?ctgggtacct?ataacgcatt?caagtagagt?taagtagcag?43920
cacaggcagt?agaaatggac?aacacaaact?gttaagtgtt?gcagagttct?ggaagacaaa?43980
gaattcaaga?actaaaccag?cacaggaagt?cagggctgag?aacttctcgc?actcccaaaa?44040
aaaggggcaa?aactaaatgt?gtagtgaaaa?ggctgaacag?tcaggagtca?gtgagaaaga?44100
gaaattgctc?gaaggtctgc?agtaatgaga?aatgagatcc?ctggtaggat?actcagagat?44160
ggccccaatc?ataagctgct?aagtgttgtt?ctaagtgctg?aatacaaatg?ggaaatctta?44220
taaaccttca?cggggaaggc?tgaggaagat?tagtttggca?gtagccatag?aaaagcctag?44280
atgagaaaaa?catgggaaag?caactagatt?tggaggataa?caggcaggat?taagctgaag?44340
gctgcatacc?aagaaaggag?gagacattca?agaggcattc?atagaagagt?tggattgggg?44400
gcacgttttc?aaagaaaaaa?agttatgaaa?tggcagaaag?gaagcaaata?gcattctcag?44460
atgggatata?catatagaca?tagtggtact?aaactgtgca?ctagggataa?ggaatcaatt?44520
tccctagaga?aacctatgtt?ggagacagaa?gttgggcaga?gaacattaaa?acatactcag?44580
aacataaaaa?ggtgcaagtc?tttaaaaggg?aagccaagtt?acagaggaaa?taaaaagcat?44640
ttgacctttt?tcagaatgtt?ttttaagggt?ggactgaggc?atcatcataa?ccaacagggg?44700
aggcagacaa?gctgaggcag?tctgggctta?gagtaataag?cacctggaca?gctttgtatt?44760
ttgtgcatac?catggagact?gtaaactcct?ccaggacatg?gactgagcaa?tgttctgtgt?44820
cttcaactaa?gtccactact?gttacttgaa?tacatgaacg?cttcttgtgc?tacttctggt?44880
ggaaaagagt?gcactgtgtt?attcaagtta?atagcggtgt?ggaaatgtta?cctgtgtttc?44940
atgcctaact?atactgattc?tcccaaatgt?ccacacagtt?atcctgcctt?cctccctagg?45000
ccaatgtcaa?aaatccattg?tttcctctaa?tgcaggccca?cgtgaaggga?ctcaacaatg?45060
tgctaagagt?cggaatgaag?cctatctgat?actcaaatca?tgaggacaga?atccaaagtg?45120
gataataaag?accaattgct?catcagacga?ctgaagaaga?aaaatgggct?acgccagata?45180
gtatgatgta?tacatattta?tatatatata?tgacatacag?gtttgggaaa?ctgagatctg?45240
agtgaaaatc?ctagctttag?cacttaagtt?attgggtact?taacgtgtct?gtaccccact?45300
ttgcacatct?gtaaagtggg?gcaaatgcca?ctactcctgg?gagtttactt?gtggtgatta?45360
aataatgtaa?ttatacaata?gtgtatgcat?ttacatcgta?gtaatgcaca?atacatagac?45420
ggtagctatt?aggactgatt?ataatcgtca?ccgtcagtct?tgatttttta?aaaaaatttc?45480
aacatctttt?gtccagtttc?agaaacagaa?atgtactttc?actgcatttt?agttgctaac?45540
actgaggctg?tgtattttag?cttctagtgt?ctcagttcag?ctgctaacga?agtttttcac?45600
tcatcccttt?gtggatacca?accacctacc?ccaacctgat?ttactatttt?gaaaaatcca?45660
gccaacagtc?ttccttgaaa?accagctata?cagatgtctg?aatcaaacta?ttaactgtca?45720
ctcaagaaaa?ggaacaacgt?gagtgatgtt?ccttcgagga?aataaaaagc?gtttaatcaa?45780
ttcacagtcg?ttcccaaaat?ttccaaaacc?cgcagaatga?gcaaacgttc?aagtttccac?45840
tatgaaaaca?atccgtagcc?gtctggttac?tggactcact?tcaacactcc?ccagacgcac?45900
gaaagaagaa?acattccgcg?catctccgcg?cttccttctt?ctcacacaaa?gcccccctgg?45960
ctggaggagc?agccccttcc?agcagggtcg?gctcgggtcg?agccgggcgg?gagtcagggc?46020
ggcctgcgga?cccaggggtc?tcaccacacg?tcgcccccga?ctcccactgg?acgaagccct?46080
agaggctcgg?agctcacacc?ccgcccggga?gccgccttcc?accccaacct?caaaccccgc?46140
cccgggttcg?gcagcctctg?gcacggaccc?tcttggggcg?ggggtcccca?gaacaaggtc?46200
acgccgtgcc?cagggggcgg?cggcgggcag?ccacggctct?gccagtcccc?gccggcctcg?46260
cactctccgc?ccctggccct?cgcccactca?caccccagag?ggcagccccg?gacctcggac?46320
gactccgccc?gactccacct?ccccggggag?tcccgagcgg?ggcggcctcg?ggcagccgga?46380
cacgtccgcc?cgcgcccgga?cacacgcccc?tgccccgcct?ccgctccccg?cttgcggttc?46440
gcccggcagc?cgccgagccg?cgcggcgcca?cgagagcccg?gcccgggccc?cggcgccgcc?46500
acctgcgccc?ccggccccgc?gccatgtttg?agaaagagca?ggagcgagcc?agaggccggg?46560
tccggcccgc?gcgccccgca?gtcgcccgcc?cgccgcgccg?ccgctcaccc?gtcgcccccg?46620
ggagcagcgc?cgccgccgcc?gccgccgccg?ccgccagcac?gaggaggagc?agccggggac?46680
gcggagcagc?gaccgccgcc?tccatggtcc?cgccgccacc?gcctgtggcc?cggcccggcc?46740
cggccgcgcc?gctgcctcac?cccagcaaac?ctcgcctcgc?cccacctccc?tagccgccgc?46800
ggcggcctcg?ctccggccct?ttgtaactgc?tcggaggacg?cgcgtccatt?ggctgccggg?46860
ctcccgccgg?ccccgcctcc?ccgccgccgc?gagctgccaa?gcgggaccca?gccgggagcc?46920
ccgcctgcgg?gcccgccagg?cagccaatcc?gcagccgcga?gcgccggttt?ctggccacgc?46980
cccacgctcc?ccgggggctg?ggccgccaga?ccccagcccc?ggcccgatcg?gctcccggct?47040
ccgagaggcc?gcgtgggggc?ggggtctgcc?agccccagca?ccgctcagcc?gctagccccg?47100
gagggccggg?tagagcgatg?ggtgtgtctg?tgtgagtctc?tttcggaaaa?aggctgtggc?47160
cgttcgacgc?tcttttcttc?taacctcctc?taggcgcgga?agatctggta?ctgcctcagc?47220
cccaccctga?ccccattcac?agctccgcat?tggcaatccc?agcacatgcc?acccagatcc?47280
gctgcagcgc?caggcccctg?catccacttc?aacttcccct?ctccaagtcc?acgcatcaac?47340
ttcagcattc?ccccgaagat?ccctcctcag?tgcccttcac?atgcgactca?ctctcctatt?47400
tcctcctgct?cccagcggtc?accccaaacc?cagctccccc?acccagttcc?aaacccagaa?47460
agtcctcaga?tcccagcgtc?agacccagat?cctgagccca?aacacacccc?caaatagcct?47520
cccgcctccc?tccagcacag?atccaggatg?gggatccaag?ccgcactcct?ctcaaacccc?47580
ttcccgatcc?aggttggaaa?gggaggatcc?ccaccccaac?ccctcaaagg?aggggttccc?47640
ccttcttagc?acccagctcc?cgcggggcgg?agggggagca?gtcatcatta?ctttgagctg?47700
tgtctgacac?tgctgtataa?taatcctgag?gtgtcactaa?aaacccaaat?aaactctacg?47760
ttttcattct?gaattcctaa?tttactgcga?gacgctccac?ccaccttccc?tctgcgacgc?47820
caaaatgagc?tccagatttg?taattcttcc?tgtcagacta?gtcctttctt?cagacacaaa?47880
cacagccaag?gaggctgtta?cgtagaacag?agaatatttt?tccgcagaac?cttttaagga?47940
ggaaatttta?ttttctgtgt?catttgagct?tagaattaaa?taaaccttga?tagcaggaat?48000
cagaatggtt?ctgattaatg?ccaatttgtg?cactacttta?gagtcactgg?gtgagcattt?48060
tccccacctg?tgaaggcttc?cttccgggag?atgaaaaggg?aaaaggcgtg?gatattggag?48120
ctgggatctg?agacccgcgc?gctttctccc?tcctgtctag?gacacttact?taagcaagtc?48180
agctaacctt?tctgaacctc?caacaggctc?agaggcctgc?aacttgctct?acaccgcagc?48240
tccagcagcc?tcagcagcaa?actcccctct?tgctcaggct?gagggattcc?agagagatgg?48300
cttctggcag?gctccagtcc?caatttgccc?tctcagttcc?agtttcttca?atggagattt?48360
ggtggacttt?gtgccacctg?aggtccctag?actgcctttt?tgctgctcta?tttgcaatgt?48420
ctttcataag?ataagagcta?atgagatttt?tattgtatga?atgaatgaat?gatctcagaa?48480
agtgactgtt?tttctctggc?cattagcttc?ttcatctcta?aaatgtaaat?aataatagta?48540
cctaccccgt?ttataaataa?aagggattga?atcacttgtc?ttgggcccct?taaatgacgt?48600
aatgtgtctg?gtacagtgtc?tggaacatag?taaatattta?gctaatgcca?tttctttgcc?48660
catccccttc?cagctctgta?tgattctaat?cagcatgtat?gttcatgtca?gtctgtgcct?48720
ttgacgtacg?gagcctagat?taatcagtgt?taatcacacc?tccagttcct?taaca 48775

Claims (12)

1, a kind of have with SEQ ID NO 1 or SEQ ID NO 2 or SEQ ID NO94 or SEQ IDNO 95 or SEQ ID NO 96 comprise the oligonucleotide of the sequence that the subsequence at least 80% of 8 to 50 nucleotide bases is consistent and stand-in, variant, salt and the optical isomer of described sequence, it is characterized in that wherein said sequence can with comprise coding TGF-R or TGF-R IIThe transcription initiation of gene opening code-reading frame or the zone of terminator codon or for " ring " or " projection " and be not the coding TGF-R or the TGF-R of part secondary structure IIThe fully hybridization of mRNA zone.
2, a kind of SEQ of having ID NO 1 or SEQ ID NO 2 or SEQ ID NO 94 or SEQ I D NO95 or SEQ ID NO 96 comprise oligonucleotide and stand-in, variant, salt and the optical isomer of the subsequence of 8 to 50 nucleotide bases.
3, oligonucleotide according to claim 2 is characterized in that it is to be selected from the group that comprises SEQ IDNO 3 to SEQ ID NO 93.
4, oligonucleotide according to claim 3 is characterized in that it is to be selected from the group that comprises following sequence:
SEQ?ID?NO?3: 5′-CAGCCCCCGACCCATG-3′
SEQ?ID?NO?33:5′-CAGCCCCCGACCCATGGCAG-3′
SEQ?ID?NO?34:5′-CAGCCCCCGACCCATGGCA-3′
SEQ?ID?NO?35:5′-CAGCCCCCGACCCATGGC-3′
SEQ?ID?NO?36:5′-CAGCCCCCGACCCATGG-3′
SEQ?ID?NO?41:5′-GCAGCCCCCGACCCATGGCA-3′
SEQ?ID?NO?42:5′-GCAGCCCCCGACCCATGGC-3′
SEQ?ID?NO?43:5′-GCAGCCCCCGACCCATGG-3′
SEQ?ID?NO?44:5′-GCAGCCCCCGACCCATG-3′
SEQ?ID?NO?49:5′-AGCAGCCCCCGACCCATGGC-3′
SEQ?ID?NO?50:5′-AGCAGCCCCCGACCCATGG-3′
SEQ?ID?NO?51:5′-AGCAGCCCCCGACCCATG-3′
SEQ?ID?NO?56:5′-GAGCAGCCCCCGACCCATGG-3′
SEQ?ID?NO?57:5′-GAGCAGCCCCCGACCCATG-3′
SEQ?ID?NO?62:5′-TGAGCAGCCCCCGACCCATG-3′
SEQ?ID?NO?73:5′-ATGTGAAGATGGGCAAGACC-3′
SEQ?ID?NO?74:5′-ATCTCCATGTGAAGATGGGC-3′
SEQ?ID?NO?75:5′-AACGGCCTATCTCGAGGAAT-3′
SEQ?ID?NO?76:5′-AACATCGTCGAGCAATTTCC-3′
SEQ?ID?NO?77:5′-AATCCAACTCCTTTGCCCTT-3′
SEQ?ID?NO?78:5′-AAACCTGAGCCAGAACCTGA-3′
SEQ?ID?NO?79:5′-AGGGCGATCTAATGAAGGGT-3′
SEQ?ID?NO?80:5′-AGTGCACAGAAAGGACCCAC-3′
SEQ?ID?NO?81:5′-ACACTGGTCCAGCAATGACA-3′
SEQ?ID?NO?82:5′-TTCCTGTTGACTGAGTTGCG-3′
SEQ?ID?NO?83:5′-CACTCTGTGGTTTGGAGCAA-3′
SEQ?ID?NO?84:5′-CAAGGCCAGGTGATGACTTT-3′
SEQ?ID?NO?85:5′-CACACTGGTCCAGCAATGAC-3′
SEQ?ID?NO?86:5′-CTGACACCAACCAGAGCTGA-3′
SEQ?ID?NO?87:5′-CTCTGCCATCTGTTTGGGAT-3′
SEQ?ID?NO?88:5′-TCAAAAAGGGATCCATGCTC-3′
SEQ?ID?NO?89:5′-TGACACCAACCAGAGCTGAG-3′
SEQ?ID?NO?90:5′-TGATGCCTTCCTGTTGACTG-3′
SEQ?ID?NO?91:5′-TTCCTGTTGACTGAGTTGCG-3′
SEQ?ID?NO?92:5′-TTCTCCAAATCGACCTTTGC-3′
SEQ?ID?NO?93:5′-GGAGAGTTCAGGCAAAGCTG-3′。
5, a kind of pharmaceutical preparation, it is characterized in that it comprise at least a according to the described oligonucleotide of arbitrary claim among the claim 1-4 with and stand-in, variant, salt and optical isomer and/or at least a antisense compounds and at least a pharmaceutically acceptable supporting agent, vehicle or thinner, described antisense compounds is to be selected to comprise carrier and/or at least a the hybridization in coding TGF-R or TGF-R that allows to transcribe antisense oligonucleotide IITarget nucleic acid and suppress the group of ribozyme, external guide sequence (EGS), few enzyme and the shot-catalyst RNA or the catalytic oligonucleotide of its expression.
6, pharmaceutical preparation according to claim 5 is characterized in that wherein said pharmaceutical preparation is infusion solution or the solid substrate that is used for continuous release of active ingredients.
7,, it is characterized in that wherein said pharmaceutical preparation is suitable for topical administration to brain according to claim 5 or 6 described pharmaceutical preparations.
8, a kind of at least a according to the described oligonucleotide of arbitrary claim among the claim 1-4 with and stand-in and variant and/or at least a antisense compounds or be used to promote the injured nerve path successfully to regenerate and the functional purposes that is connected again according to the described pharmaceutical formulation of arbitrary claim in the claim 5 to 7, described antisense compounds is to be selected to comprise carrier and/or at least a the hybridization in coding TGF-R or TGF-R that allows to transcribe antisense oligonucleotide IITarget nucleic acid and suppress the group of ribozyme, external guide sequence (EGS), few enzyme and the shot-catalyst RNA or the catalytic oligonucleotide of its expression.
9, a kind of at least a according to the described oligonucleotide of arbitrary claim among the claim 1-4 with and stand-in and variant and/or at least a antisense compounds or be used for prophylactic treatment according to the described pharmaceutical formulation of arbitrary claim among the claim 5-7, treatment prevention and treatment nerve degeneration, after wound/wound, blood vessel/anoxic, neural inflammatory and infection back central nervous system disorders and age institute's inductive neural stem cell are upgraded the purposes that reduces, and it is characterized in that described antisense compounds is to be selected to comprise carrier and/or at least a the hybridization in coding TGF-R or TGF-R that allows to transcribe antisense oligonucleotide IITarget nucleic acid and suppress the group of ribozyme, external guide sequence (EGS), few enzyme and the shot-catalyst RNA or the catalytic oligonucleotide of its expression.
10, purposes according to claim 9 is characterized in that it is to be used for inhibition and rise or enhanced TGF-R and/or TGF-R IITGF-R and/or TGF-R in the disease that level is correlated with IIExpression.
11,, it is characterized in that wherein said and rise or enhanced TGF-R and/or TGF-R according to claim 9 or 10 described purposes IIDisease that level is relevant or described nerve degeneration illness and neural inflammatory conditions are to be selected to comprise following each sick group: Alzheimer's disease (Alzheimer ' s disease), Parkinson's disease (Parkinson ' s disease), storehouse Jia Shi disease (Creutzfeldt Jakobdisease, CJD), the neomorph of storehouse Jia Shi disease (new variant of Creutzfeldt Jakobsdisease, nvCJD), HallervordenSpatz Disease (Haliervorden Spatz disease), Huntington's disease (Huntington ' s disease), multiple system atrophy (MultisystemAtrophy), dull-witted, Frontemporal Dementia (Frontemporal Dementia) or other motor neuron illnesss, amyotrophic lateral sclerosis (Amyotrophic Lateral Sclerosis), spinal muscular atrophy (Spinal Muscular Atrophy), spinocerebellum atrophy (SpinocerebellarAtrophy, SCA), schizophrenia, affective disorder, severe melancholia (major depression), meningoencephalitis (meningoencephalitis), bacillary meningoencephalitis, viral meningoencephalitis, the central nervous system autoimmune disorder, multiple sclerosis (Multiple Sclerosis, MS), acute ischemic/anoxia-induced apoptosis (acute ischemic/hypoxic lesion), apoplexy, the central nervous system trauma of spinal cord of unifying, head and vertebra wound, arteriosclerosis, arteriosclerosis, microangiopathy dementia (microangiopathic dementia), binswanger (Binswanger ' disease) (leukoaraiosis (Leukoaraiosis)), retinal degeneration (retinaldegeneration), cochlea degeneration (cochlear degeneration), macular degeneration (maculardegeneration), cochlear deafness (cochlear deafness), acquired immune deficiency syndrome (AIDS) dependency dementia (AIDS-related dementia), retinitis pigmentosa (retinitis pigmentosa), vulnerability X-dependency is trembled/ataxia syndromes (fragile X-associatedtremor/ataxia syndrome, FXTAS), ophthalmic nerve nuclear paralysis disease (progressivesupranuclear palsy on the carrying out property, PSP), striatonigral degeneration (striatonigraldegeneration, SND), Nux Canarii albi pon cerebellum degeneration disease (olivopontocerebelleardegeneration, OPCD), shy dilatory person's syndromes (Shy Drager syndrome, SDS), age dependency lethe (age dependant memory deficit), dull-witted dependency neurodevelopment illness (neurodevelopmental disorders associated with dementia), Down's syndrome (Down ' s Syndrome), multisystem synapsin disease (synucleinopathy), superoxide-dismutase sudden change (Superoxide Dismutase Mutation), trinucleotide repeats illness (Trinucleotide Repeat Disorder), wound, anoxic, vascular disease, vascular inflammation, central nervous system is aging.
12, (a) TGF-R and/or TGF-R are disturbed in a kind of discriminating IIBiologic activity or TGF-R and/or TGF-R IIThe expression or (b) method of the compound that transmits of TGF-β 1/TGF-R signal, it is characterized in that said method comprising the steps of:
(a) candidate compound is cultivated with the test macro that comprises TGF-β 1 and neurone precursor cell; And
(b) propagation of active TGF receptor expression of calibrating or described neurone precursor cell;
Wherein
(c) compare with the described test macro that does not have described test compounds, (i) there is the candidate compound with the characteristic of wanting in the disappearance of the inhibition of active TGF expression of receptor or (ii) described neurone precursor cell inhibition of proliferation indication.
CN2005800098901A 2004-02-09 2005-02-09 Inhibitors of tgf-r signaling for treatment of cns disorders Expired - Fee Related CN1989244B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04002846.6 2004-02-09
EP04002846 2004-02-09
PCT/EP2005/001298 WO2005074981A2 (en) 2004-02-09 2005-02-09 Inhibitors of tgf-r signaling for treatment of cns disorders

Publications (2)

Publication Number Publication Date
CN1989244A true CN1989244A (en) 2007-06-27
CN1989244B CN1989244B (en) 2013-04-03

Family

ID=34833578

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2005800098901A Expired - Fee Related CN1989244B (en) 2004-02-09 2005-02-09 Inhibitors of tgf-r signaling for treatment of cns disorders

Country Status (16)

Country Link
US (2) US8022045B1 (en)
EP (1) EP1716235B1 (en)
JP (2) JP4712728B2 (en)
KR (1) KR100880371B1 (en)
CN (1) CN1989244B (en)
AU (1) AU2005210151B2 (en)
BR (1) BRPI0507528A (en)
CA (1) CA2555463C (en)
ES (1) ES2387593T3 (en)
IL (1) IL177320A (en)
MX (1) MXPA06008964A (en)
NZ (1) NZ548926A (en)
PL (1) PL1716235T3 (en)
RU (1) RU2385933C2 (en)
WO (1) WO2005074981A2 (en)
ZA (1) ZA200606460B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104004762A (en) * 2014-05-20 2014-08-27 南京医科大学附属南京儿童医院 TGF-R (Transforming Growth Factor-Receptor) antisense sequence and application thereof in preparing medicament for preventing airway inflammation reaction
CN107002082A (en) * 2014-11-16 2017-08-01 神经视觉医药有限公司 The inhibitor that ASON conducts as TGF R signals
CN110548132A (en) * 2019-10-24 2019-12-10 安徽医科大学附属巢湖医院 Application of TGF-beta 1 protein in preparation of medicine for treating depression
CN114854738A (en) * 2021-02-04 2022-08-05 纳肽得(青岛)生物医药有限公司 SiRNA for treating diseases associated with TGF beta 1 expression

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008109546A2 (en) * 2007-03-02 2008-09-12 Mdrna, Inc. Nucleic acid compounds for inhibiting tgfbr gene expression and uses thereof
EP2299812B1 (en) * 2008-05-27 2017-07-12 Yale University Targeting tgf-beta as a therapy for alzheimer's disease
JP2011236128A (en) * 2008-09-01 2011-11-24 Osaka Univ Central nervous system injury-treating agent
EP2389182A1 (en) * 2009-01-24 2011-11-30 Phytopharm PLC Treatment of neurotrophic factor mediated disorders
US9919011B2 (en) 2014-03-18 2018-03-20 Samsung Life Public Welfare Foundation Method for treating an inflammatory brain disease comprising administering a stem cell-derived exosome
US10436802B2 (en) 2014-09-12 2019-10-08 Biogen Ma Inc. Methods for treating spinal muscular atrophy
EP3280425B1 (en) 2015-04-07 2022-06-01 The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone Methods for inducing cell division of postmitotic cells
CN111836624A (en) 2018-01-12 2020-10-27 百时美施贵宝公司 Antisense oligonucleotides targeting alpha-synuclein and uses thereof
AU2022341090A1 (en) * 2021-09-12 2024-04-11 Gmp Biotechnology Limited Treatment of neurological disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993019783A1 (en) * 1992-04-01 1993-10-14 The Whittier Institute For Diabetes And Endocrinology Methods of inhibiting or enhancing scar formation in the cns
US5910488A (en) 1993-06-07 1999-06-08 Vical Incorporated Plasmids suitable for gene therapy
JPH11509088A (en) 1995-06-23 1999-08-17 プレジデント アンド フェローズ オブ ハーバード カレッジ Transcriptional regulation of the gene encoding vascular endothelial growth factor receptor
US20030064944A1 (en) * 2001-06-21 2003-04-03 Isis Pharmaceuticals Inc. Antisense modulation of transforming growth factor beta receptor II expression
KR100342942B1 (en) 1999-07-05 2002-07-02 민경윤 Oral micro-emulsion composition comprising Carduus marianus extract or silybin isolated therefrom
AU765928B2 (en) 1999-09-17 2003-10-02 Isis Pharmaceuticals, Inc. Antisense modulation of transforming growth factor-beta expression
EP1133988A1 (en) * 2000-03-11 2001-09-19 Biognostik Gesellschaft für biomolekulare Diagnostik mbH Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
KR20030056538A (en) 2001-12-28 2003-07-04 주식회사 웰진 EFFECTIVE INHIBITION OF TRANSFORMING GROWTH FACTOR-β1 BY A RIBBON-TYPE ANTISENSE OLIGONUCLEOTIDE
PT1590467E (en) 2003-01-28 2010-01-05 Hoffmann La Roche Use of regulatory sequences for specific, transient expression in neuronal determined cells

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104004762A (en) * 2014-05-20 2014-08-27 南京医科大学附属南京儿童医院 TGF-R (Transforming Growth Factor-Receptor) antisense sequence and application thereof in preparing medicament for preventing airway inflammation reaction
CN104004762B (en) * 2014-05-20 2016-03-30 南京医科大学附属南京儿童医院 TGF-R antisense sequences and the application in preparation anti-airways inflammatory reaction medicine thereof
CN107002082A (en) * 2014-11-16 2017-08-01 神经视觉医药有限公司 The inhibitor that ASON conducts as TGF R signals
CN110548132A (en) * 2019-10-24 2019-12-10 安徽医科大学附属巢湖医院 Application of TGF-beta 1 protein in preparation of medicine for treating depression
CN110548132B (en) * 2019-10-24 2023-04-25 安徽医科大学附属巢湖医院 Application of TGF-beta 1 protein in preparation of medicines for treating depression
CN114854738A (en) * 2021-02-04 2022-08-05 纳肽得(青岛)生物医药有限公司 SiRNA for treating diseases associated with TGF beta 1 expression

Also Published As

Publication number Publication date
BRPI0507528A (en) 2007-07-03
WO2005074981A8 (en) 2010-04-15
WO2005074981A2 (en) 2005-08-18
IL177320A (en) 2012-03-29
ZA200606460B (en) 2008-02-27
AU2005210151B2 (en) 2010-07-01
JP2007521815A (en) 2007-08-09
IL177320A0 (en) 2006-12-10
US20110263678A1 (en) 2011-10-27
JP4712728B2 (en) 2011-06-29
CA2555463C (en) 2013-05-14
EP1716235B1 (en) 2012-06-06
AU2005210151A1 (en) 2005-08-18
RU2385933C2 (en) 2010-04-10
PL1716235T3 (en) 2012-11-30
EP1716235A2 (en) 2006-11-02
NZ548926A (en) 2009-07-31
WO2005074981A3 (en) 2006-01-12
US8283334B2 (en) 2012-10-09
KR100880371B1 (en) 2009-01-30
US8022045B1 (en) 2011-09-20
MXPA06008964A (en) 2007-02-02
CN1989244B (en) 2013-04-03
ES2387593T3 (en) 2012-09-26
KR20070004695A (en) 2007-01-09
RU2006129326A (en) 2008-03-20
JP4848042B2 (en) 2011-12-28
CA2555463A1 (en) 2005-08-18
JP2011021023A (en) 2011-02-03

Similar Documents

Publication Publication Date Title
KR100880371B1 (en) Inhibitors of TGF-R signaling for treatment of CNS disorders
AU2020203573B2 (en) Oligonucleotides for inducing paternal UBE3A expression
AU2021261909B2 (en) Antisense oligomers for treatment of conditions and diseases
AU2017200759B2 (en) Modulation of androgen receptor expression
AU2016225852B2 (en) Modulation of alpha synuclein expression
KR102149571B1 (en) Compositions and methods for modulating growth hormone receptor expression
AU2018203564A1 (en) Antisense modulation of gccr expression
KR20210025055A (en) Compounds and methods for reducing LRRK2 expression
CN112080502A (en) Compositions for modulating expression of C9ORF72
KR20120099363A (en) Generation of induced pluripotent stem cells from cord blood
KR20210065125A (en) Compositions and methods for restoring paternal UBE3A gene expression in Angelman syndrome in humans
KR20220113743A (en) Antisense oligomers for the treatment of conditions and diseases
DK2809400T3 (en) COMBINATION THERAPY INCLUDING A GROWTH HORMON VARIANT AND AN OIGONUCLEOTIDE BINDING TO THE GROWTH HORMON RECEPTOR
KR20230043914A (en) Compounds and methods for reducing APP expression
CA2474759A1 (en) Gene for peripheral arterial occlusive disease
CN116157522A (en) Use of A1CF inhibitors for the treatment of hepatitis B virus infection
KR20230005933A (en) Compounds and methods that modulate ATXN1
US20030039968A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
TW202305132A (en) Antisense oligonucleotides for inhibiting alpha-synuclein expression
CN110559440A (en) Application of active substance targeting CDC40 gene nucleotide sequence in preparation of medicine for treating liver disease
KR20230095056A (en) Compositions and methods for treating disorders associated with loss-of-function mutations in SCN2A
US20030224393A1 (en) Gene for peripheral arterial occlusive disease
CN111556894A (en) Oligonucleotides for modulating GSK3B expression

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: AIGNER LU DEWEI

Owner name: BO GEDAN YURI

Free format text: FORMER OWNER: REGENION GMBH

Effective date: 20100809

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: APPENZELL, SWITZERLAND TO: NO.27, BAPTAILIKE, REEKER, REGENSBURG, GERMANY

TA01 Transfer of patent application right

Effective date of registration: 20100809

Address after: Regensburg Taibao Reeker No. 27 in Germany

Applicant after: Bai Gedan

Co-applicant after: Ai Gena

Applicant after: You Li

Co-applicant after: Lu Dewei

Address before: Suzhou, Switzerland

Applicant before: Regenion GmbH

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130403

Termination date: 20190209

CF01 Termination of patent right due to non-payment of annual fee